Cytotoxicity testing in vitro: investigation of 5 miniaturized, colorimetric assays by Martin, Angela J.
CYTOTOXICITY TESTING IN VITRO: 
INVESTIGATION OF 5 MINIATURIZED, 
COLORIMETRIC ASSAYS.
Angela J. Martin
A thesis presented for the degree of Ph.D.
The experimental work described in this thesis was carried
out under the supervision of Professor Martin Clynes.
National Cell and Tissue Culture Centre/ BioResearch Ireland, 
School of Biological Sciences,
Dublin City University,
Dublin 9.
I declare that the work described in this thesis is entirely my 
own work, and has not been previously submitted for a degree at 
this or any other University.
Angela J. Martin.
FOR MY MOTHER...
Here
It
s to:
the way forward
ABSTRACT
Recent years have seen the development of miniaturized, colorimetric 
assays for quantification of cell growth, and their use in toxixity 
testing has grown. These methods offer significant advantages (speed, 
ease of performance, sensitivity and better use of resources) over
previously used methods such as the Stem Cell Assay or determination 
of DNA, RNA or protein synthesis. At present many such assays are
used in many different areas of toxixity testing. This thesis 
undertook to compare 5 such assays in detail, and assess their
performance in terms of linearity, sensitivity, precision,
reproducibility and ease of performance. An Acid Phosphatase (AP)
assay, not previously applied to toxicity testing, was developed and 
validated against some commonly used assays (Neutral Red (NR), MTT, 
and staining with Crystal Violet and Sulforhodamine B), where it was 
found to offer the best combinataion of sensitivity, ease of 
performance, reproducibility and versatility. It was later applied to 
quantification of growth in serum batch testing, and in determination 
of cytotoxicity in screening for new drugs, assessment of Multiple 
Drug Resistance, and screening for toxicity in samples of 
environmental relevance, including industrial sludges and wastewaters.
While results from the ecotoxicity tests were found to correlate with
invertebrate tests, difficultues with sample preparation and absence 
of biotransformation ability were identified.
The MTT assay, exhaustatively used in the literature, was found to be 
least favourable of all the methods compared in this work, due to its 
low sensitivity and technical difficulties. It was established that 
problems with reproducibility of these assays do exist, identifying 
the need to consider 1C$q values as guide values only, and not as 
absolute values.
Activity in each of these assays was found to vary when cells were 
grown under different conditions, (AP levels per cell increased in 
starved cultures). The NR assay however, was less prone to variation 
in activity than any of the other methods. Investigation into 
differences in assay response to chemicals with mechanisms related to 
their own mechanism of action showed that after 6 days' exposure to a 
range of relevant chemicals, no bias in assay ability to detect 
toxicity was evident. Conditions where each of these assays 
underestimated cell death were identified; after 1 or 2 days exposure
to low concentrations of Vinblastine, the methods (and also trypan 
blue exclusion) did not register cell death in cells which were shown 
to be nonviable by cloning studies*
A number of factors which significantly influence the i c^q were 
identified. Increasing cell seeding density had a masking effect on 
drug toxicity, while increased drug exposure time and assay duration 
resulted in greater cell kill (as expected). Small variations in 
pretreatment regime and trypsinization time prior to drug exposure 
did not significantly affect cellular response to drug.
Attempts made to improve culture conditions for lung tumour biopsies 
resulted in identification of a number of factors which must be 
optimized before individualized chemosensitivity testing can have an 
impact on selection of treatment regimes, and ultimately prognosis.
1
7
13
16
24
27
30
31
32
34
35
36
37
38
39
40
42
44
48
50
53
55
57
58
59
60
61
63
64
65
66
TABLE OF CONTENTS
INTRODUCTION
Toxicology and toxicity testing of chemicals
The dose response relationship
In vivo versus in vitro toxicity testing
Some important considerations in toxicity testing
In vitro toxicity tests
Tissue specific toxicity tests
Carcinogenicity and genotoxicity
Embryotoxicity/ teratogenicity
Reproductive toxicity
General cytotoxicity tests
Endpoints for in vitro toxicity testing
Assays for colony formation
Dye exclusion assays
Other tests for membrane integrity
Dye inclusion assays
Chromium release assays
Other release assays
Chromium uptake
Enzyme leakage tests
ATP (Adenosine TriPhosphate) assays 
Assays of respiration and glycolysis 
Determination of metabolites in culture medium 
Determination of protein synthesis and nucleic 
acid synthesis
Determination of intracellular enzyme activity 
Colorimetric assays 
Fluorometric assays 
Aim of this project
MATERIALS AND METHODS 
Safety
Maintainence of sterility 
Growth surface 
Media preparation 
Glassware 
Ultrapure water 
Bottles 
Liquid media 
Powdered media 
pH
Sterility checks
L-glutamine
Serum
Antibiotics
Incubators
Thawing frozen stocks 
Feeding cells 
Subculturing 
Counting cells 
Freezing cells 
Prevention of contamination 
Mycoplasma
Cross contamination by other cell lines 
Pretreatment of cells for experiments 
Preparation of cell suspension for experiments 
Plating of cell suspension 
Storage of cytotoxic agents
2.17
2.18
2.19
2 . 2 0  
2.21 
2 .22
2.23
2.24
2.25
2.26
2.27
2.28
2.29
2.30
2.31
2.32
2.33
2.34
2.35
2.36
2.37
2.38
2.39 
2 .40
2.41
2.41.1
2.41.2
2.41 .3
2.41 .4
2.41 .5 
2 .41 .6
2.41.7
2.41.8
2.41.8.1
2.41.8.2
2.41.8.3
2.41.9 
2 .41 .10
2.41.10.1
2.41.10.2
3.
3.1
3.1.1
3.1.2
3.1.3
3.1.4
3.1.5
3.2 
3.2.1
3.2 .1.1
3.2.1.2 
3 .2.1.3 
3.2.1.4 
3 .2 .2
3.2.3
3.2.4
Toxicity tests
Cell counting experiments to determine assay 
linearity and sensitivity
Pipetting 67
Monolayer staining with crystal violet 
Image analysis 
Colorimetric assays
Crystal violet dye elution (CVDE) 68
Neutral Red (NR) assay 69
MTT assay 70
MTT assay/ SDS modification
Sulforhodamine B (SRB) assay 71
Acid Phosphatase (AP) assay 72
Relationship between assay performance and growth 
status of cell 73
Ability of colorimetric assays to assess cell 
viability after treatment with cytotoxic agents 
Relationship between endpoints and mechanism 
of action 74
Determination of DNA synthesis
Determination of RNA synthesis 75
Determination of protein synthesis
Miniaturized serum batch testing
Culture of drug-resistant lines
Toxicity testing of landfill leachates
Toxicity testing of chemical sludges 76
Toxicity testing of industrial wastewaters 77
Analysis of results 
Primary culture
Sample collection 
Sample storage 
Sample dissection 
Explants
Enzymatic disaggregation
Dissection medium (DM) 78
Isolation of blood cells 
Primary culture assays 
Density assays
Basal media assays 79
Serum batch testing 
Maintainence of primary culture 
Fibroblast removal 
Trypsin/ EDTA 
Geneticin treatment
RESULTS:
Comparison of assays
Image Analysis 81
Cell distribution on the plate 
Staining
Instrument settings
Applicability to different cell lines 83
Ease of performance/ technical limitations 85
MTT assay 86
Optimization
Formazan solubilization 
MTT concentration 
Storage of MTT
Outer wells of 96-well plate 87
Relationship between cell number and MTT OD 
Detection level 95
Linearity 96
3.2.5 Sensitivity
3.2.6 Ease of performance/ technical flaws
3.2.7 Applicability to a range of cell lines
3.3 MTT assay/ SDS modification
3.3.1 Relationship between cell number and OD in SDS
modification of the MTT assay
3.3.2 Detection level
3.3.3 Linearity
3.3.4 Sensitivity
3.3.5 Ease of performance/ technical flaws
3.3.6 Application to a range of cell lines
3.4 Crystal Violet Dye Elution (CVDE) assay
3.4.2 Plate rinsing
3.4.2 Relationship between cell number and O.D. in
CVDE assay
3.4.3 Detection level
3.4.4 Linear range
3.4.5 Sensitivity
3.4.6 Ease of performance/ technical flaws
3.4.7 Applicability to a range of cell lines
3.45 Neutral Red (NR) assay
3.5.1 Optimization
3.5.1.1 Effect of serum in incubation medium
3.5.1.2 Removal of crystals from dye medium
3.5.2 Relationship between cell number and O.D. in NR
assay
3.5.3 Limit of detection
3.5.4 Linearity
3.5.5 Sensitivity
3.6 Sulforhodamine B (SRB) assay
3.6.1 Relationship between cell number and O.D. in
SRB assay
3.6.2 Detection level
3.6.3 Linear range
3.6.4 Sensitivity
3.6.5 Ease of performance/ technical flaws
3.6.6 Applicability to a range of cell lines
3.7 Acid Phosphatase (AP) assay
3.7.1 Optimization
3.7.1.1 Storage of buffer for AP assay
3.7.1.2. pH of incubation buffer
3.7.1.3 Elimination of bubbles before reading
3.7.2 Relationship between cell number and O.D. in
AP assay
3.7.3 Detection level
3.7.4 Linear range
3.7.5 Sensitivity
3.7.6 Ease of performance/ technical flaws
3.7.7 Applicability to a range of cell lines
3.8 Effect of increased incubation time on AP assay
activity
3.8.1 Minimum detectable cell number
3.8.2 Linearity
3.8.3 Sensitivity
3.9 Effect of NaOH addition on AP assay
3.9.1 Relationship between cell number and O.D. in
the APNaOH assay
97
98
99
102
103
104
110
111
112
113
121
122
123
124
127
128
129
131
139
140
141
142
145
147
3.9.2
3.9.3
3.9.4
3.9.5
3.9.6
3.10
3.10.1
3.10.2
3.10.3
3.10 .4
3.10.5
3.10.6
3.10.7
3.11
3.12
3.13
3.14
3.14.1
3.14.2
3.14 .3
3.14.4
3.14.5
4.
4.1
4.1.1
4.1.2
4.1.3
4.1.4 
4 .1.5
4.1.6
4 .2
4.3
4.4
4.5
5.
5.1 
5 .2
5.3
5.4
5.5
5.6
5.7
5.8
Minimum detectable cell number
Linear range
Sensitivity
Ease of performance/ technical flaws
Addition of different volumes and concentrations
of NaOH
Comparison of the characteristics of the assays 
Minimum detectable cell number 
Sensitivity of various methods 
Linear range 
Precision 
Reproducibility 
Ease of performance
Applicability to a range of cell lines
Relationship between assay activity and status 
of cell
Relationship of endpoint to assessment of cell 
viability after exposure to anticancer agents 
Relationship between endpoint and mechanism of 
action
Application of growth assays to chemosensitivity 
testing: factors affecting 
Preatment regime 
Length of exposure to trypsin 
Effect of cell density on drug sensitivity 
Effect of drug exposure regime on drug 
sensitivity
Duration of toxicity assay
RESULTS:
Applications of assays
Serum batch testing with miniaturized, 
colorimetric endpoints
General considerations of serum batch testing 
Practical/ technical significance of batch 
testing using the AP assay 
Significance of cell density 
Comparison of AP assay with IA 
Differential response of cell lines to serum 
batches: can the AP assay detect this? 
Comparison of the performance of the AP assay 
to other miniaturized, colorimetric assays
Toxicity testing of industrial sludges 
Toxicity assessment of landfill leachates 
Screening for efficacy of new drugs 
Rapid assessment of Multiple Drug Resistance
RESULTS:
Primary culture of bronchial tumours
Collection and culture of samples 
Growth of sample subsets in culture 
Sample quality
Success of various processing methods 
Collection medium as a source of cells 
Explant growth
Dissection medium as a source of cells 
Enzyme disaggregation
150
151
152
153 
155
157
158 
168 
169
171 
1 76 
188 
197
200
203
205
207
208 
2 10
213
221
223
225
230
234
243
245
246
247
248
5.9 Blood cells and cell debris
5.10 Fate of epithelial cultures 249
5.11 Effect of cell density on culture proliferation 250
5.12 Effect of basal media on culture growth 253
5.13 Effect of different serum batches on culture
growth 256
5.14 Effect of growth factors on culture growth 259
5 .15 Significance of fibroblast growth 262
5.15.1 Treatment with trypsin and EDTA 264
5.14.2 Treatment with Geneticin 265
6. DISCUSSION
6.1 In vitro toxicity testina 268
6.2 Use of cell cultures of cytotoxicity testing
6.3 Selection of cell type for cytotoxicity testing 270
6.4 In vitro biotransformantion of xenobiotics 271
6.5 Choice of endpoint for cytotoxicity testing 275
6.6 Image analysis as a method for growth analysis 278
6.7 Optimization of the MTT assay 279
6.8 Relationship of cell number with O.D. in MTT
assay 280
6.9 Technical problems of the MTT assay and
applicability to different cell lines 283
6.10 Relationship between cell number and O.D. in
CVDE assay 285
6.11 Techncial problems of the CVDE assay and
applicability to a range of cell lines 286
6.12 Relationship between cell number and O.D. in
the NR assay
6.13 Technical problems and applicability to a range of
cell lines 287
6.14 Relationship between cell number and O.D. in the 
SRB assay
6.15 Technical problems and applicability to a range
of cell lines 288
6.16 Relationship of cell number with AP activity 289
6.17 Technical problems of the AP assay, and
applicability to a range of cell lines 291
6.18 Comparison of the performance of the methods
6.19 Relationship between assay activity and condition
of cell 298
6.20 Relationship between assay activity and cell
viability after exposure to anticancer agent 302
6.21 Relationship of endpoint performance to mechanism
of action of cytotoxin 306
6 .22 Factors affecting IC$q 310
6.23 Serum batch testing with miniaturized assays 313
6.24 Application to environmental monitoring 316
6.25 Screening for cyto-toxicity in industrial sludges 317
6.26 Screening for toxiciy in landfill leachates 321
6.27 Potential applications for cell cultures in
environmental toxicity testing 326
6.28 Problems with using cell cultures in screening of
environmental compounds 331
6 .29 Screening of new drugs 332
3.31 Rapid assessment of Multiple Drug Resistance 335
3.32 Usefulness of miniaturized assays for
chemosensitivity testing 339
6.32 Relevance of chemosensitivity testing 343
6.33 Primary culture of bronchial tumours 344
6.34 Success of various processing methods 351
6.35 Fibroblast removal 352
CONCLUSIONS
RECOMMENDATIONS 
ACKNOWLEDGEMENTS 
REFERENCES
APPENDIX A: Calculations
APPENDIX B: Molecular structures of chemicals 
APPENDIX C: Conversion of MTT to MTT formazan 
APPENDIX D: Abbreviations
INTRODUCTION
1.1 Toxicology and toxicity testing of chemicals
In considering the wide area of toxicity testing, it is worthwhile to 
firstly familiarise ourselves with some important concepts and 
definitions.
A typical definition of toxicology is that used by Klaassen [1986], 
which defines toxicology as:
"..the study of the adverse effects of chemicals on living organisms".
Virtually every known compound has the potential to cause death due to 
toxicity if given in sufficient quantities. Similarly any chemical 
can be permitted to come in contact with a biological mechanism 
without producing an adverse effect, provided the concentration is 
below a minimal effective level [Loomis, 1978]. In toxicology 
therefore, it is not simply the characteristics of the compound 
itself, but the dose at which it is administered which is important in 
distinguishing between compounds that are known as safe and those 
regarded as toxic. We can sum this up by the following quote by 
Paracelsus (1493-1541), who is considered to be the father of the 
science of toxicology:
"All substances are poisons; there is none which is not a poison. The 
right dose differentiates a poison and a remedy".
Toxicology does not endeavour to determine whether a compound is toxic 
or not (since all compounds are potential toxins), but to determine 
the degree and nature of toxicity which the compound is capable of 
causing. To this end, toxicology involves investigations into 
mechanisms of actions of toxicants. Toxicity is a relative property 
of a chemical, and may be directly or indirectly desirable or 
undesirable as far as man is concerned, but always refers to a harmful 
effect on some biological mechanism [Loomis, 1978].
One of the key elements in toxicology is to determine the safety of a 
chemical. Safety itself cannot be demonstrated experimentally. 
Rather, the degree of unsafeness (hazard) associated with a chemical
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can be demonstrated, and its safety ascertained from this [James,
1985]. Thus there are two important concepts here; safety and risk. 
They are inextricably linked. Risk is the probability that a 
substance will produce harm under specified conditions. Thus we note 
that toxicology is essentially a predictive science and is primarily 
about making risk assessments on compounds [Leslie and Johnson, 1987]. 
In order to do this we make use of many different systems to assess 
the toxicity of chemicals.
The currently accepted method for chemical toxicity testing 
(scientifically and legally) is by administration to animals (in vivo) 
[Ryan and Me Sweeney, 1986]. Much effort however, is being 
channelled into the development and use of in vitro tests
(experimental tests not involving whole animals).
The degree of toxicity elicited is dependent on a number of factors. 
Firstly it depends on the chemical and physical properties of the 
agent; secondly it depends on the exposure of the chemical to the 
organism, both in terms of dose and method of administration; 
thirdly, on the biochemical reactions that occur in the organism; and 
fourthly, on the susceptibility of the organism to the chemical.
Susceptibility can vary among individuals as well as among species. 
This latter consideration means that precision is necessary in 
reporting data from a toxicological evaluation, and also implies that 
this data must not be taken out of context and applied 
indiscriminately to any situation.
Among the interactions that a chemical may take part in before
producing a toxic response at the site of action, are protein binding, 
biotransformation and excretion.
We have already noted that exposure is an important phenomenon. It is 
a factor of the physical state of the agent itself (e.g. liquid, gas, 
particle size, solubility), and of the environment in which the 
chemical presents itself to the organism (air, water, food etc.,). 
Toxic agents can gain access to the body through a number of routes, 
including ingestion (the gastrointestinal tract), inhalation (by
2
lungs), topically (exposure to the skin) or by parenteral methods 
(injection). The route of administration can measurably influence the 
toxicity of the agent [Loomis, 1978]. Duration and frequency of 
exposure are usually used to define 4 different categories of exposure 
for experimental toxicology in vivo (outlined in more detail in 
Klaassen [1986]).
A single, short term exposure (normally for less than 24 hours) is 
known as an acute exposure, although repeated exposures may be given 
within the same 24 hour period for chemicals with only slight 
toxicity.
The other categories of exposure all refer to repeated 
administrations.
Sub-acute exposure is the repeated exposure to a chemical for one 
month or less.
Sub-chronic exposure is generally for less than 3 months, and chronic 
exposure is generally for more than 3 months. These repeated 
exposures can be by any route of administration, but are generally by 
the oral route (given in diet of the test animal).
The effects produced by a single exposure are generally quite 
different to those which result from repeated exposures, so in 
defining the toxicity of a chemical from toxicity testing results, the 
frequency, duration and method of exposure are all determining 
factors, and should always be reported.
It should be appreciated therefore, that characterizion of the toxic 
effects of a chemical is not a simple matter. It becomes even further 
complicated when we consider what happens (toxicologically) when 
chemicals interact with each other. One of the following outcomes can 
occur:
Synergism, where the combined effect of the chemicals is greater than 
the sum of the individual effects of the chemicals.
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Potentiation. This is what occurs when one substance, given alone 
does not effect toxicity, but when given in combination with another 
agent, makes the second agent much more toxic.
Antagonism occurs when a number of chemicals, administered together, 
interfere with the action of one another and results in reduced 
overall toxicity than if the agents were given singly.
Another aspect of the toxic response is tolerance, which is a state of 
decreased responsiveness to the toxicity of a chemical. It results 
from prior exposure to that, or a structurally related, chemical. It 
may be due to a decreased amount of toxicant reaching the site of 
action, to a reduced responsiveness of a tissue to the chemical, or 
to increased catabolism of the chemical.
In 1938 in the USA, a drug (elixer of sulfanilamide) was associated 
with the death of 107 people. This led to the Federal Food, Drug and 
Cosmetic act, which required submission of New Drug Applications to 
provide premarketing assurance, and permitted the FDA (Food and Drugs 
Administration) to inspect factories [Anello, 1984]. After the 
Thalidomide disaster in Europe in the early 1960's, world attention 
was drawn to the importance of toxicity testing. This culminated in 
the establishment of more formal toxicological evaluation procedures 
and prompted the U.S. Congress to ammend the Act mentioned above, to 
provide for premarketing approval by FDA and to require drug 
manufacturers to establish efficacy and safety of a product before 
marketing.
With a new substance, the customary starting point in a toxicologic 
evaluation uses lethality as an index. Measurement of lethality is 
precise, quantal and unequivocal. It provides a measure of 
comparison among many substances whose mechanism and site of action 
may be markedly different [Klaassen, 1986], A key element must be 
careful, disciplined, detailed observation of the intact organism 
extending from the time of administration to death of the test 
organism. By histologic examination of major tissues and organs, 
lethal effects, target organs involved and a suggestion of mechanism 
of toxicity, may be obtained. Thus Acute lethality tests are the
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first toxicity tests to be performed on a new chemical. The median 
lethal dose (LD^q ) and other acute toxic effects are determined after 
one or more routes of administration in one or more species. The LDgg 
test has become a public issue because of increasing concern for the 
welfare and protection of laboratory animals, although many would 
argue that it is essential for characterizing the toxic effects of 
chemicals and thus determining their hazard to humans. When exposure 
is by air or by water (for example with fish), the dose received is 
usually not known, and thus the Lethal Concentration-50 (LCj-q ) is 
usually determined, that is the concentration of chemical in the air 
or water that causes death to 50% of the animals. When reporting an 
LCgQ, it is imperative that the duration of exposure be indicated.
In LDgQ determinations, the number of animals that die in a 14 day 
period after a single dosage, is ascertained. In addition to 
mortality and weight, periodic examination of test animals should be 
conducted for signs of intoxication, lethargy, behavioral 
modifications, morbidity etc. Acute dermal exposure or acute 
inhalation experiments are performed if there is a reasonable risk of 
such exposure occuring in routine use of the chemical.
Other acute tests such as skin and eye irritation testing are carried 
out and are usually performed in rabbits. Fur is removed and the skin 
is exposed to chemical for 4 hours. For ocular irritation, the 
chemical is instilled into one eye, the other serving as a control, 
and both eyes are examined at various times after application (Draize 
test) [Draize et al., 1944].
Subacute tests are typically performed at 4 different dosages given in 
the animals' feed. Repeated doses are performed for 14 days, after 
which clinical chemistry and histopathology are performed [Klaassen,
1986] .
Subchronic exposure can last for different periods but 90 days is the 
most common test duration and is usually performed in rat and dog by 
the route intended. At least 3 doses are generally used. Observations 
include mortality, body weight changes, diet consumption, 
pharmacologic and toxicologic signs, hematology and blood chemistry 
measurements. Hematology and blood chemistry are usually performed 
prior to, during and at the end of exposure.
5
Then the agent can be filed with the FDA and if approved, clinical 
trials carried out in 3 phases can commense.
These studies in humans involve:
Phase I: clinical pharmacology which focuses on dose levels,
pharmacokinetics and safety
Phase II: closely monitored clincal trials with an aim of
establishing efficacy and identifying overt and unusual toxicities, 
and
Phase III: additional clinical trials aimed at better defining
efficacy and identifying the less common adverse effects [Anello,
1984].
While these are being performed, chronic exposure of the animals to 
the test compound can be carried out in laboratory animals as well as 
additional specialized tests. They depend to a certain extent on the 
product (e.g., oral or paraenteral route of administration).
Chronic or long term exposure studies are performed similarly to the 
subchronic studies, except that the period of exposure is longer, and 
is dependent on the intended period of exposure in humans. For a 
planned short term use, a chronic exposure of 6 months might be 
sufficient, whereas for a food additive with the potential lifetime 
exposure in humans, then a chronic study up to 2 years in duration is 
likely to be required. These studies are often used to determine the 
carcinogenic potential of chemicals and are usually in rats and mice 
over the average lifetime of the species (2 years for a rat). Both 
gross and microscopic pathological examinations are made on all test 
animals, including those that die early.
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1.2 The dose response relationship
In the measurement of the toxic response, the most fundamental 
concept to be understood is that of the dose-response relationship. 
In utilizing this relationship in toxicological studies, we are 
making a number of assumptions. These assumptions, considered more 
extensively in Klaassen [1986], are as follows:
1. The response obtained is due to the chemical administered
2. The response obtained is related to the dose given. This itself
is based on 3 sub-assumptions:
a) the dose administered relates to the concentration at the reactive
site
b) the concentration of the agent at the reactive site relates to the 
response (and the degree of response)
c) the response is produced by the interaction of the chemical with a 
molecular or receptor site(s)
3. There is a quantifiable method of measuring and a precise means of 
expressing the toxicity.
It is this latter point with which this thesis is mainly concerned.
1.3 In vivo versus in vitro toxicity testing
In vivo testing is considered to be the ultimate testing system for 
toxicity because it has a number of important merits lacking in in 
vitro systems. The most important of these are outlined below:
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(a) The whole system can be examined:
unlike in vitro tests, a complete range of parameters may be 
measured and the interrelationships beteween these paramaters can be 
studied, e.g., hepatoxicity, nephrotoxicity, neurotoxicity, 
immunotoxicity, teratogenicity, temperature changes, blood pressure 
etc.
(b) Secondary organ involvement can also be ascertained and side 
effects can be established.
(c) Organ specificity can be determined to identify target organs.
(d) Blood levels, distribution and excretion are important in 
determining the fate of the chemical when it enters the bloodstream, 
and the actual dose that is available at a site to exert its toxicity. 
This is also important in revealing information about bioavailability 
and bioaccumulation of compounds, which cannot be detected in vitro.
(e) Tumorigenicity can be established using in vivo systems.
(f) The presence of a functional metabolizing system which is involved 
in many biotransformation reactions to modify the toxicity of a 
chemical. The relevance of this must be appreciated when we consider 
that some chemicals (cycophosphimide for example) are not toxic in 
themselves, but when modified by certain mixed function oxidase 
enzymes concentrated in the microsomes of cells (particularly in the 
liver), can exert toxic action [Shrivastav et al., 1980], The 
inverse of this is also true; a compound known to be toxic can be 
detoxified by this system and then excreted from the animal. Some of 
the more important aspects of biotransformation are described below.
In biotransformation, two distinct types of reactions are involved. 
They are described as phase I and phase II reactions. Phase I 
reactions involve oxidation, reduction and hydrolysis, and serve to 
make the xenobiotic more water-soluble and thus more suitable for 
excretion. Phase II reactions are conjugation reactions which involve 
the substitution of different functional groups on the xenobiotic 
causing it to become more lipophobic (water soluble). Phase I
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reactions may occasionally produce metabolites that are somewhat less 
water-soluble than the parent. However, such metabolites are 
presumably then more susceptible to phase II transformations, which 
then result in greater water solubility and excretability [O'Flaherty,
1985].
In the phase I reactions, the enzyme system of most importance is the 
group of mono-oxygenases containing cytochrome P-450. Two enzymes are 
involved in this system which together insert one atom from molecular 
oxygen into the substrate, while the other oxygen atom, in combination 
with two protons, is reduced to water. The enzyme systems involved 
are: NADPH (Nicotinamide adenine dinucleotide phosphate) cytochrome
P-450 reductase, and the cytochrome P-450 itself (which in fact, is 
not a single enzyme, but a family of isoenzymes with different but 
frequently overlapping specificities). These cytochrome P-450 enzymes 
have been found in all species of animals investigated and also in 
plants. Predominantly found in the liver endoplasmic reticulum, they 
have also been found in the endoplasmic reticulum of lung, intestinal 
tract wall, kidney, skin, brain and other tissues. While they mostly 
produce metabolites that are less toxic than the parent compound, the 
reverse can also be true. This is seen by the production of epoxides, 
particularly those of aromatic hydrocarbons, believed to be 
responsible for mutagenic or carcinogenic effects of these 
hydrocarbons [O'Flaherty, 1985],
Other reactions catalysed by monooxygenases containing cytochrome 
P-450 are; N-, 0-, or S-dealkylation; aromatic and aliphatic
hydroxylation; sulfoxidation; and desulphuration. Amine oxidase, 
epoxide hydratases and dehydrogenases are other important oxidases. 
Esterases and amidases, found in most tissues including the blood, 
are responsible for hydrolysis. These enzymes are fairly nonspecific 
with regard to their substrate requirements [O' Flaherty, 1985].
Conjugation (phase II) reactions are numerous, but perhaps the most 
important in humans is glucuronidation. The enzyme involved here is 
glucuronyl transferase, which synthesises glucuronides from 
uridine-51 -diphospho-a-D-glucuronic acid. The glucuronic acid can be 
conjugated to a number of compounds, including aliphatic and aromatic 
alcohols, mercaptans, certain acids, primary and secondary 
aliphatic and aromatic amines. Another important phase II reaction is
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catalysed by the enzyme Glutathione S-transferase, which attaches a 
molecule of glutathione (a tripeptide) to the substrate by a thioether 
bond. Then two amino acids are lost from the conjugate. Finally, an 
acetyl group is added to form a mercapturic acid derivative. This 
reaction requires that the substrate carries an electrophilic carbon, 
so highly potent metabolites such as epoxides can be rendered 
harmless. Xenobiotics may also be conjugated to the amino acids 
glutamine and glycine, or they may be sulfated, methylated, or 
acetylated. The enzymes involved in these transormations are found in 
the endoplasmic reticulum, the mitochondria or the cytoplasm of the 
cell.
In vivo tests however are not completely satisfactory. There are a 
number of problems associated with this form of testing, including the 
following:
(a) Ethical considerations represent a factor becoming increasingly 
important due to by remonstrations by animal rights activist groups, 
and an increasing concern by the general public over cruelty to 
animals. Certainly some of the tests are deserving of such concern; 
the classical example being the Draize eye test for irritancy, 
already described in 1 .1 .
(b) Time:
toxicity trials using live animals can take a number of years to 
complete.
(c) High cost of testing:
maintainence of animals, personnel, etc., on a long term basis.
(d) Expertise/ specialized facilities:
in addition to cost, the technical facilities and expertise may just 
not be available.
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(e) Statistical limitations:
due to the factors already mentioned, the trials are limited by the 
number of animals which can be used, but this has serious statistical 
limitations in terms of detecting low level incidence of effects.
(f) Extrapolation problems:
exact homology does not exist in the extent of toxicity of chemicals 
to different species; some are more susceptible to certain chemicals 
than others. This places limitations on the extrapolation of toxicity 
data from test animals to man.
(g) Individual variation:
variations in sex, age, weight, genetic background etc., all make it 
difficult to extrapolate from the data derived from a relatively small 
number of test individuals.
In recent years there has been increasing pressure on governments and 
industry to reduce the use of animals in research [Ryan and Me 
Sweeney, 1986]. There has been with this, a concomitant demand for 
methods which will model human metabolism more precisely.
Some options for reducing animal useage, conveniently denoted as the 3 
R's are oultlined below:
Reduction of numbers of animals used
Refinement of tests to reduce animal suffering
Replacement of animal tests
These can be accomplished by:
a) simplification of test procedures and protocols to reduce numbers
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of animals used; e.g., removal of LD^q test. In practice the test 
is of little use, but it does use large numbers of animals. It may 
often be equally relevant to use an LE>^ q test.
b) use of invertebrates or other lower-order animals instead of 
animals. A problem associated with these, is that often their 
physiology and metabolism are very different from man. However they 
may be useful indicators of toxicity in some cases, and in further 
instances they may be a more relevant test organism to use, e.g., for 
ecotoxicity testing, where these organisms ordinarily live in the 
ecosystem which will be affected, or for pesticides and fertilizers, 
whose effect on these organisms may indirectly effect the entire food 
web.
c) use of computer modelling and structure-activity analysis. This is 
a form of predictive toxicology and requires a large amount of 
imformation already available on the test chemical. Where no such 
information is available, such methods are of limited use.
d) in vitro (cell culture-based) tests, which have some advantages, 
for example
* speed
* reduced cost
* more potential for replication
* simplicity
* potential for automation
* tests using human tissue may be more relevant than some in vivo 
animal tests
However there are barriers to the development and use of in vitro 
tests because:
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a) they are not technically advanced enough yet, to replace animal 
tests
b) even if the above is achieved, there are many legislative barriers 
which will prevent/ greatly delay the replacement of in vivo tests. 
An issue of extreme importance here is the lack of adequate validation 
of existing in vitro techniques, which is said to be more difficult 
than assay development itself [Ekwall et al., 1991].
It is probable that there will always be a need for in vivo tests, 
but their use could be substantially reduced [Goldberg, 1986].
1.4 Some important considerations in toxicity testing
In beginning a toxicity testing programme there are a number of 
important considerations which must be addressed before deciding on a 
programme to use.
Probably the most common reason for wishing to carry out a toxicity 
test, is to demonstrate low toxicity of a new chemical or drug, or 
to demonstrate the efficacy of chemicals with a desired toxicity (e.g. 
pesticides, anticancer agents). In these cases it is necessary to 
consider and abide by existing legislation governing such procedures. 
The F.D.A., E.P.A (Environmental Protection Agency) and the O.E.C.D. 
(Organization for Economic Cooperation and Development) have specific 
rules and guidelines relating to this, and the E.C. (European 
Community) have a number of directives for member states concerning 
specific tests to be carried out. Some of the specific tests to be 
performed before the compound (new compound or reformulation of a 
previously existing compound) can be filed with the FDA, have been 
outlined already. While clinical trials are being carried out other 
tests are performed, such as chronic exposure tests, teratogenicity, 
reproductive toxicity, mutagenicity, tests relating to special routes 
of exposure, immunotoxicity etc. The specific tests performed (which 
have been approved by the governing authority) should always be 
stated.
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Development of many important drugs and chemicals has often been 
inhibited because of the time span and the exorbitant cost involved in 
toxicity testing. By 1986, the International Register of Potentially 
Toxic Chemicals had acknowledged the existence of 63,000 chemicals in 
everyday use; 48,000 of which were used in commercially significant 
amounts. Of these, only 6,000 have been tested for toxicity [Ryan,
1987]. Testing of a typical new chemical costs between 500,000 and
1.5 million U.S. dollars; takes up to 2 or 3 years; and may entail 
the sacrifice of thousands of animals [Goldberg and Frazier, 1989]. 
Because of this, and because the process of testing itself is so slow, 
there is a huge backlog of chemicals for toxicity testing. The N.C.I. 
(National Cancer Institute U.S.A.) for example, has amassed a
multitude of chemicals for testing. It is obvious that what is needed 
here, is an effective screen to determine the compounds of greatest 
potential, which can then be singled out for more intensive in vivo 
tests. For food additives and drugs, those showing excessive 
toxicity can be eliminated from further study, and in the search for 
efficacious anticancer agents, those showing significant toxicity to 
tumour cells can be examined more closely. It is here, in such
screening systems that in vitro systems have much to offer.
Other applications of in vitro toxicity testing include
chemosensitivity testing of tumour biopsies, quality control (e.g., 
water, drug batches), and environmental monitoring.
There are a very wide variety of toxicity testing systems available
for use, ranging from isolated organs and tissues, through 
invertebrate and plant systems, to purified cell constituients. In 
choosing a system for toxicity testing it is important to realize the 
limitations of the different systems. The merits of a range of 
different systems are summarized in the table below, which has been 
modified from Bridges [1980].
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Table 1.4 Range of toxicity testing systems and their merits
A  Reproducibility
Whole animal and ease of
performance
Perfused organ
Freshly obtained slice
or
isolated cell preparation
Primary cell culture
Cell line
Subcellular fraction
e.g., mitochondria
and Radioligand binding
assays reliability of
extrapolation
Purified cell constituents to in vivo
e.g. DNA, enzymes situation '1
It is important to consider the use to which the chemical will be put. 
For example, in screening an easily biodegradable compound for use as 
a fungicide in fish farming; it may be more relevant to perform fish 
toxicity tests than toxicity tests using rats; the former being more 
likely to be exposed to the chemical. In such an instance,
bioaccumulation studies may be appropriate. Thus the important
message here is that, the appropriateness of each of the available 
systems should be established before one is chosen. It may be found 
that more than one system would better represent the eventual use of 
the test chemical.
Once the system has been chosen, the next parameter to consider is
the endpoint to use. In deciding this, it is imperitive to consider
the use to which the compound is being put e.g. an anticancer agent, 
a shampoo, a food additive, or a pesticide. There would be little 
point for example, in testing for irritancy in evaluation of an 
anti-cancer agent; clearly this test would be more appropriate in 
evaluating a shampoo.
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1.5 In vitro toxicity tests
In vitro toxicity tests may be short term or long term. Various in 
vitro short term tests have been developed and extended as potential 
replacements for whole-animal toxicity assay systems and as we have 
seen, speed, test reproducibility, increased sensitivity and 
economy are some of the advantages which these sorts of assays have to 
offer over in vivo assays. Some technical problems still need to be 
addressed, though, before they can be more fully used as 
replacements for whole-animal testing. In fact, - just as the 
results of animal testing are not fully representative of the human 
experience of toxic exposure, it is unlikely that in vitro cyto- or 
genotoxicological systems will ever provide toxicity data that will be 
totally equivalent to that derived from in vivo systems [Stark et al., 
1986].
Some of the more usual types of in vitro toxicity tests will be 
briefly considered here.
1.6 Tissue specific toxicity tests
Tests on a particular tissue for a specific effect are performed when 
specific tissue or target organ toxicity is to be determined. Target 
organs are often not the site of highest concentration of the 
chemical, but are the organ most sensitive to the chemical. The 
Central Nervous System is most often the target organ, followed by 
liver, kidney, lung and then the skin. Muscle and bone are least 
often target organs [Klaassen, 1986]. For this type of testing, the 
end point used is often disruption of some normal biochemical function 
of the cell which is specific to that tissue or cell type. Some of 
the more usual tissue toxicities studied are outlined below.
Neurotoxicity :
Neurotoxins are diverse compounds that may be toxic to specific 
regions, cell types or functions within the nervous system. Some 
neurotoxins are capable of fairly selective injury and may damage only 
specific portions of the brain or peripheral nerves. Agents that 
disrupt neuronal transmission may be: blocking agents (prevent the
continuation of the electrical impulse e.g., botulinum toxin),
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depolarizing agents (depolarize the cell or eliminate the 
electrochemical gradient that normally exists within it, e.g., DDT), 
stimulants and depressants (increase or decrease the exictability of 
neurons), receptor antagonists (prevent the neurotransmitter from 
activating the receptor and initiating the impulse by binding to the 
postsynaptic receptors), anticholinesterase agents (e.g.,
organophosphate insecticides) or neuromuscular blocking agents [James,
1985]. Other agents may physically damage the myelin sheath or other 
parts of the nervous system.
Central nervous system (CNS) preparations which have been used for 
neurotoxicity assessment include brain slices, isolated nerve and 
glial cells, and brain nuclei, synaptosomes and vesicles [Walum et 
ai., 1990]. Use of invertebrate preparations for in vitro work have
also been found useful [Lee et al., 1986, 1987] because of their
relative simplicity, and also because of their relevance to the many 
pesticides that have been designed to act on the insect nervous 
system.
Because neurones (the principle compontent of the CNS) have lost the 
ability to divide, problems with cell culture systems for 
neurotoxicity testing were apparent in the past [Dewar, 1983], however 
the last few years has seen the establishment of hundreds of cell 
lines originating from both normal and malignant brain tissue from 
different cell types - methods for such culture are given by Shahar et 
al., [1989]. Differentiation of embryonic nervous tissue in culture
has often been found to mimic that of in vivo fairly closely [Walum et 
al., 1990], but because little neurophysiological work is performed
by neurons and glia in vitro, lethality manifest in vivo by 
impairment of some active CNS process can not be detected with 
cultured cell systems [Goldberg, 1980]. Cultured neuronal cells have 
been shown to express more genetic information than several other cell 
types [Kaplan et al., 1982] so it has been suggested that cultured
neurons are likely to react to a wider range of toxic agents than any 
other single cultured cell type [Walum et al., 1990]. Nardone [1983], 
Atterwill [1989] and Wallum et al., [1986] have all used batteries of
different neural cultured cells as models to distinguish between 
neurotoxic and non-neurotoxic substances. Using neuroblastoma and 
glioma cells to determine toxic effects on oxidative energy metabolism 
and membrane integrity as well as cytotoxicity, results were compared
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to effects seen in primary cultures of muscle heart and liver cells. 
Co-cultivation with hepatocytes was also used by Wallum in an attempt 
to discern the influence of liver metabolism on neurotoxicity. More 
complex in vitro systems have been used which retain more of the 
structural and functional complexity of the nervous system, such as 
organotypic cultures [Veronesi et al. , 1983], reaggregate cultures
[Atterwill, 1987] or mid-brain micromass cultures [Flint and Orton,
1984], which, in combination with general endpoints can generate 
toxicological data highly representative of the situation in vivo 
[Walum et al. , 1990]. Endpoints such as energy metabolism, protein
synthesis, receptor-second messenger and calcium homeostasis may be 
used [Walum et al., 1990], Hansson [1986] has used nerve-glia
co-cultures in an attempt to preserve some cell-cell interactions in 
vitro. Indeed practically all types of neural cell and tissue 
cultures have been used for screening for neurotoxicity and in 
attempting to elucidate the mechanisms of action of xenobiotics.
Haemototoxicity:
From the undifferentiated mesenchymal stem cells of the bone marrow, 
clones of cells differentiate and ultimately appear as mature 
(commited) cells with a specific purpose. Haemotoxic effects induced 
in the blood are hypoxia (effected by Carbon monoxide, nitrites, 
nitrates and aromatic amine compounds), hypotoxic hyposia (cyanide 
poisining, hydrogen sulfide anion poisoning) and chemical induced- 
blood disorders) [James, 1985]. Besides being tested as human 
primary cells in standard cytotoxicity assays, as well as in the 
presence of subcellular metabolising fractions to better simulate the 
conditions of in vivo exposure, peripheral blood lymphocytes can also 
be examined with respect to their specific properties, such as their 
susceptibility to exogenous mitogens [Celotti and Bianchi, 1990]. 
They have been used extensively for cytotoxicity testing and 
genotoxicity testing.
Hepatotoxicity:
The liver is the major site of biotransformation of xenobiotics. It 
is therefore an important target organ, especially in relation to 
chemicals ingested orally or administered intraperitoneally, because
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it is the first organ perfused by the blood containing the chemical
[James, 1985]. In studying hepatotoxicity, it is important to be
familiar with normal liver functions if liver injury is to be
adequately detected. Differences in biokinetic behaviour among test 
compounds in different species is an important source of uncertainty, 
and thus the use of liver cell cultures from different species may 
improve understanding of such interspecies differences [Blaauboer et 
al., 1990].
The two types of tests generally used to screen for injury to liver 
are: (1 ) those that measure liver function, and (2 ) those that
measure cellular damage - most often leakage of intracellular enzymes 
from the cells [James, 1985]. Complete organs or liver slices can be 
used for such studies; isolated hepatocytes however are often used. 
Hepatocytes retain most of the metabolic capabilities of the intact 
liver [Abraham et al., 1983; Tsuru et al., 1982], at least for a
few days [Paine et al. , 1982] and thus allow studies on metabolism of
drugs and other new chemicals, to be undertaken. While hepatocyte 
cultures from rat, mouse, hamster etc., are frequently used, 
experience with the use of human liver cells in culture is more 
limited [Blaauboer et al., 1985,; Butterworth et al., 1989]. The
human epithelial hepatoblastoma cell line Hep G2 has been widely used 
in hepatotoxicity testing, and although it has been found to be less 
sensitive than human hepatocyte primary cultures for detecting 
cytotoxic and genotoxic effects of 10 N-nitroso compounds [Campart et 
al., 1989] it has been found to possess parenchymal cell functions and 
to metabolise some procarcinogens [Eddy et al., 1987].
Lactate dehydrogenase (LDH) activity and LDH leakage are routinely 
used to measure integrity of hepatocytes. Oxygen consumption in 
freshly isolated hepatocytes, is often measured using an electrode, or 
protein synthesis may be measured. These endpoints will be considered 
in more detail later in this section. Changes in cell structure 
[Chenery et al., 1981] and observance of surface blebs are common
techniques, as well as maintenance of such differentiated functions 
as cytochrome P4 5 Q and other phase I and II enzyme activity.
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Nephrotoxicity:
The unique structure and function of the kidneys make them 
particularly susceptible to xenobiotic-induced toxic injury [Smith et 
al., 1987]. Known nephrotoxins like Cis-platinum and chloroform are 
used to set up models for nephrotoxicity testing. Other chemicals 
particularly toxic to the kidney are heavy metals such as cadmium, 
mercury and lead, agents causing obstructive uropathies, those 
producing pigment-induced nephropathies and therapeutic agents such as 
Gentamycin and Amphotericin B [Goodman, 1985; Bertelli et al., 
1991]. Isolated perfused kidneys, renal slices and explants [Tveito 
et al., 1989], tubule and cell suspensions and cell cultures have been 
used to determine toxicity to this target organ. Perhaps the most 
commonly used cell lines for such studies are MDCK and LLC-PK1 (dog 
and pig kidney lines respectively). Alterations in three renal 
processes: glomerular filtration, tubular reabsorbtion and tubular
secretion; are used to diagnose the functional state of kidneys in 
the clinical situation [Goodman, 1985], Effects on biochemical 
functions such as gluconeogenesis, or changes in levels of xenobiotic 
metabolising enzymes are some in vitro tests often used as indicators 
of nephrotoxicity. Andreoli and Mallett [1991] have reviewed methods 
for assessment of oxidant injury in renal tubular epithelial cells In 
vitro.
Pulmonotoxicity:
The lungs are another particularly sensitive organ as they constantly 
filter air, polluted with chemicals and combustion products (e.g. 
carbon monoxide, sulfur oxides, photochemical oxidants and tobacco 
smoke). In fact, this organ has the greatest exposure to the 
environment than any of the other organs. Some chemicals become 
trapped in the respiratory tract and for this reason they exert their 
toxicity there, but others are specifically toxic for this organ (e.g. 
paraquat and 4-ipomeanol). Deposition of aerosols in the lung may be 
by impaction, sedimentation and diffusion. Mathematical and physical 
models can be used to predict where particles will deposit in the 
respiratory tract [Brown and Poole, 1983]. Mucocilliary mechanisms 
and alveolar macrophages constitute the lung clearance mechanisms 
[Duffell, 1985]. Toxicant interaction with macrophages and 
phagocytic leukocytes may cause impairments of the immune system,
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resulting in conditions such as siliconetuberculosis, release of 
inflammatory mediators and the production of free radicals by oxygen 
[Brown and Pool, 1983]. These free radicals may also cause direct 
oxidation of xenobiotics, leading to formation of active metabolites.
The lungs consist of at least 40 different cell types. This 
heterogeneity complicates any attempts to isolate pure cell 
populations and maintain them in culture [Poole and Brown, 1987]. 
Clara cells are probably the most widely studied of these cell types, 
at least for toxicological purposes [Devereux et al., 1980, Jones et
al. , 1982]. These are non-ciliated cells in which levels of
mono-oxygenase activity are enhanced. A number of authors have found 
that the toxicity of various mineral dusts towards macrophages and 
macrophage-like cell lines correlated with the fibrogenic activity of 
those dusts in vivo [Brown and Poole, 1983]. The size of the fibres 
causing cell death in vitro is similar to those causing tumours in 
vivo, so the study of mineral dust cytotoxicity has been advocated as 
a preliminary screen for potentially pathogenic dusts [Brown et al., 
1978; Chamberlain and Brown, 1978; Davies, 1980]. The toxic effects 
of metals [Evans et al., 1981] and asbestos [Rajan and Evans, 1973]
on cultured human fetal lung have been reported. Mossman and 
colleagues [1981 (a) and (b )] used tracheal explants in studies of 
particulate toxicants. The epithelial type II cell line, A549, has 
been reported to have some functional drug metabolising ability 
[Wiebel et al., 1980], and may be useful for studies in this area.
Dypbukt et al., [1987], Grafstrom et al., [1988] and many others have
used cultured human bronchial epithelial cells to detect aldehyde and 
acrolein induced cytotoxicity to this tissue. Grafstrom et al.,
[1990] used both bronchial epithelial and fibroblasts cells in culture 
to study general mechanisms of the toxicity of acrolein, and to 
determine whether it caused any effects regarded to be of importance 
for carcinogenesis. In these studies, the different variables 
investigated in acrolein-exposed bronchial cells included colony 
survival, membrane integrity, growth rate, low-molecular-weight 
thiol status, cytosolic concentration of free calcium, and various 
types of DNA damage. Ryrfeldt et al., [1990] has reported the need to 
develop techniques for the isolation and culture of other lung cell 
types aside from those mentioned above, and also to improve the 
culturing techniques for those already isolated.
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Dermatototoxicity:
Toxic responses of the skin may be manifest as irritant contact 
dermatitis, pigment disturbances, ulceration, neoplasms or 
follicular and acneiform dermatoses [Reitschel, 1985]. The key 
clinical test for dermatitis is the patch test, but in vitro systems 
have been used to mimic this response. Addo et al., [1982] used a
Candida killing test, photohaemolysis (indicated substances which 
attack membranes), and photo-oxidation to assess the phototoxic 
potential of various fragrance materials (may give an indication of 
potential photoallergy). Less progress has been achieved in the use 
of in vitro tests for the detection of irritancy and potential 
sensitizers as for other areas [Marks, 1983], Studies on whole skin 
in chambers in which the release of enzymes from the skin into the 
medium has been measured has been found unreliable, but adult human 
and porcine keratinocytes have been used successfully in the 
investigation of anthralin toxicity [Marks, 1983].
The Hen's Egg Test (HET) is well known as a basic test for 
embryotoxicity and for special aspects of systemic toxicity and 
immunopathology. It has been extended and standardized as the 
HET-chorioallantoic membrane (CAM) test for membrane irritation 
[Luepke and Kempler, 1986] in dermatotoxicity as well as ototoxicity. 
In such tests, good correlations have been observed between 
classifications based on HET-CAM observations (including electron 
microscopy) and reported data from Draize tests.
Examination of keratome slices of skin for release of enzymes, altered 
histochemistry and for utilization of radioisotope-labelled amino 
acids can detect weak irritants, but is of doubtful value for moderate 
irritants, and will detect corrosive substances only through their 
inhibition of all cell activities [Parish, 1986]. Fibroblast cultures, 
tested with Clostridium perfringens toxins and chemicals show similar 
limitations in detecting moderate or severe irritants, but can be made 
more relevant by overlaying with a layer of agar containing keratin.
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Ocular toxicity:
The cornea and the conjunctiva are the portions of the eye directly
exposed to external insults. The cornea must maintain its
transparancy in order to remain functional. This is thought to be
achieved by the boundary layers of epithelium and endothelium
[Maurice, 1961]. Damage to these boundary layers result in
absorption of water and loss of transparency [Potts, 1986]. Thus the
cornea is exquisitely more sensitive to corrosive substances than are
other body tissues. Thus, corneal swelling studies and permeability
measurements as well as changes in corneal thickness [Jacobs and
Martens, 1990] are widely used to detect irritation caused by agents
such as acids, bases, organic solvents, detergents and smog; and are
frequently used in cosmetic screening systems. Many of the general
endpoints for cytotoxicity testing such as Neutral Red Uptake and
Release [Gettings and McEwen, 1990] and Glutamic Acid uptake
inhibition [Dierickx, 1989] (considered later) are used for eye
irritancy testing. The CAM and HET-CAM tests already mentioned are
also used in assessment of eye irritation. An enucleated rabbit eye
model has been described in which changes in corneal thickness are
assessed in response to test materials applied to the ocular surface
of the enucleated eyes [Price and Andrews, 1985], and a bovine eye
model combined with the CAM assay [Weterings and Van Erp, 1987], as
well as isolated ocular tissues [Muir, 1985] have been similarly
used. Obviously these systems do not offer the same advantages as
simpler in vitro tests. Assays of tissue repair are also widely used
where corneal epithelial monolayer healing is measured (wound closure
rates) after inflicting damage with a suitable probe or sharp
instrument, in the presence of the test material [Jumblatt and
Neufeld, 1985, 1986]. Assays of inflammation are also used whereupon
the release of different known mediators of inflammation (e.g.
histamine, prostaglandin) are determined [Frazier et al., 1987],
however these assays should be used cautiously as the mediators
measured to date are almost always present in measurable amounts, and
their levels are easily changed even with the most innocuous stimulus
[Wilcox and Bruner, 1990]. Another potentially useful system
— TMcurrently under evaluation is the ETYTEX System [Kelly, 1989;
Dierickx and Gordon, 1990]. It is based on appearence of opacity in a
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necessary for mutagenesis or carcinogenesis (or to detoxify a more 
toxic substance), an 'S91 mix, containing animal (usually rat) liver 
microsomes, is frequently added to the test. Such biotransformation 
systems and others, are used for many other iri vitro mutagenicity 
tests [reviewed by Jenssen and Romert, 1990].
Other bacterial systems have been used to detect gene mutations 
including Escherlscia coli [[Mohn et al., 1980]. A colorimetric 
assay (SOS chromotest) based on the primary cellular responses of this 
bacterium to genotoxic agents, has been developed [Hofnung and 
Quillardet, 1988]. Moulds such as Neurospora crassa [De Serres and 
Mailing, 1971], and yeasts, commonly Saccharomyces cervlslae 
[Zimmerman, 1973], have also been used, but the permeability of the 
cell wall is a general problem, as it can restrict entry of certain 
chemicals into the cell. Also eukaryotic microorganisms usually 
require higher concentrations of chemicals for induction of mutations 
than do bacteria, probably because yeast and moulds exhibit more 
powerful detoxification mechanisms and have more DNA repair pathways 
[Dunkel, 1983].
DNA damage can also be measured by quantifying DNA repair. In tests 
for DNA repair, the effects of a compound are established by 
comparing its toxicity to two isogenic strains of bacteria, identical 
in all respects except for their ability to repair DNA lesions (one is 
DNA-repair deficient and the other is competent in repairing DNA 
lesions). E. coli, S. typhimurium and Bacillus subtilis [Kada et 
al., 1972] have all been used for such tests.
Similar tests are carried out in mammalian systems using cell lines 
(frequently V79, CHO and L5178Y cells [Kuroki et al., 1977; Hsie et
al., 1979; Clive et al., 1979]. Metabolic activating systems have
sometimes been added to these systems, either by S-9 as already 
described, or by co-culturing with intact cells (primary fibroblasts 
and hepatocytes have been used [Huberman and Sachs, 1974; Langenbach 
et al., 1978]). It has been suggested [Bigger et al., 1980], that 
mammalian cell mediated mutagenesis appears to be a better indicator 
of _in vitro metabolic pathways than bacterial, and may also reflect 
the organ specificity of the chemicals tested.
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Some genetic alterations are visible with the light microscope. 
Chromosomal aberrations observed in mammalian cells are characteristic 
of damage sustained in cells. This damage is translated into 
breakage/exchange figures prior to chromosome replication. 
Abberations can be detected on a wide range of mammalian cells. 
Chinese hamster cells have been widely used [Mutsuoka et al. , 1979] as 
they have short cell cycles and small numbers of large chromosomes. 
Three different types of cytogenetic change can be distinguished in 
cells exposed to chemical mutagens [Evans, 1983]: 1) alterations in
chromosome structure 2) sister chromatid exchange, and 3) alterations 
in chromosome number.
Sister Chromatid Exchange (SCE's) [Perera et al., 1989], are a
special class of chromosomal aberrations which involve equal and 
symmetrical exchange between sister chromatids and hence do not result 
in an altered chromosome morphology and are not detectable unless 
grown for two cell cycles in bromodeoxyuridine and then stained.
DNA strand breakage can be measured by alkaline sucrose gradient 
centrifugation [Lett et al., 1967] or by alkaline elution from
membrane filters [Kohn, 1979]. Repair synthesis or unscheduled DNA 
synthesis can be measured be autoradiography or by liquid 
scintillation counting [Painter and Cleaver, 1969; Stich and San, 
1970] but the former is preferred because it can distinguish repair 
synthesis from replicative DNA synthesis [IARC, 1980]. Development of 
a DNA-repair assay in primary rat hepatocyte cultures [Williams, 1976] 
has become important for this type of testing (rather than using cell 
lines), and it has been shown to be sensitive and reliable for 
chemicals that require metabolic activation [Probst et al., 1980].
Human peripheral lymphocyte cultures exposed to organotin and other 
metal compounds have shown spindle-inhibition effects (assessed by 
chromosome length measurements) [Anderson and Ronne, 1990; Jensen et 
al., 1990] in a dose-related and exposure time-related fashion.
In mammalian systems, in addition to the types of tests mentioned 
above, neoplastic transformation is also measured. This has much 
relevance in assessing chemicals for carcinogenic potential and is 
considered to be the most relevant in vitro model for carcinogenesis
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[Dunkel, 1983]. Cells pile up in an irregular, criss-cross pattern 
representing a loss of growth inhibition and cell-cell orientation. 
They acquire other transformed characteristics with increasing 
passage, such as ability to grow in semi-solid medium and capacity to 
produce tumours after transplantation into syngenic or 
immunosuppressed animals. The Syrian hamster embryo clonal assay, in 
which primary or early passage cells are used as the target 
population, is one of such methods [Pienta et al., 1977]. Continuous
cell lines can be used for transformation also, and here, foci of 
morphologically transformed cells appear on a monolayer of normal 
cells.
1.8 Embryotoxicity/ Teratogenicity
Tremendous growth in development and use of in vitro teratogenicity 
tests have been made in recent years. These assays range from whole 
embryo cultures, derived from invertebrates and vertebrates, to cell 
and organ cultures [Bournias-Vardiabasis, 1990], and have been the
subject of a number of reviews [Welsh, 1990; Brown, 1987]. It is
generally percieved that teratogens can have a variety of effects on
the developing embryo and at various organisational levels, and like 
other aspects of toxicity testing it is therefore appropriate to use 
more than one in vitro system.
The HET has already been dealt with, and its use in embryotoxicity
mentioned.
Systems using lower animals, non-mammalian vertebrates and 
invertebrates are better able to indicate teratogenic hazard than 
isolated mammalian embryonic tissues or cells, because both adult and 
embryonic forms can be studied in vitro [Fabro et al., 1982].
Many of the tests which follow are still undergoing validation however 
they are mentioned in order to give the reader an idea of the sorts of 
such tests available for use.
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Chick embryo tests [Wilson, 1978] have been widely used and 
rank-order studies suggest [Jelinek and Rychter, 1979] that the 
teratogenic potential obtained is similar to that obtained from whole 
animal studies.
The frog embryo teratogenesis assay [Dumont et al. , 1982] has also
been used as a model for teratogenicity screening of industrial wastes 
for ecotoxicological assesment. Here, embryos from the blastula 
stage are examined regularly over a 4 day test exposure and tadpoles 
scored for motility, pigmentation, malformations in development as 
well as mortalities. Other amphibian tests have been used for 
ecological toxicity testing [Birge et al., 1983; Dumpert and Zietz,
1984; Fulton and Chambers, 1985],
Of the sub-vertebrate assays, the Drosophila embryo test has often 
been used [Schuler et al., 1982]. Several endpoints may be used in
this assay including detection of interference with normal muscle and 
/ or neuron differentiation, induction of heat shock (stress) 
proteins, and inhibition of normal neurotransmitter levels 
[Bournias-Vardiabasis, 1990]. The endpoint used by Schuler was the 
following: after controlled mating, eggs are deposited in nutritive
medium containing the test agent and emerging adult flies are assessed 
for shape, size and colour of body parts. Obviously this involves 
specialist practice, which limits the tests' usefulness. Other 
disadvantages are that the test does not show a dose-response 
relationship, nor does it indicate teratogenic hazard.
A similar assay using the cricket Acheta domesticus has been useful in 
detecting the teratogenicity of impurities in complex mixtures of 
industrial chemicals [Walton, 1983]. Eggs are first developed in 
contaminated sand and then on moist filter parer. Emerging nymphs and 
cricket embryos when exposed to teratogen display a range of 
abnormalities associated with compound eyes, antennae, legs and 
head. This test has distinguished between specific teratogenic effects 
and general embryotoxic effects.
Another invertebrate teratogenicity assay uses the brine shrimp, 
Artemia salina. The increase in body length of nauplii larva after 
hatching from cysts, is measured and used as an index of
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teratogencity [Kerster and Schaeffer, 1983]. The test has been used 
with heavy metals and organic compounds but no attempts have been made 
to correlate the effects of these agents on naupliar development with 
mammalian data. Differences in larval development are apparent at 6h 
and 24 h LC^q's. This data can then be used to distinguish general 
toxicants from those with a specific stage-dependent developmental 
effect [Sleet and Brendel, 1985].
Planarian tests using Dugesla dorotocephala [Best and Morita, 1982] 
examine the ability of surgical fragments of the flatworm to 
regenerate into an intact animal in the presence of the test agent. 
This procedure is assumed to model many of the differentiation and 
development processes that occur in embryogenesis. The endpoints of 
the test are quite defined: delayed regeneration of head, failure of
the subject to regenerate all or part of the head process, or
regeneration of an abnormal head or loss of normal morphology. There
has been little validation of these tests so it is uncertain whether
the tests are specifically indicative of developmental toxicity.
Hydra assays [Johnson et al., 1982] are specifically designed to
estimate teratogenic hazard. Hydra attenuata adult polyps are exposed 
to test agent in defined medium, for up to 90 hours. Degeneration and
eventual loss of tentacles, followed by a total loss of normal
morphology and the assumption of a rounded shape, indicates a
toxicological response. In a second part of the assay, dissociated 
adult cells are seeded in tissue culture wells in reaggregation medium 
containing the test agent; and reformation of adult polyps is
monitored (over 90 hours). The toxic endpoint of the test is
dissociation of the cell aggregates. This can occur at any stage of 
the developmental sequence. The ratio of the minimum effective
concentration for the adult over the disaggregated hydra gives a 
teratogenic hazard index and again can indicate a specificity of 
action on the developing organism.
Sea urchin embryos have long been used in studies of developmental 
biology and have now been extended to include a test for
teratogenicity. Hose [1985] described a system in which the sea 
urchin embryo is used in a combined embryotoxicity-genotoxicity test. 
Gametes and embryos are exposed to test agent in sea water.
Fertilization success is monitored (after combination of sperm and
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egg) by examining the eggs for the presence of a fertilization 
membrane. Embryos are allowed to develop for a further 48 h under test 
conditions and are then assessed for survival and abnormalities. 
Mitotic rates of isolated embryonic cells are used as an indicator of 
general embryonic health. Analysis of cytologic irregularities is also 
carried out, but again, this requires specialist knowledge. Only
benzo(a)pyrene has been tested with this system so far.
Durston et al., [1985] used a slime mould test to determine the lowest
concentration of the test agent causing an effect on spore yield and 
morphogenesis of Dictyostelium discoideum, and the highest
concentration at which no cell death was recorded.
1.9 Reproductive toxicity
The potential of using testicular cell cultures for investigating
chemicaly induced testicular toxicity has been considered [Ng and Liu, 
1990; Waalkes and Perantoni, 1988], but in vitro manipulation of 
gametes and embryos for evaluating the effect of chemicals on germ 
cell function and development potential has been more extensive. This 
can be measured by direct assessment of fertilization and embryo 
development, or indirect assessment by measuring physiological and
biochemical parameters related to sperm and oocyte function. Sperm 
cell bioassays [Seibert and Gosch, 1990] can also give useful toxicity 
data on the cytotoxic potential of chemicals.
1.10 General cytotoxicity tests
In the broad context of cytotoxicity testing of chemicals and
environmental pollutants, primary cell cultures and cell lines are
widely used. Many different types of cells can be grown from
different tissues and from organisms in widely different taxanomic 
groups. Human tissue may not always be available and it is important 
that the significance of using tissue from another species be 
realized. The American Type Culture Collection (A.T.C.C), has an 
extensive range of cell lines, any of which may be suitable for a 
cytotoxic evaluation in a particular case. Cultures of fish cells are 
an option that is often used, especially in relation to ecotoxicity 
testing. Early passage fish cells will obviously be more relevent than
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using cell lines [Babich and Borenfreund, 1987], or a fish hepatoma 
cell line, such as the rainbow trout hepatoma line used by Babich et 
al., [1989], may offer some advantages over lines from other tissues
if any slight xenobiotic metabolizing activity remains in these lines. 
Marine and freshwater algae and multicellular plants are very widely 
used for detection of marine and freshwater pollutants. Growth rates 
of phytoplankton species such as Chlorella stigmatophora [Nielsen and 
Clausen, 1984] and retardation of root and shoot tip development of 
multicellular plants (often duckweed and grass species) is commonly 
measured to give an indication of toxicity of heavy metals and other 
pollutants [Wong and Chui, 1990]. Invertebrate assays measuring cell 
kill for crustaceans such as hrtemia and Daphnia are often used. The 
O.E.C.D. [1984] have defined guidelines for Ecotoxicity testing.
1.11 Endpoints for in vitro toxicity testing
The ideal endpoint should be based on events that are closely 
associated with the molecular events which result from exposure to the 
toxin. If this can not be achieved, it is important to use an
endpoint which is unequivocal and clearly relevant to the toxic
effect. This is not always straightforward, because although many 
endpoints are quantitative and precise, they are often indirect 
measures of toxicity. Neither is it the case that all direct measures 
of effects are related to the mechanism by which a substance exerts 
its toxicity, but they do allow a causal relationship to be drawn 
between the agent and its action.
As established already, the choice of an endpoint for in vitro
cytotoxicity testing is very important. Many, different endpoints 
have been widely used (the literature abounds on this subject, 
particularly in relation to chemosensitivity testing). This thesis 
confines itself to the study of some of these methods for cytotoxicity 
testing. The pages which follow introduce the more important and 
widely used of these assays, and consider the more important aspects 
of them.
31
1.12 Assays for colony formation
Assessment of viability is the endpoint most often used in 
determination of cytotoxicity. While growth assays give a general 
indication of viability, the most relevent paramater for determining 
the viability of a cell is often considered to be retention of its 
replicative potential. Tests for colony formation are able to 
determine this; a cell which will replicate and form a new colony can 
be assured to be viable. These tests have been widely used in 
cytotoxicity testing studies, chiefly in the area of chemosensitivity 
testing.
The ability of malignant (and transformed normal) cells to grow 
independently of a substrate for anchorage is exploited in agar colony 
formation assays. The _in vitro colony forming assay was developed by 
Puch and Marcus in 1955. In the assay, single-cell suspensions of 
mammalian cells were dispensed in semisolid medium. After an 
appropriate time, cells capable of sustained replication produced 
small colonies containing 50 or more progeny of the original cell. 
This technique has been developed and modified so that today it is a 
powerful experimental tool. It is widely employed for the detection 
and study of clonogenic cells from a variety of normal organs and 
experimental tumours. The types of assays used to study the anchorage 
independent colony forming population within a tissue are either soft 
agar, as described by Bradley and Metcalf [1966] or methylcellulose. 
These assays have been commonly used for the detection of stimulatory 
effects of substances [Me Cullouch et al., 1974].
In 1977, Hamburger and Salmon, and later in 1978, Courtenay and 
Mills published papers describing the use of a clonogenic assay to 
determine the chemosensitivity of patients' cells to a range of 
anti-neoplastic agents. In the following 7 years, more than 700 
publications described the general use of soft agar tumour colony 
forming assays for quantitation of cancer cell proliferation and 
anticancer drug effects iri vitro [Human Tumor Cell Cloning 
Bibliography (1984)], while a paper by Bertelsen et al., [1984]
reviewed the results of 1582 such assays with 258 clinical 
correlations.
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Basically the assays involved culturing the tumour-isolated-cells in 
semi-solid medium in a 2 layer agar system together with the 
chemotherapeutic agent. Only what was termed the 'clonogenic cells' 
in the tumour cell population would form colonies in this system, so 
this was thought to be of relevance to the 'critical cells' in the 
tumour.
A particular advantage to this assay is that contaminating normal 
cells will not grow in the agar layer, so the possibiltiy of 
misinterpretation of results from contaminating stromal cells is 
minimized.
Prospective and retrospective trials resulted in various 
interpretations to the usefulness of these assays. Some highly 
positive correlations between the test results and in vivo human 
tumour response were reported [Salmon et al., 1978; Sarsody et al., 
1982; Kern et al., 1983]. The tests were performed on a wide range of 
tumour tissues and the response obtained differed not only with the 
source of material and the laboratory involved, but with repeated work 
on the same tissues in the same laboratory. Generally though, it has 
been reported [Selby et al., 1983] that the Human Tumour Stem Celling
Assay (HTSCA) gives a 60-70% true positive and an 84-98% true negative 
correlation of chemosensitivity for a limited number of different 
tumours and Drugs [Salmon & Von Hoff, 1981 and Von Hoff et al., 
1981]. These figures are variable, depending upon the tissue type.
Despite the limitations of this system [Bertoncello et al., 1982; 
Dendy, 1975], and even though the results required cautious 
interpretation, the system represented a big step forward in the area 
of cytotoxicity testing for chemosensitivity. It was felt that many 
of the technical problems could be overcome, so further work was 
carried out in this area [Bertoncello et al., 1982; Alley and
Lieber, 1984; Selby et al., 1983; Twentyman, 1985]. Problems with
low plating efficiency, clumping, long assay duration and technical 
cumbrousness still remained however.
These technical difficulties resulted in a de-popularization of the 
assay, and a reversion to other methods of cytotoxicity testing and 
development of new methods.
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1.13 Dye exclusion assays
Viability dyes have been used extensively in the past for 
determination of cellular integrity and detection of cell death. 
Their use has been reported as far back as 1914 [Evans and 
Schulemann].
Among the dyes excluded by live cells which have been used are eosin, 
nigrosin, trypan blue, erythrosin B, fast green and naphthalene 
black [Bhuyan et al. , 1976]. Flourescent dyes such as propidium
iodide have also been used (often in combination with flow cytometry) 
[Pavlik et al., 1985; Funa et al., 1986]. Upon membrane damage they
bind to nucleic acids and become highly fluorescent.
More recently, some workers have shown a preference for dye exclusion 
assays over other cytotoxicity assays. Yip and Auersperg [1972] found 
that out of a number of stains tested, Alcian Blue gave the most 
consistent results for cell viability for cell staining of fixed 
samples after different periods of time. Hanson et al., [1989] also
used this stain for work on leukemia and lymphoma cell lines. Hartman 
and Rieck [1989] found Janus green superior to other dyes used in dye 
exclusion for staining of damaged and dead endothelial cells.
Combinations of acridine orange and ethidium bromide have also been 
used to detect viability. Viable cells appear green (acridine 
orange), becoming orange on death (ethidium bromide) [Detta and 
Hitchcock, 1990],
Several pre- 1983 studies used a range of these dyes with differing 
degrees of success. While some workers reported favourably on the use 
of such assays for chemosensitivity testing [Durkin et al., 1979], 
many reported a poor correlation with other assays and with clinical 
trials in vivo. Many workers found that dye exclusion methods 
underestimated cell kill [Yuhas et al., 1974; Bhuyan et al., 1976].
Roper and Drewinko [197 6 ] demonstrated that reproductively dead cells 
may not take up dye. Other technical flaws were highlighted from 
which it was deduced that such methods were unsuitable for 
chemosensitivity testing of most tumours.
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A study carried out by Weisenthal et al., [1983a] investigated some 
variables in the use of this assay. They reported that, provided the 
technical limitations of the assay are recognised, dye exclusion 
assays may be useful in chemosensitivity testing. Using a 
modification of a fast green staining method, results comparable to 
clonogenic assays were obtained. Later studies reported similar 
conclusions [Bird et al., 1986; De Vries et al., 1987], and so these 
assays have been somewhat redeemed. Some of the limitations and 
artifacts outlined by Weisenthal are outlined below.
The timing of the assay is important. It is imperative that a 
sufficient time has elapsed to allow membrane damage to occur and to 
prevent underestimation of cell kill. Also, after prolonged exposure 
to dyes, viable cells will begin to take up the dye.
Additionally, membrane damage may not always equate with loss of
viability.
Notwithstanding these technical limitations, these type of assays have 
been suggested as useful methods for chemosensitivity testing, 
particularly in non-dividing or slow growing cells which may not be
evaluable by other methods. A feature of the more widely accepted
assays now, is that the cells are first fixed and can then be 
counterstained with haemotoxalin and eosin [Hanson et al., 1989], 
thus enabling normal and malignant cells to be distinguished. Apart
from the theoretical and technical difficulties considered above, 
their major disadvantage is their labour intensiveness as the method
cannot be automated.
1.14 Other tests for membrane integrity
Similar in principle to dye exclusion assays, chromium release
assays, fluorescein diacetate uptake, and measurement of enzyme
leakage have also been widely used for cytotoxicity testing [Van 
Rooljen, 1977; Neville, 1987]. Also widely used have been the 
release of other radiolabelled molecules from the damaged cell such as 
proline, uridine and selenomethionine [Saal et al., 1976; Van 
Rooljen, 1977]. They are all based on detection of loss of membrane 
integrity.
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1.15 Dye inclusion
Dye inclusion assays used to indicate viability are simply the 
converse of dye exclusion. Fluorescein diacetate (an ester of the 
fluorochrome Fluorescein) or similar compounds are actively 
transported into cells and are cleaved by cellular esterases to yield 
an impermeable charged molecule, e.g. Fluorescein. Undamaged cells 
retain this highly fluorescent dye, whereas cells with damaged 
membranes do not, and fluoresce only weakly [Rotman and Papermaster, 
1966]. Assessment of cytotoxicity is performed by microscopic 
ennumeration of fluorescent cells. While the assay has been reported 
to be a sensitive assay for assessment of lysis of CK cells in intact 
layers, it is subjective and does not allow for quantification of the 
fluorescence [Norris et al., 1985]. Neither can it be automated, so
it is very time consuming.
1.16 Chromium release assays
51Originally developed by Brunner [1968], the Cr release assay is 
widely used for cytotoxicity studies [Russel, 1981; Pene et al., 1986; 
Stanislawski et al., 1989; Bonavida et al., 1990] including
immunological studies for determination of cytotoxic T cell activity 
against tumour target cells [de Bueger et al., 1990]. Prelabelled
cells are exposed to cytotoxic drugs, and covalent binding of 
labelled chromate to basic amino acids of intracellular proteins 
occurs. These labelled proteins leak out of the cell when the 
membrane is damaged, at a rate which is proportional to the amount of 
damage incurred. Leakage into media is determined by Gamma counting. 
Although it has been reported that high values of spontaneous chromium 
leakage occur and thus the time period over which the assay can be
used should be restricted to approximately 4 hours, Rabinovitch et
al., [1990] have used the assay in a 5 day exposure to cytokines. In
51a study by De Bueger et a 1., [1990], a modified form of a Cr assay
is reported, where spontaneous release values of adherent CK cells in 
the 4 hour assay were reduced to 15% of the total (Triton-X-100) 
values. Further work by Colsky and Peacock [1990] report that the
addition of sodium pyruvate in these assays, greatly reduces the
51spontaneous release of Cr for extended periods.
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In one comparative study which evaluated Cr release as an end-point
for drug cytotoxicity testing, the method was found to be of no value
(Roper and Drewinko, 1976]. Studies by Tzeng and Barth [1990]
indicated that the clonogenic assay was capable of detecting
differences in target cell sensitivity that were otherwise
51undetectable by the standard Cr release assay.
1.17 Other release assays
3 5 *A microcytotoxicity assay using [ Sjmethionine developed by Akagi et
51al. , [1985] is reported to have increased sensitivity over [ Cr]
release assays in terms of detecting cell number, due to increased
incorporation into cells [Stedman and Campbell, 1989]. Other release
125 3assays which have been used are I-UDR, [ H]proline,
7 5 3[ Se]selenomethionine and [ H]uridine [Hofer and Swartzendruber,
1973; Gee et al., 1985; Saal et al., 1976; Van Rooljen, 1977].
1.18 Chromium uptake
51Use of a Cr-uptake assay (where labelled sodium chromate is taken up
by viable but not dead cells) is reported to be more useful than the 
5 1typical Cr release assay [Neville, 1987] because such problems as 
spontaneous release do not occur. The assay was shown to be linear
*3 Cwith cell number over the range 5 x 10 to 5 x 10 cells/ well. Dead
5 1cells did not incorporate Cr. This work also showed that inhibitors
51of DNA, RNA and protein synthesis did not inhibit Cr-uptake, In a
51comparison of these two assays, the Cr release assay failed to 
detect cytotoxicity in most of the cytotoxic preparations. Thomas et 
al., [1978] suggested that such a failure may be due to the short 
length of the assay, which would have been insufficient for release 
of the labelled chromium if minimal damage was done to the plasma 
membrane. Thus we see that this has similar limitations to the dye 
exclusion assays.
51
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1.19 Enzyme leakage tests
Assessment of leakage of a wide variety of enzymes has veen used for 
cytotoxicity testing endpoints. Lactate dehydrogenase (LDH) is a 
convenient marker because of the stability of the enzyme activity in 
the culture system. It is frequently used in hepatocyte cytotoxicity 
and viability studies [Mitchell and Acosta, 1981; McQueen and 
Williams, 1981; Tyson et al., 1983], but is also generally used 
for assessing viability in cell lines [Ekwall and Acosta, 1982].
Typically the LDH activity in the culture medium (after exposure to 
the cytotoxic agent) is measured spectrofluorometrically by measuring 
the production of NAD+ (or the disappearance of NADH) during the 
conversion of pyruvate to lactate [Bergmeyer, 1979; Gobran and Rooney, 
1990].
In some assays, after conversion of lactate to pyruvate, the electron 
carrier phenazine methosulphate reduces a tetrazolium salt (INT) 
present in the medium, to a red coloured product by an irreversible 
reaction. There are some drawbacks; serum can contaminate the system 
with endogenous enzymes and mask low levels of leached enzymes, and 
the presence of phenol red in the medium will mask the appearance of 
coloured products of enzyme reactions. Also MEM (Minimum Essential 
Medium) lacks added pyruvate and therefore favours the lactate to 
pyruvate specific reaction.
LDH leakage has been compared to DNA leakage, as an endpoint in 
cytotoxicity testing [Skaanild and Clausen 1989] where it was found 
that the former gave lower LC5Q values (concentration causing 50% 
lethality) than the latter. This was thought to be because the cells 
have to be more damaged to exhibit DNA leakage than for LDH to be 
lost. Thus DNA leakage would not be a sensitive endpoint for cell 
damage/ death.
Hexosaminidase leakage and glutamic oxaloacetic transaminase leakage 
[Anuford et al., 1978; Salocks et al., 1981; McQueen and Williams,
1981] have been used as indicators of cell viability, but they have 
not offered significant advantages over other methods.
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The main drawback of all these assays however, is similar to that 
discussed for dye exclusion - namely their reliance on the premise 
that membrane integrity and cellular viability are closely linked. 
This is not always the case, at least in early stages of cell death; 
so these assays may not always be true/ sensitive indicatiors of 
viability. Thus we shall move on from these types of assays to other 
functional assays, that is, assays which measure some metabolic 
components necessary for growth.
1.20 ATP (Adenosine Triphosphate) assays
ATP is a basic store of energy in living cells. Its intracellular 
concentration can be expected to be correlated with cellular viability 
because it rapidly disappears when cells die [Gronroos et al., 1984; 
Kuzmitz et al., 1984; Maehara et al., 1986]. It has been
demonstrated to be a reliable and sensitive measure of cell viability
for various cell lines and has been favourably compared with other
3cytotoxicity assays such as dye exclusion, [ H] thymidine 
incorporation, colony forming assays and a succinate dehydrogenase 
inhibition test [Kangas et al., 1984; Kuzmits et al., 1986; Garewal
et al., 1986; Maehara et al., 1987]. More recently it has been
adapted to solid human tumor specimens [Peng et al., 1987; Perras et 
al., 1990] to assess overall cell viability of cells grown in a soft 
agar cell culture method.
Measurement of ATP is often determined by the biochemiluminecence
method. Light (560 nm) is generated by oxygenation of LI^-AMP and its
intensity is precisely dependent on the total number of ATP molecules.
Measurements with luciferase-luciferin reagent are highly sensitive
and can measure the ATP content of as few as 50 cells [Moyer and
31Henderson, 1983]. Other methods for direct ATP measurement are P
32NMR measurements and P labeling of ATP, ADP and AMP pools.
Kangas et al [1984], reported that intracellular ATP levels were 
significantly correlated with cellular viability and might be useful 
for in vitro chemosensitivity testing for malignant cells. Some 
investigators also reported use of intracellular ATP measurement for
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chemosensitivity testing. In one study, Miura et al., [1988]
investigated in vitro and in vivo intracellular ATP levels for 
chemosensitivity testing in rats, and found them to be significantly 
correlated. A highly positive correlation was also found for ATP 
levels and trypan blue determined viable cell numbers in 2 cell lines. 
In Miura's work, determination of ATP levels was preferred after a 72 
hour drug incubation, rather than a 48 or 24 hour incubation, as a 
decrease in ATP levels was seen more clearly after 72 hours. Sevin et 
al., [1988] also demonstrated a direct relationship of ATP
luminescence and viable cell count over the range 250 to 485,000 
cells/ml. This group also evaluated the chemosensitivity of 56 tumour 
specimens using this assay, and correlated it to clinical response. 
They found a true positive correlation of 100% and a true negative 
correlation of 66.7% (thus yielding a sensitivity of 89.5% and a 
specificity of 1 0 0 %).
Others however, [Lahio and Trump, 1974] showed only poor correlation 
between ATP levels and dye exclusion following injury to Ehrlich 
ascites cells by various mitochondrial and respiratory inhibitors, so 
good correlations have not been universal.
ATP normally cannot penetrate the intact plasma membrane, so ATP 
leakage can be used as an indicator of cellular membrane damage. In 
such methods 2 subsequent measurements are made on the same cell 
suspension, namely extracellular ATP and within a few minutes after 
addition of a detergent, total ATP [Andersson et al., 1990].
Measures of cellular function other than direct ATP measurements have 
been used to indicate cellular viability. Some of the more commonly 
used ones are dealt with in the following text.
1.21 Assays of respiration and glycolysis
Observations of aerobic glycolysis in the presence and absence of 
drugs provide information about the manner in which a drug may affect 
respiration; for example, stimulation of aerobic glycolysis may 
indicate either inhibition or uncoupling of respiration [Bickis and 
Quastel, 1965; Quastel and Bickis, 1959].
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Tracers have been used for quantification of respiration and 
glycolysis since early days in chemosensitivity and other cytotoxicity 
testing.
Drug effects on RNA synthesis, aerobic glycolysis and aerobic 
glycolysis have each been shown to occur independently of each other 
in tumour slices, while an apparent correlation has been noted between 
energy-producing reactions and measured biosynthesis [Bickis et al., 
1965]. Further work showed that in glucose-containing media under 
aerobic conditions, the total ATP made available in the tumour tissue 
by respiration and glycolysis remains constant in the presence of 
respiratory or glycolytic inhibitors. Therefore in vitro inhibitors of 
biosynthesis, such as those mentioned above, are possibly due to 
more specific interactions than diminished availability of ATP.
The approach of using a tracer as an index of respiration and 
glycolysis, was semiautomated by Von Hoff et al., [1985] to screen
for antineoplastic agents. A modified BACTEC system (a technique for 
radiometrically measuring bacterial growth) was used on a variety of
tumour cell lines. After drug exposure, the cell suspension
14(30-40,000 cells) was mixed with uniformly labelled [ C]glucose and 
seeded into sterile, disposable 15 ml glass vials by injection 
through rubber aluminium caps. The vials were placed in the BACTEC 
system, which adjusts the atmosphere to 5% CO2 and 95% air (37°C). 
Measurement of the release of ^CC^ resulting from metabolism of 
[^C]glucose was performed on days 3, 6 and 9 and the instrument 
directly converted disintegrations into growth index values. There 
was a clear linear relationship between the number of cells seeded and 
the production of 1 Z^CC>2 from [^C] glucose. There was also a 
reasonably good correlation with the results obtained for the same 
compounds using a human tumour cloning assay, especially when a 
continuous drug exposure was used in both systems. This suggested that 
the inability to discriminate between reproductive cell death and drug 
induced delay in cell division (one of the theoretical limitations of 
a metabolic BACTEC assay) might only be of minor relevance when this 
technique is utilized for screening purposes [Scheithauer et al.,
1986].
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Further work led to development of modified microassays for the 
determination of metabolically generated ^CC^, such as that 
described by Gaines [1989]. The reaction, which measures 
decarboxylase activity, takes place in a microcentrifuge tube inside a 
2 0ml scintillation vial that contains a centre well with a 
CC^-trapping agent, resulting in greater safety than other methods.
Assays for glucose consumption are numerous, but recent work has led 
to semiautomated, colorimetric, modifications of such assays. A 
procedure utilizing the coupled activities of glucose oxidase and 
horseradish peroxidase, was described by Blake and McLean [1988] 
which is not subject to the spectral interferences caused by phenol 
red and sera in tissue culture media, apparent in other assays. The 
product of an oxidative couple between 4-aminoantipyrine and 
N-ethyl-N-sulfopropyl-m-toluidine, which is a chromophore, was used 
to develop a fixed time assay for glucose in media samples. Only 10/jl 
of media in a 1-ml assay volume was needed. Similar radiometric 
assays for glycerol and glycogen, which are also intrinsically linked 
to cellular and whole-animal energy balance, have been developed 
[Bradley and Kaslow, 1989], which are 10-100 times more sensitive than 
assays based on the detection of NADH by absorbance. They offer 
several practical advantages over spectral assays (detecting levels of 
0.2 to 1.0 /jM NADH), and haveing better reproducibility than previous 
assays.
These assays are cumbersome to carry out; those involving the use of 
radiolabels are potentially hazardous and do not lend themselves to 
successful routine screening of cytotoxicity.
1.22 Determination of metabolites in culture medium
Excreted metabolites reflect the activity of certain metabolic 
processes in vitro. Metabolites such as lactic acid, Alanine, 
2,2-Dihydroxyacetic acid, Maltol, Benzeneacetamide, Pyroglutamic 
acid ethyl ester, Pimelic acid, Phthalic acid, Citric acid, 
Cholesterol and Palmitic acid hydroxyethyl ester, have all been 
identified and quantified in biological material [Figenschou and
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Marais, 1991] and in the culture medium of fibroblasts [Antoshechkin 
et al., 1988]. Analytical assays with bacterial luciferase have been 
developed for a great many metabolites [Hastings, 1978; Brolin and 
Agrew, 1977; Ugarova et al., 1988], and commercial kits are readily
available for reactions based on soluble bacterial luciferase and 
NADH:FMN oxidoreductase, such as formation of the metabolites NADH, 
FMN, Formate, NAD, Glucose-6-phosphate and Glucose-l-phosphate. 
Improved sensitivity in detection of these metabolites is evident with 
further work in the area. Glucose-6-phosphate can now be assayed for 
in the ranges 1 - 1 0 0  and 1 - 1 0 0 0  pmol with soluble and co-immobilized 
highly purified enzymes [Me Elroy and DeLuca, 1983].
Some such metabolites have often been used as indicators of cellular 
activity in chemosensitivity testing. Familletti and Wardwell-Swanson 
[1988], have used quantification of the secondary cellular 
metabolite, lactic acid, to reflect not only cell growth, but also 
subtle changes in the cells' metabolism that might occur when exposed 
to lymphokines or other biological response modifiers. In a coupled 
oxidation of lactic acid, a tetrazolium dye present in the culture 
medium is reduced to a coloured formazan, where colour change and 
intensity are porportional to the concentration of lactic acid 
produced by assay cells. This colour is quantified photometrically in 
a 96- well plate reader. One of the advantages of this method is that 
it requires only 15/vl of sample culture medium, so a time-dose 
response evaluation can be prepared without setting up multiple 
cultures of the same cell line. It has been used to detect the 
activity of interferon.
Highly specific micromethods for the enzymatic determination of
radioactive [1 4 C]lactate have also been used [McCormick et al., 1991]
14by collecting released CO2 following the enzymatic decarboxylation
of radiolabelled lactate, enabling picomoles of the latter to be
precisely, easily and reproducibly measured in very small volumes or
in micro samples. Disadvantages to such systems however, include
unavoidable introduction of inhibitors of the enzyme, as many diverse
biological ions and other compounds are culpable. Also, significant
expense is incurred in determinations. Other enzymes have been
14employed to measure [ C]lactate. Lactate oxidase from Pediococcus 
sp. (L-lactate: O2 ~oxioreductase), which forms pyruvate and H2O2 ,
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can detect as little as 2.5 nmol of lactate after further 
peroxidase-catalyzed coupling of a sensitive chromogen to
4-aminoantipyrine [Bozimowski et al., 1985].
Yamashoji et al., [1989] used the production of ^2°2 intact cells
(promoted by the presence of menadione) to determine viable mammalian
cells. They found the concentration of H202 Proc*uced was proportional
to the density of viable cells, determined by measurement of the
chemiluminescence generated in the mixture of ' PYrenef and
bis(2 ,4,6-trichlorophenyl)oxylate, needing an incubation time of only
10 minutes for determination. No extraction of NAD(P)H from cells was
required and a stable chemiluminescent reagent can be used. While
cell density of PC-3 cells was proportional to the production of H2 02
in the presence of menadione, the correlation was not linear over the
whole cell density range tested (3 to 30 x 10^ cells/ml). The minimum
detectable cell density under the conditions used was only 3 x 10^
cells/ml, however they suggest that lower cell densities in the range 
4 51 0  to 1 0  cells/ml may be determined by using "the simple mixture" 
containing 0.25M sucrose, 5mM imidazole-intrate buffer (pH 7) and 0.1 
mM menadione.
1.23 Determination of protein synthesis and nucleic acid
synthesis
As early as 1966 and from then onwards, quantitative determinations 
of drug activity were being successfully carried out through the
evaluation of interference on nucleic acid metabolism in different 
human neoplasms [Bickis et al., 1966; Byefield et al., 1971; Knock
et al., 1971]. Tisman et al [1973] demonstrated a correlation
between the antimetabolic activity in vitro and clinical results. A 
more recent attempt to evaluate the effects of antitumour drugs was
based on the reduction of labeling index (the number of cells in 
mitosis) during 24 h incubation of cells in vitro [Thirwell et al., 
1976].
Horakova et al., [1978] showed that total cell number in control
cultures was directly proportional to the total cell protein or 
nucleic acids. However in treated cultures (exposure to 6-Thioguanine 
and Vermiculine), the relationship between these parameters was
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disturbed. They felt that this was due to the unbalanced growth which 
was an integral part of the cytotoxic reaction of the studied agents. 
They concluded from their results that only direct cell ennumeration 
was suitable for the detection of the cytotoxicity of such agents.
Knock et al., [1978] however, found that assays for incorporation of
thymidine into DNA, uridine into RNA and leucine into protein, 
reliably predicted clinical results. They also insisted on the value 
of these assays in providing an insight into mechanisms of drug 
activity. Chowdry and Neogy [1980] used incorporation of 
phenylalanine and uracil to establish the effect of a number of 
antitumour antibiotics on protein biosynthesis.
Overall, many workers used these methods^ effectively for 
chemosensitivity testing, and their usefulness was established. The 
methodology used however, was often quite involved and time 
consuming. Modifications to simplify these assays were sought. In a 
comparison of autoradiography and scintillation counting to determine 
incorporated radioactivity, Tanigwa et al., [1982] found a strong
correlation between the results of the two methods and colony growth, 
but favoured scintillation counting due to its technical ease.
Short-term radioincorporation assays were also developed [Volm and 
Matterson, 1976] and applied to chemosensitivity testing. This 
approach consists of exposing the cell suspension to drug for 1 - 2  
hours and then to radioactive precursor for a short period (around 1  
hour). Cultures were then washed, harvested and radioactivity was 
measured. Volm et al [1979, 1981] have used the short term assay
(STA) extensively to detect proliferation-dependent and induced 
tumour-resistance to cytotoxic agents. They reported that if a 
rapidly proliferating tumour responds to Doxorubicin treatment in 
vitro. then in most cases a similar effect can be detected with other 
cytotoxic agents. In these short term assays sterility does not have 
to be maintained [Zirvi et al., 1986]. Others used similar short term 
assays [Livingston et al., 1980], with the use of a longer incubation 
time with radioisotope (18 hrs). Here, one million cells per tube 
were used so due to shortage of viable cells only 63% of 35 specimens 
could be tested. This indeed is an important drawback of these assays.
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Although it was known that inhibition of incorporation into DNA and 
reduction of cell survival depended on both the time of exposure and 
the concentration of drug in the cell, the optimum time of exposure 
in the short-term assay had not been established. Discordance between 
the results in these assays and the clonogenic assay was felt to be 
due to the drug exposure time being too short, which prevented slow 
growing tumours from responding. Thus it was concluded by Zirvi et 
a1., [1986] that the short term assay was less sensitive than the
clonogenic assay in measuring tumour chemosensitivity as far as drug 
dosage was concerned. Its possible predictive value for some agents 
(eg, BCNU, Cis-Platinum and Doxorubicin) was thought to be still 
relevant though. They suggested that further studies on the STA 
should focus on alkylating agents and other antimetabolites.
When compared to results from the HTSCA and clinical observations it 
was felt that the short drug exposure created a problem [Seeber and 
Schmidt, 1977] which Bazeed et al. , [1988] later confirmed - the
incubation time for the test may be too short for a slowly growing
tumour such as a renal cell carcinoma. Their kinetic studies not only
3 3showed that the uptake of [ H] thymidine and [ H] uridine is very low
in the first 4 hours, but found that nearly 80 hours is the average
time needed for the uptake to reach a maximum.
Freidman and Glaubiger [1982] further developed the HTSCA by utilizing 
a liquid top layer containing the cells and a soft agar bottom layer.
3Tumour growth was measured by [ H] thymidine incorporation into TCA
precipitable material. Good correlations were obtained for cell
number and colony number and in drug treated samples they got a 95%
similarity. Many other workers obtained similar promising results
[Tanigwa et al., 1982; Rupinak et al., 1983; Sondak et al., 1984;
Twentyman et al., 1985; Jones et al., 1985]. Unlike the HTSCA
however this assay only takes 5 days, and has lower variances. Normal
3tissues did not incorporate significiant amounts of [ H] thymidine 
into TCA-precipitable material, so it was reported that normal
components plated did not interfere with assay results. Reaggregation 
is also avoided in this assay. In contrast to the HTSCA however, the 
growing tumour cells are not fixed, thus the assesment of individual 
colonies is not possible and the clonal origin of the aggregates is 
less certain. Overall the assay had a higher success rate and lower
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false-negative rate than the HTSCA for chemosensitivity testing. In 
1985 Kern et al., developed a miniaturized version of this assay; the 
MINI assay. The assay was performed in 16mm cluster dishes instead of 
35mm; using 15,0000 cells per well instead of 50,000 and using 
agarose instead of agar. This development offered improved growth of 
breast and colon tumour cells from 41% and 47% respectively to 63% and 
68%.
Further modifications of the 5 day test in semisolid medium were done 
[Akiyoshi, 1986; Wada et al, 1988]. Originally, the labelled cell 
pellet (from centrifugation of the solubilized agar layer containing 
cells) was precipitated overnight. Instead now, the labelled cells 
were collected on a membrane filter sealed on the underside of the 
dish. This reduced the assay to a 4 day assay and removed the need for 
a precipitation procedure. There was still significiant correlation 
between the 2 procedures.
3 5A rapid S-methionine uptake assay for drug sensitivity testing,
using scintillation autoflurography to measure the endpoint was used
by Darling and Thomas [1983], Freshney and Dendy [1983] and Thomas et
al. [1985]. Cells were exposed to drug for 72 hours and then washed
3 5and allowed to recover for 3 - 5  days, after which S-methionine 
incorporation into cells was measured. Some of this work [Freshney et 
al., 1975] showed that prolonged exposure to drug, followed by 
recovery, were necessary to obtain stable ID5 q (inhibitory dose) 
values for most drugs, especially phase specific agents. They found 
that using this system, the ID5q measured by clonogenicity and 
microtitration assay correlated well.
Overall, although good correlation was obtained with these assays and 
clonogenic assays, they were still cumbersome to carry out and 
hazardous by their use of radioactive material. They also required 
the use of a high cell number.
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1.24 Determination of intracellular enzyme activity
Assays for other intracellular enzymes have historically been used to 
indicate cellular viability. Probably the most commonly used is that 
of lactate dehydrogenase. It has been found promising as an indirect 
measure of viable cell counts by Jauregui et al. , [1981] and by Chao
et al., [1988] in assessing the number of viable hepatocytes in
monolayer cultures. In the latter study, the decline of 
intracellular LDH was observed with a concomitant detachment of the 
monolayers. Also this decline in intracellular LDH corresponded with 
the increase in extracellular LDH. Intracellular LDH was found to be 
more indicative of cytotoxic effects of a number of chemicals, than 
measurement of intracellular protein. Intracellular DNA showed a poor 
correlation with cytotoxic effects. The assay was determined to be
procedure utilizing the coupled activities of glucose oxidase and
in 2 mis. However, the number of viable cells thus determined,
should be regarded as 'viable average equivalents', since partially 
viable/injured cells may retain part of their LDH content and remain 
attached to the monolayer cell culture. Ponsoda and Castell [1991] 
developed a semi-automated spectrophotometric assay for intracellular 
LDH in 96 well plates of adherent cells for cytotoxicity studies. The 
procedure involves 'in situ' homogenization of cells, followed by 
measurement of LDH activity with a colorimetric method based on the 
reduction of a tetrazolium salt to a violet formazan by the NADH 
formed by LDH. The assay was used to measure the dose-response loss 
of intracellular LDH after 24-h exposure of rat hepatocyte cultures to 
cytotoxins.
The reader may note that a feature of the assays recently considered 
is that they have been readily adapted to miniaturization and 
semiautomation. Such a process constitutes a great advance in the 
applicability of general growth and viability assays to cytotoxicity 
testing and should be especially borne in mind as these and the 
following endpoints for cytototxicity testing are considered.
The lysosomal enzyme, Hexosaminidase, has been found to be a 
sensitive and simple microtitre assay for cell number and detection of
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lymphokines and cell surface antigens [Landegren, 1984]. This assay 
has been found to have similar sensitivity to the thymidine 
incorporation assay, but to be more precise and less laborious.
Determination of Alkaline Phosphatase has also been used to detect 
proliferation. It has been combined with Fast Red to allow 
simultaneous detection of proliferation and cell surface markers 
[Murdoch et al., 1990],
Another intracellular enzyme assay is that of Acid Phosphatase. In a 
paper by Connolly et al., [1986], linear activity of the enzyme was
demonstrated for cell number over the range 1 0 0  to 1 0 0 , 0 0 0  endothelial 
cells per well. This miniaturized, semiautomated, colorimetric assay 
was used to determine growth curves for endothelial cells in the 
presence and absence of endothelial cell growth factor from bovine 
hypothalamus and to monitor fractions during purification of growth 
factors. In the work described in this thesis, the assay was applied 
to cytotoxicity testing.
The Succinate Dehydrogenase inhibititon test (SDI) was introduced for 
chemosensitivity testing based on the correlation of the Succinate 
Dehydrogenase assay using tetrazolium salt as a hydrogen acceptor with 
cell viability [Dallne, 1960] and has since been used to this end 
[Kondo et al. ,; Kondo, 1971]. In the development of this assay, it 
has been semiautomated and miniaturized [Mossman, 1983], and 
extensively compared to other endpoints for chemosensitivity testing 
(mostly HTSCA and radioincorporation assays). With its development 
(considered in 1.25) and the development of similar tests, the merits 
of semiautomated, colorimetric assays came to be realized, and was 
responsible for changing the emphasis of chemosensitivity testing. 
Presumably this alos influenced developments in other areas of 
cytotoxicity testing. This thesis concerns itself with the 
development and use of these cytotoxicity assays.
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1.25 Colorimetric assays
Developed in 1984 by Borenfreund and Puerner, the Neutral Red (NR) 
method quantifies surviving cells by incubation with the supravital 
dye, neutral red, followed by colorimetric analysis of the dye 
extracted from the lysosomes of viable cells. The assay has also 
been combined with a microscopic screen for morphological 
alterations. This assay has been used extensively for in vitro 
screening of chemicals, heavy metals and environmental compounds as 
well as a rapid chemosensitivity assay [Borenfreund et al., 1990; 
Fiennes et al. , 1987; Zhang et al., 1990; Flick and Gifford, 1984]. 
Because the rate of NR release is similar to the rate of uptake of 
the NR, an NR release assay has also been used similarly to the 
former assay [Reader et al., 1989].
Improved sensitivity of assays for protein determination [Bradford,
1976] has been found with the use of a number of protein stains. 
Crystal violet has been used [Kramer and Carver, 1986; Matthews and 
Neale, 1987; Flick and Gifford, 1984; Bonnekoh et al., 1989] for
screening of cytotoxins, as has Napthol yellow [Skehan and Friedman,
1985] methylene blue [Finlay et al., 1984; Absher et al., 1991],
Comassie brilliant blue [Elson et al, 1992] and Kenciad blue; the
latter of which has been adopted as part of a general screening
system by the FRAME (Fund for Replacement of Animals in Medical 
Experiments) multicentre project on cytotoxicology [Knox et al.,
1986]. Skehan et al., [1990] compared the ability of 21 histologic 
dyes to measure cell density and cytotoxicity in 96-well microtitre 
plates. Each of the dyes bind electrostatically to macromolecular 
counterions in cells fixed with TCA, which allows their binding and 
solubilization to be controlled by pH. These workers found that 13 
of the dyes stained well enough to provide an adequate basis for 
assay of cytoxicity in 96 well plates, but overall they found the 
best performance with Sulforhodamine B (SRB). Indeed, because of its 
technical advantages, this assay has been adopted by the National 
Cancer Institute (NCI), USA in their _in vitro drug-screening program 
[Rubenstein et al., 1990].
Apart from the sensitivity, simplicity, safety, linearity with cell 
number, ability to be easily automated, and relative inexpense of 
these assays, a further advantage of the staining assays (SRB among
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others) is their undestructive endpoint. Using a modification of the 
Neutral Red assay, Knocks and collegues [1986] were able to read NR 
stained plates, de-stain and re-stain with the kenacid blue method. 
Plates were again de-stained and stored for re-staining at a later 
date if necessary.
By far the most extensively validated of these assays however, 
(especially in the field of chemosensitivity testing) is the MTT assay 
based on the SDI assay already mentioned. Mossman, in 1983 used this 
semiautomated, colorimetric assay to to measure cytotoxicity, 
proliferation and activation in lymphocytes. The assay was reported 
to detect living but not dead cells and the signal generated was 
reported to be dependent on the degree of activation of the cells. As 
already suggested, the main reason for its popularity was that the 
plates could be read on a multiwell scanning spectrophotometer (ELISA 
reader) with a high degree of precision. No washing steps were needed 
and low cell numbers could be used, giving potential for more 
replicates to be carried out.
The basis of the assay is that MTT [3,(4,5-dimethyl-thiazol-2-yl) 
-2 ,5-diphenyltetrazolium bromide]' a soluble yellow dye, is
metabolized by the enzyme succinate dehydrogenase in the mitochondria 
of metabolically active cells, to a dark blue insoluble formazan 
product. The precipitate formed can then be solubilized and colour 
development read on a plate reader. The enzyme reduction takes place 
via coupling at 2 points along the cytochrome oxidase system, however 
there is presently no convincing evidence that the mitochondria are 
the only site of MTT reduction in the intact cell [Jabbar et al., 
1989] .
In the years which followed, not only did this paper prompt extensive 
use and validation of this method, but also encouraged the 
development of other miniaturized, semi-automated, colorimetric 
assays (some of which have been mentioned already; e.g., the LDH 96 
well assay by Ponsoda and Castell, 1991). Some technical problems 
involving non-dissolution of the formazan dye were overcome [Twentyman 
and Luscombe, 1987]. The assay was tested on an extensive range of 
human cell lines, and linear relationships of cell number versus 
formazan production was generally shown [Carmichael et al., 1987;
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Wilson et al., 1990; Campling et al., 1991]. It was widely used for
drug sensitivity testing [Alley et al., 1986; Carmichael et al.,
1987, 1988; Finlay et al., 1986; Park et al., 1987-, Twentyman and
Luscombe, 1987; Fanning et al . , 1990; Coles, 1986]. Good
correlations were observed when the assay was compared to clonogenic 
assays [Carmichael et al., 1978; Chang and Gregory, 1987; Wasserman 
and Twentyman, 1988; Me Hale and McHale, 1988; Shimoyama et al., 
1989], electronic cell counting [Finlay et al., 1986; Twentyman and 
Luscombe, 1987] and dye exclusion assays [Carmichael et al., 1987;
Ruben and Neubauer, 1987; Pieters et al. , 1988; Twentyman et al.,
1989]. It was also used for radiosensitivity testing [Carmichael et
al., 1987], for analysis of terminal differentiation in cultures
[Wiedermann et al., 1990] and macrophage cytotoxicity activity
[Ferrari et al., 1990].
A modified form of the assay was adopted by the National Cancer 
Institute USA (NCI) as part of their screening system for
chemosensitivity testing of new drugs on cell lines [Alley et al.,
1988, Ruben and Neubauer, 1987], however it has since been shown to 
compare less favourably with the SRB assay already mentioned.
The technique has been widely used for chemosensitivity testing of
tissue samples. Among the cell types that have been tested are 
chronic [Twentyman et al., 1989] and acute [Pieters et al., 1988]
lymphatic leukemia cells and leukemic blast cells [Campling et al.,
1988], acute myeloid leukemia [Sargent and Taylor, 1989], renal cell
carcinoma [Mickisch et al., 1990] and small cell lung cancer
(Campling et al., 1991]. Wilson et al., [1990], reported that in a 
feasibility study for ovarian malignancies, in vitro results with the 
MTT assay mirrored those determined from clinical response rates. The 
importance of validating the assay for each cell type has been stated 
[Sargent et al., 1989].
Carmichael et al., [1988], reported that optimal assay duration for
human lines should be a minimum of 4 days to allow for cell death and 
loss of dehydrogenase activity, with a maximum of 7 days to obviate 
the necessity for refeeding cultures. Campling et al., though,
[1991], stated that a good reproducible variation in drug effect 
between patients is obtained after only 48 hours incubation. Excellent
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reproducibility of the assay has been reported by Sargent et al,, 
[1989], though elsewhere [Carmichael et al., 1988], some 
inter-experimental variability has been noted.
Some drawbacks to the assay have been identified however. 
Contamination by metabolically active, non malignant cells capable of 
reducing MTT formazan can falsify results [Carmichael et al., 1987; 
Wilson et al., 1990] and this has been reported to limit its use. 
Note however, that this factor is common to all similar short-term 
assays. The other factor of importance which has been mentioned 
[Carmichael, 1987] is that the assay is a growth assay, and is 
therefore incapable of distinguishing between cytostatic and cytocidal 
effects.
Other tétrazolium dyes were used in similar assays (XTT, INT, NBT) 
[Scudiero et al., 1988; Bernabei et al., 1989; Alley et al., 1988] 
but none has been as widely used in the area of chemosensitivity 
testing as the MTT assay. INT (p-iodonitrotetrazolium voilet) is 
metabolized into a red formazan derivative, evaluable at 492nm. 
Linear relationships have been found for viable cell number and O.D. 
and its use has been established in chemosensitivity testing [Bernabei 
et al., 1989; Dal Pozzo et al., 1989; Santini et al., 1989].
So, all of these assays have been shown to be fast, reliable and 
simple. Also because they have been miniaturized, smaller cell 
numbers can be used (which is a very important factor with tumor 
biopsies). Certainly they offer more advantages than any of the 
assays previously used. What further merits could be possibly needed 
for effective toxicity assays - increased sensitivity perhaps?
1.26 Fluorometric assays
Van Lambalgen and Lelieveld [1987] developed the PIT method for drug 
sensitivity testing. After drug exposure a solution containing 
propidium iodide, ink and triton X-100 (PIT) was added to the cell 
culture. Triton X-100 lysed all cells, which were subsequently 
stained by the DNA specific fluorescing propidium iodide. The ink 
quenched all background fluorescence. Results showed a linear
53
relationship between cell number and fluorescence intensity and 
reproducible dose-response curves were obtained for 6 drugs tested. 
With DNA-enhanced fluorescence [Me Caffrey et al.,, 1988] using DAPI 
or Hoescht 33342, which intercalate the DNA at A-T bonds, similar 
relationships were shown. Here, the cells were first fixed, again 
allowing storage for determination at a later date. Fluorescine 
diacetate fluorescence was used by Larsson and Nyger [1989] and was 
found to be sensitive to viable cell number for cell lines and fresh 
leukemic samples. Another fluorescence - based viability assay that 
has been used is based on a double staining technique with BECF 
(2 1-7'-biscarboxyethyl-5(6 )-carboxyfluorescein) as a vital dye and
propidium iodide [Leeder et al. , 1989]. A further combined dye is
the combined Hoechst 33342 and fluorescein diacetate [Larsson and 
Nygren, 1989; Larsson, 1990] method. It has been successfully used 
for rapid chemosensitivity testing and also for detection of multiple 
drug resistance in acute lymphoblastic leukemia cell lines. Aside 
from DNA fluorometric stains, fluorogenic enzyme assays have been 
developed. Huschtscha et al., [1989] developed a fluorogenic alkaline
phosphatase assay which estimated low cell numbers for many cell 
types.
Although some of these fluorescent dyes have been used in the past 
and have been dismissed earlier in this chapter, they are given 
greater consideration in this text because here they have been 
modified to give quantitative results for cell number. Additionally 
they have been semi-automated which at this stage in the development 
of assays for cytotoxicity testing, we have seen to be an important 
advantage. These fluorometric assays are reported to have increased 
sensitivity over other semi-automated micro assays which would appear 
to be a further advantage.
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1.27 Aim of this project
The need for in vitro toxicity tests has been well established, and 
the variety of different systems for toxicity testing have been 
alluded to here. The wide range of endpoints which have been used 
for cytotoxicity testing has been considered, but we have seen that 
some of the systems and some of the endpoints used have not been 
extensively validated. This creates a problem in ensuring the 
widespread acceptance and use of in vitro cytotoxicity testing
methods. Indeed, it has been pointed out [Balls and Bridges, 1984; 
Ekwall, 1983], that validation of the currently used methods is the 
key to extending the use of in vitro methods.
With this in mind, the aim of this project was to validate and 
compare a number of in vitro cell culture assays, primarily for use 
as chemosensitivity tests, but also for their application to other 
areas. Because we have been perhaps 'overcome' with the merits of 
miniaturized, semiautomated, colorimetric, assays, 5 of such 
assays were chosen for comparison purposes, including an acid
phosphatase growth assay, for prospective application to toxicity 
testing. The emerging importance of the MTT assay in 
chemosensitivity and immunological work, warranted the inclusion of 
this assay in the study for further scrutiny. The neutral red assay, 
which is probably the most widely used cell culture cytotoxicity 
assay for environmental screening, was also added to this list, 
along with a simple crystal violet dye elution assay. The final 
assay to be considered was the SRB assay, which has assumed much 
importance in the National Cancer Institute's screening program.
At the commencement of this work, a popular instrument for endpoint 
determination in this laboratory and in other laboratories throughout 
Europe, [Ryan and Me Sweeney, 1986] was an image analyser, so it was 
considered pertinant to relate some of this work on assay
performance, back to the performance of the technique of image
analysis.
It was proposed firstly, to define the limits of sensitivity and 
linearity for these assays; and determine if this varied for 
different cell lines. Precision and reproducibility, two very
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important factors in the eventual success of an assay, were also to 
be considered. Because these assays have widely differing end 
points, their suitability to cytotoxicity testing in general was to 
be questioned by examining their relationship to cell viability. A 
further interest in characterizing these assays, was to investigate 
the ability of these assays to suggest the mechanism of toxicity of a 
chemical (by comparing the sensitivity of each of the assays after 
exposure of target cells to chemicals with mechanisms of action 
relevant to the various endpoints). Previous work has demonstrated 
that the MTT assay at least, is not consistant in its ability to 
distinguish cellular viability [Jabbar et al., 1989]. Thus the aim 
of this work was also to consider the ability of the different assays 
to distinguish viability under different circumstances (e.g., after 
drug treatment of different durations), by determining the 
replicative potential of the cells (after cloning).
Chemosensitivity testing has been the area to which the assays 
described in this thesis have been most often used, so it would be 
pertinent to consider the application of these assays to this end. As 
we have seen, this area is fraught with technical hurdles which must 
be overcome before significant advances can be made. Probably the 
biggest stumbling block is poor tumour biopsy growth in culture. Any 
improvements in this area would contribute substantially to this end, 
as would the identification of factors adversely affecting tumour 
culture growth. Because of this, it was also decided to attempt to 
culture some primary lung tumor tissue and perhaps gain an insight to 
factors which need to be improved before chemosensitivity testing of 
these tumors can improve.
Resulting from the scrutiny of these assays, it was proposed to 
choose one or more assay from this panel, on the grounds of 
performance relative to the others, and identify areas where it 
could be applied (aside from chemosensitivity testing); for example 
environmental monitoring.
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MATERIALS AND METHODS
All cells and biological samples were handled in a class II vertical 
laminar air flow cabinet. No infected tissue samples were processed, 
and in dealing with primary tissue, latex gloves were worn at all 
times. All materials which had been in contact with cells were 
autoclaved before disposal. Stock anticancer drugs were prepared in a 
fume cupboard. All subsequent drug work was performed in a Cytoguard 
safety laminar air flow cabinet, regularly validated by contract 
engineers. All materials which had been in contact with drugs were 
transferred to a fume hood and rinsed thoroughly in running water 
leading to a main drain. Copious amounts of water were emptied down 
the drain after drug rinsings to aid dilution. (Obviously all 
cell-contaminated drug waste was autoclaved before this step). 
Mutagenic and other dangerous chemicals (e.g., MTT) were weighed out 
on an analytical balance in a fume hood. For all these manipulations, 
latex gloves and a face mask were always worn.
2.2 Maintainence of sterility
Because animal cells in culture have such slow doubling times relative 
to micro-organisms, it is imperitive that sterility be at a premium 
at all times. All materials were autoclaved before use (121°C for 20 
minutes), except for unstable reagents, which were filtered through a 
0.22 /jm filter (Millex-GV, SLGV025BS). All sterile work was carried 
out in a class 2 vertical-flow laminar air flow cabinet adhering 
strictly and rigorously to asceptic technique.
2.3 Growth surface
2Cells were grown in polystyrene tissue culture grade flasks (25cm and 
75cm ) (Costar 3055, 3375) and cluster dishes (6 , 24 and 96 well)
(Costar 3056, 3524, 3599) electrostatically treated to allow cell
attachment. When larger cell numbers were required, cells were grown 
in glass roller bottles in 75 mis of medium. Nonnadherent cells (small 
cell carcinomas) were sometimes grown in spinner flasks, which were 
first coated with Dimethyldichlorosilane solution (BDH 33164) to 
discourage cell attachment to the surfaces of the flask. Spinners 
were rinsed well after this treatment.
2.4 Media preparation
2.4.1 Glassware
All glassware used was first thoroughly washed by steeping (30 minutes 
- 2 hours) in a 1% solution of RBS (R. Borghraef) and then scrubbing 
with bottle brushes. They were washed thoroughly with tap water 
before 3 separate rinses in distilled water and one final rinse in 
ultrapure water. Caps were washed separately to prevent metals from 
leaching onto glassware.
2.4.2 Ultrapure water
High quality purity water is critical for cell culture. This was 
satisfied by firstly passing the water through two prefilters to 
remove ionic and non-ionic solutes and then through two ion-exchange 
filters, a carbon filter and a 0.22 /jm cellulose acetate filter. The
2.1 Safety
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reagent grade water which resulted was continuously monitored by an 
on-line conductivity meter and was used only when the resistance was 
between 10-18 megaOhms/cm.
2.4.3 Bottles
Stock media was prepared in 500ml bottles and transferred to sterile 
100 ml bottles for routine use. Bottles for media preparation and use 
were kept solely for this purpose and stored separately from the stock 
of bottles used for collecting waste. All bottles were checked 
regularly for the presence of a rubber seal in the cap and for the 
absence of fractures.
2.4.4 Liquid media
To 450 mis of sterile ultrapure water the following constituients were 
added:
Constituient Supplier Catalogue no concentration 
/100 mis
volume 
mis
10 x MEM Gibco 042-01430M 50.0
10 x DMEM Gibco 042-02501M 50.0
1M Hepes Sigma H9136 23.83 g 10.0
7.5% NaHC03 Riedel-de Haen 31437 7.5 g 4.5
1M NaOH BDH 30167 6.0 g *
to MEM only: 
NEAA' Gibco 043-1140H 5.0
* For MEM approximately 3.0 mis were needed to pH to 7.45 - 7.55, 
whereas for DMEM approximately 5.5 mis were needed.
' = Non Essential Amino Acids
(Hepes, NaHCO^, and NaOH solutions were autoclaved before use; all 
other constituients were sterilized during manufacture).
2.4.5 Powdered media
Hams F12 powdered media (Gibco BRL 074-01700N) was added to 5L of 
sterile ultrapure water in an erlenmeyer flask and mixed thoroughly. 
100 mis 1M Hepes buffer was added and the contents mixed thoroughly. 
The pH was adjusted to 7.45 - 7.55 with 5N NaOH. Using a peristaltic 
pump (Braun FE411) at a flow rate of 90 mls/min (the rate was set at 
10 mis/ min initially and was gradually adjusted to this maximum 
level) and a length of autoclaved teflon tubing to which a 0.22^m high 
volume millipore bell filter (Gelman Sciences 12158) was attached; the 
medium was filtered into sterile 500 ml bottles.
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2.4.6 pH
All media was adjusted to 7.45 - 7.55 pH units with sterile IN NaOH or 
1.5N HC1 (BDH 28507) before use.
2.4.7 Sterility checks
An aliquot of medium from each labelled bottle was transferred into a
sterile universal and incubated at 37°C for at least 4 days to show up
any bacterial contamination. Blood agar plates (Medlabs), 
Thioglycollate broth (Oxoid, CM173) and Sabourand broth (Oxoid, CM143) 
were also inoculated with medium to determine the presence of 
microorganisms. Only media shown to be free from microbiological 
contamination was used.
2.4.8 L-Glutamine
After sterility checking of medium and before its use, 1 ml of lOmM
L-Glutamine (Gibco 043-4030H) was added to 100 mis of medium.
2.4.9 Serum
Before use, serum was added to sterility checked media. Generally 
cells were grown in 5% serum. Because serum contains a host of 
undefined constituients, and because of the huge variability in the 
presence, amount and activity of these constituents from one batch of 
serum to another, its capacity for supporting growth can consequently 
vary substantially. It was therefore essential to screen serum 
batches before use to identify suitable batches. Suitable serum for 
growth was dictated by supply, performance (in terms of growth 
promoting ability) and cost. It was important that the same batch of 
serum be used for the whole duration of experiments to be compared. 
The serum routinely used for cell growth throughout this work was 
Foetal Calf Serum (FCS) (Sera Labs, batches 801117, 801111, 801017).
The experimentation involved in batch testing and selection of these 
sera is described in 2.35 and 2.42.8.3
2.4.10 Antibiotics
Cells were routinely grown in antibiotic-free medium.
2.5 Incubators
Incubators were set at 37°C and were regularly checked with a 
thermometer. They were connected to an emergency electricity supply 
which switched over to an electrical generator in cases of power-cuts. 
C02 incubator regulators were set to provide a 5% C02 atmosphere from 
a COz cylinder on a changeover unit. This unit switched to a standby 
cylinder, when the original cylinder became empty.
2.6 Thawing frozen stocks
To re-start a culture from stocks frozen in liquid nitrogen, a vial 
was carefully removed from storage using visor and gloves, and this 
transaction was entered in the catalogue system. The name and passage 
number of the cell line were carefully double checked. The vial was 
quickly thawed in a 37°C waterbath, resuspended in 5 mis of medium in 
a sterile universal and centrifuged (1000 rpm/ 5 mins) to remove the
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cells from the 10% DMSO (DiMethylSulphOxide) solution in which they
were frozen. Cells were then resuspended in fresh medium (10% serum), 
assessed for viability using the trypan blue method (see below) and 
seeded in a culture flask at a density of >= 10^ cells. The following 
day the culture was fed with fresh medium (1 0 % serum).
2.7 Feeding cells
As cells metabolize in culture, they produce lactic acid which lowers 
the pH of the medium and turns the phenol red indicator present in the 
medium from red to orange/ yellow. This visually indicates that the 
medium is spent and must be replaced to enable further cell growth.
Spent medium was poured into a waste-bottle and replaced by fresh
medium (7 mis/ 25cm flask; 20 mis/ 75cm flask). Flasks were
incubated at 37°C.
Different cell lines require different culture media, and the medium 
routinely used for culture of the different cell lines used here, is 
tabulated below:
cell line cell type
growth
medium
RPMI-2650 Nasal, squamous cell carcinoma MEM
SK-LU-1 Lung, adenocarcinoma D/HF12
SK-MES-1 Lung, squamous cell carcinoma D/HF12
Calu 3 Lung, squamous cell carcinoma D/HF12
DLKP Lung, squamous cell carcinoma D/HF12
DLRP Lung, squamous cell carcinoma D/HF12
SCC-9 Tongue, sqamous cell carcinoma D/HF12*
Hep-2 Cervix, squamous cell carcinoma D/HF12
MDCK Normal canine kidney, epithelial MEM
NRK Normal rat kidney, fibroblastic DMEM
- where D/HF12 refers to equal volumes of DMEM/ Hams F12
* SCC-9 culture medium contained 0.4 pg/ml Hydrocortisone 
(Sigma H4001).
All of the above were routinely grown in 5% FCS except for Calu-3 
which was grown in 10% FCS.
All of these lines were obtained from the ATCC (American Type Culture 
Collection) except for DLKP and DLRP which were established in this 
laboratory [Law et al., in print].
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2.8 Subculturing
Anchorage dependent cells require a cell surface for attachment and 
growth. Once a cell monolayer becomes confluent, cells will generally 
become contact inhibited and will enter a stationary phase of growth. 
Some cells (Hep-2, for example) will continue to grow in piled up 
layers and form multilayer colonies. For a culture to remain in 
exponentional phase though, it must be supplied with fresh medium and 
adequate free surface for attachment. To ensure this, cells are 
regularly subcultured (passaged) and seeded at lower densities in 
fresh medium. Cells were generally passaged twice weekly, but this 
depended on their growth characteristics. Very slow growing cells 
(for example, Calu-3) were passaged less often, whereas rapidly 
growing cells (MDCK, Hep-2) necessitated more frequent passaging. The 
frequency, of course, depended on the initial seeding density in the 
flask.
To passage the cells, medium was removed to a waste bottle and flasks 
were rinsed with PBS (Phosphate Buffered Saline, Oxoid BR14a; 1 
tablet per 100 mis water before autoclaving). This was to remove any 
traces of FCS in the medium, as FCS contains a trypsin inactivator. 
Then Trypsin Verseine solution (TV) (0.25% Trypsin; Gibco, 
043-05090H; and 0.022% Ethylene Diamine Tetrachloroacetic2Acid (EDTA); 
Sigma ED2SS; in PBS) was added to flasks (2.5 mis/ 25cm flask; 7.5 
mis/ 75cm flask) and incubated at 37°C for 10 - 15 minutes or until a 
single cell suspension was obtained. Then 5 mis of medium was added 
to the flask, and the liquid (containing cells) was removed to a
universal (Greiner, 201175) and centrifuged at 1000 rpm for 5
minutes. The supernatant was poured off into a waste bottle and the 
pellet resuspended initially in 1 ml of medium with a Gilson pipette 
and then in 5 mis of medium. A cell count was performed (see below) 
and the required number of flasks were seeded at the desired density.
2.9 Counting cells
A 1:6 dilution of trypan blue (Gibco 043-05250H) in cell suspension
was made in an eppendorf and after 5 minutes, 100 ¡j1 of the mixed 
suspension was placed on a haemocytometer. Each of the 4 large (16 
small) squares on each arm of the hatched cross was counted and the 
average count obtained. Viable cells remained unstained as they 
excluded the dye, and those with a damaged cell membrane (generally 
equated with 'dead' cells) took up the dye and stained blue/brown. 
This is illustrated in the photograph below.
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Photograph 2.1: Photogmicrograph of a haemoctyometer counting
chamber (x 100), showing 'viable' cells excluding Trypan blue, while 
'dead' cells are stained (blue/ brown) by the dye.
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2.10 Freezing cells
It is imperitive that cells for freezing should be free of all 
contamination and in good condition. It is preferable to freeze down 
cells at a high cell density to ensure an adequate viable cell seed
upon thawing. Because cell size differs greatly, it is not relevant
to report a universal cell number to freeze per vial. Instead no less 
than one 'almost' confluent 25cm2 flask, or whenever possible one 
75cm2 flask was frozen in each vial.
Cells for freezing were trypsinized in the normal manner, and the 
cell pellet was resuspended in 0.75 mis for each vial to be frozen. An
equal volume of 10% DMSO in medium was added dropwise very slowly,
and with intermittant shaking. The suspension was then transferred 
into a cryovial (Greiner 122278) labelled clearly with the cell line, 
passage number and date, and placed in the vapour phase of the liquid 
nitrogen container. After 3 hours it was placed in the liquid phase 
and then catalogued. The freezers themselves were regularly checked 
and replenished with liquid nitrogen so that the level always remained 
well above the vial containers.
2.11 Prevention of contamination
Adherence to aseptic technique will prevent contamination by fungi, 
yeast and bacteria. Contamination, when it occurs can generally be 
spotted by careful microscopic examination. Contamination by 
mycoplasma, or cross contamination with other cell lines however, is 
generally not easily observed.
2.11.1 Mycoplasma
Contamination by mycoplasma may be expected if the cells in the 
culture change in their morphology (become more granular or 'raggy 
looking') or growth characteristics (slowing in growth rate) 
accompanied sometimes by sudden drop in pH of the medium. However the 
best way of monitoring the cultures is to regularly screen for the 
presence of these bacteria. Cultures were regularly tested for the 
presence of mycoplasma by the procedure outlined below and those found 
to be mycoplasma contaminated were immediately eliminated and laminar 
flow cabinets thoroughly cleaned or fumigated.
222 mm cover slips were washed in 2% RBS, rinsed in ultrapure water 
and then in 70% IMS (Industrial Methylated Spirits, Lennox UN No. 
1170) and dried in lint-free cloth before autoclaving in a glass
petridish. Using a sterile forceps, one slide was placed into each
30mm"3 culture dish.
The indicator cells used were low passage NRK which were known to be 
mycoplasma free. 1 ml of a 5 x 10 /ml cell suspension was added to 
each cover slip and incubated at 5% C02 overnight.
lml culture medium (known to be antibiotic free) which had been in 
contact with cells for no less than 3 days, was added to the cover
slips (2 replicates per culture). Control dishes had only fresh
medium added.
After cells grew to approximately 50% confluence (3-4 days), slides 
were washed twice with PBS, once with PBS/ Carnoys reagent (1:1) and 
fixed in Carnoys for 10 minutes. Slides were air dried, washed twice
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with ultrapure water and stained for 1 0  minutes with 2 mis dilute 
Hoescht (1/20,000 in water). Because Hoescht is light sensitive, 
these manipulations were carried out in petridishes covered in 
tinfoil.
Slides were washed 3 times in ultrapure water and mounted in 
glycerol mounting medium, pH 5.5, and examined under x40 and oil 
immersion lens on a fluroscent microscope using the UV filter. The
phase contrast condenser was used to check cell morphology.
Cells appearing positive for mycoplasma presence had extranuclear 
fluorescence.
2.11.2 Cross contamination by other cell lines
Provided certain rules to eliminate contact among cell lines are 
adhered to, there should be no reason why cross contamination should 
occur, however, due to human error it is better to monitor cell lines 
for cross contamination. This was done by DNA fingerprinting.
Procedure followed in routine cell cutlure to prevent cross 
contamination of cell lines:
When freezing and thawing cell stocks, the entries on the label, 
catalogue card, and culture flask were double checked to ensure that 
the name of the cell line was clearly and correctly entered.
A separate waste bottle, 100ml bottle of medium and vial of trypsin 
was kept (and labelled so) for each cell line.
At any time, only one cell line was handled in the laminar flow 
cabinet. All universals containing cell suspension were clearly 
labelled with the name of the cell line, especially when 
centrifuging.
At no time was a pipette which had contained cells, placed into a 
medium bottle.
After working with each cell line, everything was removed from the 
laminar flow cabinet and swabbed thoroughly with 70% IMS. A clearing 
time of 15 minutes was left before the cabinet was swabbed down and 
used again.
Only in a clear laminar airflow cabinet was stock medium dispensed 
into freshly autoclaved bottles.
All flasks were clearly labelled with the name of the cell line, kept 
in discrete places in the incubator, and checked before any 
manipulations with the flask were carried out.
Any unlabelled medium or cell suspension were discarded.
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To ensure that cells plated out in experiments would begin to grow in 
a uniform manner, it was imperitive that all cells used were in 
exponential phase of growth when plating. Thus cells were always 
'pretreated1 2 days before being used in the experiment, by seeding at 
a predetermined density which would result in a subconfluent and 
actively dividing culture on the day of the proposed experiment. The 
day before the experiment, cultures were again fed. Optimal seeding 
density for pretreatment was determined by observation of the growth 
rate in routine culture and are given below.
Table 2.12 Pretreatment cell seeding density used for various
cell lines
2.12 Pretreatment of cells for experiments
cell line pretreatment density used 
(cells/ 75cm flask)
RPMI-2650 6 x 106
SK-LU-1 9 x 105
SK-MES-1 1.5 x 106
Calu-3 9 x 106
DLKP 1 x 106
DLRP 1.5 x 106
SCC-9 1.2 x 106
Hep-2 2.5 x 106
MDCK 1.4 x 106
NRK 9 x 105
2.13 Preparation of cell suspension for experiments
In preparation of the cell suspension, the most important factor to be 
accomodated was achievment of a homogeneous single cell suspension. 
This however, was helped by previous pretreatment of the cells which 
meant that they were easily trypsinized and so formed a single cell 
suspension relatively easily. In resuspending the cell pellet, it 
was imperitive to do so firstly in a minute amount of medium, and this 
was done with a Gilson tip. Gradually more medium was added and the
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suspension was taken up and down using the pipette tip. The entire 
cell suspension was mixed thoroughly in this manner before counting 
and while making the appropriate dilutions.
2.14 Plating of cell suspension
The appropriate aliquot was dispensed down the side and into the well 
of the miniaturized dish. Bacterial petri-dishes were used to 
dispense the medium into the 96 well dish. Plates were gently, but 
thoroughly moved in all directions to disperse the cells in the wells 
and allow formation of an even monolayer. This was particularly 
important in 24 well plates to be read by image analysis.
2.15 Assay duration
Plates were incubated in a 37°C incubator at 5% C02, which, along 
with the Hepes and Sodium bicarbonate in the culture medium, formed 
the buffering system. Dishes were monitored regularly by microscopic 
examination throughout the incubation period, and were taken down 
before the highest density wells reached confluence.
2.16 Storage of cytotoxic agents
Drugs were reconstituted either in 0.9% NaCl, or in PBS (if no vial of 
NaCl accompanied the drug), diluted (1/100) in PBS and further diluted 
in medium before aliquoting in cryovials and freezing at -20°C. Vials 
were thawed and frozen no more than 3 times, after which a fresh vial 
was used. Cis Platinum (Eli-Lilli) was stored at room temperature, as 
recommended. Controls for the drug diluent were included in toxicity 
experiments.
2.17 Toxicity tests
Cells were plated at required density and allowed to attach. 24 hours 
later, double strength drug dilutions were added to the wells to cover 
the desired range of toxicity. For 24 well plates, 0.5 mis were 
added; for 96 well dishes 100 fj 1/ well was added. After an 
additional 6 days, plates were processed using the relevant endpoint. 
For 8 hour and 24 hour exposure experiments, drug medium was removed 
after the relevant exposure time, the cultures rinsed in PBS and 
replaced with fresh culture medium and the incubation allowed to 
continue for the remainder of the 7 day period.
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2.18 Cell counting experiments to determine assay linearity and 
sensitivity
For experiments to determine linearity and sensitivity of the various 
methods, cells were plated at densities in the range 100 - 100,000 
cells/ 96 well. Either 1 or 4 days later, cells were trypsinized and 
counted both by Coulter counter and by haemocytometer. On replicate 
plates colorimetric assays were performed. To perform cell counts, 
medium was removed and wells were rinsed in PBS. Then 50/il of double 
strength TV was added to each well. When trypsinization was complete, 
cells were taken up and down with the pipette tip to ensure a single 
cell suspension and the contents of 8 replicate wells were pooled in 
an eppendorf. A further 50/ul of TV was added to the wells to remove 
any remaining cells, and this was also pooled and added to thè 
original suspension. Haemocytometer counts were performed on trypan 
blue - exposed cells in the normal manner. For Coulter counts, a 1:20 
dilution was performed in Isoton Balanced Electrolyte Solution 
(Coulter Electronics Ltd.,) and counted on a Coulter counter (Coulter 
Electronics Ltd, model DN) (blanked on Isoton). Cell counts/ ml were 
performed and these were transposed to cell number per 96 well.
2.19 Pipetting
All multiwell pippetting was carried out using an electronic multiwell 
pippette (Rainin EDP plus) using the appropriate pipette tips (Rainin 
RT 96). This generally gave low Coefficients of variation (< 1% for a 
single manipulation).
2.20 Monolayer staining with crystal violet
Medium was removed from plates by gentle flicking of medium into a
container, and plates were rinsed twice with PBS (1ml for 24 well
plate, 2 mis for 6 well plate). Plates were then fixed for 5 minutes 
in Formalin (BDH 101113) and then stained for 10 miuntes in 0.25% 
aqueous Crystal Violet (Gurr) filtered before use in Wattman no. 1). 
Plates were rinsed 4 times in tap water, dried with paper to prevent 
water stains and then allowed to dry thoroughly in a 37°C incubator.
2.21 Image analysis
Using an AMS 40-10 image analyser, the optimum reading conditions 
were chosen for the set of plates to be read, and were carefully 
noted. These instrument settings were reproduced, as far as was 
possible each time plates were being read. Generally detection level 
had to be varied each time, especially when reading different cell
lines. This paramater was chosen to compromise between what the 
instrument actually picked up and what was present on the plate. 
Because of flickering images, a voltage stabilizer had to be used and 
the instrument switched on overnight before being used. The surface 
area (mm2) occupied by the culture was determined by the instrument 
and used to represent growth.
2.22 Colorimetric assays
Each of the colorimetric assays described here were read on a Titretek 
multiskan plus ELISA plate reader using the 620nm filter as a 
reference wavelength. This subtracted interfering absorbance (from
plastics, cells etc.,) from the total optical density and presented 
the results as absorbance at the test wavelength only.
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All incubation periods were at 37°C and 5% COz, except where otherwise 
stated.
2.23 Crystal violet dye elution (CVDE)
After removal of medium, 96 well plates were rinsed with 100/il PBS/
well and stained with lOOpl 0.25% (g/ lOOmls) Crystal Violet for 10
minutes. Plates were rinsed as outlined above. When dry, lOOfjl/ well 
of 33% Glacial Acetic Acid (BDH 10001) (v/v) was added and the
contents of each well were mixed before reading at 570nm. A typical
assay is shown in the photograph below.
CRYSTAL VIOLET DYE ELUTION ASSAY
DLKP
Photograph 2.2: A typical toxicity assay determined by the CVDE assay
(increasing drug concentration from top to bottom).
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2 .24 Neutral Red (NR) assay
A 1:80 dilution of (stock) 0.4% Neutral Red (Difco, 50040) was 
prepared in culture medium, giving a final concentration of 50pg/ml. 
This was centifuged at 1,500 x g for 10 minutes before use to remove 
insoluble crystals and the supernatent removed and used. Stock 
solutions were stored for up to 8 months protected from light.
Medium was removed from plates which were rinsed in PBS (200jul/well) 
before addition of the neutral red solution (prepared as above). After 
3 hours incubation, neutral red was removed and wells were rinsed with 
SOfjl of Formol-Calcium mixture (10 mis of 40% Formaldehyde, BDH 
101113, and 10 mis of anhydrous Calcium Chloride; Sigma C7902; in 80 
mis of ultrapure water). Then 200/jl/ well of Acetic Acid - Ethanol 
mixture was added (1% glacial acetic acid in 50% ethanol (mis/ 100 
mis), before plates were shaken and read at 570nm.
Photograph 2.3: A typical toxicity test determined by the NR endpoint
2.25 MTT assay
20/j1/ well of 5mg/ml MTT [3(4,5-Dimethylthiazol-2-yl) 2,5- diphenyl
tétrazolium bromide] (Sigma, M-2128) was added before incubation for 
4 hours. Then medium was carefully removed by pipetting (so as not to 
disturbe the formazan crystals) and 100 pi/ well DMSO was added and 
aspirated repeatedly to give a uniform colour before reading at 570nm.
MTT ASSAY
DLKP2ug DLKP DLKPlug
EXPOSURE TO ADRIAMYCIN
Photograph 4: A typical toxicity test determined by MTT endpoint
2.26 MTT assay/ SDS modification
MTT was added to wells as in above, then after 4 hours incubation, 
50^ /1 of 25% SDS at pH 2.0 was added directly on top of medium. This 
pH is critial since the formazan colour is lost when the pH is too 
acid and the crystals do not dissolve if the pH is too high. Plates 
were incubated overnight to dissolve the formazan before reading at 
570nm.
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2.27 Sulforhodamine B (SRB) assay
Cells were first fixed by layering 50pl of 50% TCA (Trichloric acetic 
low, Reidel-de-Haen 27242) directly on top of incubation medium 
continued for a further hour at 2°C. Then wells were rinsed 5 times 
with tap water to remove solutes and low molecular weight metabolites, 
flicked dry and then dried thoroughly. Cells were then stained with 
200/il/ well of SRB (Sigma, S-9012) (0.4% in 1% acetic acid) for 30 
minutes and rinsed 4 times in 1% glacial acetic acid. When dry 
200/il/well of lOmM Tris buffer (Sigma T-8524; pH 10.5) was added to 
release unbound dye. After mixing well, plates were read at 570nm.
SULFORHOPmiMB B ASSAY
pi#*
*.v - m  *• #fi
IrX
HEP-2
EXPOSURE TO ADRIAMYCIN
Photograph 2.5: A typical toxicity test determined by SRB.
(increasing drug concentration from top to bottom).
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2.28 Acid phosphatase (AP) assay
Wells were rinsed in lOOpl PBS after removal of medium. Then 100 pi 
substrate - containing buffer was added to each well (lOmM 
p-nitrophenyl phosphate; sigma C-104; added just before use to 0.1% 
Triton X-100; BDH; in 0.1M Sodium Acetate; Sigma S-2889; pH 5.5). 
Incubation proceeded for the standard time of 2 hours (or the test 
time indicated in the particular results) after which time plates were 
either read at 405nm, reincubated for a further time, or 'stopped' 
with addition of 50pl/well of IN NaOH to cause an electrophilic shift 
in the P-Nitrophenyl chromophore and thus develop the yellow colour.
ACID PHOSPHATASE ASSAY
DLKP
Photograph 2.28: A typical toxicity test determined by APNaOH.
(increasing drug concentration from top to bottom).
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2.29 Relationship between assay performance and growth status of
cell
Hep-2 cells, after pretreatment, were seeded in 24 well dishes at the 
following densities; Culture A - 2.5 x 10^/ well, Culture B - 1 x 10^ 
cells/ well, and Culture C - 2.5 x 10^ cells/ well. One plate was set 
up with medium containing no cells to be used for blanking 
colorimetric assays. After culturing for 11 days Culture A was 
subconfluent, Culture B was confluent and Culture C was 
superconfluent and in very bad condition. Plates were centrifuged 
(1,000 rpm for 5 mins) and medium was carefully removed, wells rinsed 
in 500pl PBS and then carefully trypsinized with 250pl/ well 2X TV for 
10 minutes and cells resuspended and mixed with a further 250pl of 
medium containing FCS, and a Trypan Blue count performed on 50/il of 
well mixed cell suspension. Triplicate wells were counted for each 
culture and a mean Trypan Blue cell count obtained. For each culture 
cell suspensions of 500, 700 and 1100 apparently viable (trypan blue
excluding) cells/ ml were prepared and quadruplicate replicates were 
plated for cloning in fresh 24 well dishes. Cells were well shaken 
and dispersed in the dish before incubating for 10 days until colonies 
had formed from single cells.
Concurrent with trypsinization from the 24 wells, triplicate wells of
each dish were used to perform AP2h, APNaOH, NR, CVDE, SRB and CV
image analysis assays, simply by scaling up the volumes used in the 96
well dish by a factor of 6.25 (surface area of 96 well dish is
2 J 2 0.32cm ; that of 24 well dish is 2cm ). The final solution for
colorimetric analysis was transferred to a 96 well plate in 100/jl
aliquots and read as described above; wells containing no cells were
used in the normal way to prepare blanks.
Colonies arising from cloning of single cells from original plates 
were stained and counted manually and by image analysis after 7 days 
growth. Differences in viability among cultures A, B, and C were 
determined from counts of trypan blue excluding cells/ well, OD in 
colorimetric assays and colony number after cloning.
2.30 Ability of colorimetric assays to assess cell viability
after treatment with cytotoxic agents
This experiment was first carried out in 24 well dishes, in a similar 
manner to the experiment described above, except that different drug 
concentrations were added to a single density of cells. 10^ Hep-2 
cells were seeded in ten 24 well dishes in a volume of 710pl. 24
hours later, 625pl of 2x 0.005pg/ml Vinblastine was added to one 
third of the wells, 625/jl of 2x 0.006jUg/ml Adriamycin added to one 
third of wells and 625jug/ml of control medium (no drug) added to the 
remainder of the wells. Again wells containing no cells were included 
for colorimetric blanks. Each day, beginning one day and finishing 5 
days after drug addition, trypan blue counts were prepared from 
triplicate wells, cells were cloned exactly as described in 2.29, and 
AP2h, APNaOH and MTT assays were simultaneously carried out. Results 
were similarly compared as described in 2.29.
2In scaling the experiment up to 25cm flasks to improve accuracy on 
haemocytometer counts, cell densities and assay volumes were 
similarly scaled up by a factor of 78.125 over 96 well dishes (12.5 
times over 24 well dishes), so cells were plated at 1.25 x 10^/ flask 
in a volume of 7.8 mis, and a similar volume of 2x drug concentration
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were added to flasks (to give final concentrations of 0, 0.005,
0.00075, and O.OOlpg/ml Vinblastine for analysis after 2, 3 and 4 days 
exposure, and 0, 0.0002, 0.0004, 0.00075/jg/ml Vinblastine for
analysis after 6 days exposure). After 2,3,4 and 6 days exposure to
drug triplicate flasks were trypsinized and counted in trypan blue.
This time, cell suspensions for cloning were prepared and plated 
separately for two of these three replicates, for each drug point. 
Again cells were plated at 700, 900 and 1100 cells/ 24 well to give a 
range of growth for cloning. Each of the colorimetric assays was
carried out exactly as described for the miniaturized version, except 
that volumes were scaled up as already indicated, and again aliquots 
were transferred into 96 well dishes for colorimetric analysis.
After colonies had formed from cloned cells (10 days), plates were 
stained as usual and analysed manually and by image analysis for 
colony formation. Results were compared as already described in 
2.29.
2.31 Relationship between endpoint and mechanism of action
Preliminary experiments were first conducted on all of the 11 test 
chemicals from which concentrations giving a span of 0 to 1 0 0 % cell 
kill were chosen. Leaving one row of wells per plate with medium only 
(no cells), 100/jl of 2 x 105 RPMI-2650 cells/ well were plated in 96
well dishes and incubated for 24 hours, after which concentrations of
each chemical were added. After an incubation time of 6 days, AP2h, 
MTT, NR and CVDE were performed as previously described on replicate 
plates for each of the chemicals. Radioincorporation assays were 
performed as described below. Dose response graphs were prepared in 
the usual manner.
2.32 Determination of DNA synthesis
c24 hours before endpoint determination, lOpCi/ml (3.7 x 10 Bq/ml)
[3H]thymidine (sp. activity 25 Ci/mmol) was added to each well of the
plate. After incorporation of the [ ] thymidine (and after
microscopic analysis) the plate was washed twice with cold PBS, 
followed by addition of 5% cold TCA for 20 minutes at 4°C. After a
further washing with 5% TCA, the plates were washed thoroughly with 
ethanol to remove all the TCA. The cells were solubilized by addition 
of 200/jI solubilization buffer at 37°C for 1 minute. After extensive 
mixing with a pipette, 50pl aliquot samples were placed in 4 ml
scintillation cocktail [Ecolite 882475] in a scintillation vial 
[Beckman], and counted for 1 minute on a scintillation counter
[Beckman LS 7500]. Test results in cpm (counts per minute) were 
compared to control values to calculate % kill values.
Solubilization buffer:
(500ml) NaOH, 2g (final concentration 0.1M) Na2Co3, lOg (final 
concentrarion 2%) Dissolved in 500ml of distilled water. Just prior
to use 1% SDS was added (10ml of a 10% stock/ 100 ml medium).
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2.33 Determination of RNA synthesis
5 31 hour before assay termination, lOpCi (3.7 x 10 Bq/ml) [ H]uridine 
(sp. activity 5 Ci/mmol, 185 Bq/mmol) was added to plates, and 
plates were incubated at 37°C. Plates were washed once with PBS on 
ice and then 3 times with cold 5% TCA. Then 100 pi of cold 5% TCA was 
added and plates were heated for 1 hour in an 80°C water bath to 
hydrolyse the RNA. 50pl samples from each well were placed in 4 ml 
scintillation fluid and these were read for 1 minute on a Beckman 
scintillation counter.
2.34 Determination of protein synthesis
3Determination of protein synthesis by incorporation of [ H]leucine was 
carried out as above except that the 1 hour 80°C incubation period was 
omitted. Instead of a 20 min TCA treatment step the precipitates were 
washed with ethanol and solubilized as in 2.32.
2.35 Miniaturized serum batch testing
Cells were seeded into 96 well plates in lOOpl serum free medium. 
Serum samples for testing were prepared at 2x desired concentration in 
culture medium (minus FCS) and lOOpl/ well added to the cells. Before 
the cells became confluent the plate was removed from the incubator 
and the extent of growth determined using the miniaturized endpoints 
described earlier.
2.36 Culture of drug-resistant lines
DLKPA (already adapted to growth in 0.75 pg/ml Adriamycin in this 
laboratory) was cultured in DMEM/HF12 in the presence of 0.75 pg/ ml 
of Adriamycin and gradually increased to concentrations of 1 and 2pg/ 
ml before use in assays. Cells were grown in the relevant 
concentration of drug for at least 2 weeks prior to assay. For 
toxicity testing experiments, cells were seeded in 96-well dishes (4 x 
10"^ / well for variants; 3 x 10^ for parent cell line (due to higher 
doubling rate)). 24 hours later, drug concentrations were added (4 
replicates/ drug concentration) and experiment continued for a further 
6 days. AP2h, APNaOH, MTT, NR, CVDE and SRB assays were then 
performed and drug toxicity profiles determined.
2.37 Toxicity testing of landfill leachates
Leachates were collected from a landfill site (by a Local Authority) 
at 3 regular monitoring stations. They were centrifuged to remove any 
solids, pH adjusted to 7.45 - 7.55 and then filter sterilized before 
use. Concentrations prepared in culture medium, were tested in the 
range 56% - 0.032% (mis/ 100 mis) on a monolayer of MDCK cells which 
had attached for 24 hours (passage numbers 102 - 107; 5 x 10^/ 96- 
well) for 72 hours. Tap and uptrapure water were used as controls at 
equivalent concentrations. Osmolarity readings for all samples were 
obtained using a Osmomat 0300 Osmometer. IC5 q an<^  Toxic Unit values 
were obtained as described in Appendix 1.
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2 .38 Toxicity testing of chemical sludges
Sludges were obtained from EOLAS in Shannon. Leachates were generated 
by preparing a 1 0 % w/v soulution in ultrapure water and shaking on a 
shaking table for 8 hours. After settling for 8 hours (photograph 7) 
pH was then adjusted to 7.45 - 7.55 and samples were filtered through 
Wattman no. 41 and filter sterilized before testing on MDCK as 
described in 2.37.
Photograph 2.38: Two very different industrial sludges after
leachate generation and settling for 8 hours.
2 .39 Toxicity testing of industrial wastewaters
5 wastewater samples were obtained and their pH adjusted to 7.45 - 
7.55 before filter sterilizing. They were tested as above on MDCK 
using the AP assay.
2.40 Analysis of results
No less than 3, and typically 4 repiclate wells were used in the 24 
well system, while 8 replicate wells were used when using 96 well 
plates. The mean and standard error of the mean (SEM) were calculated 
from replicates for each point of a graph (see Appendix 1). Drug 
treated wells were compared to control wells and % survival was 
calculated. Graphs were plotted using the software package Sigmaplot, 
and ICgg values (values showing concentrations which have a specific 
effect; in this case loss of AP activity; on 50% of the population) 
were calculated. Error bars are shown in all graphs.
2.41 Primary culture
2.41.1 Sample collection
Samples were collected from resection and immediatedy placed in 
collection medium (1:1 DMEM/Hams F12, 10% FCS, 1% L-Glutamine, 1%
Fungizone; 500 ¡ug/ 100 mis (Gibco 043-05290D), 500 U/ ml Penicillin, 
0.5 mg/ml Streptomycin (combined; Gibco, 043-05070H) at 2°C, and
transported to the laboratory in a cooler bag with ice.
2.41.2 Sample storage
When multiple samples were obtained, samples were kept at 2°C until 
processing could be carried out.
2.41.3 Sample dissection
Necrotic tissue, blood vessels, fatty and connective tissue were
removed from the sample with scissors and scalpels in a petridish
(Greiner 633171). Then the sample was rinsed a number of times in PBS
and chopped finely with crossed scalpels.
2.41.4 Explants
2For explant cutlure, firm tissue pieces <= 1mm were placed in a
25cm2 culture flask coated with culture medium using a forceps. At
least 20 tissue explants were placed in the flask, each approximately 
0.5 cm apart. Then the flask was left to stand upright in the laminar 
flow cabinet with the lid loose for 30 minutes, to allow the explants 
to attach to the substratum. Then 4 mis of culture medium was very 
carefully added to the flask, taking care not to dislodge any of the
explants. After 24 hours another 4 mis of medium was added and the
culture monitored and fed as necessary thereafter.
2.41.5 Enzymatic disaggregation
Any further tissue was dissected with crossed scalpels to pieces of
2mm size and placed in a flat-bottomed 60 ml universal (Sterilin
125AP) with 200 units of collagenase (Sigma C6885) and 0.2% Protease
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neutrale (dispase) (Bohringer Mannheim GmbH 165859) in 10 mis of 
medium. A sterile magnetic stirring bar was included and the 
universal placed at gentle stirring speed in a 37°C warm room. At 30 
minute intervals throughout the digestion, an aliquot of the 
suspension was checked microscopically for cell clumps released from 
the extracellular matrix. When most of the tissue had been 
disaggregated and numerous free clumps of cells were observed, the 
suspension was allowed to gravity sediment. The supernatant was 
removed from undisaggregated tissue clumps and again gravity 
sedimented to allow clumps of cells to sediment. This lower fraction 
was usually enriched with epithelial cell clumps, while the upper 
fraction was enriched with single epithelial and fibroblastic cells. 
The fractions were then centrifuged (1000 rpm for 5 minutes) and 
resuspended in fresh medium. 25cm2 flasks were then seeded at a 
density of 1 0 6 cells, or as high a density as could be obtained for 
small samples. Cultures seeded at high densities of epithelial cells 
stood a better chance of overcoming fibroblast overgrowth, and of 
growing up in culture. clumps of cells were preferable for culturing 
than single cells for the same reasons.
2.41.6 Dissection medium (DM)
The culture medium in the petri-dish from which the explants and 
tissue for enzymatic disaggregation were removed, was usually heavily 
enriched with cells. This was centrifuged, washed in PBS and then 
resuspended in culture medium.
2.42.7 Isolation of blood cells
In the case of heavily bloodstained samples, these were first rinsed 
vigurously several times in a universal of PBS and then processed as 
normal. The processed sample suspension in culture medium, was then 
layered on top of 15 mis of Ficol (Pharmacia) in a universal, using a 
pasteur pippette. Two distinct phases were formed. After 
centrifugation at 3500 x g for 10 minutes, the top layer of medium, 
which contained no cells, was removed to waste. The epithelial cells 
were found at the interface between the two phases but some were also 
present in the Ficol layer itself. The erythrocytes formed a pellet 
at the bottom. The fractions containing epithelial cells were 
isolated with a pasteur pippette and centrifuged in 5 mis of culture 
medium. The cells were then processed as normal
2.42.8 Primary culture assays
Most of the samples received for processing, generated a very small 
number of epithelial cells, not sufficient to allow testing of 
different variables. Where possible, cells were plated into 24 well 
dishes and a number of variables were tested as described below.
2.42.8.1 Density assays
Cell suspensions covering the relevant density range were prepared and
lml of suspension was plated per well.
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2.42.8.2 Basal media assays
A single cell suspension was prepared and 0.5 ml added to each well. 
Then 0.5 ml of the relevant basal medium was added. The following 
day, or when cells had attached, medium was carefully removed from 
wells with a pasteur pippette and replaced by the relevant fresh 
medium. The reason for avoiding preparation of a number of cell 
suspensions for each of the different media was to avoid the error
which this would introduced by this technique. Because a cell 
suspension isolated from tissue can not be expected to be fully 
homogeneous, such an error would be significant.
2.42.8.3 Serum batch tests
The cell suspension was prepared in medium minus serum and 0.5 mis 
were added to each well. Then 0.5 mis of medium plus test serum was 
added to the wells. Because cell density per ml has now been diluted 
1 : 2  and simultaneously, the serum concentration (%) has also been 
halved, double strength of each of these preparations were used to 
overcome this dilution factor.
All plates were carefully and thoroughly shaken to distribute the cell 
suspension evenly by slowly but vigourously moving the plates in
alternate directions.
Plate exteriors were swabbed with 70% IMS and incubated at 37°C/ 5%
CO2 , and taken down before wells with most growth had reached 
confluence. They were stained with crystal violet and read by image 
analysis.
2.42.9 Maintainence of primary culture
The culture was checked regularly and fed as medium was utilized. 
Cultures, when confluent, were passaged with trypsin (0.25%) in the 
normal manner. Trypsin was preferred to TV because of its gentler 
action. Monitoring of cultures was felt to be a very important
process, as fibroblast overgrowth; which was often a limiting factor 
in the success of the cultures; could be observed and sometimes
prevented.
2.42.10 Fibroblast removal
This was carried out in two ways:
2.42.10.1 Trypsin/ EDTA
Cultures were exposed to lower strength TV (0.04% Trypsin, 0.01% EDTA) 
at 2°C for a few minutes. Fibroblasts most often became detached 
quicker than the rest of the culture and were removed. However this 
method only worked well if epithelial cells were in colonies and 
fibroblasts were in single cells or in sheets. If epithelial cells 
were present only as single cells or tiny colonies, then these cells 
were equally vulnerable to this trypsinization procedure.
2.42.10.2 Geneticin treatment 
Fibroblast experiments:
For a number of fibroblast cultures, Geniticin dose-response curves 
were constructed. Fibroblast cells were plated in 24 well dishes at a 
concentration of 5 x 10 cells/ ml and allowed to grow. When the
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culture was actively growing (2 days after setting up) concentrations 
of Geneticin (G 418 Sulphate, Gibco 066-1811) in the range 0 - 500 
pg/ml were added in culture medium. Again because of the dilution 
factor due to the medium already present in the wells, double strength 
of the final desired concentration were prepared. Each day for 4 
consecutive days, a set of plates were removed and stained with 
crystal violet and a kill curve was prepared.
For routine use thereafter, 200fjg/ ml of this agent was added to 
growing cultures in culture medium. After 2 days, medium was removed 
and cultures were rinsed with PBS before feeding with fresh medium.
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RESULTS 1: 
ASSAY COMPARISON
3.1 Image Analysis
3.1.1 Cell distribution on the plate
It was established that cell distribution on the plate is an extremely 
important phenomenon when reading plates by image analysis. The 
result obtained depends upon the surface topography of the monolayer, 
thus, even though the same number of cells may be present, if they 
are not spread evenly over the plate, then totally different readings 
may be obtained.
3.1.2 Staining
Image analysis relies greatly on effective cell staining. Only then 
can colonies be distinguished from their background, and their image 
quantified by computer analysis. If wells are stained for too long, 
then plastic will also be stained, which will then be imaged and 
quantified, giving erroneous results. A similar situation has been 
found to arise when stained wells are improperly rinsed and dried; 
water marks resulting from this will also be detected by the 
instrument.
3.1.3 Instrument settings
It was found that two very important settings on the instrument are 
the light and detector sensitivity settings. If either of these were 
changed, the image being detected and processed changed accordingly. 
It was obvious that the absolute values resulting from reading a 
single plate at different detector sensitivities varied, however it 
was not clear whether the observed trend would also be altered. By 
reading a number of stained toxicity assays at different settings, and 
preparing dose response data, it was found however that altering the 
detector sensitivity could in fact result in significantly different
overall results. Some of the observed results are shown in the table 
below. It is obvious that choosing an unsuitable setting would give 
improper results (for example if the detection level was much too high 
or too low to pick up growth); note however that both settings chosen 
here could be described as two distinct, but suitable settings for the 
plate analysed.
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Table 3.1.3 Effect of varying image analyser detector
sensitivity, on the outcome of toxicity curves 
of RPMI-2650 exposure to Vinblastine
Drug 
conc. 
pg/ml
Plate
1
Plate
2
Plate
3
Plate
4
Plate
5
Plate
6
Detector sensitivity = 35 
colony area (% of control)
0.00 100 ± 31 100 ± 8 100 ± 32 100 ± 8 100 ± 10
0.005 109 32 77 12 145 39 72 10 93 17
0.01 92 21 69 69 43 36 45 5 48 3
0.05 76 16 60 14 46 28 14 2 18 3
0.1 87 74 14 4 61 7 11 2 8 1
0.5 55 - 37 7 27 20 2 1 2 1
1.0 61 1 9 4 19 5 1 2 2 0
5.0 33 23 4 3 11 11 1 0 1 0
Detector sensitivity = 57 
colony area (% of control)
0.0 100 ± 61 100 ± 11 100 ± 27 100 ± 10 100 ± 10 100 ± 4
0.005 162 48 71 11 80 41 57 2 66 16 78 21
0.01 153 31 42 36 40 28 38 4 30 2 41 2
0.05 112 24 44 8 32 20 9 1 5 1 7 1
0.1 153 11 9 1 51 8 5 1 2 0 3 0
0.5 145 83 23 4 24 13 1 1 0 0 0 0
1.0 161 77 7 9 25 8 1 0 0 0 0 0
5.0 119 45 2 1 20 12 1 0 0 0 0 0
Plates 1 to 6 in the tables above, represent toxicity experiments
with 1 to 6 days' cell growth in drug.
Changing the detector sensitivity, does in fact, alter the final 
outcome of the results, and IC5Q values estimated from these two 
different sets of results, would be substantially different. Plate 1 
had in fact, very little growth present, so there is a vast
difference in the observed results after reading at the two different
sensitivities. This of course is largely due to low amount of cell
I
growth on the plate, however it may be concluded from this, that 
increasing detector sensitivity on low density plates does not make 
the plate any more suitable for reading; in fact it has detected no 
cell kill (when some was visible to the eye) and has resulted in 
enormous SEM values.
On plates 4 and 5, significant differences in % survival, arising from 
the two different readings are evident, when SEM values are taken 
into consideration.
It must then be concluded that detector sensitivity is a paramater 
which deserves special attention, and it must not be indiscriminately 
altered without expecting consequent alteration in observed results. 
The practical significance of this information means that for this 
model of image analyser at least (AMS 40-10), as much as is possible, 
constant settings should be used throughout a section of work, or a 
control stained plate should be used to set the instrument settings 
appropriately, before each set of plates are read. Obviously if a 
group of plates are read together, they will be more appropriate for 
direct comparisons of absolute values, than plates which were read on 
different occasions. As a consequence of such observations, settings 
were defined for each cell line, and these were adhered to in all 
experimental work thereafter.
3.1.4 Applicability to different cell lines
It has been made apparent that there may be problems in defining an 
appropriate detector sensitivity for a stained plate. In fact, it 
was generally observed that the most appropriate detector sensitivity 
(visually) for the plate gave a computerized image which did not 
correspond well with the actual stained image. This was more of a 
problem with some cell lines than others. It was determined that
dense, discrete, clearly stained colonies were reasonably well 
imaged by the instrument, while diffuse, sprawling, poorly stained 
colonies, or complete monolayers, were very poorly imaged, no matter 
which instrument settings were used.
It was determined thus, that some cell lines were more appropriate for 
image analysis determination, due to their growth characteristics, 
than others. The following photograph, which shows growth 
characteristics of a whole range of cell lines, illustrates this 
point.
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Photograph 3.1 Variation in stained growth characteristics of a
range of cell lines
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Some of the cell lines (RPMI-2650 and SCC-9, for example) form 
discrete tight colonies, and are hence suitable for image analysis
growth determination, while those forming diffuse monolayers (e.g. 
A549), are poorly estimated on the image analyser.
3.1.5 Ease of performance/ technical limitations
While the method is relatively easy to perform (plates are rinsed, 
stained with crystal violet, rinsed, dried and analysed by the 
instrument) the technical difficulties involved with reading plates on 
this model are often significant.
* Some cell lines are unsuitable for analysis
* Lines suitable for analysis, but with unevenly distribulted growth 
will not be accurately determined
* Clearly stained plates of cell lines suitable for analysis with
touching colonies may not be accurately determined
* Poorly stained plates, or plates with ’water marks' from improper 
drying may not be accurately determined
* It is important to try and use a constant detector sensitivity for a 
group of plates read together, however a single setting may not be
appropriate for numerous plates
* A single detector sensitivity setting may not give an appropriate
image for plates in which there is a wide span of cell growth, for
example, in toxicity tests
* Plates with extensive cell kill will result in much cell debris,
some of which can remain on the plate after rinsing, and may be
determined by the instrument as additional colony growth
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3.2 MTT assay
3.2.1 Optimization
3.2.1.1 Formazan solubilization
In the original method (Mossman, 1983), acid isopropanol was used to 
solubilize the insoluble formazan precipitate formed. It was found in 
the course of this work however, that this resulted in formation of a 
dense precipitate (presumably from precipitation of serum proteins) 
which strongly interfered with absorbance readings. Many slight 
modifications of this procedure were tried, including exclusion of 
serum from the MTT incubation medium and rinsing before solvent 
addition, however these additional manipulations still gave 
unsatisfactory results; some formazan was lost upon rinsing, and the 
remainder would not fully dissolve in the acid isopropanol.
Solvents used by other workers for this purpose included DMSO 
(Freshney and Plum, 1988; personal communication; Twentyman and 
Luscombe, 1987), so this solvent was used in this work and results 
were very satisfactory; there was no need to change the culture medium 
on addition of MTT, no rinse was needed after incubation with MTT and 
most pertinently, complete solubilization was quickly and uniformly 
achieved. Thereafter this solvent was used for the assay.
3.2.1.2 MTT Concentration
Presumably the concentration of MTT used in the assay influences the 
results obtained, therefore the effect of using different MTT 
concentrations was investigated. The results for RPMI-2650 and Hep-2 
are shown below.
Figure 3.2.1 (a) shows that increasing MTT concentration results in a 
corresponding increase in O.D. in an approximately linear manner from 
0.1 to 4 mg/ml MTT. At 5 mg/ml no further increase in O.D. was 
obtained. Thus the optimum concentration for use is somewhere between 
4 and 5 mg/ml MTT for RPMI-2650 under these conditions.
In Figure 3.2.1 (b), the relationship between MTT concentration and 
O.D. is shown for another cell line, Hep-2, for the concentration 
range 1 - 7mg/ml MTT over a range of cell densities. The plots are
not linear; the most significant increase in OD is gained when the 
MTT concentration is increased from 1 to 3 mg/ml. Thereafter further 
increase to 7mg/ml gives a relatively smaller increase in OD. The 
higher the cell density per well, the greater the slope of the plot 
from 1 to 3 mg/ml. At the highest cell density (just under 1 x 10^ 
cells/well), optimum absorbance has been reached at 3mg/ml MTT; for 
all the other cell densities, any concentration between 3 and 7mg/ml 
could be used, as there is little difference between these points. 
Taking 5mg/ml as the midway point, and considering that most of the 
literature reports use of this concentration, for comparative 
purposes, 5mg/ml MTT was used routinely thereafter.
3. 2.1.3 Storage of MTT
It has been reported in the literature that a single stock of MTT 
working solution may be stored at 2°C and used for a number of weeks. 
Some workers (C. Lowry; personal communication) have found it
necessary to make up a fresh working solution of MTT each day; this is
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obviously more cumbersome, particularly as special handling is 
required when dealing with the agent due to its mutagenic properties. 
Thus the importance of making up a fresh stock was considered. The 
performance of an 8-week-old stock was compared to that of a freshly 
prepared stock.
Figure 3.2.1 (c) shows that there is little difference in the
absorbance values between the old and the fresh MTT solutions; the 
error bars overlap for most points. There appears to be only a slight 
loss of activity when the MTT is stored for this period of time. In 
routine work thus, the solution was stored in a light resistant 
bottle at 2°C for periods up to 6 weeks, after which a new stock was 
used.
3.2.1.4 Outer wells of 96-well plate
Figure 3.2.1 (d) shows that there is no significant difference in 
results when the outer wells of the 96-well dish are included in the 
experimental results, thus outer wells were always used in the work 
which follows.
3.2.2 Relationship between cell number and MTT O.D
To establish the relationship between cell number and O.D in the MTT 
assay, cells were plated at densities in the range 100 - 100,000 
cells/ 96 well. After 1 day and again after 4 days growth, cells 
were trypsinized and counted both by Coulter counter and
haemocytometer. MTT assays were performed on replicate plates and 
cell number was plotted against O.D. over the entire range of cell 
densities. These experiments were performed on 6 epithelial cell 
lines and 1 fibroblastic cell line in order to establish the 
relationship for a range of cell lines. Experiments were repeated 
once for RPMI-2650, SKMES-1 and Hep-2 and twice for DLKP. Results 
from one repeat experiment have been shown in the figures and tables 
which follow, for SK-MES-1, Hep-2 and DLKP. Graphs of cell number 
versus O.D. have been shown for growth after 1 day and growth after 4 
days in culture. The method of obtaining cell counts (i.e., 
haemocytometer or Coulter counter) is indicated below each graph.
Counts from Haemocytometer and Coulter counter did not always agree. 
Some data points were missing for the haemocytometer counts because 
the limitations of the method did not allow low counts to be 
performed, and frequently resulted in high SEM values.
From these graphs, shown in Figures 3.2.2 (a) - (n), the minimum 
detectable cell density, extent of the linear range, and the 
sensitivity of the assay have been determined for each of the cell 
lines. The minimum detectable cell number has been empirically 
defined as the cell number corresponding to 0.02 OD units. The linear 
portion of the graph is indicated in each figure where it is clear 
(the range is ambiguous for those marked *). The slope of the linear 
portion of each graph has been calculated (see appendix A) to obtain a 
value for sensitivity. The cell number to which we refer in both 
graphs and tables, is actual cell number, and not the cell number 
which was originally plated.
The tables summarizing these results are reproduced in the following 
pages.
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MTT CONCENTRATION, m g /  ml 
Determination of optimum MTT concentration for RPMI—2650
10,000 c e l l s /  well were se ed ed  and p la t e s  in c u b a te d  fo r  2 days b efore  a s s a y  determ in at ion
F ig u re  3 .2 .1 (a)
0.25
0 .20
0.15
ot'-
0.10
Q
O 0.05
0 1 2 3 4 5 6 7
T7i* q o 1 MTT CONCENTRATION, m g /m lF ig u re  3.2.1 (b) s/
Determination of optimum concentration for Hep—2 cells.
Cells s e e d e d  a t  d en s it ie s  in d icated  were grown in 96 well d ishes fo r  6 d ay
MTT a s s a y s  were p er fo rm ed  and  ce lls  f ro m  re p l ica te  p la te  try ps in ized  an d  counted.
cell n o /  well: 
o —  O 100,000
• ---- •  160,000
A ----A 265,000
▲ ----▲  435,000
□ ----□  712,000
■ ----■  735,000
V ----V 055,000
T ----T  972,500
(Coulter counts)
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. /■ \ CELL NUMBER PLATED/ 96 WELL
F ig u re  3 .2 .1 .  (c)
Activity of a  freshly prepared  MTT solution (O  O) and an 8-week
old solution ( • ----• )  with varying num bers  of SCC—9 cells.
0  ^  „ r ,v  CELL SEEDING DENSITY (X 100)Figure  3.2.1 (d)
Effect of including/  excluding outer wells of 96 well plate from results
89
Eco
Q
o
Figure  3 . 2 . 2  ( a )
H ce ll  n u m b e r  (x  1 ,000)
E
c
o
in
Q
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F igure  3.2.2 (b)
C. ce l l  n u m b e r  (x  1 ,000)
0.35-1- H e p - 2
1
0 .3 0
E 0 .2 5 -
c
°  0 .2 0 -iO
0 .1 5 -
o
o
0 .1 0 -
•
0 .0 5 -
0 .0 0
•I 5  6 7 8 9  10 11 12
Figure  3.2.2 (c) c cel1 number (x 10 000)
F igures  3 .2.2 (a) -  ( c ) :
R e l a t i o n s h ip  b e t w e e n  ce l l  n u m b e r  a n d  O p t ic a l  D e n s i ty  in MTT a s s a y  
f o r  th e  ce ll  l in e  i n d ic a t e d ,  a f t e r  1 d a y ’s  g ro w th .
H. r e p r e s e n t s  h a e m o c y to m e te r  counts.  C. r e p r e se n t s  co u lter  counts .
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H. ce l l  n u m b e r  (x  1 ,000)
Figure  3.2.2 (d)
COr-
O
Figure  3.2.2 (e)
H ce ll  n u m b e r  (x  1 0 ,000)
0.20 
0 .1 8  
0 .1 6  
e o.uG
o  0.12
5  0 , 0  <0
q  0 .0 8  
°  0 .0 6  
0 .0 4  
0.02 
0.00
0 1 2 3 4 5 6 7 8 9  10
Figure  3.2.2 (f) H cel1 liumbei' (x l0'00°)
Figures 3.2.2 (d) -(f)
R e l a t i o n s h ip  b e tw e e n  ce l l  n u m b e r  a n d  O ptica l  D en sity  in  MTT a s s a y
f o r  t h e  ce l l  l ine  i n d ic a t e d ,  a f t e r  1 d a y ' s  g ro w th .
H re p re se n t s  h a e m o c y to m e te r  co u n ts .  C. r e p re se n ts  coulter  counts.
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Figure  3.2.2 (g)
H cell n u m b e r  (x 10,000)
0.25
S K - M E S - 1 T
1
12
Figure  3.2.2. (i)
H cell » u m b e r  (x 10,000)
Figures 3 .2 .2 (g) -  ( i ):
R e l a t i o n s h ip  b e tw e e n  ce l l  n u m b e r  a n d  O p t ica l  D en s i ty  in MTT a s s a y  
f o r  th e  ce l l  l ine  i n d ic a t e d ,  a f t e r  1 d a y ’s  g ro w th .
H. r e p re se n t s  h a e m o c y to m e te r  coun ts .  C. re p re se n t s  co u lter  coun ts .
0.20 
0.15 
0.10 
0.05 
0.00 
Figure  3.2.2
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Figure  3.2.2 (j)
C ce ll  n u m b e r  (x  1 0 .0 0 0 )
Figure 3.2.2 (k) C cell n u m b er  (x 10.000)
C. cell n u m b e r  (x 10,000)
Figure  3.2.2 (1)
Figures 3.2.2 (j) -  (1):
R e l a t i o n s h ip  b e t w e e n  ce ll  n u m b e r  a n d  O p t ic a l  D en s i ty  in MIT a s s a y  
l o r  th e  ce l l  l in e  in d ic a t e d ,  d f t e r  4 d a y s ’ g ro w th .
H r e p r e s e n t s  h u em o cy to m eter  co un ts :  C re p r e se n t s  coulter  counts.
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Figure  3.2.2 (m)
H cell n um ber (x 10,000)
r-o
IQ
d
6
Figure  3.2.2 (n) H cell n um b er (x 100.000)
F igu res  3.2.2 (rn), (n):
R e l a t i o n s h ip  b e tw e e n  ce ll  n u m b e r  a n d  O p t ica l  D e n s i ty  in MTT a s s a y  
f o r  t h e  ce l l  l ine  i n d ic a t e d ,  a f t e r  4  d a y s '  g ro w th .
H. r e p r e s e n t s  h a e m o c y to m e le r  counts .  C. r e p r e se n t s  co u lte r  counts .
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3.2.3 Detection level
Table 3.2.3 Minimum detectable cell number for the MTI assay-
after 1 and 4 days growth in culture (cell number 
corresponding to 0.02 OD units)
cell
line
cell number/ 96 well
day 1 day 4
RPMI-2650 31,000 7,500
NRK 5,000 1 2 , 0 0 0
DLKP 9,500 5,400
repeat 13,000 —
Hep-2 9, 500 18,750
repeat 10,500 —
SK-LU-1 6 , 750 4,750
SK-MES-1 5,250 6,750
repeat 9,000
For the cell lines tested the assay was not capable of detecting fewer 
than 5,000 cells/ 96 well. Indeed the figure was much worse for most 
cell lines, e.g. RPMI-2650, for which cell numbers less than 31,000 
per well could not be detected after 1 days' growth. The threshold of 
detection varied after culture for 1 day and 4 days, but were 
particularly different for RPMI-2650 and NRK. For the other cell 
lines, the discrepancy was not as great after the two different 
culture periods. This may indicate differing MTT metabolizing 
activity, for similar numbers of some cells under different growth 
conditions.
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3.2.4 Linearity
Table 3.2.4 Highest cell number to which the MTT assay remained
linear
cell
line
cell number (x 104) / 96 well
day 1 day 4
RPMI-2650 > 6 *
NRK > 8 > 1 0
DLKP > 9 > 1 2
repeat 16 —
Hep-2 > 8 > 38
repeat > 16 —
SK-LU-1 * -
SK-MES-1 > 4 > 9
repeat > 8.5
* = difficult to determine
For every cell line, and under both sets of experimental conditions (1 
and 4 days' growth), increasing cell number gives a concomitant 
increase in OD, right up to high cell densities. This relationship is 
linear for some part of every graph, although deviation occurs to a 
greater extent in some of the graphs than others (notably SK-LU-1 
after 1 day in culture, Figure 3.2.2 (d)). For some cell lines the 
upper limit of linearity has been reached at high cell densities 
(e.g. NRK, Figures 3.2.2 (a) and (j) ), but for others this was not 
the case. For logistical reasons, it was not possible to test higher 
densities of some cell lines (e.g. SK-LU-1 cells are large and slow 
growing - the densities required could not be cultured within the 
available time and without scaling up the size of the growth vessels 
considerably).
Differences in the extent of linearity also occurs when cells are 
grown under different conditions, but overall the trend among cell 
lines is similar. For RPMI-2650 for example the linear range is very 
short, whereas for Hep-2, the range is considerably more extensive.
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3.2.5 Sensitivity
Table 3.2.5 Sensitivity of the MTT assay over the linear graph
cell
line
change in OD/ 1 0 , 0 0 0  cells
day 1 day 4
RPMI-2650 0.007 *
NRK 0.036 0.019
DLKP 0 . 0 2 0 0.034
repeat 0.019 -
Hep-2 0 . 0 2 2 0 . 0 1 0
repeat 0.016 —
SK-LU-l 0.030 0.037
SK-MES-1 0.035 0.028
repeat 0.018 -
SCC-9 * *
* = difficult to determine
The sensitivity of the assay, indicated by the slopes of the lines, 
is quite low, and again this varies with different cell lines. It is 
however, consistantly greater, for SK-LU-l for example, than for 
Hep-2. Thus there is a greater increase in OD for SK-LU-l than there 
is for Hep-2 for the same increase in cell number. This of course is 
related to the growth rate and growth characteristics of the 
individual cell line. Again, the sensitivity differs slightly in 
repeat experiments and when cells were cultured under different 
conditions. There seems to be a correlation between the data in Tables 
3.2.3 and 3.2.5, both of which measure sensitivity in a slightly 
different way.
3.2.6 Ease of performance/ technical flaws
There are no rinsing steps involved in the MTT method, either before 
or after MTT addition; so the number of actual steps involved is very 
small. Thus the assay is very easy to perform. However, one of the 
steps (removal of assay medium after MTT metabolism) is technically 
difficult, as the insoluble formazan salt crystals formed on the 
surface of the cells (Figure 3.2) may be very easily detached and lost 
with the waste medium. The plate can not be 'flicked' to remove waste 
medium; it must be removed with a multiwell pipette, yet regardless of 
how carefully this step is performed, touching the bottom of the dish 
with the pipette tip will result in some loss of formazan. Practical 
measures such as fitting syringe needles with a small bore, to the tip 
of pipette tips themselves (to reduce surface contact between pipette 
tip and monolayer), and use of an automatic plate washer, were not 
successful.
The photographs which follow illustrate formazan crystal formation on 
the outside of RPMI 2650 cells.
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Figure 3.2: Extracellular formazan crystal formation on RPMI-2650
cells in the M T T  assay. T h e s e  " h a i r - l i k e "  p r o t r u s i o n s  (■•-) a r e  e a s i l y  
d i s t u r b e d  d u r i n g  m e d i u m  r e m o v a l .
3.2.7 Applicability to a range of cell lines
N o t w i t h s t a n d i n g  t h e  t e c h n i c a l  d i f f i c u l t y  o f  r e m o v a l  o f  m e d i u m ,  t h e  
M T T  a s s a y  w a s  e q u a l l y  a p p l i c a b l e  t o  e a c h  o f  t h e  c e l l  L i n e s  t e s t e d .
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3.3 MTT assay/ SDS modification
Given the technical flaws of the MTT assay just outlined, one 
particular modification of the procedure seemed an attractive 
alternative. In the alternative procedure (Tada et al., 1986),
removal of the incubation medium does not take place; formazan 
solubilization takes place by addition of lOOpl 10% SDS solution to 
the wells on top of the incubation medium. Not only does this obviate 
the 'medium removal1 step, but it should eliminate the errors 
associated with handling of the plates (as the formazan crystals are 
prone to detachment).
This section investigates the performance of this assay compared to 
the original method.
3.3.1 Relationship between cell number and O.D. in SDS
modification of the MTT assay
The relationship between cell number and O.D. has been determined for 
this assay as outlined in section 3.2.2., but was only performed after 
growth for 1 day in culture. Simultaneous to cell counting, MTT/SDS 
assays were performed on replicate plates on SK-MES-1, DLKP and Hep-2 
(including repeat) cell lines. The results have been graphed and are 
shown in Figures 3.3.1 (a) to (d). The cell numbers referred to, 
relate to actual cell number counted and not cell number seeded. The 
lowest detectable cell number, linear range and slope of the linear 
graph, were calculated, and the results appear in the tables which 
follow.
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F i g u r e  3 . 3 . 1  ( a )  H « 1 1  n u m b e r  (x 10.000)
Figure  3.3.1 (b) H cell n u m b er  (x 10,000)
Figures  3 .3 . 1(a) -  (b ):
Relat ionship  between cell n u m b e r  and Optical Density in MTT/SDS a s s a y  
for the cell line ind ica ted ,  a f te r  I day's  growth.
H. r e p r e s e n t s  h a e m o c y t o i n e t e r  c o u n t s ,  C. r e p r e s e n t s  c o u l t e r  c o u n t s .
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Figure  3.3.1 (cl tt. c e li in i in  b e r (x  10,000)
H eell num ber (x 10.000),
Figure  3.3.1 (d)
Figure 3.3.1 ( c ) -  (d):
Relat ionship  between celi n u m b e r  and Optical Density in MTT/SDS a ssay  
for the cell line indicated,  a f t e r  1 day's  growth.
H. r e p r e s e n t s  h a e m o c y t o m e t e r  c o u n t s :  G\ r e p r e s e n t s  c o u l t e r  c o u n t s
3.3.2 Detection level
Table 3.3.2 Lowest detectable cell number for the MTT/SDS assay
after 1 days growth (cell number corresponding to 
0.02 OD units)
cell line cell number/ 96 well
DLKP 57,000
Hep-2 40,000
repeat 29,000
SK-MES-1 6 6 , 0 0 0
Overall, the lower limit of detection corresponds to quite high cell 
densities (66,000 cells for SK-MES-1, compared to 9,000 cells for the 
MTT assay), so the assay was not capable of detecting low cell numbers 
and certainly it was a disimprovement on the standard MTT assay.
3.3.3 Linearity
Table 3.3.3 Highest cell number to which the MTT/ SDS remained
linear (after 1 days growth)
cell line
linear to: 
cell number/(x 104 ) 96 well
DLKP > 16
Hep-2 > 9
repeat > 18
SK-MES-1 > 1 1
The assay is linear to high cell numbers (equivalent to, or slightly 
higher than the standard method) .
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3.3.4 Sensitivity
Table 3.3.4 Sensitivity of the MTT/SDS method over the linear
graph (after 1 days' growth)
cell line change in OD/ 10,000 cells
DLKP 0.003
Hep-2 0.005
repeat 0.004
SK-MES-1 0.003
The extremely poor sensitivity of this modification can be seen from 
the very low slopes of the lines. Thus a substantial increase in cell 
number gave only a very small increase in corresponding OD.
The low OD readings may be explained by the increased volume into 
which the formazan is dissolved; thus it is more dilute, resulting 
in a lower absorbance reading. It may also be that the SDS has a 
lower solubilizing power than DMSO. Another explanation may be that 
the phenol red in the medium is causing spectral interferences which 
are resulting in lower readings overall.
Using this procedure, 100,000 Hep-2 cells will only produce a reading 
of 0.040 absorbance units, whereas with the standard method, a value 
of 0.170 absorbance units was reached. Comparing the slopes of the 
lines for the 2 methods, we see that the SDS modification is 6 times 
less sensitive for SK-MES-1 and 4 times less sensitive for Hep-2. It 
is clear thus, that the sensitivity is extremely low.
3.3.5 Ease of performance/ technical flaws
The SDS modification of the MTT assay is particularly easy to perform, 
and does not encounter the difficulties of medium removal discussed 
for the MTT assay.
3.3.6 Application to a range of cell lines
This assay is particularly appropriate for all cell lines; even 
non-adherent ones, because there are no rinsing or medium-removal 
steps in which cells can be lost, however its very low sensitivity 
for each of the cell lines tested, limits its usefulness.
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3.4 Crystal Violet Dye Elution (CVDE) assay
3.4.1 Plate rinsing
If the dye is improperly rinsed from the plates, results will be 
inaccurate. Crystal violet is an aqueous stain so superfluous
washings will lessen the intensity of staining. It is therefore 
important to properly rinse the plate without resulting in 
de-staining. It was found that 4 separate rinses in tap water was the 
minimum number needed for adequate washing, thus this procedure was 
routinely used for all assays.
3.4.2 Relationship between cell number and O.D. in CVDE assay
These experiments were performed as described in the materials and 
methods, and as outlined again in section 3.2.2. The CVDE assay was 
performed on replicate plates after 1 day and again after 4 days
growth. Additional replicate plates were trypsinized and counted on 
these days by haemocytometer and Coulter counter. Repeat experiments 
were performed once for DLKP and SK-MES-1, and twice for Hep-2. The 
experiment was carried out on a total of 7 cell lines (6 epithelial 
and one fibroblastic), and cell counts were plotted against O.D. 
Figures 3.4.2 (a) to (i) illustrate the data pertaining to 1 day's 
growth, while the graphs in Figures 3.4.2 (j) to (n) relate to 4 
days' growth. These include graphs of repeat experiments for for
Hep-2, SK-MES-1 and DLKP, the data for which is also given in the
tables.
The minimum detectable cell number, the linear range of the graph, and 
the slope of this linear portion have been calculated and are shown in 
the tables which follow the graphs.
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Figure  3.4.2 (a) II cell n u m b e r  (xlO.OOO)
Figure  3.4.2 (b) C cell n u m b e r  (xlO.OOO)
Figure  3.4.2 (c) H cell n u m ber  (x 10,000)
F igu re s  3.4.2 (a) -  (c)
Relat ionship  between ceil n u m b e r  and Optical Density in CVDE a s s a y  
for the cell line indicated,  a f te r  I day's  growth.
H. r e p r e s e n t s  h a e m o c y to m e le r  co un ts ,  C. r e p re se n t s  co u lter  coun ts .
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Figure  3.4.2 (d)
cell n um ber
2.0 
(x 10.000)
Ecof-m
0.30
SK-LU-1
Figure  3.4.2 (e) H eel1 number <x 10-00°)
F igure  3.4.2 (f)
F i g u r e s  3 .4 .2  (d )  -  (f) :
Relat ionship  between cell n u m b e r  and Optical Density in CVDE a s s a y  
for  the cell line indicated ,  a f t e r  1 day's  growth.
H. re p r e s e n t s  h a e m o c y to m e io r  counts,  C re p re se n ts  co u lte r  coun ts .
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Figure  3.4.2 (g) H cel1 nurnber (* 10.000)
9 10 11 12 13
H cc-ll n u m b er  (x 10,000)
1.20
1.00
E
o  0 .8 0  t"-uO
«  0 .6 0  
Q
°  0 .4 0
0.20
Figure  3.4.2 (h)
Figure  3.4.2 (i)
6 8 10 12 14
H cell n u m b e r  (x 10,000)
F i g u r e s  3 . 4 .2  ( g )  -  ( i );
Relat ionship  between cell num b er  and Optical Density in CVDE a s s a y  
for the cell line indicated,  a f te r  I day 's  growth.
H. r e p re se n t s  h a e m o c y to m e te r  co un ts :  C re p r e se n t s  co u l te r  coun ts .
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Figure  3.4.2 (j) C cell n u m b e r  (x 10.000)
Figure  3.4.2 (k)
C cell n u m b e r  (x 10,000)
Figure  3.4.2 (1) C cell n u m b e r  (x 10.000]
F i g u r e s  3 .4 .2  (j )  -  (I):
Relat ionship  between cell n u m b e r  and Optical Density in CVDE a s s a y  
for  the cell line indicated ,  a f t e r  4 days '  growth.
H. r e p r e s e n t s  h a e m o c y to m e te r  co u n ts ,  C re p re se n t s  co u lter  counts.
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Figure  3.4.2 (mj
C cell n u m b e r  (x 10.000)
Figure  3.4.2 (n H cell n u m b e r  (x 10,000)
F i g u r e s  3 .4 .2  (m ) ,  (n):
Relat ionship  between cell n u m b er  and  Optical Density in CVDE a s s a y  
for  the  cell line indicated ,  a f t e r  4 d a y s ’ growth.
H. re p r e s e n t s  h a e m o c y to m e te r  co un ts .  C re p re se n t s  co u lter  co un ts
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3.4.3 Detection level
Table 3.4.3 Minimum detectable cell number for the CVDE assay
after 1 and 4 days growth, (corresponding to 0.02 OD 
units)
cell
line
cell number/ 96 well
day 1 day 4
RPMI-2 650 1, 750 2,000
NRK 750 1,200
DLKP 600 -
Hep-2 750 -
repeat 1,000 “
SK-LU-1 1,300 750
SK-MES-1 700 875
repeat 1, 700 —
SCC-9 1,850 1,000
The CVDE assay detected relatively low numbers of cells. For many cell 
lines, it was capable of detecting 1,000 cells/ 96 well, or fewer.
3.4.4 Linear range
Table 3.4.4 Highest cell number to which the CVDE assay was
linear
cell
line
linear to: cell number (x 104) / 96 well
day 1 day 4
RPMI-2650 7 9.5
NRK 6 5
DLKP 4 -
Hep-2 5 . 5 -
repeat > 4 —
SK-LU-1 > 3.5 > 3.5
SK-MES-1 > 3 > 3
repeat > 8 -
SCC-9 * > 2.5
* = difficult to determine
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For at least some part of the graph, there is a linear relationship of 
cell number and O.D. This was easily observed with all of the cell 
lines, except SCC-9, for which this relationship was not easily 
determined. While the assay was more sensitive at detecting lower 
cell lnumbers of DLKP than RPMI-2650, the linear range was shorter for 
DLKP than RPMI-2650.
Overall the assay became non-linear at moderate cell densities, after 
which there was no further increase, or indeed a slight decrease, in 
absorbance. Ceratainly the assay was not linear up to 100,000 
cells/96 well for any of the cell lines tested; for many cell lines in 
fact, it did not even remain linear for 50,000 cells/ well. Thus, 
accompanying the increased sensitvity of theis assay over prevvious 
assays, there is a concomitant decrease in linearity.
3.4.5 Sensitivity
Table 3.4.5 Sensitivity of CVDE assay over the linear range
cell
line
change in OD/ 10,000 cells
day 1 day 4
RPMI-2650 0.160 0.088
NRK 0.188 0.169
DLKP 0.347 -
SK-LU-1 0. 122 0.227
Hep-2 0.258 -
repeat 0.273 —
SK-MES-1 0.305 0.304
repeat 0. 147 -
SCC-9 0.086 0.193
* = difficult to determine
By and large, the slopes of the lines are substantial, indicating 
good sensitivity. Again values differ somewhat for the graphs of 1 
and 4 days growth, and also for experiments carried out on different 
days.
3.4.6 Ease of performance/ technical flaws
The CVDE assay is simple to perform. The dye solution should be 
filtered before use. The lack of an incubation period of a few hours 
is also an advantage (staining takes only 10 minutes), however the 
plate must be fully dried before addition of solvent for dye release. 
If wished, the plate may be fixed in 10% Formalin previous to 
staining, whereupon it may be rinsed, dried and restained if the 
results need to be verified. The delay while the plates dry may be a
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disadvantage if the results are needed rapidly, but it may be an 
advantage if time is short - they may be stored dry, in the dark, 
until there is sufficient time to process them.
3.4.7 Applicability to a range of cell lines
Similar to the other assays, there appeared to be no difference in 
the performance of this assay among different cell lines.
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3.5 Neutral Red (NR) assay
3.5.1 Optimization
3.5.1.1 Effect of serum in incubation medium
Dye was not taken up into cells if the medium did not include serum, 
thus for all assays, complete medium including 5% FCS was used.
3.5.1.2 Removal of crystals from dye medium
In the original method [Borenfreund and Puerner, 1984] the authors 
used a procecure in which the working solution of NR in fresh medium 
was prepared and incubated in the fridge overnight before use (to 
accomodate precipitation of dye crystals). Just before use, the 
solution would then be centrifuged at 5,000 rpm for 10 minutes. 
Omission of this step would be of benefit for the laboratory worker.
On a number of assays performed simultaneously using NR solution 
prepared in different ways it was determined that the latter step was 
much more important than the former; incomplete centrifugation did 
not result in removal of all of the NR precipitate which customarily 
appeared in the solution. These precipitates in the incubation medium 
remained on the cells after removal of excess dye and interfered with 
the readings; they were observed microscopically as large crystals 
sitting on the outside of the cells. Thorough centrifugation of the 
solution followed by careful handling to ensure that pelleted 
precipitate was not resuspended, was sufficient to ensure that this 
interference did not materialize.
Careful observation of the cultures indicated that there was no 
difference between medium that had been prepared the night previously 
and that which had not; the precipitate was removed to the same 
extent upon centrifuging either way. It was therefore concluded that 
this incubation step was not necessary provided that care was taken in 
the steps which followed, so this step was omitted from the 
procedure.
3.5.2 Relationship between cell number and O.D. in NR assay
Cells were trypsinized and counted by haemocytometer and Coulter 
counter after 1, and again after 4 days' growth, as described in the 
materials and methods section. NR assays were performed on replicate 
plates for each of 7 cell lines. Figures 3.5.2 (a) to (j) show the 
relationship between actual cell count and O.D. after 1 day's growth, 
while Figures 3.5.2 (k) to (q) show the relationship after culturing 
for 4 days. This relationship was defined by determining the lowest 
detectable cell number for each cell line, the linear range of each 
graph, and finally the sensitivity of the assay for each cell line 
(slope of the linear portion). The following tables show this 
information.
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Figures 3.5.2 (a) -  (c).
Relat ionship  between cell n u m b er  and Optical Density in NR a s s a y  
for the cell line indicated,  a f t e r  1 day 's  growth
H. r e p r e s e n t s  h a e in o cy lo m cter  coun ts .  C re p re se n t s  co u lte r  counts .
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Figure  3.5.2 (c)
2 3  1 5  6  7  8
C cell n u m b e r  (x 10.000)
0 .35  r DLKP 
0 .3 0  -  
£ 0 .2 5  f
£ 0.20 j
o  0.15-i 
d
OAOj 
0 .0 5  t-
114
0.10 
0 .0 8  
0 .06  
0 .04
0.02
0.12
0.14
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Figure  3.5.2 (d)
1.0 1.5 2 .0  2 .5  3 .0
C. cell n um ber (x 10.000)
Figure  3.5.2. (e) H. cell n um ber (x 10,000)
F i g u r e s  3 .5 .2  (d),  (e):
Relat ionship  between cell num ber  and Optical Density in NR a s s a y  
for the cell line ind icated ,  a f t e r  1 day's  growth
H. re p re se n t s  haem ocvtom c-ter  co un ts .  C: re p re se n t s  co u l te r  counts,
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n . o  =: o  H. cell  n u m b e r  (x  10,000)Figure 3.5.2 (f)
Figure 3.5.2 (g) H. ce ll n u m b e r  (x  10,000)
Figures 3.5.2 (f), (g):
Relationship between cell number and Optical Density in NR assay 
for the cell line indicated, after 1 day's, growth
H. re p r e s e n t s  h a e m o c y t o m e t e r  coun ts ;  C. r e p r e se n t s  co u lte r  counts.
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Figure  3.5.2 (h) II. oc-ll n u m b e r  (x 10,000)
oi'-
—.m
Q
O
0.30
0.25
0.20
Figure  3.5.2 (i)
3  -I 5  G 7  8 9 10 11 12
II cell n u m b e r  (x 10.000)
cc
L'»n
a
o
0 .2 5
0.20
0.15
0 10
0.05
0.00
DLKP i I
1
/  *
|
1
•
!
? T
I . /
\ J
1
Figure  3.5.2 (j)
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F i g u r e s  3 .5 .2  (h )  -  ( j).
Relat ionship  between cell n u m b e r  and Optical Density in NR a s s a y  
for  the cell line ind icated ,  id le r  I day 's  growth
H. r e p r e s e n t s  h a e n io cy to m eter  co u n ts .  C re p r e s e n t s  coulter  counts.
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Figure  3.5.2 (k) C cell n u m b e r  (x 10,000)
Figure  3.5.2 (1) C cell n u m b e r  (x 10,000)
DLKP
Figure  3.5.2 (m)
2 3 4 5 6 7 8 9  
C, cell n u m b e r  (x 10,000)
10 I I  12
F i g u r e s  3 .5 .2  (k )  - ( m ) :
Relat ionsh ip  between cell n u m b e r  and Optical Density in NR a s s a y  
for  the cell line indicated,  a f t e r  4 days '  growth.
H. re p r e s e n t s  h a e m o c y to m e te r  coun ts :  C re p r e s e n t s  co u lte r  counts .
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C, cell n u m b e r  (x 1.0,000)
Figure  3.5.2 (n)
F igure  3.5.2 (o )  C. cell number (x io .oooj
F i g u r e s  3 .5 .2  (n) ,  (o):
Relat ionship  between cell n u m b e r  and Optical Density in NR a s s a y  
for  the cell line indicated,  a f t e r  -1 days '  growth.
H re p r e se n t s  h a e m o c y to m e te r  co un ts .  C re p r e s e n t s  co u lter  counts.
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Figure  3.5.2 (p) H’ cellnumber ( * 10.000)
Figure 3.5.2 (q) H. cell number (x 100,000)
Figures 3.5.2 (p), (q):
Relationship between cell number and Optical Density in NR assay 
for the cell line indicated, after 4 days' growth.
H. represents haemocytometer counts; C. represents coulter counts.
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3.5.3 Limit of detection
Table 3.S.3 Lowest detectable cell number for the NR assay after
1 and 4 days growth (cell number corresponding to 
0.02 OD units)
cell
line
cell number / 96 well
1  day 4 days
RPMI-2650 3,500 3, 750
NRK 2 , 0 0 0 3,500
DLKP 2,500 1,250
repeat 2, 750 —
Hep-2 8 , 0 0 0 5,500
repeat 5,000 —
SK-LU-1 3,500 1,750
SK-MES-1 3, 300 ~
repeat 8 , 0 0 0 4, 500
SCC-9 * 1 , 1 0 0
* = difficult to determine
The NR assay is moderately sensitive to low cell numbers of each of 
the cell lines; in fact it can detect cell numbers fewer than 5,000 
cells/ well in many cases. However it was not able to detect cell 
numbers less than 1 , 0 0 0  cells/ well.
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Table 3.5.4 Highest cell number to which the NR assay was linear
3.5.4 Linearity
cell
line
linear to: cell number (x 104 ) / 96 well
1 day 4 days
RPMI-2650 5.5 1 1
NRK 3.5 3.5
DLKP 2  6.5 15
repeat 2 - 3
SK-LU-1 > 3.5 > 3.5
Hep-2 > 9 a 1 0
repeat * “
SK-MES-1 > 3.5 > 9
repeat > 1 1 —
SCC-9 * a 2
* = difficult to determine
The linear range is easily distinguishable from the Figures for the 
various cell lines (except for SCC-9).
Again differences in the extent of linearity are apparent for 
different cell lines. For some cell lines the assay is linear for a 
substantial cell number (e.g., Hep-2; linear over a range of > 90,000 
cells, whereas for others, it is linear over only a short range of 
cell densitites.
The variation in the linear range between experiments for 1 and 4 
day's culture were particularly great for DLKP.
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3.5.5 Sensitivity
Table 3.5.5 Sensitivity of the NR assay for various cell lines
(slope of the linear graph)
cell
line
change in OD/ 1 0 , 0 0 0  cells
1  day 4 days
RPMI-2 650 0.045 0.031
NRK 0.096 0.064
DLKP 0.061 0.162
repeat 0 . 1 1 0
SK-LU-1 0.050 0.124
Hep-2 0.030 0.034
repeat 0.039
SK-MES-1 0.058 -
repeat 0.024 0.049
SCC-9 * 0.176
* = difficult to determine
At a glance it is clear that the slopes are moderately high, and 
again they vary for different cell lines. While there is very 
substantial variation on lines plotted from experiments carried out on 
different days, we can see for example, that the slope of all Hep-2 
graphs is much less than that of DLKP graphs. Overall, the NR assay 
was not of very high sensitivity.
3.5.6 Ease of performance/ technical flaws
While simple to perform, there are many steps involved in the NR 
assay. Medium is removed, the wells are rinsed, dye is added to the 
wells for 4 hours, removed, rinsed in Formal Calcium to remove 
unincorporated dye, and then solvent added to release bound dye. In 
addition the dye must be diluted in culture medium, and centrifuged 
for 5 minutes before use, to remove dye precipitates which might 
interfere with the assay, thus the assay is more cumbersome to 
perform than the other assays.
3.5.7 Applicability to a range of cell lines
This assay was not found to be inappropriate for any of the cell lines 
tested.
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3.6 Sulforhodamine B (SRB) assay
This assay, now adopted by the National Cancer Institute (NCI) drug 
screening program, is a protein binding dye assay. Cells are first 
fixed in TCA before staining with this intense pink dye. Bound dye 
is released by addition of Tris buffer at pH 10.5.
3.6.1 Relationship between cell number and O.D. in SRB assay
As described in the materials and methods section, cells covering a 
range of densities, were trypsinized and counted from 96 well plates 
after 1 day's growth. On replicate plates the SRB assay was 
performed as also described in materials and methods. Figures 3.6.1 
(a) - (d) show plots of actual cell number from haemocytometer 
counts, for DLKP, SK-MES-1 and Hep-2 (including repeat). Lowest 
detectable cell number, range of linearity and sensitivity have been 
calculated from these graphs and the tables which follow display this 
information.
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Figure  3.6.1 (a) l! CCrl1 number (x 10.000)
F igure  3.6.1 (b) H cell n u m b e r  (x 10.000)
F ig u r e s  3 .6 .2  ( a ) ,  ( b ) ;
Relat ionship  between cell n u m b e r  and Optical Density in SRB a s s a y  
for  the cell line indicated,  a f t e r  1 day's  growth.
H re p re se n t s  haemoeytorm;tc-r co un ts .  C r e p re se n t s  co u lter  coun ts .
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1.80
1.60 
|  1.40
I  1-20
a 1.00
P 0.80o
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0.40 
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Figure 3.6.1 (c) H. cell number (x 10,000)
Figure 3.6.1 (d) H. Cell Number (x 10,000)
F ig u re s  3.6.2 (c), (d)
Relationship between cell number and Optical Density in SRB assay 
for the cell line indicated, after 1 day's growth.
H. represents haemocytometer counts; C. represents coulter counts.
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3.6.2 Detection level
Table 3.6.2 Lowest detectable cell umber for the SRB assay
after 1 days' growth (cell number corresponding to 
0.02 OD units)
cell line cell number/ 96 well
DLKP 300
Hep-2 300
repeat 400
SK-MES-1 500
SCC-9 750
The assay is extremely sensitive to low cell number, being capable of 
detecting as few as 300 DKLP cells/ 96 well; and certainly fewer than
1 , 0 0 0  cells /well for each of the lines tested.
3.6.3 Linear range
Table 3.6.3 Highest cell number to which the SRB assay is
linear (after 1 day's growth)
cell line
linear to: 
cell number (x 104) / 96 well
DLKP 2 . 75
Hep-2 3 - 4
SK-MES-1 5
SCC-9 1.5
Although the cell number detected is very low, the assay does not 
remain linear to high cell densities. At cell numbers greater than
40,000 DLKP cells per 96 well, the assay is no longer linear and can 
not give an accurate estimate of cell number. For SCC-9 (which are 
particularly large cells), linearity is only maintained to 15,000 
cells per 96 well. This deviation from linearity can be seen quite 
dramatically by a brief glance at the Figures on the previous page.
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3.6.4 Sensitivity
Table 3.6.4 Sensitivity of the SRB assay for various cell lines
after 1 days 1 growth
cell line change in OD/ 10,000 cells
DLKP 0.562
Hep-2 0.537
0.433
SK-MES-1 0.358
SCC-9 0.960
The assay is very sensitive. The slope of the SCC-9 plot, is very 
steep; for every increase of 1 0 , 0 0 0  cells, there was an increase of 
almost 1 OD unit; however the range of this linear portion was not 
very extensive, spanning only approximately 15,000 cells.
3.6.5 Ease of performance/ technical flaws
Again this assay is simple to perform, but there are quite a number 
of steps involved. The first step is a fixing step, with cold 
Trichloroacetic acid (TCA) which continues at 4°C for an hour. 
Thereafter the plate is rinsed and dried, stained for 30 minutes, 
rinsed and dried, and then unbound dye is released by addition of 
Tris buffer. Like the CVDE assay, the steps where the plate is 
being dried, may be disadvantageous if the results are required 
immediately, or may offer an advantage as they may be stored and read 
at a later time.
3.6.6 Applicability to a range of cell lines
As with the other assays, the assay appeared to be equally suitable 
for a range of cell lines. Unlike the other assays, addition of TCA 
resulted in loosely adherent cells (DLKP for example) being fixed 
also, so additionally, this may make the assay appropriate for cell 
lines growing in suspension, such as Small Cell Lung Carcinoma cell 
lines.
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3.7 Acid Phosphatase (AP) assay
3.7.1 Optimization
3.7.1.1 Storage of buffer for AP assay
A short experiment was conducted to determine if the stability of the 
incubation buffer was a problem. A two week-old stock of buffer 
containing substrate (stored at 2°C) was compared to a freshly made up 
stock, in a 96 well AP toxicity experiment. The results were 
compared to those obtained by image analysis, and are shown in Figure 
3.7.1.1.
It can be seen that the freshly prepared AP buffer gives results 
similar to those from image analysis, however the results with the 
old buffer are completely erroneous; negligable cell kill has been 
detected, so the assay did not work at all. This is obviously due to 
hydrolysis of the substrate in the buffer.
It is obvious thus, that the substrate-containing buffer is not 
stable for this length of time. Thereafter, the substrate was always 
added to the sodium acetate/ triton X-100 buffer immediately before 
use.
3.7.1.2 pH of incubation buffer
Although the original method of Connolly et al., [1986] uses an
acetate buffer at pH 5.5, it has been stated [Hollander, 1971'ethat 
the optimum pH for acid phosphatase with an acetate buffer is pH 4.9. 
Thus the aim of this experiment was to determine if pH 4.9 would be 
preferential to pH 5.5. Cell number versus AP activity (OD units) has 
been plotted for these 2 buffers (Figure 3.7.1 (b). Both pH's were 
used over an entire cell density range of SCC-9. While there was 
little difference in the results of a toxicity assay using these 2 
different buffers, the OD was significantly higher at the higher pH 
than at pH 4.9. Thus acetate buffer adjusted to pH 5.5 was 
confidently used for all assays thereafter, as in the method of 
Connolly et al.
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0.001 0,01 0.1 1.0 
VINBLASTINE CONCENTRATION, fig/  ml
Figure  3.7.1.1
Activity of fresh ( • --- • )  and 2— week old stock (O — O) of AP buffer
in a toxicity experiment on RPMI-2650 cells, compared to IA ( A  A).
110
£  70 ■
O---- O AP buffer,  pH 4.9
• ---- •  AP buffer,  pH 5.5
•-
-Ó,
1 0 -
0.000 0.001 0.002 0.003 0.004 0.005 0.006 0.007 0.008 0.009 0.010 
„  VINBLASTINE CONCENTRATION, fig/ m l
Figure  3.7.1.2
Effect of buffer pH on AP activity in toxicity a ssay  with SCC—9 cells.
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Because the incubation buffer contained Triton X-100, there was a 
strong tendency for bubble formation which may have interfered with 
absorbance readings.
A number of plates were read initially and then after bubbles had been 
removed (by bursting with a syringe needle). It was apparent that the 
presence of bubbles on the plate caused some degree of interference 
while the plate is being read. Accordingly, as a matter of practice, 
bubbles, when present, were burst before the plate was read.
3.7.2 Relationship between of cell number and O.D in AP assay
This relationship was determined in exactly the same manner as it was 
for the previous assays, and is described in detail in the Materials 
and Methods section. Briefly, cells seeded at a 3-log range of 
densities, were cultured for 1 day. Replicate plates were cultured 
for 4 days and on both sets of plates, cells were trypsinized and 
counted by Haemocytometer and by Coulter counter. AP assays were 
performed on replicate plates on each of these days and read 
immediately after 2 hours incubation. Actual cell number counted was 
plotted against O.D. to compose the Figures 3.7.2 (a) to (j) for data 
relating to 1 day's culture, and Figures 3.7.2 (k) to (q) for 4 day's 
culture.
Lowest detectable cell number, range of cell numbers over which the 
assay was linear, and sensitivity of the assay were determined, and 
these are condensed in the Figures which follow.
3.7.1.3 Elimination of bubbles before reading
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0.80
0 .7 0  
£ 0 .6 0  
o  0 .50■*d*
O 0 .4 0  
6  0 .3 0  
0.20 
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0.00
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Figure  3.7.2 (a)
4 6 8 10 12 14
H. cell n u m b er  (x 10,000)
C cell n u m b e r  (,\ 10,000)
Figure  3.7.2 (b)
0 .3 0
0.25 -
S 0.20
o  0 . 1 0 -
DLKP
0 .0 5 - -
0 1
Figure  3.7.2 (c)
2 3 4 5 6 7 8 9 10 11 12
C cell n um b er (x 10.000)
Figu res 3.7.2 ( a ) -  (c):
Relat ionship  between cell num ber  and Optical Density in AP2h a s s a y  
for the cell line indicated,  a f te r  1 day ' s  growth.
H. re p re se n t s  l ia c m o e v lo m e te r  counts;  C r e p r e s e n t s  co u l te r  counLs
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Figure  3.7.2 (d) C. cell n u m b er  (x 10.000)
Figure  3.7.2 (e) H cel! number (x 10 000>
F i g u r e s  3 .7 .2  (d )  -  ( e ):
Relat ionship  between cell n u m b e r  and Optical Density in AP2h a s s a y  
for the cell  l ine indicated,  a f te r  1 day's  growth.
H. r e p re se n t s  h a e m o c y to m e te r  co un ts .  C re p re se n t s  co u lte r  coun ts .
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F igure  3.7.2 (f) H cell n um b er (x 10,000)
F igure  3.7.2 (g)
0 .4 0
e
C
o
flj
QO
H. cell n u m b e r  (x 10,000)
H e p - 2
F i g u r e s  3 .7 .2  (f) -  ( g ) :
Relat ionship  between cell n u m b e r  and Optical Density in AP2h a s s a y  
for  the  cell line ind ica ted ,  a f te r  1 day's growth.
H. re p r e s e n t s  h a e m o c y to m e te r  co u n ts ;  C. re p re se n t s  co u lte r  counts.
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Figure  3 7 2 (h) H' cel1 nunibei' (x i°ooo)
Figure  3.7.2 (i) H cel1 number (x 10.00 0)
o 2 
Figure  3.7.2 (j)
4  6 8 10 12 14
H cell n u m b e r  (x 10,000)
F i g u r e s  3 . 7 .2  (h )  -  ( j )
Re lat ionsh ip  between cell n u m b e r  and Optical Density in AP2h a s s a y  
fo r  the cell line indicated ,  a f t e r  1 day's  growth.
H. r e p r e s e n t s  h a e m o c y lo m e t e r  co un ts .  C re p re se n ts  co u lte r  counts.
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Figure 3 7 2 (1) C- cel1 number (x 10.000)
F i g u r e  3 .7 .2  (m) H. cell n u m b e r  (x 10,000)
F i g u r e s  3 .7 .2 (k) — (m) :
Relationship between cell number and Optical Density in AP2h assay 
for the cell line indicated, after 4 days' growth.
H. r e p r e s e n t s  h a e m o c y to m e te r  count; C. r e p r e se n t s  co u n te r  count.
0.60
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Figure  3.7.2 (k)
2  3 4  5 6 7  8 9  10 11 12
H. cell n u m b e r  (x 10,000)
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Figure  3.7.2 (n) C. cell n um ber (x 10.000)
Figure  3.7.2 (o) c cell number (x-10.000)
F i g u r e s  3 .7.2 (n) -  (o):
Relat ionship  between cell num b er  and Optical Density in AP2h a s s a y  
for  the cell line indicated,  a f te r  4 days '  growth.
H. re p re se n t s  haem dcytom c-ter ctniitl 1/ r e p re se n t s  co u n te r  count
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I
Figure  3.7.2 ( p )  H e « n  n u m b e r  (x io .oooj
Figure  3 7 2 (q) H cel1 number (K 10,000)
F i g u r e s  3 .7 .2  (p),  ( q ):
R elat ionsh ip  between cell n u m b e r  and Optical Density in AP2h a s s a y  
for the cell line indicated ,  a f t e r  4 d a y s ’ growth.
H. r e p r e s e n t s  h a e m o c y to m e te r  count; C r e p re se n t s  co u n ter  count
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3.7.3 Detection level
Table 3.7.3 Lowest detectable cell number with the AP2h assay
(cell number corresponding to 0.02 OD units)
cell line
cell number/ 96 well
1 day 4 days
RPMI-2650 7, 500 6 , 500
NRK 2, 500 3,000
DLKP 7, 500 4,500
repeat 16,000 -
Hep-2 8 , 0 0 0 11,500
repeat 9, 500 —
SK-LU-1 14,000 3,750
SK-MES-1 7, 750 4,000
repeat 6 , 0 0 0
SCC-9 * 3,250
The limit of detection corresponds to reasonably small cell numbers,
but overall was not very sensitive to low cell numbers. In most cases
it has detected fewer than 1 0 , 0 0 0  cells/ well, but it was generally
not capable of detecting fewer than 2,500 cells/ well.
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Table 3.7.4 Highest cell number to which the AP2h assay was
linear
3.7.4 Linear range
cell line
linear to: cell number (x 10 ) /96 well
1  day 4 days
RPMI-2650 > 1 2 > 13
NRK 2 1 2 2  1 0
DLKP 2  1 1 > 1 1
repeat 2 1 1 -
Hep-2 2 8 2 38
repeat £ 18 —
SK-LU-1 2 3 2 3.5
SK-MES-1 2 1 0 2 9
repeat 2 1 1 -
SCC-9 * *
We can see that the AP2h assay remained linear up to high cell numbers 
for many cell lines. This can be easily seen from a quick glance at 
the Figures on the previous page. In many cases, the linear range 
extends throughout the entire range of cell densities, and does not 
level off as seen for some of the other assays.
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3.7.5 Sensitivity
Table 3.7.5 Sensitivity of the AP2h assay for various cell
lines (slope of the linear graph)
cell line
change in OD/ 10,000 cells
1  day 4 days
RPMI-2650 0. 023 0.027
NRK 0.072 0.058
DLKP 0.024 0.042
repeat 0.027 -
Hep-2 0.029 0.016
repeat 0 . 0 2 2 —
SK-LU-1 0.014 0.052
SK-MES-1 0 . 0 2 2 0.050
repeat 0.030 -
SCC-9 * 0.054
* = difficult to determine from graph
Sensitivity of the AP assay, like the other assays has been
determined by calculating the actual slope of the linear portion of
each graph. Overall the assay was not very sensitive.
It is interesting to note that there is sometimes a great difference 
in sensitivity of the assay when growth after 1 day and growth after 4 
days' culture are compared. This may indicates that the AP activity 
per cell number is not constant and may vary under different 
conditions.
3.7.6 Ease of performance/ technical flaws
The AP2h assay is simple to perform, only involving one rinse and
addition of one compound. Once the incubation period has been carried 
out, the plate can be read directly without any further step. Bubbles 
were generally burst with a syringe needle as a matter of course
(refer back to section 3.7.1.3), but these were not always present,
and the exercise only took a few seconds. Whilst the substrate must
be added to the buffer just before use, this may be pre-weighed,
aliquoted and frozen in vials ready for use to speed up the step.
3.7.7 Applicability to a range of cell lines
Similar to the other assays, the AP assay was found to be appropriate 
for use, for all the cell lines tested.
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3.8 Effect of increased incubation time on AP assay activity
The merits of a 2 hour AP assay have been determined and from brief 
comparisons to other assays (dealt with extensively in section 3.10) 
it appears that the assay is convenient and is linear to substantially 
high cell numbers, but an improvement in sensitivity would be 
particularly beneficial for its use in quantification of cell number. 
If the sensitivity of the assay could be increased without any 
decrease in its range of linearity, then this would be a very 
significant improvement in the assay.
Thus, let us now consider the effect of increasing the incubation 
period of the assay, and determine the effect this has on the 
characteristics of the AP assay.
3.8.1 Minimum detectable cell number
The lowest cell number which can be detected (OD > 0.02) decreases as 
incubation time of the AP assay progresses; that is, the assay becomes 
more sensitive at detecting low numbers of cells with increased
incubation time. This was universally the case. The relationship of 
this increased sensitivity to low cell numbers, with OD, was
approximately linear over the time ranges tested, and this is
illustrated for DLKP, RPMI-2650, and SK-MES-1 in Figures 3.8.2 (a) to
(d). When the assay duration was increased from 2 hours to 3.75 hours
for example, 2,000 as opposed to 9,500 DLKP cells could be detected.
3.8.2 Linearity
The linearity of the AP assay has been compared over a time range for 
a number of cell lines and some typical data has been presented in the 
graphs shown. It can be seen that increasing incubation time, from
0.5 to 3 or 4 hours, results in no substantial change in linearity of
cell number versus O.D.
Graphs of RPMI-2650 and SCC-9 show no change in linearity for up to 5 
and 7 hour assay times respectively. After 6 hours incubation of 
SK-MES-1 cells though (Figure 3.8.2 (d)), the linear range under
these conditions, has been reduced from 4.5 x 104 cells to 2 x 104 
cells so this is an important factor to be borne in mind for this cell 
line.
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0 2 4 6 8 10 12 14 16 18 20 22 24 26
Cell n u m b er/ 96 well (x 10,000)
Figure 3.8.2 (a)
Relat ionship between RPM1-265Q cell n u m b e r  and  AP activity
for increas ing  a s s a y  du ra t ion  (growth a f t e r  4 days '  in culture).
Cell s e e d i n g  d e n s i t y ( x  10 ,0 00 )
Figure  3.8.2 (b)
Relat ionship  between S C C - 9  cell n u m b er  and AP activity 
for increas ing  a s s a y  durat ion  (growth a f t e r  1 day  in culture).
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F i g u r e  3 . 8 . 2  (c )
Cell num ber (x 10,000)
R e la t io n sh ip  b e tw e e n  DLKP c e l l  n u m b e r  a n d  AP a c t iv ity
fo r  in c r e a s in g  a s s a a y  d u r a t io n  (g ro w th  a f t e r  1 d a y  in  c u ltu r e ) .
F igu re  3.8.4 (d)
0 .0  0 .5  1.0 1.5 2 .0  2 .5  3 .0  3 .5  4 .0  4.5 5 .0  5 .5  6 .0  
Cell number (x 10,000)
R e la t io n sh ip  b e tw e e n  S K -M E S —1 c e ll  n u m b e r  a n d  AP a c t iv ity  
fo r  in c r e a s in g  a s s a y  d u r a t io n  (g ro w th  a f t e r  1 d a y  in  c u ltu r e ) .
144
3.8.3 Sensitivity
Although increased assay duration shows no change in linearity for 
assay times of 4 hours at least, there is a substantial change in 
sensitivity with increased incubation. In all cases, increased 
sensitivity results from longer assay duration in a constant fashion. 
The Table below shows that for RPMI-2650 after 4 days' growth in 
culture, the sensitivity of the assay increased approximately 
linearily as a result of increased incubation time to 5 hours at 
least.
Table 3.8.3 Change in sensitivity of the AP assay for RPMI-2650
with increasing incubation time (after 4 days in 
culture)
Time 
(hours)
change in OD/ 
change in 1 0 , 0 0 0  cells
1 0.031
2 0.055
3 . 5 0.099
5 0.145
Figure 3.8.3 shows the linear relationship between assay duration and 
O.D. over the range 0 to 5 hours for RPMI-2 650, over a complete range 
of cell densities.
Overall it appeared that while increased incubation time improved 
assay sensitivity, the linearity did not generally suffer, as the 
assay was still linear to high cell densities.
Use of a standard assay time of 4 hours (the same time as an MTT 
assay) would be a benificial step in improving the assay as the 
relationship between assay duration and AP activity was found to be 
linear up to 4 hours at least, for a range of cell lines.
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3.9 Effect of NaOH addition on AP assay
In the AP method by Connolly et al., [1986], the endpoint is
determined after 10/jI NaOH has been added to the wells. In practice, 
this has often resulted in a strong yellow colour with absorbance 
readings greater than the sensitivity of the instrument. This section 
is concerned with the effect of addition of NaOH on the performance of 
the assay.
3.9.1 Relationship between cell number and OD in the APNaOH assay
This relationship was determined in exactly the same manner as it was 
for the AP2h assay (section 3.7). After 2 hours standard incubation 
time, 10^1 IN NaOH was added to the plates to effect colour 
development. Figures 3.9.1 (a) to (d) show the relationship between 
cell number and OD after addition of 10/^ 1 IN NaOH to an AP2h plate 
(for DLKP, DK-MES-1 and Hep-2 (including repeat)). The extent of the 
linear range of the plots, minimum detectable cell number (> 0.02 OD 
units) and sensitivity of the linear region of the graph were 
determined and are shown in Tables 3.9.2 - 3.9.4.
3.9.2 Minimum detectable cell number
Addition of NaOH caused a dramatic increase in the sensitivity of the 
method to low numbers of cells, compared to that detectable in the 
AP2h assay.
Table 3.9.2 Lowest detectable cell number for the APNaOH assay
after 1 day's growth (cell number corresponding to 
0.02 OD units)
cell line cell number/ 96 well
DLKP 2 0 0
Hep-2 250
repeat 275
SK-MES-1 500
This NaOH step means that 25 times, 24 times and 20 times fewer cells 
can be detected for DLKP, Hep-2 and SK-MES-1 respectively, than is 
possible with the AP2h assay; thus leaving it highly sensitive to low 
cell numbers.
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Figure  3.9.1 (a) H. cell n um ber (x 10.000)
Fig ure  3.9.1 (b)
H. cell n um b er (x 10,000)
F i g u r e s  3.9.1 (a ) ,  (b):
Relat ionship between cell n u m b e r  and Optical  Density in APNaOH a s s a y  
for  th e  cell line ind ica ted ,  a f t e r  1 day's  growth
H. re p re se n t s  h a e m o c y to rn e te r  coun ts .  C re p re se n ts  e o u l te r  counts.
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Figure  3.9.1 (c) H cell n u m b e r  (x 10,000)
Figure  3.9 1 (cl)
3 -l 5 £> 7
H. cell n u m ber  (x 10,000)
F i g u r e s  3.9.1 (c j ,  (d):
R elat ionsh ip  between cell n u m b e r  and  Optical Density in APNaOH a s s a y  
for  th e  cell line in d ica ted ,  a f t e r  1 d ay ' s  growth.
H, re p r e s e n t s  h a e m ocytorn e ter  co un ts .  C r e p re se n t s  coulter  counts .
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3.9.3 Linear range
Although there is still a linear relationship with cell number and OD, 
it's range has been decreased immensely. This is easily seen when the 
figures below are compared to those in table 3.7.4.
Table 3.9.3 Highest number to which the APNaOH assay remains
linear (after 1  day's growth in culture)
cell line cell number (x 10,000)/ 96 well
DLKP 2.75
Hep-2 > 5
repeat 3
SK-MES-1 5
The linear range for DLKP had been shortened from > 11 x 104 to 2.75 x 
104; from > 18 x 104 to 3 x 104 cells/ well for Hep-2, and 
approximately halved for SK-MES-1 when the NaOH is added after 2h 
incubation.
3.9.4 Sensitivity
The increase in sensitivity proffered as a result of NaOH addition has 
been very substantial, as implied by the lowest detectable cell 
numbers shown in the relevant Table (3.9.2).
Table 3.9.4 Sensitivity of the APNaOH assay for various cell lines
after 1 days growth
cell line
change in OD 
change in 1 0 , 0 0 0  cells
DLKP 0.725
Hep-2 0. 500
repeat 0.683
SK-MES-1 0.395
Sensitivity of the APNaOH assay over the 2h assay has been augmented 
approximately 27 times for DLKP, 17 - 31 times for Hep-2 and 13 times 
for SK-MES-1.
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3.9.5 Ease of performance/ technical flaws
Addition of NaOH provides an additional step over those outlined for 
the 2h assay, but the assay still remains simple and quick to 
perform.
3.9.6 Addition of different volumes and concentrations of NaOH
It was thought that by decreasing the concentration of NaOH, linearity 
might be increased somewhat, so consequently, a wide range of NaOH 
concentrations were used on replicate plates of differing cell 
numbers. As in all similar previous experiments, cells were
trypsinized and counted by haemocytometer and Coulter counter, and
actual cell number per well was plated against O.D. Ten concentrations 
of NaOH in the range IN down to 0.02N NaOH were tested for cell lines
Hep-2 and SK-MES-1. No change whatsoever in linearity or sensitivity
of the assay was evident.
Use of yet again lower concentrations, may result in reduced 
sensitivity, with a concomitant increase in linearity, but this
remains to be seen.
Differences in volume addition (e.g., 50/j1 instead of 10/j1 NaOH) were 
also considered, as accuracy would be more achievable on addition of
larger volumes with a multiwell pipette. There was also no
significant difference in linearity or sensitivity when the volume of 
NaOH was increased to 50/j1.
In conclusion then, addition of 50^1 NaOH can be used for a very
substantial increase in the sensitivity of the AP2h assay, giving it
similar sensitivity (greater in fact) than the SRB assay. However the 
investigator is advised to note that there will of course be a
concomitant decrease in the linearity of this assay.
The practical significance of this point, and those made in the 
previous section about longer incubation times for the assay is 
summarized by the following conclusion/ recommendation. The AP assay 
should be briefly examined after the standard assay time of 2 hours. 
If there is significant colour development (visible to the eye), then 
it is acceptable to read the plate immediately. If there is slight 
but unsubstantial colour development, then the assay may be
re-incubated for a further time (say a further two hours) and
evaluated then. If there is no colour development at all (for example 
if there is only very poor cell growth evident) then it would be of 
greatest benefit to add 50pl of NaOH immediately after the 2 hour 
incubation. With either of these alternatives, it may be enticing for 
the investigator to first read the plate at the standard 2 hour assay 
time, and then perform the alternative treatment, so that a backup 
measure of the original data is available for double checking any 
obvious trends.
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3.10 Comparison of the characteristics of the assays
In the previous sections of this chapter, lowest limit of detection, 
the extent of linearity and the sensitivity of each of the methods was 
established for a number of cell lines and was presented separately in 
table form. The results for these parameters are now given in a form 
which will allow intercomparison among the assays. The results shown 
below are directly comparable among the assays, as each of the assays 
were carried out on the same day, on the same culture, and using the 
same experimental procedures (i.e., where Coulter counts have been 
used, they have been used for all of the assays, and similarly with 
Haemocytometer counts).
As in each of the previous sections, the Figures presented refer to 
actual cell number counted, and not to the original cell number which 
was seeded.
Coulter and haemocytometer counts did not always agree. Some data 
points were missing for the haemocytometer counts because the 
limitations of the method did not allow low cell number to be 
performed and frequently resulted in high SEM values.
It is important to emphasize that the values given in the Tables are 
not constants, so while absolute values for the different parameters 
(particularly linearity) have varied slightly when experiments were 
carried out on different days, the trends shown among the different 
assays were still retained, and the values in the Tables which 
follow, can be taken as approximate values - however the trends are 
real.
The performance of these assays shall now be compared, firstly in 
terms of lower detection limit.
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3.10.1 Minimum detectable cell number
Table 3.10.1 (a) Comparison of lowest detectable cell number for
each assay (after 1 day's growth)
Cell
line
cell number /96 well
MTT MTT/SDS AP2h APNaOH NR CVDE SRB
SCC-9 * - * - * 1,850
NRK 5,000 - 2, 500 - 2 , 0 0 0 750 -
DLKP
repeat
9, 500 
13,000 57,000
7, 500 
16,000 2 0 0
2, 500 
2, 750 600 300
SK-LU-1 6,750 - 14,000 - 3, 500 1,300 -
Hep-2
repeat
9,500 
10,500
40.000
29.000
8 , 0 0 0
9,500
250
275
8 , 0 0 0
5,000
750
1 , 0 0 0
300
400
SKMES-1 5,250
9,000 6 6 , 0 0 0
7, 750 
6 , 0 0 0 500
3,300
8 , 0 0 0
700
1,700 500
RPMI-
2650
31,000 - 7 , 500 - 3, 500 1, 750 -
Table 3.10.1 (b) Comparison of lowest detectable cell number for
each assay (after 4 days' growth)
Cell
line
cell number /96 well
MTT MTT/SDS AP2h APNaOH NR CVDE SRB
SCC-9 * - 3,250 - 1 , 1 0 0 1 , 0 0 0 -
NRK 1 2 , 0 0 0 - 3,000 - 3, 500 1 , 2 0 0 -
DLKP 5,400 - 4, 500 - 1,250 - -
SK-LU-1 4, 750 - 3,750 - 1, 750 750 -
Hep-2 18,750 - 11,500 _ 5,500 - -
SKMES-1 6 , 750 - 4,000 - 4, 500 875 -
RPMI-
2650
7,500 - 6 , 0 0 0 - 3, 750 2 , 0 0 0 -
The extremely poor sensitivity of the MTT/SDS assay to low cell 
number, has already been noted, and we can see this clearly from this 
Table; it required 4 times as many DLKP cells to be present, to evoke 
a threshold response, than it took for the standard MTT assay (and
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almost 100 times more than for the CVDE assay!), while it required 7 
times as many SK-MES-1 cells to be detected with this assay than with 
the MTT assay.
The MTT and AP2h assay were often comparable in terms of sensitivity 
to low cell number; for some cell lines the MTT assay detected
slightly lower numbers, but more often, it was the AP2h assay which 
was the more sensitive to these cell numbers. The AP2h assay was 
particularly better, in this respect, for NRK and RPMI-2650.
The NR assay appeared next in rank order of detecting low cell 
numbers. It was sometimes able to detect cell numbers only very 
slightly lower than, or similar to the AP2h assay, but on most
occasions it was able to detect about 3 times fewer cells than the AP 
assay. The CVDE assay was much more sensitive to detection of low 
cell numbers than the NR assay or the other assays already mentioned. 
It detected 2 to 4 times fewer cells than the NR assay.
The superior performance of the SRB assay in this comparison is 
obvious from the Table, however the APNaOH was even more sensitive 
again to low cell numbers. SRB and APNaOH were capable of detecting 
very low cell numbers - certainly fewer than 500 cells per well. In 
using Hep-2 cells in an experiment similar to the ones described here, 
it might be expected that the SRB assay would detect 2.5 times fewer 
cells than the CVDE assay, approximately 15 times fewer than NR, 12 -
20 times fewer than AP2h, 30 times fewer than MTT and at least 75
times fewer cells/ well than the MTT/SDS modification. If instead the 
APNaOH assay was used, then these figures would be further increased 
by a factor of 1.3!
These findings are mirrored somewhat by Tables 3.10.2 which show the 
sensitivity of the various assays over the linear portion of the 
graph.
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3.10.2 Sensitivity of various methods
Table 3.10.2 (a) Sensitivity of various methods after 1 day's growth
for a range of cell lines
change in OD/change in 10,000 cells
line MTT MTT/SDS AP2h APNaOH NR CVDE SRB
SCC-9 * - * - * 0.086 *
NRK 0.036 - 0.072 - 0.096 0.188 -
DLKP 0 . 0 2 0
0.019 0.003
0.024 
0. 027 0.725
0.061 
0 . 1 1 0 0.347 0.562
SK-LU-1 0.030 - 0.014 - 0.050 0 . 1 2 2 -
Hep-2 0 . 0 2 2
0.016
0.005
0.004
0.029
0 . 0 2 2
0. 500 
0. 685
0.030
0.039
0.258
0.273
0.537
0.433
SKMES-1 0.035
0.018 0.003
0 . 02 2  
0.030 0.395
0.058
0.024
0.305 
0.147 0.358
RPMI-
2650
0.007 ~ 0.023 - 0.045 0.160 -
Table 3.10.2 (b) Sensitivity of various methods after 4 days growth
for a range of cell lines
change in OD/change in 10,000 cells
line MTT MTT/SDS AP2h APNaOH NR CVDE SRB
SCC-9 * - 0.054 - 0.176 0.193 -
NRK 0.019 - 0.058 - 0.064 0.169 -
DLKP 0.034 - 0.042 - 0.162 - -
SK-LU-1 0.037 - 0.052 - 0.124 0.227 -
Hep-2 0 . 0 1 0 - 0 . 0 1 6 - 0.034 - -
SKMES-1 0.028 - 0 . 0 5 0 - 0.049 0.304 -
RPMI-
2650
* - 0.027 - 0.031 0.088 -
It is obvious that there is a very great difference in sensitivity
among the methods. For some of the cell lines the distinction among
the assays is extreme; take DLKP for instance, where the APNaOH assay 
is >240 times more sensitive than the MTT/SDS assay, so again
attention is drawn to the MTT/SDS method, which is much less
sensitive than all of the other assays. In fact this assay is 
extremely insensitive.
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While the MTT assay is clearly an improvement on this, it too is quite 
insensitive; certainly less sensitive than the other methods. The 
remainder of the assays are in the following order of increasing 
sensitivity: AP2h, NR, DE, SRB and APNaOH. APNaOH is
significantly more sensitive than SRB for the three cell lines tested 
above, and is considerably more sensitive than each of the other 
assays, giving a very great increase in OD per increase in cell 
number.
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3.10.3 Linear range
Table 3.10.3 (a) Highest cell number to which the assay is linear
(after 1 days growth)
Cell
cell number (x 1 0 )^ /96 well
line MTT MTT/SDS AP2h APNaOH NR CVDE SRB
SCC-9 * - * - * * *
NRK > 8 - > 1 2 - 3.5 6 -
DLKP > 9 - > 1 1 - > 6.5 - -
repeat 16 > 16 > 1 1 2.75 2 - 3 4 3
SK-LU-1 * - > 3 - > 3.5 >3.5 -
Hep-2 > 8 > 9 > 8 > 5 > 9 5.5 2.75
>16 > 18 > 18 3 * > 4 3 - 4
SKMES-1 > 4 - > 1 0 - > 3.5 > 3 -
> 8.5 > 1 1 > 1 1 5 > 1 1 8 5
RPMI- > 6 _ > 1 2 — 5.5 7 -
2650
* = not easily determined from graphs
Table 3.10.3 (c) Highest cell number to which the assay is linear
(after 4 days growth)
Cell
line
4cell number (x 1 0  ) /96 well
MTT MTT/SDS AP2h APNaOH NR CVDE SRB
SCC-9 * - * - > 2 > 2.5 *
NRK > 1 0 - > 1 0 - 3.5 5 -
DLKP > 1 2 - > 1 1 - 15 - -
SK-LU-1 - - > 3.5 - > 3.5 > 3.5 -
Hep-2 > 38 - > 38 - > 1 0 - -
SKMES-1 > 9 - > 9 - > 9 > 3 -
RPMI-
2650
* - > 13 - 1 1 9.5 -
* = not easily determined from graphs
Approximate values only could be determined from the graphs as data 
points were often far apart at the top of the linear range, or 
sometimes the top of the linear range had not been reached over the 
density range tested.
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Not only were there differences among the cell lines, but there were 
clear trends among the assays. Another quick glance at the Figures 
for each of the cell lines can illustrate this very clearly, but this 
can be quantified by the data above.
Generally it is the case that the higher the sensitivity, the shorter 
the linear range; and it is clear that the assays demonstrated as 
having high sensitivity (APNaOH, SRB, and CVDE; and in that order) 
have shorter linear ranges. Conversely, when an assay is linear over 
a longer range, then the sensitivity will be decreased.
The MTT/SDS assay is linear to greater cell numbers than the MTT 
assay, giving it the greatest range of linearity. The AP2h assay is 
linear to cell numbers as great as, or even greater than the MTT 
assay. At the other end of the scale, are the SRB and APNaOH assays 
which are linear only to quite low cell numbers. In between fall the 
NR and CVDE assays. The NR assay is sometimes (but not always) linear
to greater cell numbers than the CVDE assay.
On a general note, SCC-9 did not show as clear a relationship of cell
number and OD as any of the other cell lines. Generally it was 
difficult to determine this relationship from any of the graphs, and 
this may have been related to the experimental procedure, as low cell 
numbers had to be used to demonstrate the relationship because of the 
difficulty of growing the high densities of these large, slow-growing 
cells required for the experiment, combined with the difficulty in
counting these low cell numbers manually.
In many cases thus, linearity and sensitivity were clearly inversely 
related. Assays such a s  APNaOH, SRB, and CVDE, result in a 
relatively high O.D. per cell, and as a consequence are sensitive to 
low cell number. Because of this high O.D. though, they become non 
linear at moderate to high cell densities. The NR assay seems to be 
the exception, in that i t  i s  neither very sensitive nor is it linear
to high cell numbers.
The remainder of the a s s a y s  (AP, MTT and S D S /  MTT) although they are 
linear over a  greater range of cell densities, suffer from a 
consequental lack of sensitivity which would make them inadequate for 
some work. It has been shown though, that the sensitivity of the AP
assay can be substantially increased by increasing the assay duration 
up to 4 or 6 hours, while still retaining its favourable range of 
linearity. Also, addition of NaOH can vastly improve the sensitivity 
of the assay making it more sensitive than any of the other assays, 
but, similar to S R B ,  and C V D E ,  there is a consequental decrease in 
linearity at high numbers.
3.10.4 Precision
The task of quantifying the precision of the various endpoints was in 
fact quite difficult as results and trends varied from experiment to 
experiment. Overall values for coefficient of variation (CVar) for a 
very wide range of experiments (using sampling points between 0 . 0 2  and
1.6 OD units) are shown in Figure 3.10.4 (a). An attempt to get an
overall picture of the precision involved with each of the endpoints 
determines NR, APNaOH, AP2h and MTT to be more precise (and in that 
order), having CVar values between 6 - 8%, than the CVDE assay (CVar 
= 12%). In such a comparison, the SRB seemed to be the least precise 
of all the methods, giving inter-replicate variations averaging at
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22% of mean values. When precision for individual cell lines is 
considered however, the picture is completely altered for different 
cell lines. Figures 3.10.4 (b) - (d) illustrate the differences that 
can be seen among cell lines and endpoints with regard to precision. 
SRB was clearly the most precise assay for SK-MES-1, and the CVDE 
assay performed well in this comparison, however for DLKP the 
situation is quite the inverse - SRB giving CVar values of 20%, 
together with CVDE, NR and MTT. Yet again for Hep2, it is apparent 
that the APNaOH assay is less precise than it is for other cell lines 
(these trends have been confirmed by other sets of data).
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SRB NR
ASSAY
F ig u r e  3 .10 .4  (a):
Overal l  c o m p a r i s o n  of p r e c i s i o n  of e a c h  of the e n d p o i n t s  
o v e r  a  l a r g e  pool of e x p e r i m e n t s .
V a l u e s  r e p r e s e n t  th e  a v e r a g e d  C o - e f f i c i e n t  of v a r i a t io n  (%) f r o m  t h e s e  e x p e r i m e n t s .
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AP2h. APNaOH SRB NR CVDE MTT
ASSAY
Figure  3.10.4 (b) -  (d).
P r e c i s i o n  of v a r i o u s  e n d p o i n t s  f o r  l in e a r i t y  e x p e r i m e n t s  w ith  3 
ce l l  l in e s .  Values r e p re se n t  a v e ra g ed  Co —eff ic ien ts  of variation  for 
p o in ts  within 0.02 - 1 60 0 D units.
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3.10.5 Reproducibility
Three separate toxicity assays performed in immediate succession gave 
rise to the reproducibility data used here. The data is shown for 
each of the assays in Figures 3.10.5 (a) - (j). Figure 3.10.5 (a)
(c) show how different versions of the AP assay compare in the
expression of the dose response relationship with Vinblastine. In the 
first and the third experiment (run) shown, the values correlate well 
for AP2h, AP15h and APNaOH. In the second experiment however, there 
is significant difference between them, especially for the APNaOH
experiment which differs by at least 15% for the entire range of the 
relationship.
The reproducibility of the APNaOH assay when the 3 runs were compared
3.10.6 (f)) was very slightly worse than that from the unstopped
reaction (Figures 3.10.5 (d), (e)) and was similar to the CVDE assay
(Figure 3.10.5 (g)) (repeats were within 15 - 20% of each other for
the most part of the graph - at the latter end of this scale for 
APNaOH and CVDE). For the NR assay, repeatability was slightly
greater than the AP assay. Repeatability was less good (at 25% 
difference) for SRB (Figures 3.10.6 (h)) and even higher at 30% for 
MTT (Figure 3.10.5 (i)) which in this case was also extremely
imprecise. In fact, taking the precision data into account, the
actual MTT graph could be anywhere between two points which are '60%'
(using the units on the Y axis) apart.
With respect to the actual IC5Q values given by each of the endpoints, 
they have been calculated (as shown in appendix A) and are shown in 
the table which follows the graph.
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VINBLASTINE CONCENTRATION ( n g / m l )
VINBLASTINE CONCENTRATION ( n g / m l )
VINBLASTINE CONCENTRATION ( n g / m l  )
Figure  3,10.5 (a )  -  (c)
C o m p ar i so n  of AP2U AP I oil and APNaOH in determ in ing  
r e s p o n s e  of H e p - 2  ce l ls  lo Vinblast ine 
(after 6 days' continuous exposure).
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VINBLASTINE CONCENTRATION (ng/ml)
VINBLASTINE CONCENTRATION (ng/ml)
VINBLASTINE CONCENTRATION (ng/ml)
Figure  3.10.5 (d) -  (f):
Comparison of repeatability of AP assay (3 modifications) 
in a Vinblastine toxicity experiment with Hep-2 cells.
( a f t e r  6 d a y s '  c o n t i n u o u s  e x p o s u r e ) .
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VINBLASTINE CONCENTRATION ( n g / m l )
VINBLASTINE CONCENTRATION ( n g / m l )
Figure  3 10.5 (g). (h):
Com par i son  of r e p e a ta b i l i ty  of (g) CVDE and  (h) SRB a s s a y s  
in a  V in b la s t in e  t o x i c i t y  e x p e r i m e n t  with H e p - 2  ce i l s .
( a f t e r  6 d a y s '  c o n t i n u o u s  e x p o s u r e )
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VINBLASTINE CONCENTRATION ( n g / m l )
VINBLASTINE CONCENTRATION ( n g / m l )
Fig ure  3.10.5 (i) - (j)-
C o m p ar i so n  of r ep e a ta b i l i ty  of (i) MTT, and  (j) NR a s s a y s  
in a  V in b la s t in e  t o x ic i t y  e x p e r i m e n t  with  H e p —2 c e l ls .
( a f t e r  6 d a y s '  c o n t i n u o u s  e x p o s u r e )
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VINBLASTINE CONCENTRATION (ng/ml)
110
r u n  2 O  —  O  APNaOH
• ---- 0  MTT
A  A CVDE
A  — A  NR 
□  — □  SRB
0 0 0.5 1.0 1.5 2.0 2.5
VINBLASTINE CONCENTRATION (ng/ml)
3.0
0.5 1 0 1.5 2.0 2.5
VINBLASTINE CONCENTRATION (ng/ml)
3.0
Figure  3.10.5 (k) -  (m):
C o m p ar i so n  of r ep e a ta b i l i ty  of e ac h  of the min ia tur ized  a s s a y s  
in a Vinblastine toxicity experiment with Hep—2 cells.
(after 6 days' continuous exposure).
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Table 3.10.5 Reproducibility of the IC5q of Vinblastine to Hep-2
cells (5,000 cells/ 96 well) after 6 days drug 
exposure
Endpoint Run 1 Run 2 Run 3
IC50 (ng/ ml Vinblastine)
AP2h
±
0.261 0.078
±
0. 333 0.046
+
0.075 0.056
AP15h 0 . 2 2 0 0.049 0 . 2 2 0 0.049 0.072 0.029
APNaOH 0.377 0. 174 0.058 0.015 0.094 0.029
CVDE 0.339 0.087 0.058 0.045 0.116 0.049
MTT 0.203 0. 151 * 0.333
* 0.816
0.058
0.232
1.067 0.130
NR 0.290 0.073 0 . 2 0 2 0. 130 0.290 0.073
SRB 0. 307 0.087 0. 528 0 . 2 2 0 0. 870 0.259
* MTT graph crossed the 50% inhibition line at 2 points in run 2.
To summarize these results, the range between which the IC50 has 
fallen, for the 3 repeats of the Vinblastine toxicity experiment is 
shown in the table below. The first column shows how different the 
results can be, if SEM values are taken into account.
Table 3.10.5 (b) Range of IC5Q values in repeat determinations for
various endpoints (under the conditions described 
above, for Hep-2 cells)
Values in ng/ml Vinblastine (x 10)
Endpoint Range of IC^q values 
incorporatina SEM's
Ranae of mean IC,-q 
values
AP2h 0.019 - 0. 379 0.075 - 0.333
AP15h 0.043 - 0.269 0.072 - 0 . 2 2 0
APNaOH 0.043 - 0.551 0.054 - 0.377
CVDE 0.013 - 0.426 0.058 - 0.339
NR 0.072 - 0.363 0 . 2 0 2 - 0.290
SRB 0 . 2 2 0 - 1.029 0.307 - 0.870
MTT 0.052 - 1.197 0.203 - 1.067
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The individual IC5 Q values determined for Vinblastine exposure to 
Hep-2 cells under the conditions described, has varied from 0.054 
ng/ml to 1.067 ng/ ml when mean results from different endpoints and 
separate experiments are considered. The NR assay has most 
consistantly determined the IC5Q value. CVDE and APNaOH assays were 
both slightly less less reproducible in determining the ICjq- Very 
poor reproducibility however was evident in the SRB assay (values 
spanning 6.4 times as much as NR) and the MTT assay (which indicated 
the IC5 q value to fall between a range 9.8 times wider than that of 
the range given by NR).
For the complete graphs, including the 50% inhibition level, NR 
appears to be more reproducible, followed by CVDE and APNaOH. It is 
clear that SRB is less reproducible than the assays mentioned, 
followed then by MTT which was least reproducible of all.
3.10.6 Ease of performance
Overall, each of the assays were easy to perform and did not suffer 
from technical difficulties, with the exception of the MTT assay, 
where medium removal without disturbing the formazan product, was 
difficult. The Figure which follows, is a schematic diagram of the 
steps involved in each of the assays, and serves to illustrate the 
ease of performance when each of the assays are compared.
We can see that the SRB and the NR assays together involve the 
greatest number of steps. If the technical difficulty of removing the 
waste medium without disturbing the formazan product in the MTT assay, 
could be overcome, then the MTT assay would indeed be very simple to 
perform, as there are no rinsing steps whatsoever in this assay. 
However, as the assay stands, the difficulty remains, limiting its 
simplicity. The MTT/SDS assay overcomes this problem (but as we have 
already seen is of limited usefulness because of its low sensitivity). 
The CVDE assay has one less step than the SRB assay and NR assay. Next 
to the MTT assay, the AP2h assay is the quickest and simplest to 
perform, and as it does not have the difficulties of the MTT assay, 
it may be favoured for this reason.
3.10.7 Applicability to a range of cell lines
The same degree of difficulties with assay quantification was not 
found with any of these endpoints as was experienced with the IA assay 
for some cell lines; however the precision involved did seem to differ 
among cell lines and this has been attributed to growth 
characteristics. The TCA precipitation step in the SRB assay seemed 
to result in greater variability among results for the cell line DLKP 
for which many of the cells are loosely adherent.
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MTT MTT/SDS AP CVDE NR SRB
Add MTT
Inc. 37 C 
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REMOVE
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Figure 3.10.6 Schematic diagram of the major steps involved in each of
the methods compared
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3.11 Relationship between assay activity and status of cell
A pertinent question at this stage, is whether or not the activity 
per cell in each of the assays, changes under different 
physiological conditions. It has already been noted that, in some 
cases, AP activity per cell differed from one to four days growth 
in culture. It would be relevant then, to determine if assay
activity per cell differed when cells were cultured under different 
conditions. This of course would have repercussions on the 
suitability of these assays for toxicity testing.
To determine this experimentally, Hep-2 cells were plated out in 24 
well dishes at three very different seeding densities and cultured 
for 11 days. The seeding densities used are given below.
Culture A = 2.5 x lO'* cells/ well
Culture B = 1 x 10^ cells/ well, and4 ,Culture C = 2.5 x 10 cells/ well
After this time, cells at the lowest cell density were sub
confluent, cells in the middle range were confluent, and cells at 
the highest density were over confluent, peeling off and in very 
bad condition. Thus, each culture represented cells in different 
stages of growth.
Cells were trypsinized and Trypan blue haemocytometer cell counts 
were performed on the wells as described in materials and methods. 
To determine the true viabiltity of these cells, they were set up 
for re-growth at various clonal densities (700, 900 and 1100 cells/ 
24 well). After a further 7 days growth, colony number was counted 
manually and compared to colony counts and area measurements as 
determined by image analysis.
Simultaneous with counting by haemocytometer on day 11, AP, MTT,
NR, SRB and CVDE assays were carried out on replicate 24 well
dishes; 3 replicate wells of each culture for each method. Further 
wells were stained with crystal violet and read by image analysis.
The results are presented in the Tables below. Table 3.11.1 shows
the true viability of the cells from each of the cultures after a
similar number of cells were set up for cloning.
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Table 3.11.1 Colony formation of 700 cells deemed viable by
trypan blue, for each of the cultures
Determin­
ation Culture A Culture B Culture C
Colony 
count 
(manual)
49 ± 9 49 + 9 66 ± 8
Colony
count
(IA)
6 + 4 20 ± 1 1 14 ± 4
Colony 
area, mm^ 
(IA)
0.031 ± 0.030 0.181 ± 0.172 0.112 ± 0.045
Apparent differences in colony forming ability among the three 
different cultures of cells is not statistically significant, thus 
it can be concluded that under the conditions of the experiment, 
trypan blue viability counts have equated with true viability.
It may also be seen that image analysis colony counting did not 
accurately quantify colony number; and although it reiterated the 
same trend, the SEM values make the counts unreliable. The result 
when colony area was quantified by image analysis was extremely 
different from colony counting data, and the errors were 
unacceptably high. Thus this method should not be interchangebly 
used with colony counting (even though colony sizes were quite 
regular), and IA analysis overall using the AMS-40-10 was not as 
accurate as manual counting.
It should be concluded therefore that in this instance, image 
analysis would be entirely inappropriate for quantification of such 
cloning experiments.
Now let us examine the performance of each of the colorimetric 
assays in its ability to assess viability under the circumstances of 
different cell growth. Table 3.11.2 takes the Trypan blue counts at 
face value and compares them to the results from each of the growth 
assays performed on the same day.
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Table 3.11.2 Relationship between viable cell number
(TB determined, confirmed by cloning) and 
various measures of cell growth, for different 
cell cultures
Determin­
ation Culture A Culture B Culture C
Trypan blue 
cell count* 
x 104
15.80 ± 4.08 27.88 ± 6.15 2.70 ± 1.55
Colony 
area, mm^ 
(IA)
37.21 ± 4.80 89.11 ± 18.42 17.83 ± 7.64
AP2h O.D. 0.036 ± 0.003 0.088 ± 0.003 0.057 ± 0.006
APNaOH
O.D.
0.713 ± 0.022 1.273 ± 0.060 1.068 ± 0.042
MTT O.D. 0.036 ± 0.006 0.077 ± 0.015 0.033 ± 0.014
NR O.D. 0.065 ± 0.002 0.110 ± 0.004 0.009 ± 0.003
CVDE O.D. 0.294 ± 0.039 0.547 ± 0.109 0.218 ± 0.064
SRB O.D. 1.426 ± 0.124 1.980 ± 0.028 1.269 ± 0.010
* It was not possible to count dead cells by the Trypan blue method, 
because only debris was present.
It is clear that after 11 days in culture, the resultant cell
number from culture B, which had a seeding density of 10 cells/ 
well, is 1.76 times that of culture A (seeded at 25,000 cells/
well). At a seeding density of 5 x 104 cells/ well (culture C,
which was 20 times greater than culture A), there were 5.8 times
less cells than the number present in culture A. Thus cells have
stopped growing and have detached from the surface.
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Image analysis (growth area) determined that there was 2.7 times 
more growth on the middle density plate, and half as much growth on 
the highest density plate. Thus this technique is obviously 
appropriate for the first two densities, but was clearly unable to 
give a reliable indication of viability in the highest density 
plate.
AP2h, APNaOH, MTT and CVDE assays all indicated approximately 
twice as much growth in the middle density plate as there was in the
lowest, and the same as, or half as much growth again on the
highest density plate as the lowest (when SEM values are 
considered). This latter result does not give a good indication of 
viable cell number present, as determined by direct counting. The 
SRB assay detected greater difference among the three densities than 
did any of the other assays. NR assay results bore greatest 
resemblance to those from the viable haemocytometer counts.
To answer the question in hand as to whether the assay activity per 
viable cell varies under these different culture conditions, the 
activity (in terms of O.D. units) per 10,000 viable cells have been 
tabulated below for the assays.
Because the error on the haemocytometer count is so large for the 
highest seeding density (the % error for the other two counts is
similar to each other), the range of values for each of the assays
has been given for this count.
Table 3.11.3 Relative optical density of various colorimetric
assays per 10,000 viable cells
Determination
O.t). per 1 0 , 0 0 0  cells
A B C
range
AP2h 0.0023 ± 0.0030 ± 0.0134 to 0.0496
0 . 0 0 0 2 0 . 0 0 0 1 ±0.0014 ±0.0052
APNaOH 0.0451 ± 0.0457 ± 0.2520 0.9287
0.0014 0 . 0 0 2 2 ±0.0099 ±0.0366
MTT 0.0023 ± 0.0028 ± 0.0078 0.0287
0.0004 0.0005 ±0.0033 ±0.0122
NR 0.0041 ± 0.0039 ± 0.0021 0.0078
0 . 0 0 0 1 0 . 0 0 0 1 ±0.0007 ±0.0003
CVDE 0.0186 ± 0.0196 ± 0.0513 0.1896
0.0025 0.0039 ±0.0151 ±0.0577
SRB 0.0803 ± 0.0710 ± 0.3355 1.2400
0.0078 0 . 0 0 0 1 ±0.0292 ±0.1078
It may be seen that for all of the assays, except SRB, the activity 
of the parameter being measured is similar per cell for the first 
two cultures; but there is some variation for the superconfluent
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culture. AP activity per viable cell number is much higher in the 
superconfluent culture than it is per viable cell in the other 
cultures. The same is true of the CVDE assay. Enzyme activity in 
the MTT assay appears to be slightly higher in the last column (even 
when errors on haemocytometer counts in the first two columns are 
considered), but not to the same extent as the other assays already 
mentioned. NR is the most consistant in its activity; when related 
to cell number, the activity is quite constant in all culture
conditions.
The relative O.D. per cell obtained in the two lower density 
cultures differs slightly, but that obtained for the superconfluent 
culture is exceedingly different. In fact, the SRB assay has 
performed very badly, relative to the other colorimetric assays and 
to cell counts, in this experiment.
Unfortunately, time did not permit a repeat of this experiment, but 
even this single experiment seemed to answer the question in hand.
In conclusion then, it does appear that when cells are in a
substantially different state of growth, the activity relating to 
different endpoints per cell may change significantly. In this 
case, cells in poor condition had greater AP activity, while two 
cell cultures, both still growing (slowly, due to limited
nutrients, and to limited surface for attachment for the confluent 
culture) at different cell densities, had similar activity per
viable cell. Similar variation in results from different cultures 
occured for the CVDE assay, and less so for the MTT assay. There
was no difference in the O.D. per viable cell under different
conditions for the NR assay. The O.D. per cell in these three
cultures differed most for the SRB assay. This conclusion confirms
the assumption made in sections addressing sensitivity of the assays
(particularly section 3.7) that a standard curve for cell number vs
O.D. under the same experimental conditions must be completed on 
the same day as the colorimetric determination and under precisely 
the same conditions, if O.D must be related to actual cell number.
However these results also show that cells in different conditions
can have vastly different enzyme activity (or simply O.D.
measurements unrelated to enzyme activity, as in the case of CVDE), 
so if comparing cell number under such different growth conditions, 
it may not be entirely relevant to relate O.D. values back to O.D. 
values from control cells, to obtain values for % kill or %
stimulation.
The only exception to these constraints might be the NR assay, which 
gave a good indication of viability indiscriminate of the stage of 
growth of the cell.
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3.12 Relationship of endpoint to assesment of cell viability
after exposure to anticancer agents
In comparing the endpoints and in making conclusions about their 
performance, it is important to consider any differences which may 
exist between the ability of each of the assays to differentiate 
between viable and non-viable cells. Only then can the true value of 
these methods as toxicity tests or generalized indicators of growth be 
assessed.
To assess the true relationship between viabilty and each of these 
methods after exposure to anticancer agents, the replicative 
potential of each cell must be determined by cloning. If colony 
formation occurs, then the cell has not lost its replicative 
potential, and is therefore still viable.
To investigate this experimentally, the assays were scaled up from 96 
well (0.32mm2) to 24 well dishes (2 cm2), to enable sufficient cell 
growth for trypsinizing and replating the cells. Each day for 5 
consecutive days, and beginning one day after continuous exposure to 
one concentration each of Adriamycin and Vinblastine, Hep-2 cells were 
trypsinized from 3 replicate wells, counted by haemocytometer after 
exposure to trypan blue, and the remainder of the cells were diluted 
and plated (in 24 well dishes) at clonal densities. Three different 
plating densities (500, 700 and 1,000 cells/ well) were used, to
ensure at least one optimum density for counting. On replicate wells 
of the original 24 well dish, MTT and AP activity were determined 
(all as described in materials and methods).
After 11 days growth, the dishes with replated cells were stained 
with crystal violet and analysed both manually and by image analysis. 
All these results are presented in the table below. The first column 
contains the direct trypan blue haemocytometer counts. The three 
columns which follow this, relate to the colony growth after 700 of 
these trypan blue-determined viable cells were replated, for each of 
the cultures (i.e., control, Vinblastine-treated and Adriamycin - 
treated), and these 3 columns may be directly compared with each 
other to determine any differences in manual and image analysis 
reading of the plates. The remaining 3 columns are the results of 
colorimetric endpoints performed simultaneous to haemocytometer 
counts.
Table 3.12.1 Relationship of AP, MTT and Trypan blue exclusion
to viability (as determined by clonogenicity)
(on following page)
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.
viable i
count 1
x 1 0 4 ! 
'
I; growth
j colony
1 count
i(manual)
I
after clc 
colony 
count 
(IA)
;i
rning: : 
colony ; 
area mm2; 
(IA)
AP2h
:
APNaOH MTT
. .
0 2.96 ± :1 204 ± 142 + 5.14 ± ■:i .008 ± 0.185 ± .007 ±
1 . 6 6 I 20 7 1.53 i; .004 .034 .004
V +1oCOCM ! 124 ± 60 ± 1 . 1 1  ± !! .008 ± 0.159 ± .016 ±
1.3 1! 1 8 5 0.24 j: .006 .044 . 0 0 1
A 2.63 ± !I 207 ± 73 ± 1 . 0 1  ± i! . 0 1 0  ± 0.215 ± .013 ±
1.48 ;1 26 14 0.27 Ii .006 0.028 . 0 0 2
1
0 6.60 ± i 194 ± 88 ± 0.82 ± !i .017 ± 0.315 ± .025 ±
2.25 1 20: 17 0 . 1 1  1 1 . 0 1 2 .017 .003
V 2.95 ± ii 157 ± 83 ± 0.98 ± i: . 0 1 2  ± 0.294 ± .025 ±
1.18 1 13 26 0.19 ji .003 . 0 2 2 .003
A 6.39 ± !! 194 ± 1 1 2  ± 1.41 ± !i .018 ± 0.413 ± .025 ±
2.58 j 14 13 0 . 2 2  ij .003 .048 .003
0 5.30 ± iIi 282 ± 118 ± 1.05 ± 1 .050 ± 0.514 ± .023 ±
1.84 1 25 28 0.28 ; .005 . 105 . 0 0 2
V 1.73 ± !; 246 ± 147 ± 2.70 ± i .039 ± 0.424 ± .013 ±
0.97 5 8 0.67 |j .004 . 115 .003
A 4.60 ± i 228 ± 183 ± 4.87 ± !! .053 ± 0.562 ± .023 ±
2.14 j| 38 15 2.17 ij .004 .046 . 0 0 2
0 6.32 ± 11 349 + 238 ± 4.46 ± .067 ± 1.034 ± .026 ±
1.44 j 29 33 0. 99 .029 . 125 . 0 0 2
V 2.54 ± i 285 ± 157 ± 2.23 ± .037 ± 0.681 ± .018 ±
0.79 ! 15 12 0.82 .007 .080 .003
A 6.16 ± :! 282 ± 227 ± 5.44 ± ; .055 ± 1 . 0 0 0  ± .029 ±
1.27 I! 26 19 2.03 i .008 .066 . 0 0 2
0 7.57 ± ii 386 ± 249 ± 13.16 ± : .065 ± 1.017 ± .036 ±
1.69 |[ 33 22 1.53 i . 0 0 2 .091 .007
V 1.93 ± Ii 424 ± 260 ± 9.47 ± i .047 ± 0.644 ± .030 ±
1.08 ij 14 23 1.78 i .002 .024 .005
A 5.31 ± i 438 ± 176 ± 7.91 ± .070 ± 1.039 ± .040 ±
1.26 33 100 2.41 .005 .093 .006
(All data is given as Mean ± S.E.M.)
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where 0 = untreated by drug
V = 0.005 ¡ug/ml Vinblastine, and 
A = 0.006 ¡jg/ml Adriamycin
Values on left margin refer to DAYS OF EXPOSURE TO DRUG
Let us first consider the second, third and fourth columns which 
relate to true viability, and compare them to trypan blue counts.
If it were the case that trypan blue underestimated cell kill from
exposure to drug, (as has been well documented under certain 
circumstances in the literature) then the drug treated cell suspension 
from a trypan blue count, upon cloning, would contain a smaller 
number of viable cells than expected, and thus the plate, after 
cloning, would exhibit a smaller number of colonies than expected 
(i.e., smaller number than the control wells). This effect has not 
been observed in most cases. When the SEM values are considered, 
there is little difference between control and drug treated wells for 
each of the days, or if there is a significant difference, it is 
showing a greater number of colonies in drug treated plates; this may 
be explained by the extensive SEM values observed on the 
haemocytometer counts. The exception to this is after 1 day's 
treatment with Vinblastine - here the number of colony forming cells 
which arose when the same number of drug treated and control cells 
were plated, is significantly lower than the number of colonies 
formed on control plates.
We can now consider the other columns, all of which relate to growth 
of the cells upon exposure to drug. We can see clearly that cell 
number in control flasks has increased by a factor of 2.5 over the 5 
days of the experiment. We can also see by cell counts and by enzyme 
activity (in both AP and MTT assays), that Adriamycin did not elicit 
significant cell kill at this concentration over the entire duration 
of the experiment; Vinblastine on the other hand did.
To enable examination of these relationships more easily, the Table 
above has been transposed into a separate table, given on the 
following page, which expresses each of the values as a % of its own 
control (i.e., untreated with drug) value.
Table 3.12.2 Relationship of AP, MTT and Trypan blue exclusion
to viability (as determined by clonogenicity)
(on following page)
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where O = untreated by drug
V = 0.005pg/ml Vinblastine, and 
A = 0.006 pg/ml Adriamycin
Values on left margin refer to DAYS OF EXPOSURE TO DRUG.
Note again that the second, third and fourth columns refer to cloning 
after a similar number of control and drug treated cells were counted 
by trypan blue haemocytometry and replated for growth.
It can be seen that for day five, there is no significant difference 
between clonal growth on control and drug - treated wells, so the 
trypan blue count has correctly differentiated between viable and 
non-viable cells.
On day four, there is a slight difference between control and drug 
treated plates; that is, approximately 1 0 % of the cells, indicated to 
be viable by trypan blue, were incapable of replication. Given the 
high SEM's for the trypan blue counts themselves though, this 
discrepancy could be accounted for in the original plating.
On day three and day two, there is no significant difference between 
Adriamycin clonogenicity and the clonogenicities of the control cells. 
There may be a slight difference for Vinblastine - treated cells, but 
again, it is possible that this is due to the errors in original 
counting (especially as the error on the Vinblastine count is quite 
different to the other two counts on both days).
On day one of drug treatment however, there appears to be a 
substantial difference between the Vinblastine treated cells and the 
control cells. As errors on the original trypan blue haemocytometer 
counts are similar for all three counts, and the difference in 
cloning efficiency is significant, it appears that the trypan blue 
method is not accurately detecting dead cells - it has determined that 
there has been relatively little cell kill, whereas approximately 40% 
of these 'viable' cells have been irreparably damaged and will not 
form colonies.
From these two tables then, now consider the performance of the 
colorimetric assays.
At day one, when it appears that there is significant cell kill not 
being picked up by trypan blue, neither the AP2h nor the MTT assay 
detect cell kill either (in fact the MTT results indicate significant 
stimulation!). The APNaOH modification indicates some slight kill, 
but this is not statistically significant. Refering to Table 3.11.1, 
we see that the OD values for the AP2h and MTT assays are extremely 
low; in fact the assays are not sensitive to the amount of cell growth 
present. The APNaOH assay is sensitive to this level of growth, and 
indeed is indicating a better ability to differentiate between 
non-viable and viable cells than is the trypan blue method.
On day two, the MTT and AP2h assays are still insensitive (having low 
O.D. values); MTT does not detect any cell kill at all, whereas AP2h 
and APNaOH do detect some kill (note that the errors on the APNaOH 
assay are low). Direct counting shows that there is in fact, some 
cell kill. All three colorimetric methods agree with counts and 
cloning data in reporting no cell kill from Adriamycin.
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Now consider day three, in which there is significant cell kill by 
Vinblastine (and remember that cell kill may even have been 
underestimated by the trypan blue count). All three colorimetric 
assays detect cell kill, MTT to a greater extent than AP.
On days 4 and 5, all three colorimetric assays detect cell kill 
induced by Vinblastine (and not by Adriamycin) to more or less the 
same degree. On day 5, the errors for the MTT assay are greater than 
the AP assays.
To sum up the main disclosures of the experiment, firstly the SEM's on 
the haemocytometer counts are too large to allow a more thorough 
analysis of the results.
The concentration of Adriamycin used (0.006/jg/ml) did not result in 
significant Hep-2 cell kill, even after 5 days. At one days exposure 
of Hep-2 cells to 0.005/jg/ml Vinblastine, the trypan blue method 
appears to underestimate cell kill.
Thereafter, and for all concentrations of Adriamycin, this method does 
not appear to be inconsistent with indications of viability from 
cloning experiments; however some suggestions of inconsistency cannot 
be properly evaluated because of high variations in haemocytometer 
counts.
The MTT assay is inappropriate for use for the first two days of the 
assay; the AP2h assay, for the first day; because of insensitivity. 
Thereafter all three assays are relatively close in their assessment 
of viability. Again because of large errors, it is not possible to 
produce quantitative data on the accuracy of the methods in detecting 
true viability, but it appears that the APNaOH assay is more sensitive 
than trypan blue, at detecting loss of viabilty after one days 
exposure to Vinblastine.
It is clear that the method of counting by haemocytometer puts the 
limiting constraint on determining an answer to this question. In an 
attempt to defray the technical errors incurred by using this method, 
the assay was further scaled up into 25cm2 flasks and repeated. It is 
described below.
Hep-2 cells were set up in 25cm2 flasks at an equivalent cell density 
to area ratio as in the previous experiment (all described in section 
2.30) and continuously exposed to drug. It was decided to concentrate 
solely on Vinblastine and to include three concentrations of the drug.
This assay was technically an extremely difficult assay to carry out, 
as it was so large (700 small flasks were set up for the experiment) 
and strictly dependent on timing. It was set up three times in total, 
but because of the possibility of so many technical hitches, only 
results from the last run could be used. It was necessary to avail of 
technical assistance in performing the cell counts (due to timing of 
the other parts of the experiment) and this is gratefully acknowledged 
in the Acknowledgements.
Triplicate flasks were set up for each point. After 2 days', 3 days', 
4 days' and 6 days' exposure to drug, cells from drug - treated (3 
drug concentrations) and control flasks were trypsinized and counted 
by the trypan blue haemocytometer counting method. Cells from two out 
of the three replicate flasks were set up separately for a cloning
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assay at 3 separate cell densities. This was to ensure that at least 
one of the cell densities would have optimum colony growth for 
counting. After 7 days these plates were stained and colonies were 
counted manually.
One days' exposure to Vinblastine was specifically excluded from the 
experiment as it was felt that cell number would still be too low and 
that results would then be statistically limiting. To overcome this, 
but yet to observe an early drug effect possibly unidentified by 
trypan blue, three concentrations of Vinblastine were used.
For this experiment, a new batch of Vinblastine was used. On 
rangefinding experiments with the new batch, the activity was much 
greater, thus unfortunately the results from the first and second 
assay cannot be directly compared. Much lower concentrations were 
then needed to give the same extent of cell kill. This discrepancy 
must be attributed to storage of the drug, for though it was 
aliquotted into vials and stored at -20°C, the stocks were 2 years 
old.
Simultaneous to counting, AP, NR, MTT, DE and SRB assays were 
carried out in flasks on each of the drug concentrations (3 replicates 
per drug concentration for each assay on each day) as described in the 
materials and methods.
Cell counts, colony forming efficiencies of trypsinized cells and 
activity determined by each of the colorimetric assays was calculated 
for each day, and the results are summarized in the tables which 
follow.
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Table 3.12.3 Relationship between trypan blue count and true
viability
Vinblastine
concentration
¡jg/ml
Viable cell count 
(Trypan Blue) 
x 1 0 4
Colony formation 
after 1  week
two days 1 exposure to drug
0
0.0005
0.00075
0 . 0 0 1
4count, x 1 0 % survival colonies % control
106.0 ± 6.9
50.0 5.6 
23.7 5.6
22.0 5.0
1 0 0 . 0  ± 6 . 6
47.2 5.3
22.3 5.3 
20.7 4.7
54 ± 13
30 5 
32 10
100.0 ± 24.1
56.0 9.3 
59.4 18.5
three days' exposure to drug
0
0.0005
0.00075
0 . 0 0 1
177.0 ± 28.9
87.9 16.3
22.9 2.7 
22.5 0.8
100.0 ± 16.4
49.7 9.2 
12.9 1.5
12.7 0.4
56 ± 6
58 15 
62 16
59 18
100.0 ± 10.7
103.6 26.8
110.7 28.6 
105.4 32.1
four days' exposure to drug
0
0.0005
0.00075
0 . 0 0 1
250.0 ± 29.6 
112.5 27.8 
32.5 8.9 
18.2 4.9
1 0 0 . 0  ± 1 1 . 8
45.0 11.1
13.0 3.6 
7.3 2.0
110 ± 30 
132 8
79 31
100.0 ± 27.3
120.0 7.3
71.8 28.2
six days' exposure to drug
0
0 . 0 0 0 2
0.0004
0.00075
116.5 ± 38.8 
103.8 23.6 
33.4 0.4 
11.8 18.4
100.0 ± 33.3
89.1 20.3 
28.7 0.3
10.1 15.8
The first thing to note from the table is that significant cell kill 
does occur for the Vinblastine concentrations chosen, and at the 
higher drug concentrations used, the extent of cell kill increases 
slightly with time. At 0.005^g/ml Vinblastine though, approximately 
50% of the population has been killed after 2 days' exposure; longer 
incubation (up to 4 days) with this concentration of drug does not 
elicit further cell kill. The errors for haemocytometer counts for 2, 
3 and 4 days' exposure are relatively low (often < 10%), but for the 
sixth day are much more significant. In expressing the cloning data, 
one of the three densities plated out was chosen, and actual colony 
number was expressed as a percentage of controls (for the above data, 
the plating density used was 700 cells/ well).
The main conclusion that may be drawn from the above experiment is 
that on days 3 and 4 there was no significant difference in cloning 
efficiency (after replating) from 'viable' drug - treated cells (as
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defined by trypan blue exclusion) and viable control cells. Thus 
trypan blue, under those conditions, does not appear to be 
underestimating cell kill.
For day two though, there is a difference between drug - treated 
cloning efficiencies and control cloning efficiencies. At 
0.00075^g/ml Vinblastine, Trypan blue has underestimated cell kill by 
up to 40%; for the higher drug concentration the difference is not 
statistically significant though a similar trend is seen.
This finding mirrors the finding of the last experiment where early in 
drug exposure, trypan blue has underestimated cell kill.
Unfortunately a dilution error in the control plate for day 6 prevents 
the cloning data from being analysed. Likewise was the case for the 
lowest drug concentation on day 2. The experiment still allows 
comparisons to be made among the colorimetric assays however.
Where it has been shown that these trypan blue counts are an accurate 
measure of viability in determining the relationship between the 
colorimetric assays and cell viability under the conditions of this 
experiment, it is now appropriate to compare the colorimetric results 
to actual trypan blue viabilty counts. These results are presented 
overleaf.
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Table 3.13.4 Effect of Vinblastine on Hep-2 viability:
comparison of miniaturized endpoints
VBL.
(fug/ml) AP2h APNaOH MTT NR DE SRB
DAY 2
0 .059 ± 1.801 ± .071 ± .140 ± .436 ± .718 ±
.001 .085 .003 .009 .016 .017
0.0005 .047 ± .984 ± .027 ± .087 ± .218 ± .310 ±
.003 .015 .011 .002 .015 .029
0.00075 .036 ± .476 ± .016 ± .040 ± .067 ± .093 ±
. 0 0 1 .050 .006 .006 .034 .067
0.001 .042 ± .329 ± .013 ± .034 ± .077 ± .060 ±
. 0 1 0 .084 .005 .007 . 0 1 2 .025
DAY 3
0 .041 ± 1.687 ± . 1 1 1  ± . 2 1 2  ± .718 ± .... ±
.004 .036 .003 . 0 0 1 .006
0.0005 .016 ± . 8 6 6 ± .071 ± . 113 ± .269 ± .664 +
. 0 1 0 .066 . 0 0 2 .007 . 0 1 1 .090
0.00075 .007 ± . 350 ± .028 ± .028 ± .084 ± .114 ±
. 007 . 0 1 0 . 0 1 2 .007 .033 .048
0 . 0 0 1 . 0 0 0 ± .125 ± .031 ± . 0 2 2 ± .074 ± . 1 2 0  ±
. 005 .018 .003 . 0 1 0 .028 .048
DAY 4
0 .071 ± 2.332 ± . 157 ± .147 ± 1.086 ± 1.962 ±
. 008 .039 .003 .007 .045 . 0 2 2
0.0005 .048 ± 1.385 ± .107 ± .088 ± 0.544 ± 1.425 ±
.013 . 113 .006 . 0 0 2 . 0 2 1 .137
0.00075 .015 ± .337 ± .036 ± .047 ± 0.133 ± .119 ±
.006 .086 .009 .016 .060 .055
0 . 0 0 1 . 0 0 1  ± .195 ± .031 ± . 0 2 1  ± 0 . 1 2 0  ± .186 ±
. 002 . 02 0 .007 . 0 1 1 .027 .133
DAY 6
0 .077 ± 2.709 ± .133 ± .256 ± .823 ± .994 ±
. 0 0 1 . 080 .003 . 017 .018 .003
0 . 0 0 0 2 .042 ± 2 . 131 ± . 107 ± . 179 ± .528 ± .527 ±
. 0 0 2 . 2 2 1 . 003 .014 .026 .013
0.0004 .014 ± .486 ± .040 ± .035 ± .134 ± .097 ±
.007 . 153 .005 .004 .003 .005
0.00075 .007 ± .069 ± . 0 1 0  ± .007 ± .023 ± .009 +
.003 . 016 .005 . 0 0 1 .007 . 0 0 1
where VBL. = Vinblastine
It is clear that the AP2h O.D. values are very low - even lower than 
the MTT values. All three drug concentrations from 2-day exposure, and 
the last three concentrations for the other days, have particularly 
low O.D values; lower, in fact than their sensitivity range. For all 
the other methods O.D. values are acceptable, as are SEM values.
Haemocytometer counts for control wells show that cell number 
increases from 2 days to a maximum at 4 days (2.36 times that of day 2 
counts). CVDE elution and SRB (possibly) show this trend, but the 
other assays, by their O.D. values, generally indicate increasing 
growth as time progresses.
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Unlike the last experiment, the O.D. values for all of the assays are 
significant, and thus the interpretation of the results can be more 
reliable. Also the errors in the haemocytometer counts are lower due 
to a greater cell number.
In comparing the performance of the assays in their ability to 
distinguish between viable and non-viable cells, consider the 
following table, where the results have been represented as 
percentage of control values.
Table 3.12.5 Relationship of various colorimetric assays to
cell viability after drug treatment
All figures represent % survival from control figures
TB Viable
count AP2h APNaOH MTT NR CVDE SRB
DAY 2
+ + ± ± + + +
A 1 0 0 6 1 0 0 2 1 0 0 5 1 0 0 4 1 0 0 6 1 0 0 2 1 0 0 4
B 47 5 79 5 55 1 38 7 62 1 42 4 50 3
C 22 5 61 6 26 3 23 8 29 4 13 9 15 8
D 2 1 5 71 17 18 5 18 7 24 5 8 4 18 3
DAY 3
+ + ± + + +
A 1 0 0 16 1 0 0 1 0 1 0 0 2 1 0 0 3 1 0 0 1 1 0 0 1 -
B 50 9 39 24 51 4 64 2 53 3 38 2
C 13 2 17 17 2 1 1 25 1 1 13 3 1 2 5
D 13 1 0 1 2 7 1 28 1 1 0 5 1 0 4
DAY 4
+ + ± + + + +
A 1 0 0 1 2 1 0 0 1 1 1 0 0 2 1 0 0 2 1 0 0 5 1 0 0 4 1 0 0 1
B 45 1 1 68 18 59 5 68 4 60 1 50 2 73 7
C 13 4 2 1 8 16 4 23 6 25 6 1 2 6 6 3
D 7 2 1 1 8 1 20 4 2 1 5 1 1 3 9 7
DAY 6
+ + ± + + + +
A 1 0 0 33 1 0 0 1 1 0 0 3 1 0 0 2 1 0 0 7 1 0 0 2 1 0 0 0
E 89 20 54 3 79 8 80 2 70 5 64 2 53 1
F 29 0 18 3 18 6 30 4 14 2 16 0 1 0 1
G 1 0 16 9 4 3 0 8 4 3 0 3 1 1 0
where :
* = Trypan Blue count (TB) has underestimated cell kill by > 12%
A = no drug (control)
B = 0.0005 jug/ml Vinblastine E = 0.0002 pg/ml Vinblastine
C = 0.00075 jug/ml Vinblastine F = 0.0004 ¿ug/ml Vinblastine
D = 0.001 ¡ug/ml Vinblastine G = 0.00075 ¡ug/ml Vinblastine
On day 2 at the lowest drug concentration, it can be noted that 
compared to Trypan blue counts (which also may have underestimated 
cell kill, as cloning data for this concentration could not be used), 
NR has underestimated cell kill, by at least 10%. AP2h for all three
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drug concentrations has underestimated cell kill by 32%, 40% and at 
least 33% (for increasing concentration of drug). As the Trypan Blue 
count has been underestimated (by up to 12%) for 0.00075/jg/ml, this 
means that APNaOH, MTT, NR, CVDE and SRB have also underestimated 
actual cell kill.
Each of the other assays for the other drug concentrations correlate 
quite well with actual viable cell number, with the exception of MTT 
which slightly but consistently underestimated cell kill on many 
occasions throughout the experiment.
On day 3, AP2h has high SEM values (12 - 24%), as does MTT for the
middle drug concentration (± 11%). For 0.0005 and 0.001jug/ml
Vinblastine, MTT slightly underestimates cell kill, as does APNaOH for 
0.0005/jg/ml.
On day four, for all three drug concentrations, NR underestimates 
cell kill (by between 10 and 15%); MTT performs similarly for the 
first and third drug dilution. The SRB assay disagrees somewhat with 
viable counts for the two lowest drug concentrations; initially it 
appreciably underestimates cell kill, but for 0.00075pg/ml 
Vinblastine it overestimates cell kill by about 6% - these 
discrepancies may simply be due to overlapping SEM values.
Because there is no cloning data for Day 6 , it is not possible here to 
relate trypan blue counts to actual viable cell number. It is likely 
that the correlation is good for the 2 highest drug concentrations, as 
this was the case for the previous two days, however this may not be 
so for the lower drug concentration, as only low cell kill has 
occurred. Also the high SEM errors on the haemocytometer counts make 
interpretation of the results difficult. What can be said is that MTT 
has detected less cell kill than the other colorimetric assays at the 
two lowest drug concentrations. SRB and CVDE tended to declare higher 
cell kill than the other methods (particularly the former), especially 
at lower drug concentrations, where it is possible that cell kill has 
been overestimated by the Trypan Blue reference; thus, these assays 
may relate more closely to true viability than MTT, AP2h, APNaOH and 
even NR.
In conclusion then, it appears that in the early stages of drug 
exposure and at low concentrations of drug, there is a discrepancy 
between trypan blue viability determinations and true cell viability. 
In such instances trypan blue has underestimated cell kill as have 
each of the methods used here. At all other times, trypan blue was an 
accurate indicator of cell viability and apart from MTT which was very 
slightly but consistently different, each of the methods correlated 
quite well with TB results.
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While the work shown thus far has given a good indication of the 
relative performances of these assays, it has not indicated how well 
each of these assays responds to toxicity induced by agents of
differing mechanisms of action. Because the assays measure different
cellular functions, it may be reasonable to expect that each one may
be more/ less sensitive than the others for a drug with a particular
mechanism of action related to that function.
3.13 Relationship between endpoint and mechanism of action
To investigate this possibility, a panel of chemicals were chosen, 
each having a different mechanism of toxicity.
RPMI-2650 cells were exposed to each of the chemicals listed below 
over an entire range of concentrations in a continuous exposure regime 
for 6 days, and toxicity was determined using the endpoints listed.
The chemicals tested were:
Vinblastine (VBL), 
Mitomycin C (MMC), 
5-Fluorouracil (5FU), 
Hydroxyurea (HU), 
Actinomycin D (ACT), 
Cycloheximide (CHX),
2,4-DinitroPhenol (DNP), 
Triton-X-114 (TX), 
L-Tartaric Acid (TA), 
Tunicamycin (TMC) and 
Cordycepin (CCP).
The endpoints investigated were:
MTT,
AP2h,
NR,
CVDE, 3DNA synthesis (incorporation of [ H] thymidine) 
RNA synthesis (incorporation of [3 H] uridine) and 
protein synthesis (incorporation of [^H] leucine)
The chemical concentrations were chosen, after initial rangefinding 
experiments, to produce dose response curves within the range of cell 
kill. Each of the assays mentioned was then carried out on a
replicate plate for each chemical. Six replicate wells were used for
each chemical concentration. For comparison purposes, it was felt 
prudent to perform all of the assays on the same day, even though the 
work-load was extremely large. The radioincorporation assays for [^H] 
thymidine, uridine and leucine were also performed in 96 well dishes 
under identical experimental conditions, to enable a confident 
comparison to be made.
For each of the assays the dose-response curves produced are presented
here in Figures 3.13.1 to 3.13.7.
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F igu re  3.13.1 (a)
F igu re  3.13.1 (b)
F ig u r e s  3 .13 .1  (a ) ,  (b):
Comparison of perform ance of various assays in detecting 
toxicity of Cycloheximide to RPMI-2650 cells.
(6 -d ay  exposure to chem ical)
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F ig u r e  3 .1 3 .2  (a)
F ig u r e  3 .1 3 .2  (b)
F ig u r e s  3 .13 .2  (a), (b);
Comparison of performance of various a ssays in detecting 
toxicity of Hydroxyurea to RPMI^-2650 cells.
(6 -d ay  exposure to chemical)
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F ig u r e s  3 .1 3 .3  (a ) ,  (b);
Comparison of performance of various a ssays  in detecting 
toxicity of 2,4—Dinitrophenol to RPMI—2650 cells.
(6-day  exposure to chem ical).
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F ig u r e  3 .13 .4 :
Comparison of performance of various a ssay s  in detecting 
toxicity of Mitomycin-C to RPMI—2650 cells.
(6—day exposure to chemical).
;< 25
0 --
0.001 VINBLASTINE CONCENTRATION, fig/ ml
0.010.001
VINBLASTINE CONCENTRATION, fJ.g/ ml
OKA synth eal» 
PROTEIN ,
RNA
F ig u r e  3 .13 .5 :
Comparison of performance of various a ssay s  in detecting 
toxicity of Vinblastine to RPMI—2650 cells.
(6—day exposure to chemical).
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Figure 3.13.6: Figure 3.13.6
Comparison of perform ance of various assays in detecting 
toxicity of L—Tartaric  acid to RPMI-2650 cells.
(6-day  exposure to chem ical).
Figure 3.13.7:
Comparison of perform ance  of various assays in detecting 
toxicity of Triton—X—114 to RPMI—2650 cells.
(6 -d ay  exposure to chem ical).
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There is a clear distinction in terms of the toxicity of the agents to 
RPMI-2650 as determined by these endpoints.
In some of the experiments, SEM values for the radioincorporation 
assays were extremely large; in fact some were quite unacceptable. The 
other major point to note from repeat experiments, was that the CVDE 
assay (much more than the other colorimetric assays) was very 
inconsistant in its ability to show a response to a chemical. This 
effect was observed for Hydroxyurea, DNP, Mitomycin C and L-tartaric 
acid, where it was seen that in one experiment the CVDE assay was 
extremely insensitive to cell kill (initially at least) and was 
responding completely differently to the other assays; whereas in the 
repeat experiment, it was closer to the other experiments or was fact 
much more sensitive in detecting cell kill. The other assays, are not 
nearly as inconsistent. This is illustrated in Figures 3.13.2 and
3.13.3 (a) and (b).
Next, let us look more closely at the response obtained for 
individual chemicals.
Cycloheximide:
Because this is an inhibitor of protein synthesis, it might be 
expected that the leucine incorporation assay would detect toxicity at 
lower doses of cycloheximide more quickly than the other assays. In 
fact this effect is not seen. Among the colorimetric assays, there 
does appear to be a trend, consistent through the repeat; MTT being 
slightly more sensitive in detecting toxicity, followed by AP2h and 
then NR. When SEM's are considered however, the difference is not 
appreciable. Because SEM values for all the radioincorporation assays 
are very high, in both experiments (including repeat) it is difficult 
to discriminate between these assays. However, it does seem that the 
uridine incorporation assay is the most sensitive of all assays. 
Certainly it can not be said that the leucine incorporation assay 
shows more sensitivity than all of the other assays.
Hydroxyurea:
This is a specific inhibitor of DNA synthesis in vivo: RNA and
protein synthesis are not affected; thus it might be expected that the 
thymidine incorporation assay for DNA synthesis would be more 
sensitive than the other assays. On analysis of the graphs, it 
appears that the assays for DNA, RNA and protein synthesis may be 
slightly more sensitive than the other assays. The thymidine 
incorporation assay is actually slightly more sensitive in detecting 
toxicity, but unfortunately the SEM values for this assay on run 2 
made those results unusable.
2,5-Dinitrophenol:
DNP is an uncoupling agent, and thus inhibits oxidative 
phosphorylation. It would therefore be expected to affect 
mitochondrial MTT reduction by succinate dehydrogenase more quickly 
than affecting activity in the other assays. In the first run of the 
experiment, the MTT assay appears to be very slightly more sensitive 
than the other assays, but in the second run this is not the case. In 
fact it appears from the first experiment, that inhibition of DNA 
synthesis is most sensitive of all. It must be concluded overall
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then, that when the SEM values are considered, the MTT assay is no 
more specific for detecting toxicity due to DNP than any of the other 
methods.
Mitomycin C:
This anticancer drug is a DNA alkylating agent so particular attention 
will be paid to the thymidine incorporation assay. Indeed it does 
appear that this assay is more sensitive than each of the other assays 
(the effect is apparent in the repeat experiment also). Closely 
following, in terms of sensitivity to the chemical, are the uridine 
and then the leucine assays, all being more sensitive than any of the 
colorimetric assays.
Vinblastine:
This vinca alkaloid ultimately inhibits DNA synthesis, so again note 
the response of the thymidine incorporation assay. It is clear (from 
both experiments) that the thymidine incorporation assay is again more 
sensitive to this drug than are the other assays, followed by AP2h. 
The other assays all have simultaneous sensitivities.
L-Tartaric acid
The L- isomer of this chemical is reported to be a specific inhibitor 
of Acid Phosphatase activity. In fact the AP assay is no more 
sensitive to detecting the inhibitory effect of this chemical than any 
of the other assays. In this case, unlike the previous two chemicals, 
there is no great difference among all the assays (even the 
radioincorporation assays). As noted already, the 'sensitive' 
response of the CVDE assay was the inverse of the result obtained in 
the repeat experiment, and tended to be a trait of this assay.
Triton-X-114:
This surfactant is a membrane damaging agent. AP and NR reactions 
occur in the lysosomes, so both should rely on an intact lysosomal 
membrane (perhaps less so for AP; this is considered more fully in the 
discussion). MTT reactions, which occur in the mitochondria, may 
also be dependent on an intact mitochondrial membrane. Indeed the AP 
assay appears to be very slightly more sensitive to this chemical than 
the other colorimetric assays (the effect is repeatable), however it 
seems that the radioincorporation assays are slightly more sensitive 
again, particularly uridine incorporation, which is significiantly 
more sensitive than all of the other assays.
Actinomycin D:
This agent, which affects RNA synthesis, was highly toxic to cells, 
even at ng/ml concentrations.
Tunicamycin and Cordycepin:
Although Tunicamycin (0.01 - 200 ¡jg/ ml) and Cordycepin (0.0001 - 500 
/ug/ml) were tested in these experiments, none of the concentrations 
used produced any significiant cell kill, so the results are not 
useful (-it is possible that the stocks were not active).
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It should be noted that the AP2h assay, has shown a slightly 
increased sensitivity in detecting toxicity to Vinblastine, 
Triton-X-114 and Hydroxyurea than either MTT or NR.
Overall, it must be concluded that the colorimetric assays do not 
give a clear indication of the mechanism of toxicity of any of these 
chemicals, not generally expressing most sensitivity when expected 
to. The same has been the case for the leucine incorporation assay. 
Thymidine incorporation, when moderate SEM's allowed analysis, was 
generally more sensitive to chemicals exerting their action on DNA. 
Perhaps if effects are measured after shorter periods of drug 
exposure, mechanism-specific effects might be more prominent.
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3.14 Application of growth assays to chemosensitivity testing:
factors affecting the IC^q
Problems with poor reproducibility have been determined during the 
course of this work (see section 3.10.5), thus a number of factors 
which might affect this were investigated.
3.14.1 Pretreatment regime
For experimental work it is imperative to ensure that cells are in the 
correct phase of growth. Cells still in lag phase, or having left the 
exponential phase and entered into stationary phase are not suitable 
for use in assays. It is necessary to first subculture the cells into 
fresh medium so that they will be actively dividing when they are 
removed for use in an experiment (hereafter termed 'pretreatment'). 
This experiment attempted to determine how critical the pretreatment 
density was in affecting the results.
RPMI-2650 cells in logarithmic phase growth were trypsinized and set 
up at a range of seeding densities. The following day, the cells were 
fed as indicated, with fresh medium. Two days after setting up, each 
flask was trypsinized, and a 6-day, 96 well, Vinblastine toxicity
assay performed on each one as described in section 2 .
Figures 3.14 (a) and 3.14 (b) illustrate the results obtained from an 
AP assay carried out on each of the plates.
The graphs show that there is no particular trend as to the effect of 
pretreatment density on response to this drug. The dose response 
curves did not fall in an order bearing any correlation with its 
seeding density, and given the interexperimental variation of the 
assay (discussed in 3.10.5 for each of the assays in turn) and taking
the SEM values into account, there was no significiant effect noted
on toxic response.
Note that although there were 13.6 times more cells in the highest 
density pretreatment flask than in the lowest, all the cells were in
good condition under microscopic scrutiny, and none were totally
confluent. Thus the main conclusion from this experiment was that as 
long as the cells are subconfluent, appearing healthy and in good 
condition, the pretreatment regime will not largely affect the cells 
subsequent performance in a toxicity assay of this sort.
Also note that elimination of a 'feed' after one days growth (at 1 x 
1 0  ^ cells/ flask) has no significant effect on the cells performance 
in a toxicity assay.
3.14.2 Length of exposure to trypsin
Trypsin, an extracellular enzyme which cleaves peptide bonds on the
carboxyl side of lysine or argenine residues, is used to release 
cells from the biological glue of the extracellular matrix which cells 
in culture secrete for themselves. In exposing cells to trypsin for 
anything other than a short period of time, the cell can become 
damaged and thus its physiological response to agents can be altered. 
Agents, such as trypsin, affecting the membrane permeability of 
cells may also affect the drug sensitivity of the cell.
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VINBLASTINE CONCENTRATION (n g /  m l)
Figure  3.14.1 (a)
VINBLASTINE CONCENTRATION (n g /  m l)
F igure  3.14.1 (b)
F ig u r e s  3 .14 .1 (a),  (b):
Effect of different pretreatm ent regimes on outcom e of toxicity 
experiment when (a) various seeding densities of RPMI-2650 and 
(b) different feeding regimes, were used prior to a 6 day exposure to Vinblastine.
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In an attempt to identify factors causing intraexperiment variation, 
this experiment aimed to determine if relatively minor increases in 
exposure time to trypsin, would have a significant effect on the 
observed response to Vinblastine.
Figure 3.14.2 shows that there is no significant difference in drug 
sensitivity, after the exposure time during preparation of cells for 
assay is increased from 10 to 20 minutes. In experiments described in 
this thesis, trypsinization never exceeded 2 0 minutes duration.
3.14.3 Effect of cell density on drug sensitivity
When using different cell seeding densities, one should not 
necessarily expect that the response to drug should be the same. This 
would have implications for comparing assays which used different 
plating densities (e.g., assays set up at different densities in 
different size dishes). The following experiments were designed to 
investigate density effects, if any, on a range of cell lines, in 
toxicity experiments.
A clear density - dependent effect is noted in Figure 3.14.3 (a) and
(b) with Navelbine and Vinblastine on RPMI-2650 using the AP assay. 
Plating increasingly higher numbers of cells introduces a masking 
effect on the efficacy of the drug. The effect was established with 
all of the assays and is shown here for NR, MTT, CVDE, and IA.
To demonstrate this phenomenon more extensively, similar experiments 
were carried out using Hep-2. The results are shown in Figure 3.14.3
(c) .
3.14.4 Effect of drug exposure regime on drug sensitivity
Presumably the drug exposure regime will be a determining factor in 
the observed response of the cells to the drug. One of the goals of 
research into _in vitro chemosensitivity testing, is to design 
procedures which will bear relevance to exposure of the drug to the 
tissues in vivo. Thus the success of the in vitro assay will rely 
heavily on a good exposure regime. The relationship between drug 
exposure and toxic effect was investigated here in a number of simple 
systems.
Figures 3.14.4 (a) and (b) show that, as expected, observed toxicity 
is related to duration of exposure. As exposure is increased from 6 
to 24 hours, significantly many more cells were killed, and this 
effect is further increased at an exposure time of 7 days. At the 
drug concentration 0.01/jg/ml Mitomycin C, for example, 30% cell kill 
occurs after a 6 hour incubation time, whereas cell kill has 
increased to 55% at 24 hours, and 80% at 7 days incubation with drug. 
The graphs reproduced here demonstrate this effect for 5-Fluorouracil 
and Mitomycin C, but the same effect was established for other 
classes of drugs, including Cis-Platinum, Adriamycin and Vinblastine. 
Table 3.14.4 also summarizes this.
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Figure  3.14.3 (c)
d e n s i t y /  96 w e ll: 
O —  O  2-5 x  103 
•  —  •  5 X 103
A  —  A  7 5 x io3 A  — A l x io4
□ ---- □  2 5 x  1 0 *
■ ---- ■  5 x  104
V — V 7.5 x 104 
T  — T  l  x  io 5
F ig u r e s  3 .1 4 .3  (a) -  (c): 
E ffec t  of cell seeding d en sity  on  drug e fficacy  as a s s e s s e d  by: 
(a) NR, (b) AP (both for RPM I-2650 cells) and (c) IA for H e p -2  cells.
Toxicity tests were perform ed as 6 day continuous exposures.
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F i g u r e s  3 .1 4 .4  ( a ) ,  (b):
Effect of different drug exposure regimes on drug 
efficacy for RPMI —2650 cells.
2 0 2
Table 3.14.4 Effect of drug exposure on IC,jq for RPMI-2650 cells
Drug exposure 
time IC50 Mitomycin C IC505-Fluorouracil
7 days 
24 hours 
6 hours
0.007 ± 0.015 
0.010 0.015 
0.036 0.015
0.070 ± 0.020 
0 . 1 0 0  0 . 0 2 0  
0.440 0.020
25,000 RPMI-2650 cells seeded per well (24-well dish)
3.14.5 Duration of toxicity assay
Closely linked with the last parameter is the duration of the toxicity 
assay itself. It would be expected that assay dutation after or 
including drug exposure time would have some effect on the IC^q. In 
the previous experiment, two of the plots show short exposure times 
of 6 and 24 hours, after which drug was removed and the assay was 
allowed to continue for a total of 7 days. This of course was to 
allow the toxic effect to be manifest by quantifiable cell number.
The experiments represented by the table below shows a time course 
toxicity assay on RPMI-2650 cells. Replicate plates were exposed to 
drug in the normal manner with a continuous exposure regime. Beginning 
at one day continuous exposure to drug, and continuing for six days, a 
single plate was removed and stained each day, and read by image 
analysis. The effect of the drug on the cell population in terms of 
cell killing can be observed as it occurs.
Table 3.14.5 Effect of assay duration on IC5q for Vinblastine
exposure to RPMI-2650 (determed by IA)
Days in culture 
with drug
approximate IC^g 
/ug/ml Vinblastine
1 2 . 5
2 0.225
3 0.06
4 0.0875
5 0.00975
As the assay duration increases, the IC5 Q decreases; that is, the 
same concentration of drug becomes more potent to the cells. This is 
in accordance with the outcome which would be expected on assimilation 
of the results from experiment 3.14.4. Thus the time at which the 
endpoint is determined will directly, and very significantly affect 
the observed results.
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In the early days of the experiment, cell number was low, as cells 
had not divided much. In the latter stages of the experiment, cell 
number had increased significantly in control wells and in wells with 
low levels of drug where growth was only partially affected. This of 
course will have consequences in deciding when to determine the 
endpoint of the assay.
Obviously the critical factor in deciding when to terminate the assay 
will be not allowing the control wells to reach confluence. Aside from 
this, the factors mentioned here should be considered.
Thus it should be decided for each individual case when the assay
should be taken off. This was routinely done in these experiments.
Take for example SK-LU-1, shown here in Figure 3.13.5. The OD of the
control wells throughout the duration of the experiment were plotted 
when 5 x 10^ cells/ 96 well were plated, for a toxicity assay. It can 
be seen that after 6 days growth, the level of growth has actually 
decreased. This is because cells have become confluent and ceased to 
grow. Cells may then have dislodged from the plates. Thus taking 
this plate off at day 7 would lead to erroneous results, as wells had 
become confluent and control wells have stopped growing while drug 
treated wells had continued to grow, thus the 1C5Q would be 
overestimated.
ASSAY DURATION (d ay s)
F i g u r e  3 .1 4 .5
Activity of control wells (no drug) in AP a s s a y  with tim e 
when 5,000 SK—LU-1 cells were p la ted  on dayQ.
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RESULTS 2: 
APPLICATIONS OF ASSAYS
4.1 Serum batch testing with miniaturized, colorimetric 
endpoints
4.1.1 General considerations of serum batch testing
Serum batch testing is an inconvenient but necessary requirement for 
effective cell culture, to exclude bad serum batches from prospective 
use and to identify samples supporting good growth. The high cost of 
serum makes this consideration more important than ever.
Where a range of cell lines are being cultured, it is important to 
consider the optimal batch for each cell line, as different cell lines 
have different preferences for serum batches. Figures 4.1 (a) to 4.1
(c) exemplify how a given serum batch can be a good growth promoter 
for one cell line, and yet effect poor cell growth with another cell 
line. All of the batches tested were Foetal Calf Serum (FCS). Serum 
batch 801066 is the optimal batch for DLKP, followed by batch 801051; 
however these 2 batches are the least optimal for RPMI-2650, and in 
the reverse order also. In fact, the results of serum preference for 
RPMI-2650 are quite the inverse of those from DLPK. SKMES-1 displays 
yet another different profile for serum batch preference, with batches 
901020 and 801117 giving the most growth.
For serum batch testing, it is crucial to test at more than one 
serum concentration, as the observed effect sometimes changes at 
different serum levels. If possible, testing should be done at 3 
serum concentrations; low, moderate and high (3%, 5% and 10%, for 
example), but if this is not possible then one of the test 
concentrations can be excluded. To illustrate this point, again 
consider Figures 4.1 (a) to (c).
Whilst 1% serum for SKMES-1 results in little growth all round, some 
differences in serum performance are noted with this concentration for 
the other two cell lines. With RPMI-2650, it is particularly 
interesting to note the degree of growth stimulation apparent with 
batch 801066. The importance of considering multiple serum 
concentrations is evident when we observe the growth resulting from 
higher concentrations of this serum. Contrary to what might be 
expected with increasing serum concentration, no increase in growth 
was noted. In fact, growth has been inhibited at 5% serum, though 
at 10%, the inhibition is less marked. A similar phenomenon occurs 
at 5% serum batch 801117.
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Figure 4.1.1 (a)
Figure 4.1.1 (b)
SERUM BATCH
Figure 4.1.1 (c)
Figures  4.1.1 (a) — (c):
Effect of different FCS b a tc h e s  on cell growth: 
(a) 5 ,000  SK -M E S-1  cells, (b) 5 ,000  RPM I-2650 ce lls and
(c) 10,000 DLKP cells, a fte r  7 d ay 's  grow th.
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Considering the afforementioned variables which need to be addressed, 
in addition to other factors (such as cell density) which may affect 
serum batch performance, it must be appreciated then, how easily the 
size of the experiment can amplify. If several cell lines have to be 
tested, for, say 15 batches of serum, then this represents an 
immense amount of incidental work.
Previous work in this laboratory relied on preparing growth curves and 
monolayer experiments in 24 well dishes (analysed by IA) to 
distinguish between good and poor batches of serum, but difficulties 
with IA (previously discussed) especially with some cell lines 
which did not form concise colonies, and plates in which the colonies 
were not well distributed, resulted in inaccurate results with the 
monolayer method. Not only did this mean that there was an urgent 
need for improved accuracy of quantification in this system, but 
clearly the procedure would benefit from miniaturization and 
semi-automation.
This section considers the problems of serum batch testing and deals 
with the application of one of such miniaturized, semi-automated 
assays (AP) to serum batch testing, and then assesses its 
performance.
The graphs which follow illustrate the performance of 11 different 
batches of serum on a range of different cell lines at some different 
cell densities. Results from the AP assay are compared with results 
obtained using other assays.
4.1.2 Practical/ technical significance of batch testing using
the AP assay
Changing from a previously used monolayer system of batch testing 
(analysis of crystal violet stained cells in 24 well dishes by image 
analysis) to the AP assay was not a major task. Adaptation of the 
procedure required few modifications. Obviously the smaller surface 
area and volume of 96 well plates meant that cell loading density and 
volumes had to be adjusted. Volume was reduced from 0.5ml cells +
0.5ml double-strength serum containing medium, to 0.1 ml of each.
Cell density was reduced; some preliminary work was needed to 
establish the extent for each cell line. Because less media and cells
were used, more replicates could be set up, or more variables could
be tested. The time saved during setting up and reading of the assays 
was considerable. The tedium of carefully trying to establish an 
evenly spread monolayer was removed and the importance of having a 
single cell suspension was lessened. Any subjectivity relating to 
quantification of results (by choosing a detection level and other 
settings on the image analyser for optimum performance) was 
relinquished.
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4.1.3 Significance of cell density
Cell density is extremely important in determining the success of the 
image analysis assay due to cell distribution phenomena, but let us 
just see how critical it is when using a different testing system such 
as a miniaturized, colorimetric assay.
Figures 4.1.3 (a) to (e) demonstrate the effect of cell density on 
response to serum batch for DLKP cells. As cell seeding density 
increases, so too does the O.D. This is summarized in the Table 
below.
Table 4.1.3 Relationship of cell seeding density to O.D. (DLKP)
Viable cell number seeded 
(/96 well)
Aapproximate optical density 
(Absorbance Units)
1  x 1 0 3 0 . 1
2.5 x 103 0.2 - 0.25
5 x 103 0.3
7.5 x 103 0.35
1  x 1 0 4 0.3 - 0.4
* after 6 days in culture
Optical density increases as a consequence of cell plating density 
after 7 days in culture, but not in a linear fashion. Significant
increase in O.D. was achieved with increasing plating density up to
7.5 x 103 cells per well, but at 1 x 104 cells/well, no further
increase was noted. This response is due to confluent conditions 
being reached at seeding densities greater than 7.5 x 103/ well.
Whilst increasing the cell seeding density generally gave a
significant increase in O.D., doubling the serum concentration from 5 
to 1 0 % made very little difference to the extent of cell growth in the 
case of most of the sera. This was the case for all cell densities
tested.
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Figures  4.1.3 (a) — (e):
Effect of DLKP cell seeding density on response to serum  batch: 
(a) =  1,000 cells, (b) =  2,500 cells ,  (c) =  5,000 cells, (d) =  7,500 cells 
and (e) =  10,000 c e l l s /  96 well (growth a f te r  6 days' culture). 
flail =  5% serum ; ■ ■  =  10% s e r u m  .
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All the serum batches tested resulted in good cell growth; there were 
no extremes in batch performance, which makes it more difficult to 
analyse the findings; however, some differences are apparent. All 
batches were FCS, except for batch 2 (Donor Calf Serum (DCS)) and 
batch 4 (Donor Horse Serum (DH)).
Figure 4.1.3 (a) shows that at 103 cells/well, batches 11 and 4
support least growth, but for batch 4, this effect is only noticable 
at the lower concentration of serum. At 2.5 x 103 cells however 
(Figure 4.1.3 (b)), batches 11 and 4 are much improved and now it is 
batch 1 0  which gives low cell growth at the low serum concentration; 
all the other batches showing little difference in performance. 
Moving on to 5 x 103 cells/well, again batch 10 is poorer than the 
others (at low serum concentration); this time though, batches 4 and 
2 seem to be slightly better than the rest of the batches at high 
serum concentration (Figure 4.1.3 (c)). This trend is also maintained 
for 7.5 x 103 cells/ well, but at the higher density of 104 cells/ 
well the situation changes again. Here, batch 10, which has generally 
been the poorest of all the batches at other cell densities tested, 
now performs as well as any of the other batches, and significantly 
better than batches 1, 3, 5 and 6 (Figure 4.1.3 (e)).
Thus it is evident that plating density can significantly affect the 
results observed in a miniaturized colorimetric assay system.
4.1.4 Comparison of AP assay with IA
In comparing serum batch testing results obtained from using the AP 
assay with that seen in a monolayer assay quantified by image 
analysis, comparable results were found for both assays. Figure
4.1.4 (a) shows similar response to the range of FCS batches tested 
(at a concentration of 5%) on NRK cells when quantified by IA, to 
that observed after testing by the AP method in the two graphs below 
it. Figure 4.1.4 (b) shows AP response after a 3 hour incubation 
time, while Figure 4.1.4 (c) shows the same experiment after a 5 hour 
incubation time. It can be seen that the response is very similar 
after both AP incubation times.
At 10% serum it is clear that both AP(3h) (Figure 4.1.4 (d)) and
IA(4d) (Figure 4.1.4 (e) have detected similar cellular response to 
batches 6 , 7 and 8 , while batches 9 and 10 have been poorer at
promoting NRK growth. Additionally it was noted that the IA assay, 
when allowed to grow for an extra day (5 days) (Figure 4.1.4 (f)) has 
resulted in a very different response to that seen a day earlier. 
After 5 days growth, no differences whatsoever were detected in batch 
performance.
Having shown that the AP assay produced results similar to those 
obtained by the IA method, it was then applied to screening the same 
panel of 1 1  sera over a wide range of cell types to indicate serum 
performance.
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F ig u re s  4 .1 .4  (a) -  (c ) :
C om p arison  of activ ity  o f s e r u m  b a tc h e s  in  IA an d  AP a ssa y s . 
NRK grow th a fte r  5 d ay s in  cu ltu re , a t  5% seru m :
(a ) =  IA, (b) =  AP3h, (c ) =  AP5h.
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F igu res 4 .1 .4  (d) — (f);
C o m p ariso n  of activ ity  of se ru m  b a tch e s  in  IA an d  AP a ssa y s . 
NRK grow th  a fte r  4 and 5 d ay s grow th with 10% seru m :
(d) =  AP3h, (e) =  IA a fte r  4 days, (f) =  IA a f te r  5 days' growth.
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4.1.5 Differential response of cell lines to serum batches: can
the AP assay detect this?
Seven cell lines; SK-LU-1, SK-MES-1, Calu 3, DLRP, DLKP, RPMI-2650,
and NRK; were tested for their serum batch preference with the panel 
of 11 batches of serum. Five of these cell lines were of lung origin. 
They were tested at seeding densities of 5 x 103 and 104 cells/ well 
and at serum concentrations of 5 and 10%. The paragraphs which follow 
are a synopsis of the main trends observed for each cell line.
SKLU-1 (Lung adenocarcinoma; Figure 4.1.5.1 (a) and (b))
Batches 4 (DH) and 10 (FCS) were significantly worse than the other 
batches. This trend was noted at both serum concentrations (5% and 
10%) .
SKMES-1 (Lung squamous cell carcinoma; Figures 4.1.5.2 (a) and (b))
Batch 10 was consistently the worst. Batches 8 and 5 were slightly 
better than the other batches, followed by batches 1 and 11. All 
others were very close together. This trend was maintained at both 
cell densities and at both serum concentrations.
CALU 3 (lung squamous cell carcinoma; Figures 4.1.5.3 (a) and (b))
Doubling serum concentration to 10% did not result in a very
significant increase in growth, (particularly for batches 2 and 1 0 )
however, doubling cell seeding density to 1 0 4 cells/ well resulted in 
greater than double the amount of growth at the end of the experiment. 
At 5% serum, batch 1 was the worst growth promoter, but this improved 
at 10% serum, surpassing batches 4, 10, and less significantly, 
11. Under all conditions, batch 9 gave the best performance in terms 
of stimulating cell growth.
DLRP (lung squamous cell carcinoma; Figures 4.1.5.4 (a) and (b))
At low cell density, augmenting the serum concentration to 10% made 
little difference to growth; at higher plating density the increase 
was more benificial. For this cell line also, batch 10 was the 
poorest growth promoter. Batches 1, 8 and 11 were slightly better
than the remaining batches.
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Fig u res  4 .1 .5 .1  (a ), (b):
E f fe c t  of d i f fe r e n t  s e r u m  b a tc h e s  on ce ll g ro w th  (assayed by 
AP2h a c t iv i ty ) .S K —L U -  1 cells  a f te r  6 days' g r o w th  a t  
seeding den s ities  of 1 I 5 ,0 0 0  and  Y /X  10 ,000  c e l l s /  96 well, 
(a ) =  5% s e ru m , (b )  - 10% se ru m .
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Figures 4.1.5.2 (a), (b):
Effect of different serum  b atch es  on cell growth (assayed by 
AP2h ac t iv i ty ) .S K -M E S -1 cells a f te r  6 days growth at
seeding densit ies  of L ! 5,000 and  Y ///A 10,000 c e l l s /  96 well.
(a) =  5% serum , (b) =  10% serum .
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F ig u r e s  4 .1 .5.3 (a), (b):
E f fe c t  of d i f f e r e n t  s e r u m  b a t c h e s  on cell g ro w th  ( a s s a y e d  by
AP2h a c t i v i t y ) .C a l u - 3  a f t e r  6 d a y s  grow th a t
se e d in g  d e n s i t i e s  of  I I 5 ,000  a n d  Y///A  10 ,000 c e l l s /  96 well.
(a)  =  5% s e r u m ,  (b) =  10% s e r u m .
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F ig u r e s  4 .1 .5 .4  (a) ,  (b):
E f fe c t  of  d i f f e r e n t  s e r u m  b a t c h e s  on cell  g row th ( a s s a y e d  by 
AP2h act iv ity) .DLRP cel ls  a f t e r  6 d a y s  grow th  a t  
s e e d in g  d e n s i t i e s  of I I 5 ,000  a n d  Y///A  10 ,000 c e l l s /  96 well, 
(a)  =  5% s e r u m ,  (b) =  10% s e r u m .
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DLKP (lung squamous cell carcinoma; Figures 4.1.3 (c) and (d))
This cell line has a higher growth rate than has Calu 3 or DLKP; note 
that increasing the cell density from 5 x 103 to 10^ cells did not 
result in the same observed improvement in growth as seen by the 
previous two cell lines. At high cell densitiy, batches 2 (DC) and 4 
(DH) were slightly better than the other sera. At low cell density, 
batch 8 , which was good for many of the other cell lines, was the 
worst for this cell line.
NRK (normal rat kidney fibroblasts; Figures 4.1.5.5 (a) and (b))
4Increasing the cell density to 10 cells/ well gave similar, or 
indeed even lower OD readings than the lower cell density did. Batches 
4 and 10 gave lowest growth, especially at 5% serum. All the other 
batches were quite similar, except for batch 5, which was marginally 
better than the others.
RPMI-2650 (nasal squamous cell caricnoma; Figures 4.1.5.7 (a) and (b)
Again batches 8 and 5 were slightly better than the other batches, 
while batch 10 was the worst, followed by batches 2, 4 and 9.
Synopsis:
The cell lines have behaved differently in response to different serum 
batches. The AP assay has detected differences in responses.
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F ig u r e s  4 .1 .5 .5  (a), (b):
E f fe c t  of d i f f e r e n t  s e r u m  b a t c h e s  on cell  g row th  ( a s s a y e d  by 
AP2h act iv ity) .NRK c e l l s  a f t e r  6 d ay s  grow th  a t  
s e e d in g  d e n s i t i e s  of  I I 5 ,000  a n d  Y //A  10 ,000 c e l l s /  96 well, 
(a )  =  5% s e r u m ,  (b)  =  10% se ru m .
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F ig u r e s  4 .1 .5 .6  (a),  (b):
E f f e c t  of d i f f e r e n t  s e r u m  b a t c h e s  on cell  growth ( a s s a y e d  by 
AP2h a c t iv i ty ) .R P M I-2 6 5 0  ce l ls  a f t e r  6 d a y s  growth a t  
s e e d i n g  d e n s i t i e s  of I I 5 ,000  a n d  E22 10,000 c e l l s /  96 well, 
(a )  =  5% s e r u m ,  (b) =  10% s e r u m .
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4.1.6 Comparison of the performance of the AP assay to
other miniaturized, colorimetric assays
Using the cell line RPMI-2650, the results obtained with the AP assay 
were compared to the NR, MTT and CVDE assays. This was carried out 
with 10 cells/ well and at the same two serum concentrations; 5% and 
10%. Figures 4.1.6.1 to 4.1.6.2 illustrate these results.
The O.D. values obtained for all of the assays were similar; 10^ 
cells/ well (after 7 days growth) produced values in the range of 0.1 
to 0.15 O.D. units. As already noted above, the AP assay detected 
poor growth with batch 10, followed then by 2, 4 and 9. This result 
was also obtained with the NR assay; the difference between these 
'poor' batches and the rest of them is more marked with the NR assay 
though. However the SEM values were much bigger for this assay than 
for the AP assay ((c) Figures). A similar situation resulted when the 
MTT assay was used; error bars were significantly bigger ((b) 
Figures). The results from this assay are very similar to AP - while 
batch 1 0  is clearly seen as the worst, the differential between the 
others is less marked. Both systems identify significantly poorer 
growth at 5% batch 7, which is improved at 10% of this serum. The 
other 2 assays did not show this trend. The CVDE assay ((d) Figures) 
shows the same trends that have been mentioned already, but the assay 
is accompanied by small error bars (similar to the AP assay).
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F igu re  4 .1.6.1
Figure 4.1.6.2
Figures 4.1.6.1 and 4.1.6.2:
C om parison  of d iffe re n t  endpoin ts in a s se s sm e n t  of se ru m  
b a tch  ac tiv ity  on  RPMI—2650 cells (10,000 c e l l s /  96 ■well 
a fte r  6 d ay s grow th ): (a) =  AP2h, (b) =  MTT, (c) =  NR,
(d) =  CVDE, y ///*\ =  5% serum ,E 22  =  10% seru m .
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4.2 Toxicity testing of industrial sludges
For many industries the waste treatment system used, aims to produce 
an effluent with as high a quality as is economically and technically 
possible. This is brought about by removal of solids and oxidizable 
material from the waste stream to produce an effluent of lower 
polluting potential. This however, results in a sludge which must 
then be disposed of. Disposal is often by landfilling (considered in 
4.3). Sludges should be demonstrated to be suitable for landfilling or 
spreading on land, by their low toxicity.
This section describes how a number of industrial sludges were assessed 
for their suitability for landfilling, and how the results obtained by 
the AP assay compared to in vivo toxicity testing with one invertebrate 
species.
Eight authentic sludge samples were obtained from EOLAS, Shannon. They 
were designated, samples A - H, and the chemical nature or toxicity 
of the samples was not disclosed (to circumvent biased testing/ 
results, and also for reasons of confidentiality). A leachate was 
generated from each of the samples as described in section 2.38 and 
samples, after preparation were tested on MDCK cells for 72 hours. AP 
activity was used to determine cell cytotoxicity. IC50 values were 
determined in the usual manner and results were expressed as Toxic 
Units (TU), where 1 TU = 1000/ IC^q . In vivo tests were performed on 2 
species of inverterbrates by EOLAS at Shannon in addition to a 
bacterial Microtox test. All of the procedures have been described in 
section 2. The Table below compares these results to the AP test 
results obtained in this work.
Table 4.2 Toxicity of some industrial sludges in various
toxicity testing systems (ICgg, TU 1 s)
Sludge sample AP
assay
Microtox
assay
D.magna A . sallna
A (unidentified) 5 nt
B (pharmaceutical) 5 . 5 1 2 9
C (pharmaceutical) 22 36
D (metal ore extract) <2 3.9-9 7
E (pharmaceutical) <= 2 . 1.7
F (circuit board wash) <=2 • nt
G (dry cleaning sludge) 770 . 13,157
H (harbour sediment) <2 < 1 nt < 1
where nt = not toxic
Unfortunately only some of the EOLAS results were available for 
comparison purposes. Rainbow trout studies were also carried out but 
the results could not be made available for comparison.
Bear in mind that the values will vary depending on experimental 
factors - so in routine testing, an internal control should always be 
used and the same experimental conditions adhered to.
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However it is certainly clear from above that the only sample showing 
real toxicity in the EOLAS tests is sample G (*) - the dry cleaning 
sludge sample. Sample C, a pharmaceutical sludge showed slight 
toxicity. In the AP results, the same general trend was seen. Sample 
C showed slight toxicity and sample G was very toxic to the cells. 
Although the same trend was found with the AP assay, the sensitivity 
in terms of TU1s was lower for the AP assay - 20 times less so for 
sample G than for the bacterial Microtox assay. The same rank order 
was seen for the invertebrate and cell culture tests - only sludge G 
would have been rejected for landfilling.
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4.3 Toxicity assessment of Landfill Leachates
In Ireland, most of the domestic and industrial waste produced is 
disposed of by 'landfilling' (considered in detail in the general 
discussion). A characteristic feature of these landfill sites is the 
production of a 'leachate' which may find its way into ground and 
surface water and cause serious pollution problems. Leachates are 
often high in heavy metals and other toxic compounds. Constant
monitoring of groundwater is not practical due to lack of resources 
needed to carry out comprehensive chemical monitoring schemes.
If a simple, inexpensive biological monitoring system were available, 
to determine the total toxicity of the leachate or the groundwater, 
then this would go a long way to helping in the correct management of 
a landfill site.
This section describes attempts to apply the AP assay to such an end.
Heavy metals, which may be significantly present in landfill
leachates, are toxic in their own right (do not require 
bioactivation) and are particularly toxic to the kidney [Goodman, 
1985], thus it was felt appropriate to use the kidney cell line MDCK 
as the target for toxicity assessment.
To determine the ability of the AP assay to assess chemical toxicity 
of heavy metals to MDCK cells, some standard solutions of Cadmium
oxide, Nickle nitrate and Lead nitrate were prepared and tested on
cultures in a 5 day continuous exposure system (as described in 
Materials and Methods).
The dose /response relationships (which, when repeated resulted in 
excellent reproducibility) are shown in the the Figure 4.3.1.
It is clear that Cadmium oxide is much more toxic to MDCK than either 
of the other metals, having an approximate IC^q (under the conditions 
of this work) of 11.4 ¡jH. Nickel nitrate is next toxic to the cells 
with an approximate IC^g of 23.6 /jM, and least toxic of the three is 
Lead nitrate which has resulted in approximately 65% cell survival 
based on AP levels at 155 / j M . Having seen that the culture system and 
the assay are capable of detecting some toxicity to the type of 
compounds expected to be found in a landfill leachate, it is now 
appropriate to test some leachate samples themselves.
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F ig u r e  4 .3 .1 :
Toxicity of heavy m eta l  sa l t s  to MDCK cells  (5 ,000 c e l l s /  96 well seeded, 
5 —day  con tin u ou s  exposu re) using AP endpoint.
O =  C adm ium  oxide, •  =  Nickel N itrate , A =  Lead Nitrate.
EFFLUENT CONCENTRATION, %
F ig u r e  4 .3 .2:
Toxicity  of O m etalw orks effluent an d  •  landfill leach ate  to MD^CK 
cells  (5 ,000 c e l l s /  96 well seeded, 5 - d a y  con tin uous exposure). 
Endpoint: AP activity.
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Further preliminary work was carried out with MDCK in the culture 
system alluded to above (and described in detail in Materials and 
Methods), with a range of effluents and a landfill leachate obtained 
from a Local Authority (LA). Because of the problems considered in 
the general discussion in relation to obtaining authentic, 
sufficiently toxic samples for testing, no backup analytical data was 
available for these samples (and due to severe time constraints could 
not be undertaken as part of this thesis), so this data has not been 
shown. However, it is seen in Figure 4.3.2, that even with low 
dilutions of effluent (up to approximately 1 2 % effluent in medium) 
there has been some cell kill. The significance of this in a 
practical situation will be discussed more fully in the following 
chapter. We note that the landfill leachate did not exert significant 
toxicity in to the cells in culture, even at concentrations of 50% 
leachate in culture medium.
Three further leachate samples were obtained from a LA sanitary 
landfill site. The site is a well run and regularly monitored site. 
While it was hoped to obtain leachates of varying potency it seemed 
unlikely that very toxic sample would be obtained. Samples were 
labeled 1-3 and identified by this label alone. When the results from 
AP testing were surrendered to the LA, analytical data pertaining to 
the samples was then obtained and retrospective analysis was carried 
out. The leachates were pH1ed to 7.45 - 7. 55 and filter sterilized
before testing on an MDCK culture (set up 24 hours previously) for 72 
hours. TU (Toxic Units) values were calculated from IC^q S and these 
have been compared to the chemical characteristics of the wastes in 
the table below.
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Table 4.3 Relationship between chemical analysis of leachates
and performance in AP assay
Paramater
Leachate sample
1 2 3
PH 7.35 6 - 8 6 - 8
conductivity 2 0 , 0 0 0 2 0 , 0 0 0 500 - 3,000
BOD > 800 > 800 5 - 200
COD 5,000 5,000 10 - 500
n h4+ 2,400 5 - 100 5 - 1000
Cl 3,900 50 - 100 20 - 2 0 0
susp. solids 10 - 500 10 - 500
Zn 2 . 2 <0 . 2 <0 . 2
Na 2 , 0 0 0 30 - 150 30 - 150
K 1470 1 0  - 1 0 0 1 0  - 1 0 0
Ca 100 - 500 100 - 250
n o3" 36 1 - 1 0 1 - 1 0
NO “ <0 . 2 <0 . 2
22 + s o / + 8 5 - 100 50 - 500
total hardness 131 500 - 600 50 - 1,000
Fe 1 - 1 0 50 - 600
Mn 8 . 6 1 - 1 0 1 - 1 0
Pb < 1 1 - 1 0
Cu <0 . 1 <0 . 1
Cd <0 . 1 <0 . 1
Ni <0 . 1 <0 . 1
alkalinity 1 0 , 0 0 0 50 - 1,000
D.O. 0.7
temperature 15.3
Cu 0.15
Cd 0.05
AP toxicity 7.5 <= 2 < = 1
Units: AP toxicity in Toxic Units
pH in pH units 
Conductivity in mOhms/kg 
Temperature in °C 
All other parameters in ppm
Where relevant these terms have been explained in the discussion.
We note from chemical analysis (by the Local Authority) that none of 
the samples are extremely potent. Metal concentrations are low for 
all of the leachates, thus on retrospective consideration it was not 
expected to observe toxicity similar to that in Figure 4.3.1, in this 
toxicity screen.
Sample 1 is quite high in nitrogen; nitrate levels are enriched over 
the other two samples, but most of this nitrogen is in the form of 
ammonia. COD levels, which would probably give the best indication of 
potency from all of the parameters listed here, are not terribly high.
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A leachate having a COD of 10's or 100's of thousands (ppm) would be 
considered to be very potent; substantially less than this would not 
be considered so. Thus, we note that none of the three leachates 
appear to be particularly toxic. If some distinction had to be made 
among them, it would have to be said that leachate no. 1  was the most 
potent, having higher ammonia, nitrate, and zinc levels than the 
others. The sodium and potassium levels are also higher. The results 
obtained from the AP assay are in good agreement with this assesment. 
All 3 leachates were non-toxic, however the rank order of potency from 
this assay was the same as that observed from the analytical data; 
sample 1  was somewhat more potent than the other 2 ; samples 1  & 2 
were close together, with sample 3 (which had the lowest BOD and COD) 
being very slightly less toxic than sample 2 .
Overall, it was disappointing that no particularly noxious leachates 
were available; as more could have been extruded from such results, 
nevertheless it would appear that this assay may be very useful in 
routine screening programmes, as the trend observed from extensive 
chemical analysis of the leachates was shown also with the AP results.
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4.4 Screening for efficacy of new drugs
This section describes the use of AP, NR, MTT and IA to detect 
cytotoxic activity using a novel anti-cancer agent. The 
investigational drug used was Navelbine (Vinorelbine) [developed by 
Pierre Fabre Research Centre] which at the time of this study [1989] 
was undergoing Phase II clinical trials, and had given promising 
results to date, encompassing low neurotoxicity. It is a vinca 
alkaloid, but differs from the other compounds in this class, and 
has a very high affinity for Tubulin. Initial experimental 
toxicological findings were interpreted to suggest that Navelbine 
provided higher inhibition of tubulin polymerization than Vinblastine, 
and consequently was suggested to provide a better toxicity ratio and 
improved therapeutic index, particularly for non small cell lung 
carcinomas [unpublished company report].
In order to investigate this, the efficacy of Navelbine was compared 
to Vinblastine for the non small cell lung cell lines DLKP, DLRP (both 
squamous) and SK-LU-1 (adenocarcinoma), and for a number of cell 
lines from other sites. The structures of these drugs are given in 
Appendix B.
The lines were tested first in an image analysis monolayer system and 
then tested with the AP, NR, CVDE and MTT assays. Some of these image 
analysis results are condensed and presented in the table below 
(assays were repeated 4 times, so the data is extensive and cannot 
all be reproduced here) together with results obtained in some of the 
colorimetric assays.
7 - day continuous exposure assays were used and were carried out
exactly as described in section 2 .
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Figure 4.4.1:
Toxicity of Navelbine to SK—MES—1 cells after 6—day continuous 
exposure, o =  AP, •  = NR, a = CVDE.
VINBLASTINE CONCENTRATION, fig/ ml
Figure 4.4.2:
Toxicity of Vinblastine to sk —m e s—1 cells, after 6 —day continuous 
exposure. •  = NR, a  = CVDE, a = MTT.
Table 4.4.1 Toxicity of Navelbine and Vinblastine to DLKP, SKMES-1 
and SCC-9 cell lines
drug 
conc.
DLKP SKMES-1 SCC- 9
Assay activity (% of control)
A'g/ml Navelb Vinbl Navelb Vinbl Nabelb Vinbl
0 . 0 0 0 1 0 0 + 2 2 100±30 1 0 0 ± 8 100± 4 100+18 100±19
0.005 - 75 1 1 - - - -
0.00075 95 10 54 3 - 87 10 94 11 79 24
0 . 0 0 1 71 14 50 7 90 9 81 8 72 7 3 0
0.0025 16 5 0 0 77 4 7 5 8 1 2 0
0.005 1 0 0 0 11 19 0 0 4 0 3 0
0.0075 1 2 0 0 5 2 0 0 2 0 4 0
Image Analysis results
Table 4.4.2 Toxicity of Navelbine and Vinblastine to RPMI-2650
drug 
conc.
Navelbine Vinblastine
Assay activity (% of control)
pg/ml IA MTT AP IA MTT AP
0 . 0 0 0 1 0 0 + 1 2 100±15 1 0 0 ± 2 100+33 100±15 100±5
0.00075 1 1 2 26 75 1 0 99 8 - 66 14 109 4
0 . 0 0 1 92 18 73 8 84 1 64 21 48 10 52 4
0.0025 40 2 35 4 37 8 25 11 4 3 5 1
0.005 15 7 1 0 3 18 3 2 0 1 2 4 1 6 2
0.0075 1 0 5 3 5 3 0 0 - -
0 . 0 1 0 0 1 1 0 0 0 0 1  1 2 1
Table 4.4.3 Toxicity of Navelbine and Vinblastine to Hep-2
drug 
conc.
^g/ml
Navelbine Vinblastine
Assay activity (% of control)
IA MTT AP NR IA MTT AP NR
0 . 0 0 0
0 . 0 0 1
0.0025
0.005
0.0075
0 . 0 1
1 0 0 ± 2  
99 2 
87 5 
56 2 
1 1  1  
1 1
100±3 
83 6 
72 7 
28 7 
1 1  6 
5 1
100±4 
71 4 
23 8 
1 3 
0 0 
0 0
1 0 0 ± 8  
85 5 
62 6 
16 3 
5 1 
3 1
100±13 
35 2 
0 0 
0 0 
0 0 
0 0
1 0 0 ± 8  
61 6
3 1
4 2 
0 0 
0 0
1 0 0 ± 1 0  
34 9 
1 0 
1 0 
0 0 
0 0
1 0 0 ± 6 
36 11 
5 1 
2 1  
4 1 
0 0
The above tables show that there is certainly a difference in toxicity 
between the two drugs. Navelbine, which was expected to be as toxic 
or more toxic than Vinblastine, resulted in significantly less cell 
kill than Vinblastine. The results have been given in /jg/ml, but as
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Navelbine has a higher molecular mass than Vinblastine (see appendix 
B), the results are even less efficaceous for Navelbine when they are 
compared in terms of molarity (see Table 4.4.4). Each of the 
endpoints used were capable of detecting this difference in efficacy, 
however the methodology was simpler and quicker, and the resources 
used were less when the miniaturized assays were used instead of IA. 
This trend was similar for all of the cell lines tested, even for the 
lung lines.
When differential toxicities to the cell lines were compared, it 
appears that SCC-9 was more sensitive to both drugs, and SK-LU-1 more 
resistant. This is seen in the table below where the approximate ICgg 
values for both drugs are summarized.
Table 4.4.4 Approximate relative IC^q S of Navelbine and
Vinblastine for some human cell lines determined 
by AP activity
cell line (all human) Vinblastine Navelbine
oinOH (nM)
lung squamous carcinomas
SK-MES-1 2 . 2 6.4
DLKP 2.7 CN
DLRP 2 . 7 6.4
lung adenocarcinoma
SK-LU-1 9.9 »  2 0 . 0
non-lung carcinomas
RPMI-2650 1 . 6 6.4
SCC-9 1.9 3.2
Broadly the assays agree on the extent of toxicity, although some 
differences exist. With RPMI-2650, the SEM values were much lower 
for the MTT and AP assays than for IA. Analysis of all the dose 
response curves produced for each of the cell lines with the various 
assays, shows broadly similar results for each of the assays. Repeat 
assays qualified this further. Figures 4.4.1 and 4.4.2 are typical 
examples of the results obtained.
In conclusion, the miniaturized endpoints assessed would form a 
suitable part of a prescreening programme for establishment of 
efficacy of new drugs, and for ranking their toxicity alongside other 
clinically proven drugs.
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4.5 Rapid assessment of Multiple Drug Resistance
Multiple Drug Resistance (MDR) of tumours is a clinically important 
phenomenon, the adverse effects of which could be diminished in some 
cases by alteration in drug therapy choice if early detection of the 
phenomenon was possible. Here too, the availability of a simple, 
rapid, sensitive method for assessment of MDR is of importance. Such 
methods can be investigated in the laboratory by assessing their 
ability to detect drug sensitivity in cell lines with increased 
resistance to specific chemotherapeutic drugs.
This section describes how the AP assay performs as a new alternative 
to rapid assessment of MDR, and compares it to the performance of MTT, 
NR, SRB and DE.
Variant cell lines were cultured in growth medium with Adriamycin, as
described in section 2.36. 96 well plates were seeded 24 hours before3 3drug addition at densities of 4 x 10 cells/ well (3 x 10 / well for
the parent line, due to a higher doubling rate). Cells were exposed to
various concentrations of the drugs Adriamycin, Vinblastine,
5-Fluorouracil and Cis-Platinum. After 6 days continuous exposure, an
AP assay was carried out and IC^q values were obtained from dose/
response curves for all of the drugs. They are presented in the table
below.
Table 4.5.1 Approximate IC^q 's of 4 drugs to DLKP and 2
variant cell lines under the conditions described
Cell line
Drug (^ /M)
Adriamycin Vinblastine Cis-Platin 5-Fluorour.
DLKP 2/ug/ml 7,600 ± 
1 , 0 0 0
25 ± 
1
900 ± 
30
8.5 ± 
3.0
DLKP 1/jg/ml 13,000 ± 
500
67 ± 
2
155 ± 
20
44 ± 
1 2
DLKP 750 ± 
50
0.275 ± 
0 . 0 2
640 ± 
15
15 ± 
8
Table 4.5.1 shows that the variant cell lines are at least 10- fold 
resistant to Adriamycin and almost 100- fold resistant to Vinblastine. 
There is significant variation in resistance of the three cell lines 
to Cis Platinum and 5-Fluorouracil, but these differences show no 
particular trend. Thus the cross resistance pattern can be seen for 
the Vinca Alkaloid, Vinblastine, as well as the drug for which it was 
selected against, but cross resistance has not included drugs with 
mechanisms of action like that of Cis Platinum and 5-Fluorouracil.
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While the assay can easily detect the significant difference between 
the parent and variant cell lines, it does not detect the increased 
resistance of the variant cultured in 2/jg/ml Adriamycin over that 
cultured in l/jg/ml (7,600 or 13,000 /jM respectively).
To determine if this was applicable only to the AP assay, the same 
experiment was carried out on the other colorimetric assays; MTT, 
CVDE, NR and SRB. The dose-response curves from these experiments 
are given in the following pages (Figure 4.5.1 - 4.5.6) for each of 
the 4 drugs.
It was speculated that the problem with the AP2h assay identified in 
the table above might be due to insensitivity, as the OD was in fact 
quite low; so the APNaOH assay, with its much increased sensitivity 
was performed. We can see by comparing Figures 4.5.1 and 4.5.2 that, 
while the result with the parent cell line is still the same, we can 
now detect the increased resistance of DLKP2 over DLKP1 for both the 
relevant drugs (Adriamycin and Vinblastine). Thus it appears that as 
expected, the problem was due to low sensitivity, since this is the 
only difference between the two procedures.
Let us now consider the other assays, and investigate if the problem 
recurred elsewhere.
Using the MTT assay, Figure 4.5.3 demonstrates that again upon 
exposure to Adriamycin and Vinblastine, the parent cell line, DLKP, 
is much more sensitive to drug than are the variants, DLKP1 and 
DLKP2. In the case of the antimetabolite 5-Fluorouracil, and for 
Cis-platinum, there is however, no difference in drug sensitivity, 
that is, the variants have not spontaneously aquired resistance to 
these drugs as has occured with Vinblastine. While the MTT assay, 
like the AP2h assay, is clearly able to demonstrate the difference in 
sensitivity between parent and variant cell lines, it is less well 
able to do so among the variants themselves. From the figure, it 
would appear that DLKP2 is slightly more resistant to Adriamycin and 
Vinblastine than the variant selected in the lower concentration of 
drug- DLKP1, however the error bars from SEM values are quite large in 
many cases; much more significant in fact than either the AP2h or 
APNaOH assays.
Figure 4.5.5, which illustrates the results obtained by the CVDE assay 
shows the same ability of the assay for detecting the much greater 
sensitivity of the parent line over the variants. Here however, a 
slight increase in the resistance of DLKP2 has been detected over 
DLKP1 for Vinblastine, and a substantial difference for Adriamycin.
The same has been reported for the effect of Vinblastine on the
variants in the NR assay (Figure 4.5.4), while no difference is
perceived between the two lines when the Adriamycin graph is studied.
DLKP, the cell line used for these studies, was chosen not for its 
growth characteristics, but because it was the only cell line adapted 
for growth in higher concentrations of Adriamycin which was available
for use at the time of this work. In fact, the cell line has an
undesirable characteristic for screening work of this type; as many of 
the cells attach only loosely to the substratum, and some in fact grow 
in suspension.
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Figure  4.5.1:
A s s e s s m e n t  of  Multiple Drug R e s i s t a n c e  in DLKP ( a ) a n d  2 v a r i a n t s  
o f  t h i s  l ine c u l t u r e d  in 1 /ug./ml ( • )  a n d  2  / u g / m l  ( o )  Adr i amyc in  
using the AP2h assay
(For  clari ty ,  e rro r  b a r s  shown only on one s ide  of eitch plo t)
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fM  VINBLASTINE
Figure  4.5.3:
Assessm ent of Multiple Drug Resistance in DLKP (a )  and 2 variants 
of this line cultured in 1 /¿g/m l ( • )  and 2 fig/ml (o )  Adriamycin 
u s in g  th e  MTT a s s a y
( F o r  clarity , e r r o r  b a r s  s h o w n  only on one s id e  o f  e a c h  plot)
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f iU  VINBLASTINE
CIS-PLATINUM
Figure 4.5.4:
A s s e s s m e n t  o f  Mult ip l e  Drug R e s i s t a n c e  in DLKP ( a )  a n d  2  v a r i a n t s  
of  th i s  l ine c u l t u r e d  in 1 yu.g/ml ( • )  a n d  2  ¿ ¿ g / m l  ( O )  A d r i a m y c i n  
u s i n g  the  NR a s s a y
(For clarity,  error  b a r s  shown only on one s ide  of e ach  plot)
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fiU  C IS—PLATINUM
Figure 4.5.5:
Assessm ent of Multiple Drug Resistance in DLKP ( a ) and 2 variants 
of this line cultured in 1 /¿g/m l ( • )  and. 2 /xg/ml (o )  Adriamycin 
u s in g  th e  CVDE a s s a y .
(For c la rity , e rro r  b a r s  shown only on one aide  of e a c h  p lot).
2 4 0
mM 5-FLU0R0URAC1L
Figure 4 .5 .6:
Assessment of  Multiple Drug Resistance m DLKP (&) and Z variants  
of  this l ine cultured in 1 M g / m l  ( • )  a n d  2 ¿tg/rnl ( o )  Adriamycin 
using the SRB assa y
(Tor clarity, error bars shown only on one side of each plot}.
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The TCA addition step of the SRB assay, described and discussed in 
section 3.8.5, was thought to have been an advantage when assaying 
loosely adherent cell lines such as DLKP, so similar, or slightly 
better results (in terms of precision/ accuracy) would have been
expected with this assay. In fact it is surprising to note the very
high SEM values and low OD results. A practical explanation for this
may be that the plates were fixed as usual, and stored dry for a
number of days in the dark before staining took place. Perhaps the
assay is not suitable for storing and later analysis, as has been
suggested (Skehan et al., 1990). The low OD readings and the high
standard deviations for DLKP1 in the Vinblastine graph rendered the 
results unacceptable, so they have been omitted from the graph
(Figure 5.4.6). The assay was not able to detect the higher
resistance to drug of DLKP2 over DLKP1, and had unacceptably high SEM 
values for all of the drugs tested.
In summary, there was a problem with low precision of the SRB assay 
and low sensitivity, which should not be the case, according to 
results in earlier sections. This may have been due to storage of the 
plates after fixing and before staining, as there was little time to 
perform this task at the appropriate time (due to attention being 
given to the other assays); perhaps this should not be done in future. 
The AP2h assay was insensitive to the growth of the variant cell lines 
(which grow slower than the parent line) and was not able to 
distinguish the difference in drug sensitivity between the two, but 
this was not a problem when NaOH was added to increase sensitivity. 
With both procedures, SEM values were lower than for the other 
assays, giving more precise results. Precision was more of a problem 
with MTT, NR and CVDE assays.
Slight differences in sensitivity resulting in the correct rank order 
of resistance of the two variants was given by APNaOH, CVDE and NR 
assays, however given the greater precision and simplicity of the 
APNaOH assay, this was preferred for use as a convenient and rapid 
screen for detecting cross resistance patterns and assessing the level 
of resistance of selected variants.
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RESULTS 3:
PRIMARY CULTURE OF BRONCHIAL TUMOURS
5 Primary culture of bronchial tumours
5.1 Collection and culture of samples
Eighty four samples were collected and processed during the course of 
this project. Of these samples, 82 were from the thoracic region, the 
other two were accessory skin samples. One was a normal lung biopsy. 
Of the prospective tumour samples received, 25.9% were bronchoscopy 
scrapings, 29.5% were mediastynal nodes, 21% were lobectomies and 
7.4% were pleural effusions. Blebectomies or other lung biopsies 
constituted 7.5% of samples, and the remaining 8 .6% were oesophageal 
samples (4.9%), or thoracic, non-lung samples (3.7%). This
breakdown is shown in Table 5.1.
Table 5.1 Breakdown of total number of samples cultured
SAMPLE TYPE NUMBER
Bronchoscopies (Bronc) 2 1
Mediastynoscopies (Med) 24
Lobectomies (Lob) 18
Blebectomies (Biop) 1
Other Lung Biopsies (Biop) 5
Pleural Effusions (PE) 6
Oesophageal (Oes) 3
Other Non-Lung, thoracic 3
Normal Lung 1
Normal Skin 2
TOTAL NUMBER 84
Bronchoscopy samples were obtained when the surgeon used a fibre optic 
bronchoscope to remove tiny scraps of tissue from the bronchus. 
Biopsies of mediastynal nodes gave rise to mediastynoscopy samples. 
Both are the result of investigative surgery to determine the presence 
of malignant tissue. These samples together with those from other 
operations such as removal of a lobe (lobectomy) or bleb of the lung 
(blebectomy) were the samples most often obtained.
5.2 Growth of sample subsets in culture
The extent of growth from each of these samples is summarised in Table 
5.2.1. 'Growth' is broken down into: growth of fibroblast cells
only; initial attachment of epithelial cells, but no further growth; 
and differing degrees of successful epithelial growth. For 37% of 
samples cultured, there was no cell attachment or growth whatsoever. 
For a further 29.6%, there was no epithelial cell growth - only growth 
of fibroblasts. The number of samples for which epithelial cell 
attachment occured, but no further growth took place was 16.1%. This 
leaves us with only 17.3% of samples for which some degree of 
epithelial cell proliferation took place. 7.4% of samples had initial 
limited growth, while a further 6 .2 % resulted in significiant growth 
and proliferation. In 3.7% of samples, extensive epithelial cell
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growth occured and was maintained for a period of at least a number of 
weeks in culture. However none of the cultures proliferated to such 
an extent or for long enough to produce a permanent cell line.
Table 5.2.1 Growth of thoracic samples in culture
NG Fib Att I Sig Ext CL
30 24 13 6 5 3 0
Table 5.2.2 Success of sample in culture according to sample
origin
Bronc Med Lob Biop PE Oes Other
NG 9 7 7 3 3 - 2
Fib 6 7 7 2 - 2 -
Att 5 6 - 1 - - -
I 1 - 1 - 3 1 -
Sig - 4 1 - - - -
Ext - - 2 - - 1 -
CL - - - - - - -
2 1 24 18 6 6 4 2
Where:
NG = No cell attachment or growth
Fib = No attachment or growth of epithelial cells - 
fibroblast growth only 
Att = Attachment of epithelial cells, but no subsequent 
growth
I = Initial epithelial growth 
Sig = Significant epithelial growth 
Ext = Extensive epithelial growth 
CL = Permanent cell line established
Table 5.2.2 categorizes sample growth performance in culture, with 
respect to the origin of the sample. 95.2% of bronchoscopy samples 
did not produce any cell growth in culture, and the remainder only 
gave initial growth - i.e. growth sustained for a few days only. With 
the mediastynoscopy samples, a huge proportion again did not give any 
epithelial cell growth - this time 83.3%. The remaining 16.7% though, 
grew significantly for at least 10 days. Excluding the lobectomies, 
none of the other biopsy samples effected any epithelial cell growth.
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Of a total of 18 lobectomy samples, 77.7% did not result in any 
epithelial cell growth. Of the 22.2% that did, 5.5% produced 
significiant growth, and another 1 1 % produced extensive epithelial 
growth, for a number of weeks. This status was achieved also by 
16.7% of the pleural fluid samples processed, accompanied by a further 
33.3% giving initial growth; the remainder had no growth or 
attachment. Of the remaining subset of samples showing even limited 
success in culture, the oesophageal samples behaved quite well. 25% 
did afford extensive epithelial growth; another 25% grew initially but 
did not continue, and the remaining 50% were unsuccessful.
In essence, growth from bronchoscopy samples was extremely poor. This 
was only slightly better for mediastynoscopy samples. Lobectomy 
samples, pleural fluids and oesophageal samples were the most 
successful in culture.
Teasing this out further we can make some observations from the sample
quality and relate this back to growth in culture.
5.3 Sample Quality
The general appearance of each sample was noted before culture. Some 
samples were just too small to produce an adequate number of cells for 
the culture to 'take off'. Some were severely necrotic or heavily 
bloodstained. These samples generally did not produce epithelial
growth. It appears that visually 'poor' samples behaved worse in
culture than visually 'good' samples.
Out of a total of 25 samples which were characterized as:
* necrotic,
* presence of numerous blood vessels, or
* composed of significant amounts of adipose or cartilage tissue,
23 resulted in no epithelial attachment due either to absence of 
sufficient epithelial cells, or inhibition of attachment due to 
settling out of blood cells and cell debris. One of these 25 samples 
exhibited initial attachment but no further growth of epithelial 
cells, while a single sample displayed some epithelial growth which 
was very limited.
5.4 Success of various processing methods
Table 5.4 Epithelial growth from solid tissue:
Analysis of effective methods of processing
Number of 
samples..
Explants Enzymatic Dissection
medium
Collection
medium
set up 13 8 1 1 5
success 7 6 1 0 4
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Note Is number of ways a sample was processed was dependent on sample 
size and texture
Note 2: some samples developed cell growth in more than one of the 
categories above
Table 5.4 shows the frequency of success (represented by epithelial 
growth or attachment) for each of the different methods from the total 
of 22 samples that grew (to any extent). It must be appreciated that
the sample size and quality dictated the method(s) which could be used
(refer to section 2 ); it was not possible to set up a fragment of the 
sample for each of these methods. Thus it is not appropriate to 
calculate success rates for each of the methods based on the above 
figures.
5.5 Collection medium as a source of cells
If the sample was particularly friable (prone to dissociate easily
into smaller particles) and tiny fragments had detached from the main 
specimen, then this collection medium (CM) was used as an additional 
source of cells. The medium was agitated repeatedly in the universal 
to dislodge as many fragments as possible from the main specimen. If 
heavily bloodstained, it was then necessary to spin the suspension on 
a Ficoll gradient after rinsing in PBS. Although epithelial growth
did result from this fraction in a number of cases, most often, 
resilient blood cells remained to contaminate the culture.
5.6 Explant growth
Only in the case of samples which were easily dissected did explants 
prove to be successful. In other words, samples which were stringy 
and difficult to cleave, or which did not produce cleanly cut edges
were not successful and thus were not routinely set up by this
procedure. Explants from such samples did not attach very well. 
Generally it appeared that the smaller the explant, the better chance 
it had of attaching and of remaining attached to the growth surface; 
thus the greater the chance of growth occuring from these explants. 
Unless several explants in the flask resulted in outgrowth, the 
culture was unlikely to be a success. Growth from an isolated 
explant, even if extensive, led to localised confluency (if, for 
example, the leading edge was near the edge of the flask, or near
other unproductive explants, growth would thus be confined). Then the 
cells in the middle of the outgrowth would begin to senesce. In these 
cases, passaging did nothing to alleviate the situation as the cells 
were difficult to trypsinize, and did not respond well to replating 
(often necessarily at too low a cell density). Additionally, during 
this procedure fibroblasts would be removed and re-seeded, quickly
benefitting from the rearrangement in location and permeating the 
monolayer of epithelial growth. Photograph 5.6 shows epithelial 
outgrowth from a lung tumour explant.
246
Photograph 5.6s Epithelial cell outgrowth from a lung primary 
culture (x 100). Note that cells are small and tightly packed. These 
cells were very slow to grow.
5.7 Dissection medium as a source of cells
The medium in the petri-dish, in which the dissection took place was 
termed the 'dissection medium' and was often found to be rich in 
cells. Particularly in the case of friable tumours, and with large 
(usually lobectomy) samples, cutting of the tumour to produce 
fragments suitable for explants or for ezymatic disaggregation, 
yielded a medium abundant in tiny clumps of epithelial cells. These 
clumps were more successful at attaching and growing than were single 
cells (Photograph 5.7). Also, damage to the cells was minimized as 
they were not exposed to enzyme treatment.
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Photograph 5.7: Epithelial colonies arising from clumps of cells
isolated from 'dissection medium'. Note absence of fibroblasts at this 
stage (4 days in culture; magnification x 100).
5.8 Enzymatic disaggregation
Frequently the fragments were not disaggregated at the end of a 2 - 3 
hour incubation with Collaganase/ Dispase. Further incubation with 
enzyme did little to improve disaggregation, but instead caused 
disintegration of the cells which had been released. Sometimes the 
suspension formed a slimy mass (indicating DNA damage) even though the 
bulk of the tissue pieces remained un-disaggregated. In an effort to 
improve this performance, the sample pieces were dissected into pieces 
as small as possible, however the results did not improve.
Because clumps of epithelial cells performed exceptionally better in 
culture than did single cells, it was attemped to design 
disaggregation practices to isolate epithelial clumps from the 
suspension in preference to single cells.
Cultures derived from enzymatic disaggregation characteristically had 
a greater problem with fibroblast growth in the culture. Initiation 
of fibroblast overgrowth was much more rapid after enzymatic treatment 
than was the case with cultures derived from the other procedures.
5.9 Blood cells and cell debris
Excessive numbers of blood cells in the cell suspension or extensive 
debris (resulting from dissociation of necrotic tissue) resulted in a 
film forming on the culture surface. This film either prevented cell 
attachment, or, if cells had already attached, it coated the cells 
and fixed upon them. Rinsing with PBS was ineffective at removing 
much of this film, and consequent deterioration of the culture 
occured. Cells became grainy and vacuolated, stopped growing and 
then died (see photograph 5.7).
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Photograph 5.9: Cells isolated from a malignant pleural effusion
after 8 weeks in culture. Cell cytoplasm has expanded dramatically, 
become vacuolated, darkened and granular as the cells terminally 
differentiate (magnification x 1 0 0 ).
While centrifugation of the cell suspension with Ficoll generally 
pelleted the erythrocytes, leucocytes and lymphocytes tended to 
appear together with the epithelial cells, and thus remained in the 
culture.
Figure 5.11 (b) shows that a similar number of epithelial cells in 2 
different cell suspensions prepared from the same specimen, result in 
differing amounts of growth. Suspension *, which was isolated from 
the collection medium (see section 2.41) contained much more blood 
cells and cell debris than the other cell suspension (a purer cell 
suspension isolated from the dissection medium (DM) which had been 
rinsed several times), and subsequently resulted in less growth. This 
would appear to enforce the constantly observed phenomenon that blood 
cell contamination inhibited the attachment and growth of epithelial 
cells.
5.10 Fate of epithelial cultures
Table 5.10 shows the manner in which the epithelial cultures were 
lost.
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Table 5.10 Fate of epithelial cultures
Differentiation
\senescence
Fibroblast
overgrowth
Both diff. and 
fibroblasts
Fungal
contamination
5 12 4 1
54.5% perished exclusively due to overgrowth by fibroblasts, even 
though extensive efforts were made to rescue the epithelial cell 
population, both by treatment with Trypsin/ EDTA at room temperature, 
and by exposure to Geneticin. However in 18.2% of cases, the 
cultures stopped growing and fibroblasts, which had not been 
prevalent, then took over the culture. Thus, in total, fibroblast 
overgrowth was involved in the demise of 72.7% of cultures.
The second most common reason for failure of the culture was 
differentiation. The cells, bright and irregular in profile, began 
to flatten out more, become much darker and become vacuolated. With 
this change in appearence, the growth rate decreased and cells 
stopped dividing. No longer could mitotic cells, bright and slightly 
detatched from the surface, be seen. The cells appeared very 
granular. Some cultures developed cells with grossly enlarged 
cytoplasm, which contained multiple nuclei. In these cells fibres
stretching from the nucleus out to the cell membrane could be seen. In
some samples, as the cells darkened they seemed to compact together, 
as the nucleus and cytoplasm began to shrink. They would then shrivel 
up, before they finally detatched from the surface.
This phenomenon occured independently in 22.7% of epithelial cultures 
and, accompanied by fibroblast overgrowth, resulted in loss of the 
culture in a further 18.2% of cases.
Microbial contamination was usually not a significant problem, as, 
generally the sample was immediately placed in a universal of culture 
medium containing antibiotics and fungizone. However, occasionally 
delays were incurred while the specimen was dissected from the 
complete biopsy; or was not placed immediately into the sterile
collection vessel. In culture, some samples, which did not attach or
grow, had evidence of bacterial contamination. One epithelial 
culture had low level fungal contamination, which was not controlled 
by fungizone, and it eventually spoiled the culture.
5.11 Effect of cell density on culture proliferation
In the case of 3 samples, a sufficient number of cells were obtained 
to support investigations into cell seeding density. Cells from the 
primary cell suspension were seeded directly into 24 well cluster 
dishes and the extent of growth assessed by image analysis after 7 
days in culture (photograph 5.11). The results from this work are 
represented in Figures 5.11 (a) - 5.11 (c) As the experiments
represent growth of cells directly from the primary cell suspension,
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it must be appreciated that the high SEM value arises from the 
presence of clumps, for which it was not always possible to obtain a 
single cell suspension without damaging the cells.
CRYSTAL VIOLET STAINING
J.L. PRIMARY EPITHELIAL COLONIES 
EFFECT OF PLATING DIFFERENT CELL DENSITIES
Photograph 5.11: Effect of different cell seeding densities on
establishment of a lung primary culture.
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CELL SEEDING DENSITY /  2 4  w e ll ( x  1 0 ,0 0 0 )
F igu re  5.11 (a)
* *  f r o m  CM; o t h e r s  f r o m  DM.
Figure 5.11 (b)
F i g u r e s  5 .11  (a )  — (c):
E f fec t  of cell seeding density on e s ta b l i sh m en t  of 
(a) a n d  (b) lung prim ary  tu m o u r  cu l tu re s  and 
(c) a lung f ibroblast  culture.
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Figure 5.11 (a) shows that a marked increase in growth is obtained
when the cell seeding density is increased from 1 x 1 0  ^ cells/ well to
2.5 x 10^ cells/ well. Densities below 1 x 10^ cells/ well do not 
result in significant cell growth.
Figure 5.11 (b) also illustrates the importance of an adequate seeding
density in a sample from a different patient. Two different cell
suspensions were prepared for this experiment; suspension * was
isolated from the collection medium and contained many blood cells and
cell debris, whilst the remaining cells were isolated from the
dissection medium and gave a 'cleaner' cell suspension. We note that
two vastly different amounts of growth were obtained from plating a
silmilar number of cells isolated at the two different stages, so we
gather from this that the procedure used for cell isolation is
extremely important in determining the potential growth of the cells,
and also that the purity of the cell suspension (and lack of
contaminating blood cells and cell debris) is important in encouraging
cell growth. As in the previous experiment, the Figure shows a
similarly extended increase when the cell loading is increased from 5 4 4x 10 to 7.5 x 10 cells/ well. Above this seeding density, the 
increase in growth is less marked. Doubling the starting density from 
1  x 1 0  ^ to 2 x 1 0  ^ cells per well gives no significant difference in 
cell growth, so the maximum benificial cell loading has been reached 
at between 7.5 x 104 and 1 x 105 cells per well.
The third graph, Figure 5.11 (c), shows the effect of cell seeding
density on a lung fibroblast culture (passage 1 ), in combination with 
the effect of high and moderate serum levels. Doubling the serum 
concentration to 1 0 % results in an approximately linear increase in 
stimulation for different cell loadings. Increasing the cell density 
from 100 to 500 cells gives an expected increase in growth 
performance. Doubling the cell density from 5 x 10^ to 1 x 10^ cells/ 
well however, results in a corresponding increase in growth which is 
much more than double. It is obvious that the Fibroblast culture is 
less density dependant than the epithelial cultures, as significant 
growth was apparent at a seeding density of only 500 cells/ well.
5.12 Effect of basal media on culture growth
This variable was briefly investigated and some results are shown in 
Figure 5.12 (a) and 5.12 (b). In graph 5.12 (a), a mixture of Hams 
F12 and DMEM (1:1), which was routinely used in this laboratory, 
encouraged less attachment and initial growth than did some of the 
other media tested. MEM and Hams F12 (1:1) gave significantly better 
growth. Again the large variations among replicates are attributed to 
the presence of clumps (since this was a primary cell suspension).
It was observed however that each of the media, or combinations of 
media tested differentially encouraged epithelial or fibroblast growth 
to some extent. MEM/Hams F12 encouraged best epithelial growth, with 
relatively fewer fibroblasts, and Hams F12 alone also encouraged more 
epithelial than fibroblastic cell growth. At the other end of the 
scale, RPMI-1640 promoted mostly fibroblastic growth. The remaining 
media (MEM, DMEM/Hams F12 and DMEM) resulted in mixtures of the two 
cell types (with relatively few epithelial cell colonies in total).
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Figure 5.12 (b) shows that Hams F12 alone (in the presence of a 
of Newborn Foetal Calf Serum (NBCS)) promoted significantly 
growth than did a mixture (1:1) of DMEM and Hams F12. With the 
serum batch this is less obvious, but still apparent.
batch
less
other
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Figures  5.12 (a) a n d  (b):
Effect of different b a s a l  m ed ia  on e s ta b l i sh m en t  
of two pr im ary  lung tu m o u r  cultures .
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5.13 Effect of different serum batches on culture growth
In addition to Figure 5.12 (c), Figures 5.13 (a) through to 5.13.4 
demonstrate the huge variation in growth that different batches of 
serum can provide. This is particularly obvious in Figure 5.13 (a)
where batch 10F Foetal Calf Serum (FCS) promotes 5 times more growth 
than do batches 15FCS and 10F6182 NBCS, while it promotes 
approximately 33 times more growth than does NuFCS.
This huge stimulatory effect of batch 10F FCS is less marked in two 
separate experiments with cells from another patient (experiment shown 
in Figure 5.13 (b) is a preliminary test, that shown in Figure 5.13.3 
is a more extensive test from the same patient), however the poor 
performance of batch NuFCS is also noted for this patient's cells. 
This may be due to the presence of some growth inhibitor(s) in this 
serum batch. In the extended experiment (Figures 5.13.3), at the 
lower serum concentrations of 2% and 5% slightly lower growth is again 
observed with batch 701 FCS than was observed with the majority of
batches. Batches such as 10f6182 NBCS and 10G1676 FCS were also
identified to be poor batches. As a result of this work, half of the
culture stocks from this patient were changed from the general
laboratory serum batch (15 FCS) to batch 30F7079 NBCS, however all 
stocks (then in culture for 4 weeks) soon began to terminally 
differentiate and eventually died off. This was a significant finding 
because the 30F7079 NBCS was much cheaper than the FCS batches.
For many of the serum batches, augmenting the concentration to 10% 
resulted in substantial stimulation over growth at 2% or 5%, so this 
was some encouragement for continuing to use the higher serum 
concentration for routine work, which was already the general 
practice.
The experiment represented in Figure 5.13.2 was prepared from a
primary cell suspension which was quite unhomogeneous due to 
accompanying blood cells and tiny tissue clumps from which the cells 
had been expelled (by enzyme treatment); thus the SEM values are 
particularly high. However, we still observe considerable variation
in growth stimulation distinctly arising from different batches of 
serum. Yet again, Nu FCS was a relatively poor batch, but for batches 
10G2368, 30F7075 and 10Q4280 (all NBCS), the performance was even
worse.
A total of 12 batches of serum were tested on the tumour sample in 
Figure 5.13.4. The range of growth induced by the different batches 
was quite remarkable. Batch 33 (DHS) was the worst of this group 
tested, generating less than one quarter the extent of growth as that 
seen with batch 41 (FCS). Some of this patient's autologous serum was 
also tested, and while this promoted good growth, perhaps 
surprisingly it was not the best of all the batches tested.
Because the dynamics of serum batch testing in this laboratory (which 
dictated the batches of serum available for testing) were no match for 
the intermittant and disjointed appearence of a suitable sample for
these tests, unfortunately the same batches were not always available 
to test on successive cultures. However, what the results clearly
illustrate, is the benefit of carrying out a screening test to choose 
an appropriate batch of serum, as the effect of this parameter on 
culture growth has been shown to be of great significance.
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Unfortunately also, this work could not be followed up because of the 
lack of appropriate samples (large, non-necrotic) available for 
investigation, and, after an attempt was exerted to obtain 
appropriate samples from many different sites, lack of time.
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Figure 5.13 (b)
SERUM BATCH
F i g u r e s  5 . 1 3  ( a )  a n d  (b ) :
E f f e c t  of  d i f f e r e n t  s e r u m  b a t c h e s  (10%  in  m e d i u m )  
o n  e s t a b l i s h m e n t  of tw o  lu n g  t u m o u r  p r i m a r y  c u l t u r e s
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F i g u r e s  5 . 1 3 . 2  — 5 . 1 3 . 4 :
Effect of se ru m  b a tc h  var ia t ion  on growth of a  lung 
pr im ary  tu m o u r  (5 .13.4) and  cells from  a m a lig n a n t  
p leu ra l  e ffusion (5 .13 .2  and  5.13.3).
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5 .14 Effect of Growth Factors on culture growth
In the same sample as referred to above, there were sufficient cells 
to allow preliminary investigation into the effect of some growth 
factors on the growth of the culture. Figure 5.14 demonstrates the 
results. Growth resulting from a growth factor cocktail (Transferrin 
(T), Insulin (I), EGF (E), Selenium (S), and Hydrocortisone (H) to
batch 25FCS did not result in a significant increase in growth, 
however addition of H alone gave a very significant increase (x2) in 
growth.
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F i g u r e  5 . 1 4 SERUM /  GROWTH FACTOR COMBINATION
F ig u r e  5 .14:
Effect of some growth fa c to r s  on establ ishm ent 
of a lung tum our pr im ary  culture.
Where: T.= 5 /¿g /m l Transferr in  
I. =  1 ¿¿g/ml Insulin 
E .=  1 0 n g /m l  EGF 
S .=  1 x 10- 8  M Selenium 
H = 0.4 /j,g /m l Hydrocortisone
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5.15 Significance of fibroblast growth
Table 5.10 has already established the importance of fibroblast
overgrowth in epithelial cultures, where more than half of the
cultures were finally overcome by fibroblast growth. The fibroblasts 
grew much more quickly than did the epithelial cells, and so were able 
to overcome the culture in a very short time. When this happened they 
spread on top of the epithelial colonies and overwhelmed them. They 
metabolized the medium very rapidly and were quite unfastidious in 
their growth requirements. They could readily 'take off' from single 
cells or small isolated associations of cells (they did not form 
colonies, but aspired to form regular monolayer formations 
continually). They generally grew in 'sheets' across the culture 
(Photograph 5.15 (a)) and growth from even a relatively small initial 
number was extremely fast. If unchecked, the culture could be 
completely overcome by these cells in only a few days. Their
morphology, in contrast to epithelial cells, are illustrated in
Photograph 5.15 (b).
Photograph 5.15 (a): 'Sheet'—like culture-morphology of fibroblasts
isolated from a primary lung tumour (magnification x 1 0 0 ).
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Photograph 5.15 (b)s Mixed culture of epithelial (e) and fibroblast 
cells (f) from a thoracic primary culture. This culture was soon 
overcome by fibroblast growth despite removal of fibroblasts with 
0.04% EDTA/ 0.01% Trypsin (magnification x 100).
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Throughout the life of each of the cultures, fibroblasts were 
targeted for removal or distruction respectively, by either exposure 
to Trypsin /EDTA, or Geneticin. Although limited success was 
achieved periodically, eventually the number of epithelial colonies 
were outnumbered by the fibroblast monolayer. Photographs 5.15 (a)
shows a primary culture which is being overcome by fibroblasts.
5.15.1 Treatment with Trypsin and EDTA
A number of variations on the use of Trypsin/ EDTA solutions were 
attempted. Three such alternatives and their relative degree of 
success are outlined below.
Table 5.15.1 Fibroblast removal by Trypsin and EDTA
Procedure Temperature Time 
(mins)
Success Rating
0.02% EDTA R.T. 5 poor
0.02% EDTA, followed R.T. 5
by 0.02% EDTA + 
0.01% Trypsin 37°C 5
poor
0.04% EDTA +
0.01% Trypsin o
0CM 1 0 moderate
Previous work in this laboratory with primary skin carcinomas (S. Me 
Donnell, unpublished thesis, 1987) had determined the first two 
methods outlined in the table to be of use. This work however, showed 
that no differential effect was achieved as regards removal of 
fibroblasts without disturbing epithelial cells or vice versa; all of 
the cells became unattached simultaneously. This may be due to 
inherent differences between the different tissue types, the 
epithelial cells from the skin cultures attaching more tightly to the 
substrata than the lung epithelial cells. This will be considered 
more fully in the general discussion.
In further attempts to separate the two cell types, the cell 
suspension was added to a culture flask and the rate of attachment was 
observed. While it typically appeared that the fibroblasts tended to 
attach more quickly than the epithelial cells, any attempts to remove 
the remaining unattached cells and replate them did not meet with 
success. There was always a sufficient proportion of fibroblasts 
remaining to ensure an adequate seeding density for subsequent 
overgrowth in the new flask. Endeavours to separate the two cell 
types using cell separation media (as described in Materials and 
Methods) were unsuccessful. Even a small number of contaminating 
fibroblasts was usually enough to cause overgrowth in the culture once 
again.
The latter of the three methods shown in the table above, seemed to 
give better results. Trypsin/ EDTA solution at refrigerator 
temperature (2°C) and checking the culture very frequently under the 
microscope, a differential removal effect was often seen. Typically 
the fibroblasts disattached first. The spindle morphology of the 
fibroblast was readily attacked by the Trypsin/ EDTA solution and the
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polar regions of the cell could be readily seen to peel-off. Often 
the fibroblast monolayer would remain in a remarkably intact sheet. 
The epithelial cells, were generally slower to detach.
The success of this method, however, was dependent on the 
arrangement of the fibroblasts and epithelial cells in culture. If 
the epithelial cells appeared in tight colonies with 'sheets' of 
fibroblasts on the extremities of the colony, then the method would 
be more likely to remove the fibroblasts and leave the epithelial 
colonies intact. If on the other hand, the epithelial cells appeared 
as single, tiny colonies, or loose associations of fibroblasts and 
epithelial cells, then the method was less likely to remove
fibroblasts without also removing the epithelial cells.
5.15.2 Treatment with Geneticin
In the latter case, treatment with Geneticin was preferred. Previous 
work in this laboratory (S. Me Donnell, 1987; unpublished thesis) 
indicated highly successful differential toxicity to fibroblasts 
versus established epithelial cell lines at a concentration of
100/jg/ml Geneticin in culture medium for 2 days, however; this 
method was found to be largely unsuccessful in this work where primary 
epithelial cell cultures, rather than established lines were used. 
Fibroblasts still remained after the 2 day incubation period and then 
had to be removed with 0.02% EDTA or 0.04% EDTA/ 0.01% Trypsin. Thus 
the problem still remained. Thus it seemed pertinent to carry out 
Geneticin toxicity studies with primary and secondary fibroblast 
cultures.
Figures 5.15.2 (a) to 5.15.2 (d) show toxicity of some different
cultures (A - F) of lung fibroblasts (passage 2 - 3) to different 
concentrations of Geniticin for different periods of time. The dose/ 
response relationship is clear, and is also clearly related to time of 
exposure. Generally, 200 to 250pg/ml Geneticin for 3 days was 
sufficient to kill 80 to 100% of fibroblasts. Concentrations and 
exposure times less than this resulted in correspondingly less cell 
kill, but the magnitude varied among the different cultures.
Plates were not easily read by IA due to the diffuse growth 
characteristics, so CV dye was eluted from the 24 well dishes and read 
as in the CVDE assay.
The variation in efficacy of Geneticin is seen in Figure 5.15.2 (d) as 
shown in 6 different lung fibroblast cultures (passage 3). thus it is 
obvious that a single concentration of Geneticin for a specific 
exposure period may not be universally used on every cell culture. 
Further work with epithelial samples alone, and then combinations of 
epithelial and fibroblast cells should suggest a range of 
concentrations/ times which are most appropriate for eliciting 
differential toxicity to fibroblasts.
265
Figure 5.15.2 (a)
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DISCUSSION
6 .1 In vitro toxicity testing
The relevance of in vitro tests in screening programmes, and the need 
for their continued development and validation has by now been 
accepted. This has come from exhaustive interest and research into 
this area in the last 10 years. Many new in vitro methods have been 
developed since then, including the NR assay developed in the 
Rockefeller institute for the Revlon cosmetic company. Many other 
methods have been extensively validated against animal studies and 
against in-vitro tests already established. In selecting a system for 
use as an in vitro toxicity test, one must question very closely the 
characteristics which must be expressed for evaluation of the toxic 
insult. If the effect of differentiated functions is to be measured, 
then the system chosen must clearly express these differentiated 
functions in the absence of the test chemical. If a chemical is 
preferentially toxic to the liver, then the tissue used should be 
liver. Additionally, there is little point in developing a model 
system involving the use of a tissue that is not sensitive to the test 
chemical. Thus one must chose a system (and of course a relevant 
endpoint) which is capable of detecting the desired effect, whether it 
be carcinogenicity, mutagenicity, teratogenicity, irritancy, 
modification of a particular organ function, or more broadly, 
cytotoxicity. In essence, for most studies, some knowledge of the 
mechanism of action and the target organ toxicity is preferred before 
embarking on a toxicity testing schedule. In attempting to elucidate 
the mechanism of action of chemicals, both in vivo and in vitro tests 
have been of use in the past.
6.2 Use of cell cultures for cytotoxicity testing
For general cytotoxicity screening, cell cultures (both established 
and freshly isolated cells) have been widely used. Cells used have 
been from very many species, from different tissues, and from 
histologically different cell types. While the complexity of 
biochemical functions evident in organ cultures may not be evident in 
cell cultures, the relative simplicity involved in using cell 
cultures together with the much improved reproducibility, offer 
important advantages over other more complex in vitro systems. An 
important impetus to using animal cell cultures as opposed to other 
commonly used toxicity testing systems such as algae, spermatozoa,
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and invertebrate tests, is the possibiltity of using human derived 
material, which diminishes the uncertainty of extrapolation from 
other species back to humans. This uncertainty, when extrapolating 
results from other mammals such as rats and mice to potential effects 
in humans, has already been introduced, and encompasses general 
biological differences as well as differences in biotransformation 
abilities. These differences in biotransformation abilities have been 
described [Sipes and Gandolfi, 1986] as quantitative or qualitative; 
the former resulting from differences in enzyme levels or natural 
inhibitors which might adjust the balance of reverse enzyme reactions 
or the extent of competing reactions, thought to be restricted to 
phase I reactions; while the latter are apparently related to phase II 
reactions. Variability in phase I reactions are explained by 
differences in profiles of cytcohrome P-450 isoenzymes, while those 
in phase II reactions are associated with defective enzymes in certain 
species, unique species reactions and other evolutionary developments. 
Quantitative variations are more apparent and result from differences 
in the animals' ability to synthesize and (or) activate the cofactor, 
transferase and conjugating agent involved, and from differences in 
the nature of the xenobi-otic itself.
To illustrate this point, some differences in a number of 
bioactivation reactions from different species are shown in the table 
below, which has been modified [Sipes and Gandolfi, 1986] from Jakoby 
[1980].
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Table 6.2 Species defects in xenobiotic metabolism
Reaction Defective species
Aliphatic amine N- hydroxylation 
Arylacetamide N- hydroxylation 
Arylamine N- acétylation 
Glucuronidation 
Sulfation
Hippuric acid formation 
Mercapturic acid formation
Rat, marmoset 
Guinea pig 
Dog
Cat, lion, lynx, Gunn rat
Pig, opossum, brachymorphic 
mice
African fruit bat 
Guinea pig
From this we must appreciate that considerable differences may exist 
in the biotransformation abilities among different species of mammals, 
which may result in a metabolite more or less toxic than that formed 
in humans. If such variability exists among mammals, even more 
variation would be expected when invertebrates are compared to 
mammals, and more specifically to humans.
6.3 Selection of cell type for cytotoxicity testing
The number and diversity of tissues or cell types which can now be 
successfully cultured is most extensive, and the choice of tissue 
will to some extent be dictated by what is available to the 
investigator. Cell banks such as the American Type Culture Collection 
(ATCC) supply an extensive range of established cell lines from 
different species, including a large number of human tumour cell 
lines, and cells from a large variety of tissues.
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Selection of a target cell line for cytotoxicity evaluation from a 
range of different tissues may appear a daunting task. Although the 
growth characteristics of the cell line will have to be considered 
(e.g., monolayer culture or suspension culture, rapid doubling time, 
high cloning efficiency etc.,) cells from the organ/ tissue which is 
most sensitive to the chemical should be chosen. All human cells have 
similar basal functions [Ekwall, 1983] but organ-specific functions 
which vary among different cell types may be necessary for certain 
studies, so a cell line expressing these functions may be selected 
with this in mind. In areas where little is known of the mechanism of 
action of the test chemical, it may be prudent to use two cell lines 
of differing cell type, e.g., fibroblasts and hepatocytes. It may be 
of some assurance to the investigator in such a dilemma, that in work 
by Babich et al. , [1987], the rank order of sensitivity of the
chemicals to the cell lines remained the same, even though differences 
in sensitivity of cell lines from different tissues were apparent in 
the cytotoxicity testing of a number of polycyclic aromatic 
hydrocarbons.
6.4 In vitro biotransformation of xenobiotics
One of the biggest problems with using cell cultures as opposed to 
intact organisms or organs is the loss of biotransformation ability 
when cells are cultured. Although some cell lines have been reported 
to maintain some mixed function oxidase and other enzyme activity, in 
general this faculty deteriorates quickly during culture. Some 
established cell lines reported to have functional drug metabolizing 
activity are A-549 [Wibel et al. , 1980], alveolar type II cells
[Devereux and Fouts, 1980] and NCI-H322 and NCI-H358 [Falzon et al., 
1986]. Primary hepatocytes have been reported to retain their drug 
metabolizing activity for limited periods. Acosta et al., [1978] have
maintained differentiated liver functions for as long as 20 days and 
Gomes-Lechon et. al., [1988] have found the use of hepatocytes
maintained in culture (as opposed to isolated hepatocytes) to be a 
good model for cytotoxicity testing, as they can allow the design of 
experiments with longer xenobiotic exposure times. However, it has 
long been known that the cytochrome P-450 content of liver-derived
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cell cultures can be quite different from that of liver in vivo, and 
cautions have been given with respect to extrapolations between these 
two systems [Owens and Nebert, 1975].
Other methods of addressing the problem of biotransformation when 
using such metabolically incompetent cell lines are as follows:
* Prior induction of cell lines to augment enzyme levels before drug 
exposure (chemicals such as 5-6-bensoflavone, phénobarbital, 
benz(a)anthracene or pregnenolone-16a-carbonitrile have been used for 
this purpose [Swierenga et al. , 1983])
* Addition of crude tissue (usually liver) homogenate, supernatant 
from centrifugation of crude homogenate (S-9 fraction), or a 
microsomal preparation consisting of S-9, NADPH and glucose- 6  
phosphate.
- obviously the metabolic properties of these various subcellular 
systems will not be identical; loss of soluble glutathione 
transferases, sulfotransferases and cofactors are evident with the 
microsomal preparation [Dipple and Bigger, 1983]
Problems with toxicity in the absence of the test chemical have been 
encountered when using microsomal preparations, and thus exposure 
times with addition of S-9 are short (often in the order of 3 to 5 
hours) whereas comparative experiments using freshly isolated or 
cryopreserved hepatocytes have used exposure times up to 2 days 
[Swierega, et al., 1983]. It is imperative therefore to use the
necessary and relevant controls for experiments including microsomal 
preparations.
* Co-culturing the target cells with cells of greater drug 
metabolizing ability, often hepatocytes [Langenbach et al., 1978].
Comparison of toxicological data among laboratories even where a 
broadly similar activating system has been used, must be carried out 
with caution. Differences in species, genetic strain, age, weight, 
sex, diet and nutritional status of the animal used to prepare the
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microsomal preparation, all serve to introduce variability into the 
performance of the preparation, and thus may alter results quite 
significantly. In fact significant inter-individual variability of 
activity and induction of cytochrome P-450 and UDP-glucuronosyl 
transferases has been identified [J.P Cano 1990, personal 
communication] in human liver microsomes and primary cultures of human 
hepatocytes. Whether or not the animal has been induced prior to 
isolation of the tissue for its microsomal fraction, and the actual 
inducing agent involved, can measurably affect the results obtained.
Inducing agents may be drugs, chemicals or natural compounds such as 
ethanol. The most widely studied are phénobarbital and the polycyclic 
aromatic hydrocarbons (benzo(a)pyrene and 3-methylcholanthrene). 
Although it was first thought that it was only the cytochrome P-450 
dependent monooxygenases which could be induced, it is now known that 
certain conjugating enzymes can also be induced [Sipes and Gandolfi, 
1986]. Although the enzymes or isoenzymes induced by different 
chemicals may be similar, the morphologic and biochemical effects in 
the liver can be different. Thus the choice of an inducer for 
biotransformation is another variable which must be taken into 
account; it may be that the one chosen for use does not affect a 
particular reaction, so this must not be presumed for any inducer. 
This is clearly exemplified when some characteristics of phénobarbital 
and polycyclic hydrocarbons are compared in the table below.
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phénobarbital and polycyclic aromatic hydrocarbons
Table 6.4 Characteristics of some hepatic effects of
Characteristic Phénobarbital Polycyclic
hydrocarbons
Onset of effects 8 - 1 2  hours 3 - 6  hours
Time of maximum effect 3 - 5  days 24 - 48 hours
Persistance of induction 5 - 7  days 5 - 1 2  days
Liver enlargement marked none
Protein synthesis marked increase small increase
Enzyme components:
Cytochrome P-450 increase no effect
Cytochrome P-488 no effect increase
NADPH-cytochrome-c reductase increase no effect
Substrate specificity:
N-demethylation increase no effect
Reductive dehalogenation increase no effect
Glutathione conjugation small increase small increase
Cytosolic receptor none identified identified
modified from Sipes and Gandolfi [1986].
Other major classes of inducing agents include halogenated pesticides 
(DDT, aldrin, hexachlorobenzene, robenzene, lindane, chordane); 
polychlorinated and polybrominated biphenyls; steroids and related 
compounds and chlorinated dioxins (2 ,3,7,8-tetrachlorodibenzo-p-dioxin
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(TCDD)). Some of these produce a spectum of induction similar to 
phenobarbital or the polycyclic aromatic hydrocarbons, whereas some 
induce the synthesis of other forms of cytochrome P-450.
Use of different concentrations of S-9 fraction in the S-9 mix, and 
different co-factors, may also result in qualitative as well as 
quantitative differents in results, so this should also be given 
careful consideration.
It would appear, therefore that an investigator should choose the 
cells and culture system with due consideration of the variabilities 
discussed, optimize the conditions if necessary, and stick to this 
standard procedure as tightly as possible in subsequent and 
comparative work.
6.5 Choice of end point for cytotoxicity testing
This then brings us to discuss the choice of endpoint for the 
cytotoxicity system.
Many different end points were considered in the opening section of 
this thesis. While there will be advantages and disadvantages to any 
endpoint, and in theory some end points are more applicable to certain 
types of experiments, there are often severe technical disadvantages 
which preclude their use.
Measurement of a very specific or differentiated cell function or 
pathway may be used to assess the effect of xenobiotics on cells. 
Certain cellular functions affected by the chemical may not cause 
manifestation of cell death [Gomez-Lechon et al., 1988]. However the
relevance of these sort of effects must be questioned for the 
particular investigation involved; most often it is only the direct 
cytotoxic effects on the cells which it is necessary to measure. 
Generally then, such effects will ultimately be manifested in 
cellular death; and in cytotoxicity determinations, the most commonly 
used measure of toxicity is impairement of cell growth.
In determination of impairment of cell growth a distinction must be 
made between cytostatic and cytotoxic effects. Cytostatic effects may 
only affect the growth rate of the cell, or may reversibly damage the
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cell, resulting in only a temporary impairment of cell growth. 
Cytotoxic effects on the other hand result in irreversible damage to 
the cell. The question of the ability of different assays to 
distinguish between these effects and its relevance will be addressed 
later.
How can we measure cell growth? Cell growth is an increase in biomass 
(cell number x mean cell mass) and can be achieved by an increase in 
either of these individual components. In practice, regulatory 
factors keep the cell mass within strongly defined limits, so 
'growth' mainly refers to proliferation; i.e., an increase in cell 
number. To measure inhibition of growth induced by cytotoxic agents, 
we can use methods of direct cell counting by haemocytometer. 
Electronic particle counters are not able to distinguish between 
viable and non-viable cells, and are thus of no value in this sort of 
assessment. Dye exclusion and inclusion methods can be used to 
distinguish viable from non-viable cells, so these methods [Bhuyan et 
al., 1976; Funa et al., 1986; Hartman and Riech, 1989; Weisenthal
et al., 1983a; Detta and Hitchcock, 1990] have been incorporated
with haemocytometer and flow cytometer measurements. These and other 
methods (e.g., cytoplasmic leakage of radiolabelled molecules and 
enzymes) are based on detection of membrane integrity, and thus may 
not always be true indicators of cell viability.
Many methods have been used for measurement of cellular viability, but 
the critical parameter in relation to cell viability, is retention of 
the replicative potential of a cell. Viable cells have the ability to 
self propagate, whereas dead cells have lost this ability. Thus if we 
place cells in an environment conducive to cell replication, and they 
form colonies, then there can be no doubt as to their viability. 
However this method is not without theoretical problems, as conditions 
may not always be optimal for cellular colony formation, and so 
absence of colonies after re-growth might be due to this factor, and 
not in fact to loss of viability. In cytotoxicity testing, use of a 
relevant control can overcome this problem and so colony formation 
efficiency has been widely used for cytotoxicity testing, particularly 
for chemosensitivity testing. On closer scrutiny of assays for 
clonogenicity, there appear to be a number of problems. Problems with
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low plating efficiencies [Hill and Wheelan, 1983; Selby et al., 1983], 
unsuitability of some tumour types [Von Hoff et al., 1981, Selby et
al., 1983], clumping of cells (leading to false negative results)
[Agrez et al., 1982; Rockwell, 1984], requirement of large numbers of 
cells, long assay duration (typically 14 - 21 days), extensive time 
taken to evaluate the result (manual microscopic counting); all 
served to reduce the applicability of the assay.
Other measures of growth such as measurement of synthesis of cellular 
macromolecules (protein, DNA, RNA) and amino acids have been used as 
end points for cellular survival but these assays are generally 
tedious to carry out and many involve the use of radioisotopes which 
has associated hazards. In cytotoxicity screening programmes, the 
requirements for an appropriate end points are as follows:
* fast
* reliable
* accurate
* sensitive
* simple
* requiring only small numbers of cells, and amounts of 
reagents
* non hazardous
* applicable to a wide range of cell types
* not dependent on obtaining a single cell suspension
* technically easy to quantitate
Many if not all of these requirements are met by semi-automated, 
miniaturized, colorimetric assays. Some of these methods have been 
used for toxicity testing to a greater extent than others. The MTT 
assay for example [Mossman, 1983], and the Neutral Red assay 
[Borenfreund and Puerner, 1984] have been widely used for 
cytotoxological studies, however, there have been few studies 
comparing the characteristics of these different assays and their 
potential applicability to different situations.
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This work aimed to carry out an extensive study of 5 of such assays, 
in an attempt to distinguish any differences in their performance and 
perhaps in their relevance for some current and potential 
applications.
6 . 6 Image analysis as a method for growth analysis
Computerized analysis of stained cells is becoming more prominent in 
determination of growth and cytotoxicity. Baker et al., [1986] and
Rotman et al., [1989] have successfully used computerized image
processing to determine cellular viability and cell kill. Some 
techniques are now able to assess damage to individual cells [Tillmann 
et al. , 1989]. In using image analysers to such an end it is possible 
to obtain readings for cell number and colony area. It is important 
that the most relevant of these parameters be used for the 
investigation. It is possible that cell and colony size will be 
altered when grown under different conditions, and when exposed to 
different drugs and mitogens; Jabbar et al., [1989] for example,
found that cell size increased in cultures treated with interferon. 
Thus in comparing colony size from test wells to control wells, 
erroneous results may be obtained. Good resolution may not be obtained 
if colonies are very close together or partially joined - certainly 
this was a problem with the instrument (AMS 40-10) used in this work, 
but other more sophisticated (and expensive) models are available. 
Other technical problems encountered when using this instrument 
included inability to properly analyse some cell lines, a critical 
requirement for evenly spread (and evenly stained) cultures, and 
problems when using the same settings for a range of growth. An 
additional disadvantage to this method is that relatively large 
numbers of cells are required, as assays are carried out in 24 well 
dishes.
In comparison to miniaturized, semiautomated, colorimetric assays, 
Image Analysis does not compare favourably as a method for 
quantification of cell growth, particularly if cell lines are to be 
tested which do not form tight, discrete colonies, if available cell 
number is low, if ranges of cell growth are to be analysed, and if the 
laboratory is to be equipped with only basic or low cost 
instrumentation.
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6.7 Optimization of the MTT assay
Since its development in a miniaturized, semiautomated form, the MTT 
assay has been very widely used, not only for chemosensitivity 
testing but for other areas of cytotoxicity testing as well as growth 
studies (e.g., growth factor stimulation [Nakanishi et al. , 1988]).
Section 3.2.1 described the optimization of the assay for use with 
RPMI-2650 and Hep-2 cell lines. Use of DMSO [Plumb and Freshney, 
1989, personal communication] was found superior to acid - isopropanol 
the solvent used in the original paper [Mossman, 1983], and this 
finding agreed with that reported by Alley et al., [1986]. Addition
of acid isopropanol resulted in the formation of a dense precipitate, 
even after medium removal, and this was felt to be caused by acid 
denaturation of residual serum proteins from the medium. This did not 
occur when DMSO was used as a solvent. Carmichael et al., [1987] found
use of mineral oil also acceptable as a solvent, but in comparative 
experiments, Twentyman and Luscombe [1987] preferred DMSO to either 
acid propanol or mineral oil, and reported that even the 1 0 -2 0pl of 
medium remaining per well greatly impeded solubilization of formazan 
when using the latter two solvents.
Optimal concentration of MTT (2 0/j 1 / well) for use was found to be 
between 4 and 5 mg/ml for RPMI-2650, and between 3 and 7 mg/ml for 
Hep-2 (section 3.2.1.2) so 20/j1 of 5mg/ml MTT was selected for routine 
use (0 .lmg/well); this concentration has been widely found to be 
optimal for many cell lines [Twentyman and Luscombe, 1987; Edmonson 
et al., 1988; Scudiero et al., 1988; and others].
Differences of opinion as to the stability of MTT stock solution is 
evident in the literature. Many investigators use freshly prepared 
and filtered MTT stock [Leprince et al.,, 1989], but other
investigators have found it acceptable to use stocks which have not 
been freshly prepared. Pieters et al., [1988] used frozen (-20°C)
stock; Green et al., [1984] reported stability of the stock solution 
at 4°C in a darkened tube for at least several days, while under these 
conditions it was considered acceptable for use when stored for a 
maximum of 3 weeks [Ford et al., 1989], 1 month [Alley et al., 1988;
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Mickisch, 1990], 'more than a month' [Tada et al . , 1986]; 1 -lJj
months [Kotnik and Fleischmann, 1990 and at least 6 weeks [Twentyman 
and Luscombe, 1987].
The ability to store the solution for some length of time would be an 
advantage, as preparation of this solution, and filtering through a 
0.45^m filter immediately prior to use, introduces an extra measure 
of cumberence to the procedure. This is particularly so because the 
compound is mutagenic, and thus requires special handling procedures. 
The results of an experiment described in this thesis show no 
significant loss in activity after 8 weeks storage of the solution at 
4°C in the dark (Figure 3.2.1 (c)).
6 . 8  Relationship of cell number with OD in MTT assay
Succinate dehydrogenase, an enzyme involved in MTT reduction to
formazan, is part of the Trichloroacetic cycle, where it catalyses the 
oxidation of succinate to fumarate. Its reducible coenzyme FAD 
functions as a hydrogen acceptor in this reaction [Lenninger, 1970]. 
The reduced enzyme can then donate electrons to various artificial 
electron acceptors, e.g., tetrazolium salts and other reducible 
dyes, whereupon they undergo a change in their absorbtion spectrum 
(MTT changes from yellow to purple). The reaction involved in 
conversion of MTT tetrazolium salt to formazan can be seen in appendix 
C. Tetrazolium salts have long been used to quantitate cellular 
reductive capacity (Vistica et al., 1991] and to approximate cell
growth.
The Figures shown in 3.2.2, illustrate a linear relationship of cell 
number and MTT reduction (OD at 570nm), for every cell line tested 
under different culture conditions (1 and 4 days growth), the range 
of which varies for the different graphs. Similar relationships have 
been shown by many other workers for many cell lines [Mossman, 1983; 
Green et al., 1984; Gerlier and Thomasset, 1986; Carmichael et al.,
1987; Edmonson et al., 1988; Romijin et al., 1988; Me Hale and Me 
Hale, 1988; Campling et al., 1988,]. The most significant work on
this area [Alley et al., 1988] (as part of the NCI feasability
assessment for preclinical screening of anticancer drugs) demonstrated 
suitable colorimetric profiles of cell number and OD, for 30 lung cell 
lines and 76 lines from other sources. Linear relationships of cell
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number and OD have also been shown for primary cell suspensions of 
tumour cells [Pieters et al., 1988; Sargent and Taylor; 1989,
Shimoyama et al., 1989; Twentyman et al., 1989; Mickisch et al., 
1990; Wilson et al., 1990; Campling et al., 1991],
Sensitivity has also varied greatly among cell lines. Such 
differences in extent of linearity and sensitivity among cell lines, 
have been obtained in much of the work referenced above. Ford et al., 
[1989] reported that the individual variation around the ability of 
cell lines to metabolize MTT can be considerable, and in this work, a 
non-linear relationship of cell number and OD was obtained for some 
cell lines (while the relationship was linear with a uridine 
incorporation assay).
In comparing the performance of the assay for NRK and Hep-2 cells, we 
see that there has been greater sensitivity for NRK, but a shorter 
linear range. This observation has not been limited to MTT, but is 
seen for each of the other assays. In considering why this may be so, 
we must examine the growth characteristics of the different cell 
lines.
The relationship of cell number and OD, which determines differences 
in linearity and sensitivity, is obviously related to growth. Cells 
actively growing will reduce the MTT to a greater extent than cells 
which are not. This has been shown by Mossman [1983] and others. In a 
recent investigation of selected parameters affecting formazan 
production, prompted by differences in MTT reduction among cell lines 
[Vistica et al., 1991], MTT reduction in cell lines was found to
correlate with the D-glucose content of the medium. MTT reduction in 
cells lines which metabolized D-glucose extensively (SN12K1, HOP 62, 
and HT 29; with doubling times of 18, 29 and 32 hours respectively)
was more extensive than in other cell lines.
Differences in growth characteristics (e.g., contact inhibition of 
cells such as NRK) as well as inherent differences in activity of MTT 
reducing enzymes among cell lines will also lead to differences in 
sensitivity of the assay. This may be due to differences in enzyme 
levels among cell lines, and/ or differences in the specific activity 
of such enzymes.
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Overall the linear range of the assay was considerable, but the 
sensitivity of the assay was felt to be quite low, and particularly so 
for some cell lines (e.g., RPMI-2650). While in general, workers
report good sensitivity of this assay, there have also been reports of 
low sensitivity [Carmichael et al. , 1978, Alley et al., 1988; Ford
et al., 1989], and there have been some recommendations that the assay 
be further optimized and modified to increase sensitivity. Alley et 
al [1988] identified a number of cell lines (several fibroblasts and 
certain Small Cell Lung Carcinomas) for which he considered the assay 
to be relatively insensitive. In some cases low sensitivity has been 
attributed to technical difficulties (e.g., cell and formazan crystal 
loss during washing and aspiration) [Ford et al., 1989],
The results from this work showed clearly that that the assay suffered 
from low sensitivity which must be greatly improved if it is to be of 
widespread use in cytotoxicity testing. This may be brought about by 
increased incubation time, as found beneficial in some work - Alley et 
al. , [1988] used incubation times up to 8 hours for problem cell lines
with some improvement in sensitivity. Use of a reference wavelength 
of 690nm, rather than the 620 nm filter used here and in other work
[Twentyman and Luscombe, 1987], has been reported to increase
sensitivity [Denizot and Lang, 1986]. Exclusive use of
spectrophotometric grades of DMSO has been reported to produce stable 
'background' absorbance levels for up to 2 hours following solvent 
application, whereas use of nonspectrophotometric DMSO preparations 
or DMSO preexposed to air are accompanied by ever-increasing levels of 
'background' absorbance [Alley et al., 1988], and will thus lessen
sensitivity. The wavelength used for colour quantification has 
varied, and while 570nm, (the filter used in this work) has been
found acceptable by other workers [Wilson et al., 1990], the
absorbtion maximum for MTT in DMSO is at 553nm (570nm in acid -
isopropanol); so, although many workers resort to using the nearest 
fixed filter available, (as was the case in this work), it may be 
necessary if not critical, in the light of this low sensitivity, to 
use the specific filter for the appropriate solvent being used.
The sensitivity of the MTT/SDS assay was found to be extremely poor, 
much worse in fact than the usual method. This is contrary to that 
described by others [Tada et al., 1986; Eliason et al., 1990], who
found similar sensitivity for the method using SDS as the solvent. In
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such work, cell numbers (KB-8-5 cells; MDR cervical carcinoma) less 
than 1 0 0 / well were capable of being detected, even when the 
wavelength used was 540nm [Eliason et al. , 1990] (when the optimum for 
SDS was shown to be 570nm [Tada et al., 1986]). It is possible that 
this significant discrepancy in sensitivity may be explained by 
technical errors involved in this work; however all critical points 
(such as critical pH depencence for dissolving formazan and 
maintaining colour) were addressed and followed. It is unlikely that 
this huge difference in sensitivity can be accounted for by 
differential MTT reduction among cell lines (between the cell lines 
used in the published work, and those used here). Other workers, such 
as Nikis and Otto [1990] reported low solubilizing power and colour 
stability using this method, and their results indicated poor 
sensitivity, similar to that reported here.
Due to the poor sensitivity of the MTT assay determined by this work, 
in future work it is recommended that the factors discussed here which 
may effect improvement in assay sensitivity, are considered and 
adopted if found useful.
6.9 Technical problems of the MTT assay and applicability
to different cell lines
Some of the work published in the last 4 years has reported
significant technical difficulties with the assay. Many of them 
relate to the use of acid - isopropanol as a solvent. Some 
investigators (Ford et al., 1989, for example) observed fewer
difficulties when they switched to using DMSO. Nikis and Otto [1990] 
have recognised the need (experienced in this work) for optimizing the 
MTT assay. They recount technical problems with formazan
solubilization, and compare various modifications made by different 
workers. DMF-SDS solubilization buffer (Hanson et al., 1989] was 
found to be superior to other buffers, but it was laborious, as
manual mixing or overnight incubation is required to achieve complete 
solubilization. Sonication has been suggested as a measure to relieve 
this.
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Other difficulties are low optical densities, and thus low
sensitivity. Investigators using a washing step report the loss of 
cells and formazan crystals (this step also increases the time 
involved for the assay), but if no such step is involved, residual 
medium can interfere with the absorbtion spectrum of MTT in DMSO and 
cause a drift in it. Therefore complete removal of residual medium is 
preferred. The procedure used in most of the work described, is to
invert and 'flick' the plate, to assist rapid medium removal. This
eliminates the need for medium removal with a pipette and is a time
and labour saving step, however, it was found throughout the duration
of this work that such a step resulted in loss of formazan crystals. 
Use of an automatic platewasher did not relieve this situation. Some
papers report the need for 'careful' removal of medium, but on the
whole, the difficulty has not been extensively aired. I feel that 
this is a significant technical difficulty with the assay, and one 
which needs to be addressed if the assay is to be improved.
Other reported difficulties are primarily related to 'problem cell 
lines'; those producing low MTT reduction and giving particularly low 
sensitivity [Alley et al., 1988], and floating cell lines. Although
centrifugation is used to prevent cell loss, it is still considered a 
problem. Practical experience of flicking plates with non-adherent 
cells to effect medium removal in this work, even after
centrifugation (and use of poly-lysine coated plates), was still a
problem after careful formazan removal with a pipette, and resulted in 
extensive cell and formazan loss.
Difficulties due to chemical reduction of MTT by chemicals present in 
the medium; or reduction by contaminating microorganisms has also been 
reported.
Overall the assay has been reported to be useful for growth 
determinations on many, many cell lines [Alley et al., 1988 has shown 
its suitability for 106 cell lines; others have shown this for other 
lines]. Cells not determined as suitable (due to low sensitivity) 
have been mostly floating cell lines (Small Cell Lung Carcinomas), but 
also some fibroblasts.
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6.10 Relationship between cell number and OD in CVDE assay
In optimizing cell densities for L-M cells in a bioassay for Tumor
Necrosis Factor, Kramer and Carver [1986] showed resultant OD values
4 4over a short range of cell densities (3 x 10 to 6 x 10 cells/well) 
which was linear under some conditions (M199/0.5% Peeptone) and non 
linear under different conditions (EMEM/5% FBS). Work by Bonnekoh et 
al., [1989] illustrated the increased uptake of CV from a cell
culture, with time, but did not specifically measure the relationship 
between cell number and dye uptake. Indeed many other workers have 
used this method for growth related assays, but few have examined this 
relationship.
The relationship between cell number and crystal violet uptake shown 
in Figures 3.4.2 (a) - (m) for the panel of cell lines used in this 
study, was again found to be linear at least over some part of the 
range of cell numbers tested for every cell line. At high cell 
densities, the relationship deviated from linearity substantially 
(see graphs 3.4.2 (j) and 3.4.2 (k)), while the relationship remained 
linear for other assays at these cell numbers (see e.g., graph 3.7.2 
(1)). As with each of the other assays, the linearity and sensitivity 
of the assay varied among cell lines.
In an extensive study by Skehen et al., [1990] comparing 21 dyes for
quantitative assessment of cell number, 13 were found to be 
acceptable for this use; Crystal Violet was not one of them. It, 
along with azure C, Coomassie brilliant blue, ethidium bromide, 
methyl green, naphthol yellow S, propidium iodide and pyronin B, 
either stained cells too lightly to be useful or stained different 
cells with widely varying intensity. In another comparative study of 
a number of dyes, Scragg and Ferreira [1991] compared the sensitivity 
of 4 dyes to fibroblast cells, and found Comassie brilliant blue to be 
the least sensitive, followed by Methylene blue, Crystal violet and 
Toluidine blue. Loss of linearity at 8 x 10^ cells/ 96 well was found 
with CV and Toluidine blue. Comassie blue was found preferable 
because of its moderate sensitivity, increased linearity, and low 
interexperimental variation relative to the other methods. The 
staining intensity observed here was found to be much improved over
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the MTT, AP2h and NR assays, and variations in activity among cell 
lines was found to be no worse in the CVDE assay, than for these 
assays.
Kueng et al., [1989] found a linear correlation of cell number and OD
3 . . .for the CVDE assay with sensitivity to < 2 x 10 cells. Sensitivity
decreased when the pH of the dye solution was decreased from pH 6
downwards. This figure correlates well with figures obtained in this
work, where 2 x 10^ SCC-9 cells were detected, 1 x 10^ Hep-2, SK-MES-1
and RPMI-2650 cells were detected, and as few as 500 NRK and DLKP
cells were detected. Kueng and colleagues found a significant
decrease in OD when cells were not dried prior to staining - wet cells
took up less dye than dried cells.
6.11 Technical problems of the CVDE assay and applicability to a 
range of cell lines
No significant technical problems were encountered with the assay- it 
was simple to perform, and it was equally applicable to all of the 
cell lines tested.
6.12 Relationship between cell number and OD in the NR assay
The NR assay, semiautomated and miniaturized by Borenfreund and
Puerner [1984] is based on the incorporation, by lysosomes in living 
mammalian cells, of this supravital dye [Zhang et al., 1990]. Dead 
cells however, have been stained (albeit more diffusely) by NR
[Allison and Young, 1973; Dingle and Barnett; 1969; Hammond et al., 
1980] so an unequivocal relationship with cellular viability should 
not be assumed. Hammond and colleagues however, have found the method 
to be 'at least' as sensitive a measure of cell viability as trypan 
blue.
Figures 3.5.2 (a) - (p) illustrate the relationship between increasing 
cell number and OD for 7 cell lines; some under the different culture
conditions of 1 and 4 days growth. For some part of the graph at
least, there is a linear relationship between NR uptake and cell 
number. Like the other assays discussed, the extent of linearity and 
sensitivity differs among cell lines, and this is summarized in Tables
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3.5.3 and 3.5.4. Linear relationships similar to this have been shown 
by other workers for different cell lines; 3T3 mouse fibroblasts
[Borenfreund and Puerner; 1984], colonic cancer lines (HT29 and EC), 
human renal carcinoma (GYL), pancreatic cancer (GER), breast cancer
(MDA 157) [Fiennes et al., 1987], and human and rat hepatocytes
[Zhang et al., 1990].
Fiennes et al., [1987] observed differences in the relationship of
cell number and NR activity among the cell lines tested, and some 
deviations from linearity among cell lines. This is similar to what 
is reported here. SCC9 for example, after 1 days growth, did not 
show a linear relationship at the lower cell densities tested. 
Differences in sensitivity were also noted among the cell lines tested 
in Fiennes' study (tenfold in one case). This too is apparent from
the figures presented here; the assay is much more sensitive to
numbers of NRK for example, than to SK-MES-1. Explanations as to why 
this might be, have been discussed already (section 6 .8 ) in the 
context of the MTT assay.
In general the assay was much more sensitive to cell number for the 
various cell lines tested than the MTT assay or the AP2h assay, while 
it was less sensitive to cell number than the CVDE, SRB and APNaOH 
assays.
6.13 Technical problems and applicability to a range of lines
The assay had a substantial number of steps and was slightly more 
tedious to perform than the other assays, but was equally applicable 
to different cell lines.
6.14 Relationship between cell number & OD in the SRB assay
This assay was only recently developed for miniaturized quantitation 
of cell number [Skehan et al., 1990], where it was found to be
superior to 20 other dyes when tested on A-2780 ovarian, HT-20 colon 
and UO-31 renal, tumour cell lines. It was subsequently examined
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more closely with additional cell lines covering a wide variety of 
tissue types. Intense staining of cells, lack of wide differential 
staining among cell lines, and low signal-to-noise ratio, were the 
characteristics contributing to its selection. Loss of linearity at 
high cell densities described here (Figures 3.6.1 (a) - (c)), was
similarly described in the paper by Skehan. This loss of linearity 
was more pronounced for SRB than NR assay, and only slightly 
different from CV. It is explained by the high OD values obtained at 
these values, which were all greater than 1.6 OD units, and above the 
sensitivity of the platereader. Another explanation is given by 
Finlay et al. , [1984] (who used methylene blue in the same manner),
who suggests that this deviation from linearity at high cell density 
is due to a decrease in the amount of stain bound per cell, because of 
a possible decrease in size as cultures approach saturation density in 
the wells and cells accumulate in phase.
Topley et al., [1991] also found the method to be more sensitive than
methylene blue.
In this work, the SRB assay was found to be extremely sensitive - much 
more sensitive to cell number than the MTT, AP2h and NR assay, and 
somewhat more sensitive than the CVDE assay. It had similar ranges of 
linearity and sensitivity to the APNaOH assay. It was capable of 
detecting 400 Hep-2 and SK-MES-1 cells under the conditions used in 
this work, and 300 DLKP cells, compared to 5,000 DLKP cells for AP2h
and 10,000 for MTT. It is thus a highly sensitive assay for low cell
numbers. The sensitivity available with this assay appears to be be 
greater than that described in Skehans work (quantitative at 2,500
cells/ well, and semiquantitative at 1 , 0 0 0  cells/ well).
6.15 Technical problems and applicability to a range of cell
lines
The method had an equal number of steps to that of the NR assay, and 
was thus slightly more tedious than the other methods, but no 
technical difficulties were evident, and was applicable to all the 
cell lines tested.
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6.16 Relationship of cell number with AP activity
Acid phosphatases (orthophosphoric monoester phosphohydrolase) are 
ubiquitous throughout nature, where they catalyse hydrolysis of a 
variety of orthophosphate esters as well as transphosphorylation 
reactions. They are distinguishable from alkaline phosphatases, not 
only by their low pH optimum (5.5, as opposed to 8 . 8  - 9.0), but by 
differences in ability to cleave a number of substrates [Hollander, 
1971]. Four electrophoretic bands of AP activity have been separated 
[Beckman et al., 1969], and their distribution among different
tissues has been noted. In the work by Beckman it was found that 
cultured cells showed a different pattern of activity of the 4 bands 
(designated A, B, C, D), than was apparent in the original tissue. 
Also the presence in 4/7 cell cultures, of the C component, which 
was present in many foetal tissues, was suggested to represent 
dedifferentiation to a primitive state.
In assaying for acid phosphatase activity, most investigators have 
used p-nitropheny1 or a-napthyl phosphate as substrate [Hollander, 
1971] to spectrophotometrically determine the activity of the enzyme. 
The substrate used in this work was p-nitrophenyl phosphate, and the 
assay was essentially carried out as described by Connolly et al. 
[1986]. In this work, Connolly described the use of a semi-automated, 
miniaturized assay for quantitating small numbers of endothelial 
cells, and reported sensitivity to as few as 1 0 0 endothelial cells. 
No other significant work has been carried out using this method, so 
the work reported here serves as an important contribution to this 
area.
The high sensitivity of the assay, reported by Connolly, was also 
experienced in this work. Sensitivity was even greater than that 
found with the SRB assay. This was linked with a consequent lowering 
of the range of linearity of the assay, as was experienced with the 
other assays, to cell numbers of up to 20,000 for DLKP and Hep-2.
This however, meant that cell numbers greater than this were 
unevaluable when using the AP assay as described by Connolly, as it 
often resulted in a deep yellow colour, the intensity of which was 
often beyond the range of sensitivity of the microplate
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spectrophotometer. This of course was due to the addition of NaOH, 
which caused an electrophillic rearrangement in the p-nitrophenyl 
released from the substrate by AP, and caused its colour to
intensify. During the course of this work, it was found that there 
was often adequate colour present without this NaOH step, to effect a 
substantial spectrophotometric reading, so the relationship of cell 
number and OD in the standard 2 - hour AP assay without NaOH addition 
(AP2h), was investigated in section 3.7.
As was noted for the other assays, and as was established for the
APNaOH assay there was a linear response of cell number and AP
activity. Again, this was seen to vary with the cell line involved, 
in terms of lowest detectable cell number, linear range, and 
sensitivity along this linear range. The AP2h assay was not 
particularly sensitive but it gave a detectable (>0.02 OD units) 
increase in OD with every increase of 10,000 cells, and was linear up 
to high cell densities.
Extending the incubation period from the standard 2 hour time however, 
resulted in a substantial improvement in the lowest detectable cell 
number and an increase in sensitivity; activity was linear up to 5 
hours at least, for a range of cell lines (section 3.9.2). This 
assay still remained linear to high cell densities, so this 
improvement in sensitivity has not resulted in a substantial loss of 
the extensive linear range of the AP assay.
The practical significance of this, is that an experimental plate, if 
not sufficiently developed after the 2 hour incubation (this can be 
determined visually), can be re-incubated for a further number of 
hours until sufficient colour has developed. Alternatively, at the 
end of the 2 hour incubation period, NaOH can be added for greatly 
improved sensitivity. If very low cell numbers are used in the 
experiment the NaOH modification would therefore be appropriate, but 
where linearity to high cell densities is required (e.g., if high 
cell numbers are present), then the AP assay as described in this work 
may be more relevant.
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6.17 Technical problems of the AP assay, and applicability to a 
range of cell lines
No technical problems were encountered with the assay. It was simple 
to perform and involved a small number of steps. Obviously addition 
of NaOH was an extra step in the method, but even this considered the 
assay was still quick and easy to perform and it was equally 
applicable to the range of cell lines tested.
6.18 Comparison of the performance of the methods
The advantages offered by semiautomated, miniaturized, colorimetric 
assays for growth quantitation with the features of speed, simplicity, 
sensitivity, reliability, and cost - effectiveness have been widely 
publicised [Mossman, 1983; Finlay et al. , 1984; Carmichael et al.,
1987; Margis and Borojevick, 1989]. Their miniaturization means not 
only that smaller numbers of cells are needed, but that more 
replicates of expensive components such as growth factors, can be 
included. Individual methods have been shown to correlate precisely 
with cell number, as indicated in the previous sections. Correlations 
too, of cell quantitation for different applications, have been made 
with some such assays (mostly MTT and clonogenic assays, 
radioincorporation assays and dye exclusion tests) [Carmichael et al., 
1987; Carmichael et al. , 1988; Ferrari et al., 1990 and many
others], and in many of these studies good correlations have been 
achieved.
No extensive intercomparison study of these commonly-used 
semiautomated, miniaturized assays has been carried out, except for 
a study with one cell type (primary fibroblasts) where MTT, NR and 
Hexosaminidase activity were compared [Givens et al. , 1990], so the
work described in this thesis represents a reference point for further 
work in this area.
This work has established that APNaOH, the protein staining assays, 
and NR were more sensitive than MTT, although linearity for the high 
sensitivity assays is subsequently decreased. Similar findings were 
reported by Givens et al., [1990] and also by Alley et al., [1988] who
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compared MTT to a cellular protein microplate assay using methylene 
blue. The latter group found that while the protein microplate assay 
exhibited greater sensitivity to lower cell density than the MTT 
assay, the former did not accurately measure the mass of overly 
confluent wells (e.g., inocculation densities > 1250 cells/ well on 
day 8 ). In other words, they reported better linearity and poorer 
sensitivity of the MTT assay, compared to the protein stain. This 
agrees well with what was reported here when MTT was compared to CV 
and SRB. In their work, Givens et al., [1990] described the poor
sensitivity of MTT noted in this work, and reported the inability of 
the assay to detect cell number accurately below 1 0 , 0 0 0  cells/ well. 
Romijin et a1, [1988] reported that the MTT assay was superior to DNA
measurement for sensitivity and accuracy when both were used to assess 
cell number, but the converse was found by Ford et al., [1989] when
RNA synthesis was compared to MTT cleavage. In measuring numbers of 
parasites, Kiderlin and Haye [1990] found similar dose response 
relationships of cell number and DNA synthesis/ MTT, but concluded 
that the DNA synthesis assay was more sensitive at low cell densities 
and less sensitive at high cell densities.
Other tetrazolium assays have been used, but none seem to provide
better sensitivity or significant advantages over the MTT assay. INT
3 5(p-iodonitrotetrazolium violet) was linear over 1.5 x 10 to 1 x 10 
cells [Bernabei et al., 1989], but overnight reincubation was required 
to give a substantial colour for determination, indicating sensitivity 
problems yet again. Scudiero et al., [1988] found that XTT offered 
advantages over MTT in that it was water soluble and was non-toxic, 
however low sensitivity was apparent after the standard 4 hour 
incubation time used for MTT. An incubation period of 96 hours was 
needed to obtain OD values as high as those obtained in 4 hours with 
MTT, so this limited the applicability of this method.
Given the low sensitivity of the MTT assay and its technical problems 
already discussed, protein assays would seem to be more successful for 
quantification of cell number. Some work on intercomparison of a 
number of such stains has been done. Comassie brilliant blue has been
4used by Margis and Borojevic [1989] to detect 10 cells in microplate 
cultures, and by Laughton [1984] to detect fewer than 1,000 cells per
4well. Methylene blue was linear with cell numbers up to 5 x 10 in 
the hands of Finlay et al. , [1984] and sensitive to cell numbers
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around 1 , 0 0 0  cells/ well, and this method was found to be well 
correlated with thymidine incorporation for quantification of cell 
number [Absher et al. , 1991]. Skehan et al., [1990] carried out a
validation programme on 2 1  histological dyes used to quantify cell 
number and found that SRB compared favourably with several 
fluorescence assays in terms of sensitivity and was superior to those 
of both the Lowry and Bradford assays and 20 other visible dyes
(including CV). The results reported here agree with the superior 
sensitivity of the SRB assay when compared to CV and when compared to 
sensitivity indicated in the published work for other protein dyes.
Problems with loss of linearity at high cell densities, due to high OD 
readings, may occur with intensely staining protein dyes, however a 
helpful way round this was suggested by Kueng et al., [1989] who
destained such plates, and restained them with a dye solution (CV) of 
a lower pH, which was found to stain less intensely. Presumably less 
concentrated dye solution could be used either. Dilution of the dye 
from the excessively coloured test plate, or reading at a suboptimal 
wavelength has been suggested [Skehan et al. , 1990].
However, the problem with protein dyes is that they stain live and
dead cells indiscriminately, unlike MTT and similar assays which 
elicit some response from the cells, and are reported to stain only 
living, metabolically active cells.
The AP assay is a potentially better indicator of viability than
protein stains, and in this study it was found to be capable of
detecting very low cell numbers (200 DLKP cells); even lower than that 
detected by SRB. Other workers apart from Connolly et al., [1986] 
have not used the APNaOH assay and few have used the SRB assay so 
there is no previous work to compare this finding to. A method 
similar to the AP assay, using hexosaminidase (another lysosomal 
enzyme) has been used though [Landegren, 1984], and it too was found 
to be very sensitive to cell number (0.05 OD units = 800 - 6,000
cells, depending on cells). In a later study comparing this enzyme 
activity to MTT and NR [Givens et al. , 1990] the hexosaminidase assay
was consistently more sensitive to low cell number than NR or MTT, and 
this corroborates the findings reported in this work. A fluorescent 
alkaline phosphatase assay has also been used in a similar way for
293
counting cells 'in situ' [Huschtscha et al,., 1989] but it was not as
4  5sensitive as the AP assay, detecting only 10 - 5 x 10 cells/ well.
Other semiautomated fluorometric assays have been used however, and 
appear to have extremely good sensitivity to cell number. A 
fluorometric DNA assay described by Me Caffrey et al., [1988] appears
to be able to detect 100 cells/ well. A BCECF (2'-7'-biscarboxyethyl 
-5(6 )-carboxyfluorescein) assay used for quantifying cell number was 
found to be 3-fold more sensitive, >10-fold faster, and required 
1/10-1/100 the cell numbers needed for the MTT assay [Leeder et al.,
1989]. A disadvantage to this assay however, is that it required the 
use of a vacuum filtration plate for cell measurement. FDA 
(Fluoroscene Diacetate) fluorescence was linearly related to living 
cell number from < 100 cells to 100,000 cells/ well [Larsson et al.,
1990] so this too was an extremely sensitive assay. For each of these 
assays though, a fluorometric platereader is required, so this limits 
their application to some extent. The APNaOH assay, is almost as 
sensitive as these assays, and does not require the use of this 
instrument.
Another high sensitivity assay used in quantitation of cell numbers is 
the ATP-Bioluminescence assay. While it can detect cell numbers 
ranging from 250 to 485,000 cells/ ml [Sevin et al., 1988] this assay 
has not been semiautomated and miniaturized, so it does not offer the 
same advantages as any of the colorimetric assays mentioned.
In comparison of precision data for the various methods, there was 
little consistency from experiment to experiment in terms of 
identifying the extent and rank order of precision among the 
endpoints. On closer examination, it appeared that the performance 
was in some way related to the cell line tested, as different rank 
orders of assay precision were apparent for some cell lines (Figures
4.10.4 (a) - (c)). Work by the NCI has also noted differences in 
CVar's with different cell lines [Pauli et al., 1988 (b)] . SRB,
which had given low CVar values (in the region of 5%) for SK-MES-1 and 
moderately low values (c. 10%) for Hep-2, was very imprecise for
replicate wells of DLKP cells. The CVDE assay also showed a similar 
tendancy. If this trend does exist, as is indicated here, then it is 
most likely related to the morphology and growth pattern of the cell 
lines in question. DLKP, for example, expresses a subpopulation of
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cells which are loosely adherent [Law et al., in print], so the 
monolayer surface is undulated. The tendancy of cells to pile up is 
also greater for Hep2, than is for SK-MES-1, which grow in very flat 
squames - thus endpoints which involve staining the surface of the 
monolayer, might be expected to express greater variability in 
results than those relying on an intracellular mechanism. While the 
MTT is enzyme related, the product of the reaction is formed on the 
exterior of the cell (an operation more susceptable to disturbance by 
flicking and pipette manipulations in loosely adherent cells than 
those on planar surfaces). Indeed it has often obvious when 
microscopically observing cell colonies which have been stained by CV 
or SRB, how unevenly distributed the dye is on the plate.
Generally speaking the assays were quite precise, with CVar values in 
the range of 7 to 15%, however, this was significantly better or worse 
for assays on different occasions (values have reached up to 40%, 
especially for CV, SRB and less often for MTT).
Whole graph reproducibility was slightly better for NR than for 
others, followed by AP, CV, SRB and lastly MTT (the latter two 
suffered from poor reproducibility). While the same trend was shown 
for reproducibility of IC^g values determined from the whole graphs, 
the distinction among the assays was greater. NR was significantly 
better at concisely determining IC^q for Vinblastine to Hep-2 under 
the conditions specified, than were the other assays. The values 
within which the I C 50 during the 3 runs of this experiment,
represent 'middle of the range' IC50 values for all of the endpoints.
This brings to light a number of important points which should be kept 
in mind when performing toxicity assays. Firstly the reproducibility 
of the assays may be poor, and this may vary over different parts of 
the curve. In comparing the toxicity of different drugs thus, the 
range of variability which generally accompanies the graph should also 
be considered. In selecting a single value to express toxicity, a 
certain danger is inherent, in that it ignores what happens for the 
rest of the graph. Other more useful ways of expressing such data may 
be by using the Area Under the Curve method (AUC), which takes into 
account the shape of the whole relationship including the slope of the
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different regions [Park et al., 1987; Houde and Arora, 1990;
Campling et al., 1991], If the reproducibility of the IC^q value is 
well established, then it does serve as a useful index of toxicity. 
If however this factor is ignored then a misconstrued situation arises 
where the value is taken and precisely compared to other similarly 
ildefined values for other drugs, giving reportedly precise, but 
erroneous values. In these comparisons (which abound in the 
literature), neither does it happen that precision figures are taken 
into account. Frequently in the literature, IC5o values are given as 
absolute values without consideration of the variability involved. 
Indeed precision data has been blatently disregarded in much published 
work, accompanied by phrases such as 'error bars have been omitted for 
clarity [Ford et al.,; 1989]. It is felt that it would be much more 
accurate to give the (or equivalent values) as a range within
which the value most likely falls, based on reproducibility and 
precision data; for it can be seen that the range of values in which 
it falls can be very dispersed, especially if different methods are 
used to establish these values (see Figures 4.10.5 (1), (m ) ) .
It is also interesting to observe that in the two repeats of the 
Vinblastine toxicity experiment where there were significant 
differences among the dose-response graphs determined by different 
endpoints, the same rank-order has been maintained - AP and CVDE 
being the most sensitve at detecting toxicity, followed then by NR, 
SRB and lastly by MTT. This prompted further investigations into the 
possibility that there may generally be significant differences in 
ability to detect toxicity among such endpoints, and this point is 
further discussed elsewhere in this thesis.
To return to indices of expression of toxicity, it is felt that values 
describing toxicity to 70% or more of the population (e.g., IC70' 
ICgg) are too inaccurate for use in toxicity comparisons using the 
type of assays described in this thesis: firstly because sensitivity
is questionable at the low cell numbers corresponding to these values 
for many of the endpoints, and secondly because this end of the graph 
generally tails off for some time, giving a span of drug 
concentrations which could correspond to these values (this is 
probably due to the survival of one or more subpopulations of cells 
which continue to grow at increasing drug concentrations).
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In terms of speed, simplicity, ease of performance and sensitivity, 
the APNaOH assay was superior to all of the other assays tested, and 
is recommended here as the method for use for growth quantification. 
We have seen that a paradox exists in the range of available 
miniaturized, colorimetric assays for quantification of cell number; 
MTT and other similar assays are not sensitive enough, while often 
protein assays such as SRB are so sensitive as to be non-linear at 
some high test-densities. Some suggestions have been made to overcome 
this problem, but the versatility of the AP assay means that it is 
less prone to causing this problem. In situations where a range of 
cell numbers must be quantified, which exceed the linear range of the 
assay, the AP2h or extended duration assay can be used alternatively, 
as it has a longer linear range of cell number and OD.
The caveat of using this assay, however is that the precise
relationship of cell number and OD varies under different culture
conditions, so in cases where quantification of exact numbers of 
cells is important (instead of comparison of test wells to control 
wells), a standard curve of cell number and AP activity must be 
performed at the same time as the test plate, and under the exact same
conditions. This not only applies to this assay but each of the
assays considered here [Herz, 1989], as none are direct measures of 
cell number.
The NR assay however, has also performed well in the comparison 
undertaken, expressing enhanced precision and reproducibility over 
the other endpoints. It is more sensitive than the AP2h assay, but 
sometimes not terribly more sensitive, and its linear range is very 
significantly shorter than the AP2h assay. In situations where 
sensitivity to low cell numbers is not required (assays for 
stimulation, e.g., serum batch tests, growth factor assays), the NR 
assay would be very suitable. Overall these two assays represent the 
best performance under the headings outlined and are recommended to be 
more useful than the remaining endpoints.
The ability of the AP assay, and other assays, to accurately 
distinguish differences between viable and nonviable cells is an 
important question which must be properly addressed, and will now be 
considered.
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6 .19 Relationship between assay activity and condition of cell
In the work described in this thesis, the AP assay was found to 
exhibit a number of advantages over other similar assays. It was 
found to be a simple, sensitive, and versatile determinator of cell 
number. Given however, that AP activity (and activity in other 
assays) was found to vary when cells were grown under different 
conditions, it was considered important to quantify how great this 
variation could be, under differing culture conditions. When cells 
were grown at three very different cell densities resulting in 
subconfluent, confluent and superconfluent cultures, AP activity per 
cell (as well as activity per cell in the other end points) varied 
greatly among the three cultures.
There is a general difficulty, in assays of this type, to positively 
distinguish the dead cells from the live cells. Trypan blue and other 
dye exclusion assays have generally been used as an indicator of cell 
viability [Yuhas et al. , 1974; Yip and Auesperg, 1972; Hanson et al. ,
1989]; however the correlation between dye exclusion and viability 
has not always been absolute [Roper and Drewinko, 1976; Bhuyan 1976]. 
Recently-dead cells may not exclude dye, and if left in contact with 
the dye for extended periods, viable cells too will take up the dye. 
It may therefore be inaccurate to state that cells unstained with 
trypan blue are viable, all that can be said is that their membrane is 
still intact.
In order to determine the viability status of the test cells in this 
experiment, and provide a reference point from which the assay's 
ability to determine viability could be evaluated; similar numbers of 
trypan blue excluding (presumably viable) cells were plated at low 
density for clonogenicity. After colony formation had occured, it 
was possible to determine the colony forming potential of each 
culture; from which it was ascertained that there was no significant 
difference in colony forming ability (and thus numbers of viable 
cells) in the cells plated from the three cultures. It is possible 
that Trypan blue dye exclusion has wrongly estimated cell viability, 
but if this was the case, it did so to a similar extent in all three 
cultures. Thus an assay which could be used for accurately 
determining numbers of viable cells, should deliver similar readings 
for the three cultures.
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In performing the counts, it was not possible to obtain a count for 
dead cells, because any cells other than those excluding Trypan blue 
had disintegrated and were only represented by debris in the 
superconfluent cultre. According to trypan blue counts, the number 
of intact unviable cells present in each of the cultures was 
negligible, thus all of cells were 'viable' (as can best be 
determined by trypan blue). The activity per 'viable' cell was given 
for each of the assays in Table 3.11.3. It was seen that activity, or 
staining intensity was increased for all assays, except NR, in the 
confluent culture.
In fact, the only assay which fulfilled this criterion during this 
experiment, was the NR assay, which maintained a constant activity 
per cell for the three cultures. Thus this assay may be the only 
reliable indicator of viability under these conditions. All of the 
other assays had increased activity in the superconfluent culture. 
The high SEM values pertaining to this count leaves greater 
uncertainty on the values per cell in this culture, however activity 
in culture C for each of the assays (excluding NR) may have been as 
high as 10 times that experienced in cultures A and B.
The high AP activity may be related to the fact that the cells in 
culture C were starved of nutrients and in very poor condition. 
Lysosomal enzymes are involved with cell destruction and 
disintegration, so it is conceivable that cells close to death as 
these were (cells were peeling off and in very poor condition), would 
have increased activity. Indeed it has been shown by Cristofalo 
[1972] that in cultured cells, lysosomal enzyme levels often rise with 
age, and lysosomes may become more numerous. These rises may have 
some physiological importance (perhaps in removing accumulating 
aberrent proteins, as suggested by Bradley and Schmike [1975]). This 
may similarly occur with cells stressed, as in culture C.
It may be that total lysosomal enzyme levels increased under these 
conditions, or that selective induction occured, but the latter is 
less likely as there are few known instances (one example is the 
hormonal induction of rat kidney J3-glucuronidase [Dean and Barrett,
1976]). Most reported changes in lysosomal enzyme levels in tissues 
in vivo are small and quite often, as under several starvation 
regimes, total lysosomal enzyme activities per organ are unchnaged
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and so there may be little change in synthesis or degradation of 
lysosomal enzymes. In vitro however, large increases in lysosomal 
enzyme activity detected in limb bone rediments and macrophages were 
found (these tended to be accompanied by secretion of lysosomal 
enzymes into the culture medium). In macrophages, phagocytosis of 
many digestible substrates causes the induction of lysosomal enzymes 
in a concentration-dependent manner [Dean and Barrett, 1976],
The augmented activity observed in the starved culture C, may have 
been due to an increased amount of enzyme, or due to increased 
activity of the same amount of enzyme per cell. To determine this 
would necessitate further experimental work where the rate of enzyme 
activity would be measured.
Succinate dehydrogenase (involved in MTT reduction) on the other hand, 
is most active in metabolizing cells and is decreased in stationary 
phase cultures, or those in which levels of glucose in the medium are 
low [Alley et al., 1988]. Because of this it might have been
expected that activity of this enzyme per cell would have been lower 
than the activity seen in the more actively growing cultures (A and
B). An explaintaion as to why an increase was seen in the confluent
culture might be that enzyme, still active from dead cells, remained 
in the culture medium to metabolize the MTT to formazan. In the case 
of the AP assay the washing step would be likely to remove any cell 
debris (and presumably associated enzyme) but in the MTT asssay, there 
is no washing step, and the medium removal step occured after the MTT 
had been reduced, thus any active enzyme from dead cells would
contribute to the reaction, and overestimate cell viability. This 
would seem to concur with the report by Jabbar et al., [1989] in
which the MTT assay was found to overestimate the growth inhibitory 
effects of interferon, and cell survival was overestimated.
With regard to the protein stains it is evident that cell debris was 
present on the cultures, and was stained also. This may account for 
the increased intensity of staining, as such stains do not distinguish 
between live and dead cells, and cell debris (Laughton, 1984],
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NR uptake on the other hand is dependent on active uptake into 
lysosomes. Four main mechanisms of uptake of materials into lysosomes 
have been discussed by Dean and Barrett [1976]: phagocytotis
(particulate matter), pinocytosis (soluble and adsorbed matter), 
autophagy (intracellular materials), and permeation.
Many low molecular weight compounds including drugs, dyes and 
carcinogens rapidly penetrate the lysosomal membrane in uncharged 
forms and are accumulated, probably by protonation of bases and 
hydrophobic interactions [Dean and Barrett, 1976]. NR may be 
accumulated in this manner. Hammond [1980] was unable to identify 
which of these mechanisms are involved in uptake/release and transport 
of NR, but felt that it could be a combination of endocytosis and 
diffusion.
This mechanism of uptake is obviously not affected in the same manner 
as intracellular lysosomal enzyme activity is. NR is taken up 
extremely rapidly (as early as 30 seconds after exposure), and in 
macrophages has been shown to be secreted with similar kinetics to 
it's incorporation [Hammond, 1980]. Contrary to that discussed for 
AP above, NR uptake has been shown to be unaffected by the duration 
of macrophage culture prior to exposure to dye [Hammond, 1980] and 
this would concur with the results obtained in this work.
While the experimental work described here would benefit from a repeat 
to confirm these results (time did not allow this), a distinct 
difference in the activivity of the assays was shown in cultures grown 
under different conditions. Activity in the NR assay was constant in 
cells in the different conditions, but this was not the case for each 
of the other assays. Thus the use of any of the assays described in 
this thesis, other than NR, as a method of determining cell viability 
under the different culture conditions used here, would have resulted 
in erroneous results. This report agrees with some observations 
reported in the literature, discussed above. This serves to confirm 
cautions given for similar assays [Alkaline Phosphatase, Herz, 1989] 
of the possible effects of changes in specific enzyme activity during 
growth and the necessity to complete a standard curve of each cell 
line under the precise conditions of the experiment, if the exact 
relationship between cell number and activity is required. A similar
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caution has been given with protein stains, in that they do not 
distinguish between intracellular and extracellular protein [Laughton, 
1984].
6.20 Relationship between assay activity and cell viability after
exposure to anticancer agent
We have seen that cells grown at different densities or for different 
periods of time [Cristofalo, 1972] can vary greatly in their
expression of intracellular enzyme activity, or in the capacity of the 
culture to bind a protein dye. We should therefore expect that 
cultures of cells in the presence of different growth modifying agents 
(e.g., antineoplastic drugs and other cytotoxic compounds) may affect 
the performance of some growth assays. Tests for membrane integrity, 
such as 51Cr release, LDH leakage and dye exclusion assays, have 
been shown in the past to give poor correlations with cell viability 
after exposure to cytotoxic agents [Roper and Drewinko, 1976; 1979].
In proffering the assays described here, and particularly the AP 
assay (which has been found to have several advantages over the other 
assays described here), as useful indicators of cell survival in
cytotoxicity assays, it is important to determine if similar 
limitations exist.
In investigative work such as this, it is important to have a
reference method for which actual viability can be measured.
Clonogenic assays (as used here) provide an unequivocal criterion for 
measuring viability in a proliferating culture of cells [Roper and 
Drewinko, 1976]. In this experiment, test cells were trypsinized 
(after the test exposure) and replated under optimum conditions for 
colony forming ability. Because control cells which had not been 
exposed to drug, were treated in a similar way, differences in 
colony forming ability were deemed to be due to drug treatment, and 
thus viability differences between the two cultures were quantitated 
(by differences in resultant colony number). One possible pitfall 
with this method is the trypsinization step needed to carry out the 
determination. It is conceivable that antineoplastic agents may have 
caused cellular damage, and subsequent exposure to trypsin may have 
have a had synergistic effect and caused the ultimate death of the
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cell. Because the success of the method relies greatly on the presence 
of a distinct single cell population, the time of exposure to trypsin 
is longer than in usual subculture procedures. In order to minimize 
the damage that may have been caused by trypsinization, cells were 
exposed to trypsin for the minimum amount of time necessary to obtain 
a single cell suspension. An additional caution about the results of 
these experiments is that high SEM values were evident on 
haemocytometer counts, and this introduces greater uncertainty to the 
results - a limitation of haemocytometer counting with small numbers 
of cells.
Using replicative potential (clonogenicity) as the ultimate test for 
viability, differences between control and drug treated cells were 
attributed to drug effect. When similar numbers of 'viable' cells (as 
determined by trypan blue exclusion) from control and drug treated 
cells gave similar clonogenicity results, it was concluded that the 
trypan blue exclusion method had assessed cell viability accurately. 
When significant differences occured, the difference was attributed 
to inaccurate assessment of cell viability by trypan blue exclusion.
Because some problems with IA growth analysis were outlined earlier in 
the results section, manual counting of colonies was performed and 
compared to IA assessment. IA colony counting did not accurately 
determine colony numbers, and gave significantly different results 
when control and drug treated plates were compared (Table 3.12.2). 
These differences were even more pronounced when colony area was used 
as the measure of growth. Based on these results thus, analysis for 
colony number by IA would not be recommended under these conditions.
After 5 days of drug treatment, Trypan blue (TB) had assessed 
viability accurately; however at drug exposure times earlier than 
this, the relationship was not absolutely accurate. After 1 days 
exposure to drug, 40% of TB determined viable cells were not able to 
form colonies, thus they had been irrepairably damaged, but their 
membranes were still intact. The results for 2,3 and 4 days are more 
difficult to determine because of high SEM balues in counts, however 
there is some indication of further underestimation of cell death. 
This inability of TB to accurately determine non-viable cells at early 
stages in drug exposure was reiterated in the second experiment on day 
2 at low drug concentration. Similar results have been observed by
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other workers under similar conditions [Yuhas, 1974; Bhuyan, et al. ,
1976]. Weisenthal et al. [1983] has discussed findings such as these
[1983], and his data strongly implies that some lethally damaged 
cells may not take up a stain until several days after exposure to a 
cytotoxic drug. Provided this limitation is realized then, TB (and 
other dye exclusion tests) may be successfully used to indicate drug 
induced cell death after sufficient time has elapsed to allow toxicity 
to be manifest by membrane damage, but if used shortly after drug 
treatment, will underestimate cell kill.
Regarding the colorimetric assays themselves, problems with poor
correlation of AP2h were felt to relate to low sensitivity, as low OD 
values were encountered (particularly on day 2 of exposure, Table 
3.12.5) By using the APNaOH assay this was not as apparent. At
concentration C on day 2, APNaOH, NR and SRB assays have estimated 
cell survival to be similar to (or slightly higher than) TB, and thus 
they have similarly underestimated cell kill (in the region of at
least 12% but possibly up to 40%). Thereafter the results with these
assays were close to the TB results, and cannot be said to differ 
very significantly from viability determined by cloning. Vinblastine 
acts by inhibiting polymerization of tubulin and halting cells in 
mitosis [Bender, 1986]. Thus it could take time substantially in
excess of one doubling time for damage to lysosomes and cell membranes 
to be exerted. After this time, while the cell might be lethally 
damaged, AP activity may not have been affected, and would not thus 
reflect this damage, whereas cells taken and plated for replicative
capacity would be unable to continue replicating.
MTT gave results which were slightly, but consistently higher than TB 
counts for days 3 and 4, and thus may be said to overestimate cell 
viability slightly on these days. This may be due to the procedure 
discussed in 6.19, whereby MTT is added directly to the medium
without washing, so any enzyme remaining active from dead cells is 
included in the reaction. This on the other hand does not happen with 
the AP assay due to the washing step involved. It may also be due to 
the finding that cells growing in medium with reduced pH (control 
cells) reduce MTT to a lesser extent than cells growing in a higher pH 
(growth inhibited cells) as this has been used to explain why the MTT 
assay has underestimated the growth inhibitory effects of interferon 
[Jabbar et al., 1989]. Either way, this artefact could be overcome
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by introducing a washing step and changing the medium before the MTT 
assay is carried out. It is recommended here that such a step be 
introduced into the assay, to overcome such problems, as it the basis 
of the assay i.e., inhibition of MTT reducing enzymes (particularly 
succinate dehydrogenase) may potentially be a more sensitive indicator 
of cytotoxicity than lysosomal damage or inhibition of protein binding 
capacity.
NR gives slightly higher values for cell viability throughout the 
assay, and so does not correlate absolutely with TB determined (and 
clonogenicity confirmed) viability but this may be slight when SEM 
values are considered. It is thought that NR is taken up by lysosomes 
by a combination of endocytosis and diffusion, and thus these 
processes would not be immediately affected by cell stoppage in 
mitosis, and thus may not be expected to correlate abslutely with 
clonogenicity, however it should be no less sensitive to cell death 
than dye exclusion. This indeed has been indicated by Hammond et al., 
[1980], NR has been found to stain dead cells [Allison and Young, 
1973; Dingle and Barnett, 1969] although the pattern of staining of 
damaged cells is diffuse nuclear staining rather than particulate 
cytoplasmic staining [Hammond et al., 1980], so it may be expected
that this might happen in drug damaged cells which are dead.
CVDE and SRB correlated quite closely with TB determined cell 
viability but on many occasions they tended to overestimate cell kill 
slightly. They consistantly indicated greater cell kill than the 
other colorimetric assays. Protein stains have been reported to be 
relatively insensitive in some cytotoxicity studies, as protein 
levels have not always been found to correlate with cell number 
[Salzaman, 1959]. In addition, secretion of matrix proteins by some 
cell lines may add to absorbance values, giving higher estimates of 
cell number, or relative proportions of various proteins within cells 
might vary with cell number [Laughton, 1984] or upon exposure to a 
growth modifying agent. It might have been expected thus that these 
assays would underestimate cell death because dead cells still present 
and partially attached to the surface would also be stained, however 
this was not the case. It therefore appears that synthesis of some 
important (in terms of biomass) proteins may have been affected by 
drug activity, and this inhibition was shown up more quickly with the 
protein stains than by dye exclusion or the enzyme assays. Tubulin
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assembly into microtubules is inhibited by Vinblastine and other vinca 
alkaloids [Lenninger, 1970], and as tubulin is an important protein 
for cell structure this inhibition may have been detected more quickly 
by protein binding assays.
Overall the methods correlated quite closely with TB counts, and 
appear to have underestimated cell kill on the occasions with low drug 
exposure or short exposure time, when TB has done so. MTT appears to 
have underestimated cell kill slightly more than the others and 
reasons for this have been discussed, while the possibility that the 
protein staining assays have overestimated cell kill has also been 
addressed.
6.21 Relationship of end point performance to mechanism of
action of cytotoxin
The ability of endpoints based on different principles, to 
differentially detect cell death induced by cytotoxins has already 
been shown [Roper and Drewinko, 1976, 1979; Bhuyan 1976]. When
using incorporation of radiolabelled nucleic acid precursor assays, 
concerns have been expressed that incorporation of nucleic acid 
precursors can occur without completion of the cell cycle, and hence 
may not reflect actual cell replication [Absher et al., 1991].
Differences in these endpoint's performance related to particular 
drugs, or different classes of drugs, have also been discussed. 
Drugs for example that influence nucleoside uptake and alter 
intracellular nucleoside precursor pools can result in changes in 
isotope incorporation which do not reflect actual nucleic acid 
synthesis [Maurer, 1981], Horakova et al., [1978] has found that
measurement of cell protein, nucleic acids and glucose consumption 
were not directly proportional to cell number when cultures were 
treated with cytotoxic agents [6-Thioguanine and Vermiculine] due to 
unbalanced growth induced by the cytotoxic agents. Similar results 
were obtained using other drugs including 6-mercaptopurine [Horakova, 
1974(a)], dactylarin [Horakova 1974(b)] and various inhibitiors of DNA 
and RNA synthesis [Cohen and Studinzinski, 1967]. From the 1978
study it was concluded that only direct cell enumeration was suitable 
for the detection of agents' cytotoxicity.
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It is conceivable that similar disruptions of normal biochemical 
reactions relating to MTT reduction, AP activity, NR uptake and 
binding of protein stains may occur when cells are exposed to 
different classes of drugs. In fact the results from the previous 
section have indicated the possibility of this, with respect to 
protein stains and Vinblastine toxicity. This would denote an assay to 
be more or less sensitive to a given class of chemicals and would have 
implications for chemosensitivity testing. To investigate this 
relationship, cells were exposed to chemicals with widely varying 
mechanisms of action. In the choice of chemicals, at least one 
chemical was chosen with a mechanism of action particularly relating 
to each of the assays. The chemicals chosen and the assay system in 
which they were more likely to have most activity, are given below.
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Table 6.21 Mechanism of action of a panel of chemicals, and 
assay in which they were expected to have maximum 
effect
agent known mechanism of action- 
inhibition of:
relevant
assay
Vinblastine DNA, RNA synthesis (blocks 
cells in mitosis)
[Dawson et ai., 1986]
thymidine and 
uridine incorp.
Mitomycin C DNA synthesis 
(interchelates DNA) 
[Dawson et al., 1986]
thymidine incorp.
5-Fluorouracil DNA and RNA synthesis 
(antimetabolite) 
[Dawson et ai., 1986]
thymidine and 
uridine incorporât.
2 , 4-DNP oxidative phosphorylation 
(uncoupling agent) 
[Lenninger, 1970]
MTT assay
Cordycepin RNA synthesis 
[Dawson et al., 1986]
uridine incorp.
Tunicamycin Glycosylation 
[Alberts et ai., 1983]
Actinomycin D RNA synthesis
(blocks DNA transcription)
[Lenninger 1970]
uridine incorpor.
Cycloheximide Protein synthesis (blocks 
ribosomal peptidyl transf­
erase, Alberts et al., '83)
leucine incorp.
Triton-X-114 membrane disruption 
[Alberts, 1983]
AP, NR, MTT
L-(+)Tartaric 
acid
Acid Phosphatase activity 
[Dawson et ai., 1986]
AP
Hydroxyurea DNA synthesis
(RNA and protein synthesis
not affected)
[Dawson et ai., 1986]
thymidine incorp.
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While the high SEM values obtained with the radioincorporation assays 
prevented extensive analysis of results, it appeared that the 
thymidine incorporation assay was indeed more sensitive to agents 
acting directly on DNA, than were any of the other endpoints. With 
the colorimetric assays however, this was not the general finding - 
the chemicals expected to have specific impact on each of the 
colorimetric assays, did not appear to induce a significantly 
different response in these assays, at least not in a consistent 
fashion. The increased sensitivity of the AP2h assay for Vinblastine 
toxicity suggested in the previous section, was slightly apparent in 
one run of the experiment, but this effect was not reproducible. This 
implies that these assays do not generally give an indication of the 
mechanism of action of the chemical, because they were not 
differentially toxic in the colorimetric assays. It also means that 
the assays are not biased towards particular chemicals with a 
mechanism of action related to the endpoint being measured, and they 
are thus of equal relevance as indicators of cell viability for any of 
these cytotoxic agents.
These findings also query the reproducibility of these assays; as it 
was concluded that none of the colorimetric assays were consistantly 
more or less sensitive to a particular class of chemicals than 
another. The order in which these methods responded was not constant, 
and the SEM values for each assay overlapped to give a wide range in 
which the might appear. This would imply that the assays were
not able to detect small differences in toxicity (within this range of 
overlap, in which any endpoint was likely to give a result).
In similar studies (using only a small number of the endpoints above) 
varying results have been obtained. Triglia et al., [1990] examined
the cytotoxicity of various classes of test agents on a human 
three-dimensional psysiologic skin model, but only examined the 
differential toxicity with a single assay - the NR assay, so this does 
not allow comparison. Mickey et al., [1990] used thymidine
incorporation to detect antiproliferative effects of steroids, and 
MTT to detect cytotoxicity and found that in only 1 of 22 steroids (on 
one out of 4 cell lines) was there s significant difference between 
the results observed in the two assays - in most cases the dose -
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response curves were similar when using the two endpoints. Ford et
al., [1989] found great differences in IC^q values obtained by MTT
3and [ H]-uridine incorporation with Doxorubicin and Vindesine with 
some cell lines, but that agreement was much closer for other cell 
lines. In this work, similar problems with inter-assay variation for 
uridine incorporation assays were found, and this varied with the 
cell line and with the drug, while similar findings were reported by 
Park et al., [1987]. Givens and co-workers [1990] have previously
compared the largest number of colorimetric assays in this aspect, 
when they compared MTT, NR and Hexosaminidase assays against Coulter 
counting. In this work they found very substantial differences in the 
ability of these assays to determine Mithramycin induced cytotoxicity 
(NR and coulter count ID^q values were much lower than values obtained 
by MTT and Hexosaminidase) .
Overall, the results of this investigation imply one of two things - 
either the endpoints are not differentialy sensitive to the agents 
tested after the exposure used, or they are differentially sensitive 
to a small extent, but poor reproducibility and low sensitivity does 
not allow this effect to be seen (perhaps it is a combination of 
both). Further experiments with shorter exposure times might further 
elucidate this investigation. From low observed OD values in each of 
the colorimetric assays tested here (AP2h, MTT, NR and CVDE), it is 
believed that low sensitivity is a significant problem. Further 
discussions on reproducibility of these assays will help to determine 
if this is so.
6.22 Factors affecting
It has been widely shown that cells in different stages of growth or
under different conditions behave differently in bioassays [Freshney,
1987]. This is no less true for toxicity assays. The work described 
here has investigated a number of factors which might affect the IC5Q 
value. The increased cell kill observed when duration of exposure to
drug was increased (3.14.4 and 3.14.5) is probably very obvious and is
well documented [Barlogie et al., 1976].
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Other factors, not quite as obvious, were also investigated. The
importance of using cell cultures in logarithmic phase has also been
stated [Freshney, 1987] but the influence of slightly different
pretreatment regimes has not been so widely studied. The results from
the work carried out here demonstrated that the relatively minor
modifications in seeding density and feeding regime used for the
pretreatment regime, had no predictable outcome on the results of the
toxicity experiment. While there were differences in the IC5 Q values
obtained, these differences did not follow a particular trend, and it
appeared that results were simply attributable to random variation
around mean values. While this answers the question in hand as to a
possible definite effect of increasing cell seeding densities (it was
concluded that there was no trend, so use of any of the pretreatment
regimes resulted in equally relevant results), it does return again to
the question of reproducibility of these assays. While many of the
points on these graphs overlapped with many others, when the SEM
values were considered individual graphs (representing individual
assays carried out separately) spanned a range of 30% of the Y axis,
which would lead to substantial differences in IC,-^  values.o U
The effect of exposure to trypsin for short variations in time (10 or 
2 0 minutes trypsinization periods) was determined to be not 
significantly important when carrying out a toxicity assay with 
RPMI-2650. Presumably this would hold true for short variations in 
trypsinization times for other cell lines also, however this would 
not be presumed for longer periods of time. It has been shown by 
Barranco et al. , [1980] for example that immediately after a 5-minute
exposure to 0.025% trypsin, Chinese hamster ovary cells treated with 
anticancer drugs exhibited changes in drug sensitivity (depending on 
the drug). In this thesis however, the cells were allowed to attach 
fully (for 24 hours) before addition of drug, so the same differences 
in sensitivity (4 to 50 fold) would not have been expected. In fact 
Barranco et al., determined that by the 12th hour post 
trypsinization, the drug survival responses had returned to values 
obtained with untrypsinizated cells. This however, would be an 
important finding to bear in mind in short term drug exposure assays 
(such as that described by Rosanda et al., 1985) if recently
trypsinized cells are used.
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The effect of increasing cell seeding density on drug toxicity was 
clearly demonstrated in this work. It was shown that increasing cell 
density resulted in reduced cell toxicity for the same drug 
concentration. It would appear that there are three obvious 
possibilities as to why this may be so; differences in drug uptake, 
differences in drug action when inside the cell, and differences in 
drug efflux. It may of course be a combination of these three 
factors. The most likely explanation is probably reduced drug uptake 
in the high cell density plates, due to masking effects at increasing 
cell density. This may be a physical phenomenon - if cells are more 
dilute and spread out, they will have greater surface area exposed to 
drug, and may therefore have increased drug uptake over cells which 
are crowded together. Cells seeded at different densities will 
obviously have different proportions of cells in different stages of 
growth. Cell surface and plasma membrane proteins have been shown to 
increase in quantity as cells progres from G1 to G2 cells [Pasternak 
et al. , 1974]. It is possible therefore, that the differences
existing between the cell membranes or surface components of dividing 
and nondividing cells may affect the binding and transport of sime 
drugs into the cells and ultimately cause rate limiting differential 
survival responses [Barraanco et al., 1980], Similar cell density
effects have been shown by Pelletier et al., [1990] who partly
attributed the phenomenon to a general alteration of passive diffusion 
across the cell membrane (sodium chromate, analine and glucose uptake 
being affected in the same way).
Different exposure regimes were shown to effect differing degrees of 
cell kill, but in a concentration and time dependent manner. For the 
purposes of the work shown in this thesis, a continuous exposure was 
used, however this may not always be relevant (discussed further in 
6.31). Duration of experiment with continuous exposure, was seen 
also to demonstrate the time dependent relationship of drug exposure 
to cells. Another factor which should be considered in this context 
would be the time taken for the drug to effect cell kill detectable by 
the endpoint. After 1 days exposure to drug, it is possible that the 
cells were lethally damaged, but not discernably so by image 
analysis. After 5 days growth however, the total maximum effect 
would be more likely to have been achieved, and thus lethally damaged
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cells would be expected to portray all the characteristics of dead 
cells, including detatchment from the culture, and thus measurable 
(relative to control cultures) by staining and reading with IA.
Other factors which are important in IC5 Q determinations are pH and 
serum [Nissen and Tanneberger, 1980] and obviously the cell line used 
[Pauli et al. , 1991].
6.23 Serum batch testing with miniaturised endpoints
Serum batch performance is often assessed by constructing growth 
curves, or by plating cells into flasks or multiwell dishes and 
counting cell numbers at the end of the test period [Jayme et al.,
1988]. Both of these methods involve trypsinization of the cells and 
counting by haemocytometer or Coulter counter. Either way (but 
particularly with the haemocytometer) is extremely labour intensive 
and tedious. Attempts to simplify this procedure have been to stain 
the cultures (in multiwell plates) and count them by eye (still very 
time consuming) or score plates according to the extent of growth they 
express. The latter technique is semi-quantitative only and is 
sufficient for vastly different batches of serum, but is inadequate 
for batches of serum with more subtle differences in growth promotion 
abilities. Image analysis has further attempted to ease the burden on 
'serum batch testers' by computerized quantification of stained growth 
surfaces, however this method leaves a lot to be desired. Its 
pitfalls have been identified in section 3.1.
We can verify some of these drawbacks from Figures 4.1 (a) - (c), in 
which growth has been analysed in this manner. Chief among the 
drawbacks are the gross error bars that accompany the graphs. These 
arose, not from plating errors and inaccuracy, but from suboptimal 
spreading of the cells upon the culture surface, the significance of 
which has already been stated. Values for replicate wells may 
consequently be reported to be significantly different (even though 
visually the total growth may be seen to be quite similar), and 
concommitantly, serum batches giving similar growth may produce 
extensively different absolute values, depending on the way in which 
they are spread and how the light plays on them.
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This is attested by the relatively smaller error bars for RPMI-2650 
and DLKP; both of which form colonies which are more successfully 
processed by image analysis (particularly RPMI-2650); compared to the 
high bars observed for SKMES-1 which quickly forms a monolayer.
Additional to problems of quantification of results, is the amount of 
resources (in terms of serum, medium, plastics and time) which are 
depleted in setting up serum batch testing experiments. Replicate 
wells must then be reduced to a minimum. In the case of primary or 
low passage cultures, low available cell number is another factor to 
consider; so it may not be possible to test all the required 
variables in the batch testing system.
Thus the case for applying a miniaturized, semiautomated assay to 
this procedure is made. In comparative experiments with IA assays, 
the AP method clearly gave similar results (Figures 4.1.4), so it was 
applied to a wider panel of sera and cell lines in an attempt to 
differentiate among the batches.
At the most basic level, it was clear that different cell lines had 
differences in their preference for sera - this is seen with batch 8 , 
which was good for many cell lines, but appeared to be the worst of 
the panel for DLKP at low cell density. It was thought that similar 
trends in serum preference might be shared by cell lines from the same 
tissue type (hence the reason for testing 5 lung lines), however this 
conjecture did not seem to be any more true for the lung cell lines 
than for lines from any other tissue type.
Overall the screening system used did determine two consistently poor 
batches of serum, relative to the others. Batch 4, which was from 
donor horses, was recurrently poor for many of the lines, as was 
batch 10 FCS. Selection of serum batch for routine work (on a large 
scale) must be a compromise between serum performance and price, and 
generally FCS are more expensive than other sera (particularly DC, NBC 
and DH), so it was important to have identified these poor batches. 
Another significant finding was that batch 2, which was a Donor Calf 
batch (and was significantly cheaper than the FCS batches) was equally 
as good as many of the FCS batches for most of the cell lines.
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The importance of cell density in this exercise was plainly 
established by the work shown in Figure 4.1.3. It appears that at 
very high cell densities there is less differential effect among the 
sera. At 'critical' cell densities - close to the cut-off point below 
which cells will not continue to grow - a good batch of serum will 
inspire growth above critical densities which will then continue to 
give a very substantial differential between it and the other serum 
batches. At high cell densities the cells are better able to take-off 
and grow, so will be less dependent on the presence of a good serum 
batch to aid them with this. Additionally, at high cell densities, 
there is less time before the wells become confluent and stop growing 
- giving poor sera a chance to catch up with good sera if the 
experiment is not taken down in time.
Thus the recommendation from this work is that cell lines are tested 
for serum batch preference at low cell density (preferably densities 
just above the cut-off seeding density at which they refuse to grow).
Comparison of the AP assay results to that of three of the other 
miniaturized methods (MTT, NR and CVDE) did result in similar trends. 
With the NR assay, the differential between good and poor batches was 
greater than that seen previously with the AP assay, which of course 
is desirable, however the SEM values were substantially greater for 
the NR assay, as was the case with the MTT assay (thought to be 
attributed to the technical difficulties of the assay; already 
discussed). Low variability among replicates was seen with the CVDE 
assay.
Overall, the AP assay gave results comparable to the other 
miniaturized assays (as well as comparable to NR), indicating that any 
of these methods would be suitable for serum batch testing. Lower 
precision on MTT and NR methods favours the AP or CVDE methods. In a 
comprehensive screen involving numerous cell lines and sera, two 
consistently poor sera were identified and a good quality Donor Horse 
serum (which offered substantial monetary advantages over other FCS 
batches) was identified. Similar cautions that accompany other 
methods for batch testing (and indeed other growth assays) such as use
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of low cell loading, apply to these systems, nevertheless the method 
has been shown to be suited to this application, and to offer 
significant benefits over previously used monolayer/ IA screening.
6.24 Application to environmental monitoring
Pollution may be typically defined as the causation of a change in the 
natural environment which results in harm to a biological system. 
Effects of pollution are as diverse as the pollutants which cause 
them, which themselves are extensive. Pollution is often classified 
in terms of where the impact arises, i.e., water pollution, air 
pollution, land impact or social/ economic impact. In the case of 
water pollution, a simple classification of pollutant effects in 
water systems would distinguish between biodegradable compounds 
exerting their effect in the form of an oxygen demand, particulates 
which result in silting-up and physical effects on ecological life, 
and toxicants which exert a direct toxic action on ecological life. 
Sources of these pollutants include domestic and municipal activities, 
agriculture and industry.
Chemical monitoring of emissions of pollutant material is helpful, in 
fact necessary, to characterize waste and effluent produced by 
different sources, however chemical monitoring alone is not
sufficient to characterize and indeed identify pollutants. While 
organic pollution is easily predicted by such tests as BOD 
(Biochemical Oxygen Demand), prediction of pollution by toxicants, or 
identification of a toxic pollution incident may not be realized if 
the particular agent(s) in question are not specifically analyzed for. 
In order to increase confidence in chemical monitoring, increasingly 
larger numbers of discrete tests may have to be carried out, and thus 
the cost and the time involved for processing a single sample is also 
increased. Generally then, the number of parameters tested is 
minimized, and thus testing of the critical pollutant may be missed. 
Use of biological monitoring on the other hand gives a result relating 
to the combined effects of the pollutant and can give an index of 
total toxicity by the use of a single test. Biological monitoring is 
often carried out at the site of pollution (or prospective pollution)
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where the organisms already present in the ecosystem are monitored to 
give an indication of the health of the system, however this approach 
is often limited by the diversity of ecology at the site due to 
natural factors. Use of ecotoxicity tests on the other hand offer 
advantages of being able to screen such effluents before they are 
disposed of, and can thus aid in the prevention of toxic pollution, 
instead of simply identifying it after it has occured. Such tests 
additionally are not dependent on the natural ecology present at the 
site, as sensitive indicator organisms can be chosen for use. Use of 
cell cultures have been used in the past for ecotoxicty testing of 
complex mixtures, and have been used in quality control assessment in 
the water industry and for raw materials. Miniaturized, semiautomated 
assays offer further advantages in terms of resources and time saved, 
and are thus less expensive to carry out once the basic equipment 
needed has been acquired. Endpoints such as NR and Kenacid Blue have 
been used for such purposes. The results described in this thesis
show the use of the AP assay in screening for toxicity in a number of 
environmentally related samples.
6.25 Screening for cyto-toxicity in industrial sludges
Sludges are generated by wastewater treatment systems which result in 
removal of solids from the effluent. This is accomplished by a
combination of primary and secondary treatment, and in some cases
tertiary treatment. Primary treatment is the mechanical removal of 
grit, fats and large solids already in the effluent and is essential 
to the effective maintainance of a secondary treatment system. 
Secondary treatment is a biological treatment system, where 
specialized populations of micro-organisms use the nutrients in the 
wastewater as a food substrate, and in so doing, reduce the 
suspended solids, the organic content, and thus the polluting 
potential of the wastewater. Secondary treatment is commonly by 
Activated Sludge, Trickling Filter (both aerobic), Oxidation Lagoon 
(aerobic/anaerobic) or Anaerobic Fermentation [Hammer, 1977]; but 
all are based on the same principle of encouraging micro-organisms to 
break down the offending organic matter. Tertiary treatment,
utilized only for high quality effluent, or for a wastewater high in 
nutrients such as phosphate and nitrates, may also result in the 
removal of colloidal material by precipitation and the use of
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polyelectrolytes. From all these treatments, the quality of the 
effluent is improved as solids are removed from the waste stream. The 
resultant solids constitute sludges and are often problematic in 
terms of disposal because of their high polluting potential. The 
possibility generally exists that toxic elements are adsorbed to 
solids and are then concentrated in the sludge. Thus toxicity 
testing of sludges is an important environmental control parameter.
In this country, toxicity testing of industrial sludges is often a 
requirement before local authorities will accept sludges for 
landfilling. The systems available for such testing are carried out 
by EOLAS at Shannon and are carried out as fish (rainbow trout) 
toxicity tests and invertebrate tests. Apart from the huge expense 
involved in performing such tests, the available facilities for 
performing such tests are not adequate to facilitate the amount of 
testing to be done. Hence the availability of a cost-effective, 
rapid screen for toxicity that is correlated with toxicity tests 
already in use, would be a significant advancement to the Irish 
position in environmental monitoring.
It is felt that a miniaturized, semiautomated cell culture assay, as 
described here, would provide such a system for monitoring of 
toxicity in sludges for disposal. The AP assay was chosen for use 
because of its convenience and sensitivity - it is more sensitive 
than any of the other assays, and more convenient to carry out than 
the NR and SRB assays. Sensitivity is of the utmost importance when 
testing the low numbers of cells present in toxin treated cells, so 
it is appropriate to use the AP assay in preference to other assays 
described in this work.
In comparison of data from an algal bioassay [Rachlin et al. , 1983]
with a cell culture bioassay, Mochida [1986] found that the latter 
was more sensitive in determining aquatic toxicity. Similar findings 
in relation to the cell culture assay were reported by Kfir and 
Prozesky [1982] and Richardson et al., [1977] when a Daphnia bioassay
was used. In the results presented here, AP has differentiated 
between the sludges similarly to the Daphnia magna test, but in 
expressing the results in terms of toxic units, has been less 
sensitive. It is thought that this was due to pretreatment of the 
wastes prior to cytotoxicity testing with the cell culture. Some of
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the leachate samples were high in suspended solids (see photograph 
2.38), so it was necessary to filter and centrifuge the samples 
before adding to the cell culture. This was particularly obvious 
with sample G which was extremely high in very small dissolved and 
suspended solids - thus much of the toxicity may have been lost 
before testing. It would be important therefore to investigate other 
methods of extracting leachates from samples, and cleaning up 
'dirty' samples before assaying in cell cultures, without loss of 
the specific toxicity (considered later in more detail). 
Alternatively/ additionally, the difference in sensitivity may be 
attributed to the different systems. The cell culture system used 
here did not incorporate any method for biotransformation of 
xenobiotics, so this may account for some loss of sensitivity. While 
this factor had been appreciated from the onset of this work, it was 
outside the scope of this work to address this matter. Future work 
however, would benefit greatly from considering this factor. 
Addition of S9 mixes, co-culturing with hepatocytes or cell lines 
retaining some metabolic activity do attempt to address the problem, 
however such approaches as transfection of cytochrome P-450 cDNA from 
metabolically induced cells, into target cells, offers greater 
relevance, as the biotransformed compound will be generated inside 
the target cell and closer to the site of action [Dogra et al.,
1990], Significant work in this area is being carried out at 
present, in this and other laboratories.
Nevertheless, significant toxicity was identified by the method as 
it stands, and in utilizing the results determined here, it may be 
appropriate to set different acceptable limits to the toxicity (in 
terms of toxic units) when accepting/ rejecting sludges for 
landfilling depending on the screening method used. This should be 
done by comparing the AP assay to OECD recommended bioassays for 
ecotoxicity testing, and ascertaining the relationship between these 
for a number of standardized compounds of varying toxicity with 
varying methods of action. Obviously in such work, comparison of 
Toxic Units must be carried out with caution, because this 
expression, like the IC50 is not a 'stand alone' figure and depends 
strongly on the experimental paramaters which were used to obtain 
this information. In routine screening with any of the endpoints 
investigated on cell cultures exposed to test samples, optimum 
conditions would first have to be set up for the cells in use
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(including seeding density, exposure time and assay duration) and 
the endpoint to be used, and these would have to be strictly adhered 
to for all subsequent work to allow meaningful comparisons to be 
drawn, or reference to predetermined limits - otherwise, this would 
be just a meaningless figure.
With a little more work on pretreatment of samples for testing in 
cell culture systems, it is felt that the AP assay could replace some 
of the more expensive tests (e.g., fish tests) or be used to 
pre-screen samples for the more expensive tests. Sludges not having 
significant toxicity could be eliminated from further screening, if 
suitable comparative trials showed a very low incidence of false 
negatives.
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6.25 Screening for toxicity in landfill leachates
Disposal of domestic and industrial solid waste is a major 
environmental problem. In the consumerist society in which we live, 
the amount of waste generated is constantly increasing.
Some typical figures available for the composition of refuse collected 
in the Dublin Corporation area (1977/78) are as follows:
Table 6.25 Typical composition of Dublin refuse (1977/’78)
Category Average
%
Paper 35
Plastic 1 2
Vegetable and 33
Perishable matter
Glass 8
Rags 3
Metals 3
Ashes/ Fines 5
Others 1
From: Cabot, 1985
It can be seen that even from domestic refuse alone, metals and ashes 
constitute 8% of the waste.
Use of options such as recovery and recycling of municipal and 
industrial wastes, are only slowly being accepted and require a huge 
commitment from the general public, as well as centralized, well 
manned sorting stations and increased expenditure [Chynhoweth, 1978]. 
Incineration, which can be an important option, requires huge
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initial capital expenditure, and is receiving bad press at the moment 
[Mac Dubhghaill, 1991] due to production of dioxins and other toxic 
chemicals through incomplete combustion. Thus the only feasible 
alternative for use in Ireland at the moment is landfilling, which 
also represents the opportunity to generate methane in high volumes 
from emplaced wastes [Forster and Wase, 1987]. Much of our solid 
waste (both municipal and industrial) is disposed of in this way. 
Uncontrolled tipping of solid waste was reported [EEC, 1984] to 
account for 35% of the total wastes disposed of in Ireland 
(substantially greater than the proportion disposed of in this way in 
other countries), and of wastes arising from the manufacturing 
sector, 44.3% (276,000 tonnes/ yr) has been disposed of by
landfilling; 17% of which is special waste with hazardous properties 
[Cabot, 1985].
A landfill site, as distinct from a 'tiphead' or 'dump', is where 
the compressed waste is emptied into discrete cells in the ground. 
Each cell is separated from the next by a layer of soil, and the 
complete site is covered with soil and grassed over when the area has 
been filled. Water trickling down through the soil and into the 
individual cells will saturate the waste and cause a leachate to be 
generated. This leachate will pass through the entire site and down 
into the underlying bedrock and can then pollute the groundwater in 
any aquifers underlying the site. This consititutes a major 
environmental problem, because, once contaminated, there is 
virtually nothing that can be done to save the aquifer; groundwater 
not having the same self cleansing abilities as surface waters [Daly 
and Wright, 1981], The Water Pollution Advisory Council of Ireland 
[1983] have reported that the large scale pollution of groundwaters 
has mainly arisen from the land filling of sewage and industrial waste 
sludges or the spreading of agricultural wastes on land, so we can see 
that the area of landfilling is an important source of groundwater 
pollution.
There are 2 major types of landfill sites; 'dilute and disperse' and 
'containment' sites [Kharbanda and Stallworthy, 1990], Dilute and 
disperse sites rely on the topography and geology of the site to 
effect suitable control over the leachate. Suitable sites for dilute 
and disperse landfills have a thick layer of glacial material, with a 
high percentage of clays (or other material with a high cation
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exchange capacity) overlaying a bedrock which is unfissured and has a 
low permeability. This will allow attenuation of the leachate before 
it reaches the saturated zone. In addition, the groundwater 
underlying these sites should not be significiant, e.g., a low 
conducting aquifer. Sites which do not have these characteristics 
should be made into containment sites. In these sites an impermeable
material covers the bottom and sides of the pit (either a naturally
occuring layer or a polymerized material is laid down). The tip is 
then covered over with similar material when landfilling is complete. 
The object of such engineering is to prevent further leachate 
generation (a certain amount will take place anyway due to disposal of 
saturated materials), and collect that which does, by a series of 
drains and pumps. This can then be isolated and treated on site. The 
cost of a properly run containment site is prohibitive, so we find 
that in Ireland, due to insufficient funding, the local authorities 
generally 'make do with' the dilute and disperse sites even in areas 
where the geology is totally unsuitable and where maximal pollution of 
groundwater can occur. These sites [Cabot, 1985] are often disused 
quarries, in low- lying waterlogged land or in areas which can be 
reclaimed from the sea or estuaries.
Leachate from landfill sites can frequently be highly noxious. The
leachate is normally highly concentrated and can have a COD (chemical
oxygen demand) of several hundred thousand ppm. Difficulties with 
landfilling also occurs because the composition of the waste is not 
known. Legislation to prevent uncontrolled landfilling of toxic and 
dangerous waste exists [The European Communities (Toxic and Dangerous 
Waste) Regulations, 1982], however controlled landfilling of such 
wastes is often considered as a management option by co-disposal with 
household wastes and building site rubble. This relies on the 
properties of the inert material to attenuate the toxic waste, so 
that some chemical and microbiological oxidation of the waste can 
occur. In practice then, the possibility of pollution by toxic 
elements in leachates is a real worry. Because groundwater involves 
laminar flow, dissolved chemicals will follow groundwater and form 
distinct plumes, which may be up to several miles downstream of the 
pollution source [Went, 1989]. These plumes move very slowly and thus 
the pollutants tend to remain unchanged, where they may later effect 
harm if abstracted by wells or in their supplying baseflow to a river.
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Frequent analysis of a few well - planned monitoring boreholes in 
addition to local wells and surface waters would provide much 
information which would be helpful in the management of these sites 
and help to identify contamination plumes, however this does not 
optimally occur, again, due to lack of resources.
BOD (biological oxygen demand) is not generally an effective measure 
of the polluting potential of landfill leachates because resilient 
components may not be easily oxidised by microorganisms and because of 
toxic effects on microflora due to chemical components in the waste. 
COD determined by oxidation by a strong chemical oxidant (potassium 
permanganate [OECD, 1984]) is generally a more useful paramater in 
characterizing the strength of a leachate.
In analysis of these samples, the operator would optimally need to 
know what paramaters to test for, and even though a comprehensive 
series of tests may be carried out, the critical toxic component may 
not be analysed for, and thus a wrong judgement made about the quality 
of the water (and thus the polluting potential of the leachate and the 
management of the landfill site).
Use of biological monitoring for total effects of toxicity would offer 
several advantages in this field, and while this has been recognized 
theoretically for many applications, biological monitoring programmes 
are often technically specialized (as alluded to in the introduction), 
extremely time consuming and expensive, so such options are not open 
for general use. The use of cell culture screening systems may be 
more appropriate than other biological monitoring systems, can give a 
rapid indication of toxicity (48 hours) and may be much more cost- 
effective than other such systems, particularly fish toxicity tests. 
We can see that such a system, using MDCK cells has demonstrated 
toxicity effected by heavy metal salts, and by a number of industrial 
waste waters. Similar results have been shown by Jenssen and Syversen 
(1991) for Nickel using a fibroblast culture system, however exposure 
was only for 24 hours so IC^q 's were obviously much higher (286.7 +
4.7 /jM) than those determined after 5 days exposure here.
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The AP cell culture assay used here has determined toxicity of a 
metalworks effluent at concentrations greater than 12.5% effluent in 
the medium, but detected no significant toxicity with 50% addition of 
a landfill leachate. It has shown differential toxicity for three 
landfill leachates, and determined leachate 1 to be most toxic,
however it can be seen (retrospectively) from the chemical data 
relating to the leachates that they do not appear to have significant 
toxic properties, having low COD and low heavy metal levels (indeed 
metal levels are similar to levels allowable by surface water criteria 
for public water supplies [Hammer, 1977]). However heavy metals, 
ammonia and nitrate are elevated in sample 1 , and this may have
accounted for the increased toxicity of leachate 1 to the cells in 
culture.
In considering this section it is important to highlight the
difficulties which were involved in obtaining the samples for this 
work. Because environmental protection is becoming such an important 
and sensitive public concern, industries and local authorities are
highly reluctant to distribute samples of effluent and waste, because 
they feel that if in the wrong hands it could result in prosecution 
(if the waste is above licence limits) or, in the case of local 
authorities, loss of votes at election time. These difficulties were 
only appreciated after extensive efforts to obtain samples from a wide 
variety of industries and local authorities, and the temptation for a 
prospective co-operator to donate only the cleanest samples, is now 
particularly realized.
Further work with chemically defined effluents of differing ranges of 
toxicity would enhance this work, but as yet it appears that the 
assay would be suitable for routine monitoring of leachates from 
landfill sites. This would be particularly useful for inclusion in 
groundwater protection policies - samples from strategically placed 
monitoring boreholes could be screened regularly with a single test, 
which would give an overall indication of toxicty of relevance to 
humans. Formation of noxious leachates could then be easily 
detected, and the plume of the pollutant could easily be traced using 
toxicity to cultured cells as an index. With assays of low 
sensitivity, high cell numbers would be needed to enable detection 
after exposure, and thus higher concentrations of toxin would 
necessarily have to be present i the sample. Alternatively, low
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cell numbers could be used with low concentrations of toxin, but then 
the incubation time would have to be increased to enable surviving 
cells in wells expressing cell kill to replicate to well above 
detectable levels. The advantage of using the highly sensitive acid 
phosphatase endpoint for such studies is that a lower number of cells 
could be used, thus lowering the effective concentrations of toxin 
necessary to be present (see 3.14), and thus shortening the time 
necessary before a result could be reached. If this were standard 
practice in all of the landfill sites in the country, then this 
would be a good quality control system for groundwater toxic 
pollution by landfill sites, and would go a long way towards 
protecting the public from such pollutants arising from this source, 
and would alert the managers to problems as they occured. Use of a 
miniaturized, semiautomated system such as this reduces the costs of 
performing such a test and makes it more practical for use as a 
monitoring system.
6.27 Potential applications for cell cultures in
environmental toxicity testing
Some possibilities for using miniaturized, semiautomated, 
colorimetric cell culture assays have been considered here, and 
indications from experimental results would point to their usefulness 
in these areas. One of the disadvantages of using the system 
described here is that it will only detect acute effects - to detect 
sublethal effects requires the use of a modified system with 
different endpoints. In characterizing wastes for disposal, 
sublethal effects as well as acute effects may be important. This 
may be particularly important in identifying carcinogens. Thus in 
screening wastes for disposal, toxicity test systems should ideally 
cover different paramaters of toxicity. The AP assay has been 
recommended here as the method of choice for cytotoxicity testing of 
such samples. In a detailed screening programme, where a second 
endpoint is being used, the NR assay would be recommended based on 
the results of this work. Using these two assays together would give 
a better representation of cytotoxicity when different classes of 
compounds would be encountered (even though no significant difference 
was noticed for the chemicals chosen for this work). While the NR
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assay is not particularly sensitive, it has given more constant 
results in detecting viability, when cells were grown in different 
culture conditions during this work.
To obtain a better indication of the characteristics of the waste, it 
would be useful to test for cytotoxicity (for example with the system 
described in this thesis), mutagenicity, and carcinoenicity (by 
morphogenesis of cells in culture) with in vitro tests. The Ames 
test is commonly used for such mutagenicity testing, but it may be 
much more relevant to use a human cell culture assay for this.
An important aspect of classical biomonitoring studies for pollution 
is that these tests allow detection of bioaccumulation of pollutants, 
which is an important biological phenomenon - cytotoxicity tests by 
their nature do not. This however may be addressed in some way by 
monitoring the sediments in a freshwater or marine ecosystem. 
Ultimately sediments act as a sink for pollutants in aqueous systems 
as they act as adsorbants, binding a wide range of organic and 
inorganic compounds. In fast flowing rivers they may be continually 
resuspended, while in deep ocean sediments and lakes they will
settle out. There are three main ways [Samoiloff, 1990] by which
toxic materials bound to sediments may enter biological systems. The 
first is by contact between a target organism and the sediment, and 
absorbtion of contaminant through the integument. The second route 
is by ingestion of sediments by target organism and desorption of the 
contaminant in the digestive system into the general circulation of 
the host organism. The third route is by desorption of the 
contaminant from the sediment to the water column, and uptake to the 
target organism via the water. In situ toxicity may be considered to 
be a direct consequence of the desorption capacity of the sediment as 
well as a consequence of the actual toxicity of the contaminants. 
While detection of toxic chemicals bound to sediment suggests that 
there is a toxic potential of the sediment, chemical analysis alone 
is insufficient to provide a realistic appraisal of the toxicity of 
those sediments [Samoiloff, 1990]. Work by Samoiloff [1990] 
comparing chemical to biological analysis of sediments, showed
discrepancies in the ability of these two systems to detect toxicity.
The biological availability of the toxic contaminant is a factor 
which is not determinable by chemical tests alone. Ecological 
studies of natural populations of organisms present can determine
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this, however preparation of sediment leachates to be tested on cell 
cultures may also give an indication of the potential biological 
toxicity of the sediments. Elutriation of loosely bound contaminants 
to yield an aqueous material for testing has been widely used, but 
chemical extraction is the only method that gives an evaluation of 
the entire range of toxic contaminants [Samoiloff, 1990] - these 
extracts can then be bioassayed.
Rapid cell culture screening may be potentially used in quality 
control of industrial effluents, not only for the final effluent but 
at different stages through effluent treatment. Activated sludge 
treatment systems may become poisoned due to contaminants in the 
effluent which kill off the microflora responsible for oxidation of 
the organic matter. Microbial or algal toxicity tests may be more 
easily used than cell cultures for such screening, however if a cell 
culture system is already being used for screening final effluent 
quality, it would also be appropriate to use it for screening the 
influent to the activated sludge chamber. In such a case a positive
and negative control influent for toxicity would have to be used, as
the wastes would be expected to be quite 'dirty' and not generally 
suitable for cell culture screening.
Another potential use for the methods described here is in screening 
for algal toxins in red tides. These toxins are produced by
dinoflagellates which bloom when water temperatures heat up and
surface turbulence is reduced so that mixing throughout the water 
column is minimized. Gonyaulaxm species and Gymnodinium breve are 
most often associated with production of these toxins [Wood, 1968] 
and when these algae are filter - fed upon by molluscs, toxin levels 
can bioaccumulate to very high levels which can be detrimental when 
ingested by humans. Depending on the toxin, one of two reactions is 
evoked; Paralytic Shellfish Poisoning (PSP) which paralyses muscular 
contractions and inhibits conduction along nerves [Evans, 1970], 
causing brain damage and death very soon after ingestion of toxic 
shellfish, or a less severe form of poisoning which causes diarrhoea 
after ingestion (Diarrhoetic Shellfish Poisining (DSP)). For many 
years, the only method used to test for these toxins was by feeding 
test shellfish to rats or mice and observing toxicity in the form of
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diarrhoea or death [APHA, 1970]. More recently chromatographic 
methods have been developed to separate these toxins, as chemically 
some have been identified as being virtually identical to saxitoxin 
[Evans, 1970] and ocadiac acid, however development of reliable 
techniques has been slow, due to the presence of a number of toxic 
components in active extracts [Risk et al. , 1979]. Recent work has
used HPLC methods successfully for this task [Min. Agriculture and 
Food, 1990] but such methods may involve complex purification steps. 
Cell culture assays have been used to screen for these compounds 
[Aune, 1987] and it is suggested here that cell culture assays using 
the endpoints described here could be more widely used for this 
application, in centres where i_n vivo tests are still used (e.g., in 
the Fisheries Research Centre in this country).
Although outbreaks of PSP are not common in this part of the world, 
some incidences have been reported close to these waters, such as an 
incidence in Northumbria in 1968 [Eavns, 1970]. In the Southeast of 
Ireland however, outbreaks of DSP do occur. During the course of 
this work when the application of these assays was being 
investigated, no toxic shellfish were sampled from Irish waters, so 
it was not possible to put this application into practice.
More than 20 genera from the phylum Pyrrhopyta contain organisms
which produce potent poisons [Risk et al., 1979]. Toxins similar to
those discussed are also produced by blue green algae. Lyngbya 
majuscula for example, is the causative agent of a severe contact 
dermatitis known to affect bathers at beaches in the Pacific. The
active constituents of extracts from these organisms (aplysiatoxin,
debromaplysiatoxin and lyngbyatoxin) have been shown to be tumour
promotors in vivo. In other countries, including Ireland, death of
cattle and other agricultural animals from other cyanobacterial 
toxins is not an unusual occurrence [L. Brava, personal 
communication] when they drink from fresh water contaminated by
blooms of toxic microorganisms. Use of the assays described in this 
thesis would be an appropriate and relevant way for agricultural
authorities to screen for such toxins over critical period when the 
microorganisms bloom.
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Monitoring for toxicity on Tributyltin (TBT), which is carried out 
regularly by analytical methods in the UK, could also benefit from 
miniaturized cell culture cytotoxicity testing. Some UK marine sites 
showed elevated levels of mcvrogram / litre values (i.e., higher than 
concentrations known to affect survival of larval fish, crustacea and 
molluscs) while discharges from dry dock areas were found to exceed 
40 ng/1 TBT [Ministry of Agriculture, Fisheries and Food, 1990]. 
Zucker et al . , [1989] in examining cytotoxic effects of TBT and
other tryalkyltins on murine erythroleukemic cells, demonstrated 
cytotoxicty at above 1/uH TBT (0.29 /jg/ml), thus it should be 
feasible to use the assays described in this thesis to detect 
tocicity from the TBT levels experienced in contaminated sites.
In monitoring for other contaminants such as organochlorine 
pesticides and PCBs, analysis of body tissue of aquatic organisms may 
be used to provide samples with levels concentrated over those found 
in the water column. Eels, because of their high levels of fatty 
tissue, have been used by the UK Ministry of Agriculture, Fisheries 
and Food [1990] for this purpose, providing results from some sites 
which were much greater than those encountered previously in fish 
tissue. Again use of a miniaturized cell culture assay could 
conceivably be used for monitoring extracts from such samples to 
denote cytotoxicity (and perhaps other parameters such as 
mutagenicity/ carcinogenicity) to human tissues.
Cell culture assays have been well used in the past for cytotoxicity 
testing in quality control of surgical equipment [Wilsnack, 1976] 
and dental material [Wennberg, 1986]. More recently they have been 
used in the water industry to test for cytotoxicity in leachates from 
water exposed to fittings in plumbing [Ashworth and Colbourne, 1981], 
and in detecting the presence of toxins in water for re-use. Because 
Ireland's water supplies are more abundant than other European 
countries, at the present time this application may not be as 
important as in other countries, however in treatment of water for 
drinking purposes, water quality may be monitored by using cell 
culture assays similar to those already used e.g., Fauris et al.,
[1985], and the assays described in this work would be relevant to 
such an end.
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environmental compounds
Problems with screening samples of environmental importance relate to 
the 'dirty' nature of many such samples. Animal cell cultures in 
vitro are quite fastidious and often difficult to grow even in the 
presence of favourable conditions (this is easily seen from the 
section on primary culture), so addition of a waste sample hiqh in 
dissolved and suspended solids may cause significant differences in 
osmolarity from culture medium, and other differences which may not 
relate to toxicity in in vivo systems, or indeed less fastidious in 
vitro systems such as microorganisms, and this may result in cell 
death unrelated to the toxic contaminants present in the medium. 
Clean-up procedures, similar to those used in chromatography analysis 
may be used to deal with this (some such methods are described by 
Birknolz [1982] and Samoiloff et al., [1983]), but this of course
increases the complexity of the procedure and makes it less 
attractive for use as a screening method. In relatively clean samples 
(e.g., water samples) the actual sample may be used to make up the 
growth medium by dilution of concentrated medium or by addition to 
powdered medium [Hunt et al . , 1986]. In water samples where the
contaminant level may be very low, samples may be concentrated by a 
range of methods [Jolley, 1981]. Concentrates of treated hospital 
wastewater appeared to be more toxic in studies by Cody et al., 
[1979], than concentrates of tap water samples, so this approach 
would appear to offer potential to many areas. Of course it is 
important to use the relevant controls for such tests, because salts 
and other molecules may also be concentrated, and these may also 
affect the growth of the cells.
In screening effluent samples throughout treatment processes, another 
factor of importance is time to when results are available. In such 
cases it is imperative that a result is obtained rapidly so that
effluent holding is kept to a minimum (as holding effluent may also
create odour problems additionally). In order to detect low levels 
of toxicity, small seeding densities of cells should be used due to 
masking effects at higher cell densities, thus an assay displaying
good sensitivity at low cell numbers should be used. Continuous
exposure assays would give greatest demonstration of effect over
6.28 Problems with using cell cultures in screening of
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short periods, thus a 24 - 48 hour continuous exposure is suggested 
for use for this application (it may not be suitable to hold effluent 
for longer periods).
6.29 Screening of new drugs
Screening of new drugs is generally carried out to demonstrate low 
toxicity of a chemical for potential therapeutic use. While this is 
in progress though, cytotoxic agents may be identified which may then 
be considered for use as antineoplastic agents. The merits of using 
in vitro methods for toxicity testing of new agents have been well 
recognized (Goldberg and Frazer, 1989] and have been discussed more 
thoroughly in the introduction. The number of antineoplastic agents 
in routine therapeutic use is indeed quite small, and significant 
moves are being made in the discovery of new agents. Strategies for 
preclinical discovery and development of such agents, have, in the 
last 30 years, been based largely on testing of agents in mice 
bearing transplantable leukemias and solid tumours derived from a 
limited number of murine and human sources [Alley et al. , 1988], This 
screening system however, has been largely unsuccessful in the 
discovery of new agents with activity against human solid tumours 
[Marsoni and Wittes, 1984].
With the development of the concept of tumour cell heterogeneity 
[Fidler and Kripke, 1977; Heppner, 1984], the realization came that 
more than one patient's tumour of a particular histological type of 
solid tumour should be represented in a tumour screen [Von hoff et 
al., 1985]. To address this problem the NCI sponsored a program using 
a human tumour cloning system as a screen for new neoplasties 
[Shoemaker et al., 1985]. There are many theoretical reasons why
cloning techniques are the most biologically attractive method for 
screening. Prime amongst these is that stem cells in tumours 
represent those cells capable of sustained replication and are thus 
the critical cells in the tumour [Steele, 1977]. In addition, it has 
been said that accurate assessment of cell survival requires the use 
of a clonogenic assay [Hill and Dendy, 1983]; other growth assays may 
only measure cytostatic effects rather than cytotoxic effects.
332
However, the stem cells in the tumour may not equate with the colony- 
forming cells in a clonogenic assay - in placing cells in a totally 
foreign and artificial environment (e.g., extremely low densities, no 
cell-cell interaction, totally different nutrient and oxygen levels 
to that found in the tumour), this in itself can lead to a distortion
of cell behaviour [Susumu and Ottenbreit, 1978], More importantly,
it may be that the stem cells are not the only critical cells in the 
tumour; they may be the ones most sensitive to the drug, and it may 
be that other cells remain to form resistant sub-populations. It has
been shown that 90% of clonogenic cells can be killed by CCNU without
causing a significant delay in tumour growth [Stephens and Peacock,
1977]. There are also many technical problems associated with 
clonogenic assays, e.g., low plating efficiency [Hill and Wheelan, 
1983], unsuitability of some tumour types to colony formation [Von 
Hoff et al., 1981; Selby et al., 1983], clumping, and
difficulties with distinguishing clumps from colonies at assay time 
[Agrez et al., 1982], but of most practical importance is the length 
of time taken from assay beginning to end [14 -21 days] and the 
extreme labour intensiveness involved in reading the plates (manual 
counting).
The feasibility of implementing an alternative approach has been
investigated by the National Cancer Institute, U.S.A. This new
approach uses combined in vitro/in vivo screening for selective 
cytotoxicity among panels of human tumour cell lines derived from a 
broad spectrum of human solid tumours, and simpler, quicker
endpoints for assessment of drug efficacy [Alley et al., 1988].
The goal of the program is to evaluate experimental agents against 
groups of cell line panels, each representing a major clinical 
category of human malignancy. Each panel (e.g., lung, colon, 
melanoma, renal, ovarian, and central nervous system) contains 
multiple, representative human tumor cell lines. Agents showing 
differential or selective patterns of jjn vitro growth inhibition are 
evaluated subsequently in athymic mice bearing the same human tumour 
cell lines found sensitive iri vitro. Simultaneous testing of new 
drugs in both tumour and normal tissues has also been suggested 
[Gosalvez et al., 1976] as a consideration to detect agents with 
selective toxicity against tumour cells.
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In the work presented here it has been shown that some simple in vitro 
systems have been capable of demonstrating the efficacy of Navelbine, 
a novel vinca alkaloid. The toxicity of this compound was compared to 
Vinblastine, but contrary to expectations, it was not as toxic as 
Vinblastine itself. Navelbine may be an important agent because of 
its potential high toxicity, a possible absence of cross-resistance 
to Vincristine [Maral et al., 1984] and its relatively low toxicity
in cancer patients. In this study however, it did not show enhanced 
toxicity to non small cell lung carcinoma cell lines, as might have 
been expected. This was felt to be a direct attribute of the drug 
itself, and not a defect in the system used for toxicity screening, 
as a differential toxicity effect among cell lines was seen both with 
Vinblastine and Navelbine, especially with SK-LU-1, which was 
considerably more resistant to both agents than were the other cell 
lines (SCC-9 was more sensitive). The pharmacokinetics of Navelbine 
have not yet been fully elucidated though, and it is possible that
the active metabolite(s) may show the specificity for non small cell
lung carcinomas expected. Unfortunately our collaborators working on 
this aspect of the drug [Rhamani et al., 1987] could not supply such
metabolites at the time of this study.
The rationale for using cell lines in screening for new drugs has been 
extensively considered [Boyd, 1986]. Use of fresh human tumour cells 
for primary drug screening is theoretically more acceptable, but the 
technical problems involved in this are extensive (see section 5), so 
use of a wide variety of human tumour cell lines representing many 
different forms of human cancer offer an attractive alternative [Boyd,
1989] .
The fact that the small number of carefully chosen cell lines in this
study has demonstrated differential drug efficacy to different cell
types is encouraging, and it emphasises the importance of including a 
wide range of cell types from different tissues, as is the current NCI 
strategy (at least 60 human tumour cell lines are now being used). The 
miniaturized assays used in this work were also found not only to be 
capable of detecting the differential sensitivities mentioned above, 
but offered all the advantages associated with such endpoints, alluded 
to previously, which are of particular importance in the screening of 
new drugs because of the scale of such projects (the NCI screen
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300-400 chemicals per week!, [Kerkvliet, 1990]). The different 
endpoints have given results that are not absolutely the same, (and 
reasons for this have been discussed already) but the trend was always 
the same, so any one assay allows the main findings to be seen.
Overall, these assays have clearly shown the cytotoxicity of Navelbine 
to a range of human tumour cell lines, and thus demonstrate the 
effectiveness of these endpoints in preclinical screening for new 
antitumour agents.
6.30 Rapid assessment of Multiple Drug Resistance
Multiple Drug Resistance (MDR) is a phenomenon by which cells 
spontaneously develop resistance to a range of structurally unrelated 
drugs. It is thought to be associated with altered membrane 
permeability, resulting in a decreased drug uptake and/or efflux of 
drug [Inba and Johnson, 1977; Kessel and Wheeler, 1984]. This 
emergence of resistance is the major cause of death in small cell lung 
cancer, breast cancer, ovarian cancer, acute leukemia, and others 
[Kaye, 1988]. It is of importance in the treatment of human cancers, 
as those initially responding to chemotherapy may suddenly, and for 
no apparent reason, acquire resistance, not only to the drug used for 
treatment, but to a host of other drugs which are then rendered 
useless in the management of the patient. Some cancers (colon
carcinoma, for example) are inherently resistant to several agents. 
While a wide range of chemotherapeutic agents are rendered inactive by 
occurence of this phenomenon, not all are. Resistance to
Anthracycline Antibiotics, Vinca Alkaloids, Epipodophyllotoxins and 
Actinomycin D occurs, but this does not happen with Alkylating 
Agents. This means that if a patient's tumour could be demonstrated 
as MDR positive or negative, the treatment regime could then be
designed around alternative drugs, which would not normally be 
chosen, but which would not be affected by MDR.
Extensive work is taking place in this whole area. To design
experimental protocols for rapid, routine demonstration of MDR in
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tumors, a complete understanding of the mechanisms involved must be 
acquired. In the study of these mechanisms, experimental
establishment of MDR lines from sensitive lines, is a valuable tool.
The lines are grown in medium containing low levels of one of the 
agents known to be involved in MDR (most often the Anthracycline 
Antibiotic, Adriamycin (Doxorubicin)). Gradually subpopulations of
cells adapt to growing in this level of drug, and when this happens, 
the drug concentration is increased. Thus the resistant cells are 
constantly selected for, and gradually a population of cells will
result which is many orders of magnitude more resistant to the drug,
than the original (parent) cell line. The cell line may then be 
demonstrated to be cross-resistant to other drugs which it may never 
have been in contact with before.
Studies on variant cell lines, in comparison with the parent lines, 
can then demonstrate any differences, which will be valuable in
understanding the mechanisms involved and in identifying markers which 
will aid in the diagnosis of MDR tumours.
In this whole area, initial ability to demonstrate MDR will rely on
toxicity testing of selected agents. Regular monitoring too, of
variant cell lines will be an essential procedure, for which use of a 
rapid, sensitive toxicity assay will be essential. Circumvention of 
MDR can be carried out by using various compounds including calcium 
channel blockers, e.g., Verapamil and calmodulin antagonists [Tsuru 
et al. , 1982; Kessel and Wilberding, 1985]. The ability to screen for 
such efficacious compounds, and for their performance in complex 
combined therapy regimes will also be largely dependent on the
availability of such an assay. Endpoints such as cell counting or 
scoring will be prohibitive to such a goal, whereas miniaturization 
would bring certain advantages to the system.
The work presented here shows that the APNaOH assay, as with the other 
colorimetric assays, was a convenient and rapid screen for detecting 
vastly enhanced resistance in cells expressing the MDR phenotype, over 
the parent cell line. They also detected the cross resistance of 
variant cell lines to other agents involved in MDR (Vinblastine), and 
the continued susceptibility to 5-Fluorouracil and Cis-Platinum.
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However, the endpoints were less well able to discriminate the 
difference in Adriamycin and Vinblastine sensitivity between the two 
variant cell lines. This was particularly a problem with MTT and AP2h 
assays, and is felt to relate to low sensitivity, as the problem was 
not as evident when the APNaOH assay was used. While Eliason et al., 
[1990] used MTT to demonstrate resistance modification of Verapamil 
and Quinidine in Vincristine resistance, the MDR line used was not 
tested at different levels of resistance, and so this difficulty was 
not encountered. Problems relating to SRB inability to detect this 
difference in resistance, may relate to technical problems in this 
experiment rather than theoretical problems, as OD values were 
exceptionally low, and this was felt to be due to storing plates after 
fixing, and before staining, or to incomplete fixing of cells.
In cell culture assays of this type it is important to carry out the 
determination while control cells are subconfluent (see section 3.14). 
Depending on the cell type, growth characteristics and cell size, the 
cell number corresponding to 90% confluency will vary. In 96 well 
dishes though, the number will be quite small. Toxicity assays aim 
to result in a range of cell kill from 0% up to 1 0 0 %, so many wells
will have very few cells present. We have already established the
sensitivity of the endpoints described here, and in general, for the 
cell lines examined here, there should be no significant problem with 
loss of linearity at the cell densities which would be reached in such
a toxicity assay. There may be however, significant problems with
sensitivity in detecting the low cell numbers which would be evident 
after 50% cell kill. Take the MTT assay for instance. In a toxicity 
assay using RPMI-2650, 10,000 cells seeded on day 0, has resulted in
90% confluency in control wells 7 days later. These wells will have 
doubled approximately 4 times during this period, so there will be in 
the region of 80,000 cells/ well present in control plates. The MTT 
assay in this work has not been sensitive to fewer than 23,000 cells/ 
well; so at drug concentrations giving 30% kill, the assay will be 
insensitive, and will be of low sensitivity for drug concentrations 
giving 50% kill. Thus in expressing ^cso values using the MTT assay 
(and AP2h. obviously) these assays may not give an accurate account of 
cell survival. This problem may or may not be apparent with the NR 
assay, and should not be a problem with CVDE, APNaOH and SRB methods.
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Another factor for concern is the variation associated with these 
results. While the AP assay is relatively precise, variations 
incurred with the other assays were substantially greater (see Figures 
4.5.1 - 4.5.6). The combination of low precision and low sensitivity 
together may make a significant impact on the final results from a 
chemosensitivity assay, particularly in relation to the MTT assay, 
and this may explain, partially at least, why the MTT was unable to 
detect the increased drug resistance of DLKP2 over DLKP1.
An interesting observation from these results and other 
chemosensitivity work carried out during this research programme was 
an increase in growth noted with small concentrations of anticancer 
agents, followed by cell kill at higher concentrations. While this 
finding has not often been particularly significant when SEM values 
were considered, it has been noticed time and again, especially in 
the case of Adriamycin (see Figures 4.5.1 - 4.5.6). We can see that 
slight stimulation has occurred when the AP, SRB and CVDE endpoints 
were used after Adriamycin addition up to 50/jM, but this has not been 
evident when MTT and NR assays were used. Other reports in the 
literature have shown slight increases in DNA synthesis at subtoxic
doses of the drug, and Vichi and Tritton [1989] have clearly
demonstrated this effect in a number of cell lines at concentrations 
about one order of magnitude lower than those causing 
antiproliferative effects when growth medium in cultures at high 
density has been used up. The results obtained using the endpoints 
for protein detection and AP activity would agree with this report.
MTT and NR however, did not show this effect. The concentrations
used to observe the stimulatory effect in the work by Vichi and
Tritton were much lower than the concentrations giving the effect in 
the work presented here, so what is observed in these experiments is 
obviously the threshold where Adriamycin stops being stimulatory and 
begins to exert its toxicity.
The discrepancy seen by the two assays may corroborate the points 
discussed in relation to the ability of the endpoints to exhibit 
differential sensitivity to agents of differing mechanism of action; - 
it may be that mitochondrial and lysosomal - function damage have 
occured at these Adriamycin concentrations whereas the cellular 
functions measured by the other endpoints haven't yet been impaired, 
or it may simply be that the discrepancy is due to assay insensitivity
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(a 10% increase in growth is not detected as well in MTT assay as in 
other assays). Perhaps again it is a combination of both, for 
Mimnaugh et al., [1985] have shown Adriamycin-induced mitochondrial
lipid peroxidation at lower levels than were needed for other lipid 
peroxidation (50 - 100/jM) , or other harmful cellular events.
Overall, any one of the methods was acceptable for detecting gross 
differences in resistance/ sensitivity to chemotherapeutic drugs, but 
MTT and AP2h assays were not able to determine small differences in 
resistance (1/jg/ml - 2/jg/ml). On this point, it is felt that it is 
inappropriate to describe results from resistance experiments as 
giving '2 - fold' resistance or '2 0 - fold' difference for example, 
without giving the increase in terms of drug concentration, as this 
depends very much on the method used to detect this difference in 
sensitivity. An increased resistance from 0.01 to 0.1/^g/ml is a 
tenfold difference in resistance, but so is an increase of 1 0 0 to 
1 , 0 0 0  fjg/ml; but the ability to detect these differences may not be 
equal for a particular endpoint.
The APNaOH assay has been the most useful of the endpoints here, as it 
has detected the difference in drug resistance between DLKP1 and 
DLKP2, has had better precision than any of the other assays, and as 
has been pointed out previously, was easier to perform.
6.31 Usefulness of miniaturized assays for chemosensitivity
testing
Certainly miniaturized, semiautomated, colorimetric assays (MSCA) 
seem to offer numerous advantages over other methods for
chemosensitivity testing used in the past, particularly in comparison 
with the human tumour stem cell assay (HTSCA). These include the 
following:
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(1) Improved plating efficiency:
The biggest problem with the HTCSA is low plating efficiencies for 
most tumour types, resulting in low numbers of evaluable samples 
despite attempts to improve this [Hill and Wheelan, 1983]. In 
monolayer assays, including MSCA, plating efficiencies are obviously 
improved.
(2) Less problems with clumping:
Unlike other assays including MSCA, the HTCSA requires that single 
cell suspensions are plated but in practice this is difficult to 
achieve without sacrificing cell viability. Agarez et al. , [1982]
identified an important source of error in clonogenic assays to be 
counting of existing aggregates of cells which had enlarged during the 
course of the experiment, as true colonies. Re-aggregation of isolated 
cells under assay conditions was also considered to be a problem, as 
were artifacts such as cell volume changes [Rockwell, 1984].
(3) Simpler assay outcome evaluation:
Manual counting of colonies in the HTCSA was more than tedious despite 
attempts to automate this by computerized image analysis and staining 
clumps by incubation with MTT [Alley and Lieber, 1984], which still 
presented problems. MSCA are also simpler to set up and perform than 
many of the other available endpoints already discussed.
(4) Less hazardous:
MSCA do not involve the use of radioisotopes and are thus obviously 
less hazardous than the metabolic assays already described which 
involve radioisotope use.
(5) Quicker to perform:
Using the assays described in this thesis, a chemosensitivity profile 
may be obtained relatively shortly (approximately 4 days) after 
testing. This is obviously much faster to perform than the HTCSA
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(which takes 2 - 3  weeks) and of equal duration to many of the other 
assays discussed (shorter drug exposure periods may result in 
inaccurate determination of cell viability [see Weisenthal, 1983]).
(6 ) Fewer numbers of cells needed:
Because the assays are miniaturized, fewer cells are needed, so 
greater numbers of replicates, drugs and drug concentrations may be 
tested than may be tested with most of the assays already considered. 
Although Capillary Tumour Systems were developed [Von Hoff et al., 
1983, 1990] which improved tumour growth and resulted in fewer cells
being needed, the miniaturized assays considered here still represent 
an improvement over this.
These and other related technical problems are reviewed by Arbuck et 
al . , [1985] and Shoemaker et al., [1985].
The question as to the relevance of clonogenic as opposed to 
non-clonogenic assays remains unclear though. The presence in the 
tumour, of distinctly different subpopulations of different cell 
lineage has by now been generally accepted, and to say that the 
clonogenic cells are the most relevant tumour cells to assess for
chemosensitivity is highly questionable [Weisenthal 1984, 1985], In 
vivo tumours are a mixture of dividing and temporal/ non-dividing ( G q  
cells) [Steel, 1977]. It has often been speculated that it is the 
failure to affect Gq cells which is partly responsible for
ineffectiveness of chemotherapy in human neoplasms [Drewinko et al., 
1981] therefore the relevance of testing the total cell population 
(including Gq cells) and not only the clonogenic cells, is seen. Even 
in this respect, it is still presumptous to think that the clonogenic 
cells truely represent stem cells at all [Suda and Ogawa 1983]. A 
further rebuke to the clonogenic assay system is the requirement for 
using single cells, which result in loss of normal cell-cell 
interactions [Miller et al., 1981] and while such interactions
occuring in non-clonogenic assays are unlikely to mimic those in vivo 
accurately, they are more likely to represent the in vivo situation 
more closely. The emerging picture is that clonogenic assays seem to 
be of less relevance than originally suspected, and the use of non 
clonogenic assays such as MSCA described here may be more relevant.
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A significant problem related to the use of non-clonogenic assays 
however is the contribution which normal cells present in the tumour 
will make to the overall response. Continuing developments in 
generating media specific for each tumour type may alleviate this 
problem, but cell characterization techniques will be needed to 
confirm the identity of the tumour cell population. Dietel (1989, 
personal communication) has considered that the presence of 2 0 % 
fibroblasts in monolayer chemosensitivity assays does not 
significantly affect test outcomes, but minimization of normal cell 
growth is theoretically essential to the success of the experiment.
The findings of this thesis would seem to indicate that sensitivity to 
cell number may be a problem when MSCA are used in toxicity testing. 
While this is more serious for some endpoints more than others, any 
attempt to increase sensitivity in these endpoints should be 
encouraged. My feeling is that the MTT assay should be replaced with 
other similar assays of higher sensitivity, such as the APNaOH, SRB 
or NR assays (after suitable validation with previously used assays 
such as HTCSA and Thymidine incorporation assays) which involve fewer 
technical difficulties. Development of fluorometric assays with 
increased sensitivity still, would also be seen as advantageous. It 
would then be appropriate to use other methods of expression of 
results, such as area under the curve (AUC), which tells more about 
the total response than simply IC^q values - it is felt that the low 
sensitivity of some of the assays at low cell number (high cell kill) 
may not give an accurate indication of the lower part of the dose 
response graph, and thus may not reliably contribute to this figure at 
present. Obviously the relationship of cell viability could be 
further established under different circumstances, however it seems 
from this work that the AP assay is no worse than the MTT assay in 
this respect, and the NR is possibly an improvement on these. 
Certainly all are no worse than trypan blue dye exclusion assays, so 
this type of assay, because of its technical cumberence would seem to 
offer no real advantages over MSCA.
Other aspects of chemosensitivity testing systems as they stand which 
require improvement are the drug exposure regimes in use. It would 
seem that a single continuous dose is not sufficiently similar to the 
in vivo system as to be appropriate. Calculation of drug 
concentrations to give exposure to cells similar to the peak plasma
342
levels in the patient, is obviously more relevant and should perhaps 
be implemented on a wide scale. Some workers [Darling and Thomas,
1983] have expressed the viewpoint that 'recovery' assays - where drug 
is removed after a certain amount of cell kill has occured, and
remaining cells (which will be of extreme relevance in the patient) 
are monitored for recovery ability - may be much more appropriate than 
those which simply measure cytotoxicity after a single exposure. Such 
assays are more likely to distinguish between cytotoxicity and 
cytostaticity (not distinguishable by many endpoints) as the
distinction is certainly of relevance in vivo for cells which will 
remain and repopulate the tumour.
In monolayer assays, another possible area for artefacts is viable 
cell loss during washing procedures - especially for loosely adherent 
cells. This would therefore favour the use of endpoints with fewer
washing steps and manipulation steps (in this regard the AP assay is
preferred to the NR and SRB assays).
Of course the overriding factor as to whether one specific in vitro 
sensitivity method is superior to another depends on which provides 
the best degree of clinical correlation [Elson et al., 1982], however
the number of relevant clinical trials carried out have been small. 
The need for trials utilizing MSCA is hereby established.
6.32 Relevance of chemosensitivity testing
General opinion seems to be that individualized chemosensitivity 
testing can improve the success rate of therapy as opposed to 
emperical regimes. It is apparent from the literature that once one 
chemotherapeutic treatment has failed, the chances of another 
treatment being successful are extremely low [Mattern and Volm, 1982]. 
There is therefore a clear need for a system that would at least 
indicate treatments that are doomed to failure [Double, 1975]. In two 
prospective clinical trials, Von Hoff et al., [1990] using a capillary
cloning system and Gazdar et al., [1990] using the Weisenthal dye
exclusion assay reported superior clinical responses with chemotherapy 
regimens based on in vitro drug sensitivity testing compared with 
those based on clinical experience (21% versus 3% response rate in Von 
Hoff study; 25% versus 7% in Gazdar study for in vitro versus
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clinician respectively). While the results did not appear to be 
statistically significant (due to low numbers both of evaluable 
tumours and of patients for which results could be compared) they 
clearly indicated that in vitro drug sensitivity testing does offer
promise in this area. Two areas which prevent in vitro 
chemosensitivity testing from improving patient prognosis are the lack 
of ineffective drugs and drug regimes with differing mechanisms of 
action to combat multiple drug resistance, and poor tumour growth in 
vitro. These still remain to prevent tangible improvements in patient 
prognosis accrueing from drug sensitivity testing. In vitro tests, 
particularly those considered to be particularly useful from the work 
in this thesis, can positively affect the search for new anticancer 
agents because of the increased speed these systems offer (so that the 
rate at which the huge backlog of new agents for testing can be 
screened is improved). Significant improvements in in vitro tumour 
cell growth is however needed before the predictive drug testing will 
make a difference to many patients - any attempts in this area will be 
beneficial to eventual improvement in prognosis for patients receiving 
chemotherapy (and radiotherapy).
6.33 Primary culture of Bronchial Tumours
Each year in Ireland, more than 1,500 patients die from lung cancer, 
thus it represents around 25% of deaths from cancer in this country.
The World Health Organisation [1981] has recognized four main
histological types of lung cancer, with differing patterns of 
clinical and biological behaviour and various prognostic and 
therapeutic implications. These distinctions are as follows: Small
Cell Carcinomas, Squamous Cell Carcinomas, Adenocarcinomas and Large 
Cell Carcinomas. Since the former are relatively responsive to 
therapy [Duchesne et al . , 1987], these tumours are less likely to
be presented for surgery. The object of the work described here was 
to identify factors important in establishing a primary lung 
cultures, (worthy of further investigation) thus it did not lend 
itself to follow-up experiments due to inadequacy of tissue samples 
and lack of time available for this work. By its nature, primary 
culture is a time consuming, and often poorly rewarding area in 
terms of generatable data, nevertheless it is an extremely important 
area of study in order to further understand the biology of the
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cancer cell. Difficulties in establishment of cell lines from lung 
tumour tissue are universal - Duchesne et al., [1987] for example,
reported no success at culturing primary non-small-cell tumours in 
vitro from 41 tissue specimens, while 10 such cell lines were 
established from xenografts. No cell lines were generated from the 
work described in this thesis, nevertheless some important 
observations were made, and these are discussed in the following 
pages.
In a primary culture programme, it is essential to have complete 
co-operation and enthusiasm from the participating surgeon, who is 
familiar with the aims of the study, and who will only supply tissue 
which is relevant to the programme. For the most-part of this 
programme, collection of samples necessitated attending the 
operation and receiving the sample at the precise moment of tissue 
excision. This ensured that the microbiological status of the sample 
could be directly controlled, which was essential for subsequent work 
and ensured that a sample was collected. While this meant that a 
great amount of time was spent waiting for samples, it was generally 
accepted that this was a necessary and worthwhile procedure.
Limited success was attained after attempting to culture 84 thoracic 
samples, mostly lung. Because lung tissue comprises more than 40 
different cell types, and includes large amounts of cartilage, 
elastic fibres, smooth muscle fibres, the presence of significant 
numbers of stromal cells was therefore expected. It is therefore
inherently more difficult to culture epithelial lung tumours than
other tumour types, for example brain.
At surgery, a portion of tissue was resected, and divided up 
leaving some for culturing and some for cytologic analysis in the 
hospital laboratory. Such a step is important to ensure that the
histology of the sample can be confirmed at a later date.
Mediastynoscopy and Bronchoscopy samples generally resulted from 
investigative surgery, to enable determination and characterization 
of malignant tissue by histological analysis.
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In Figures 5.11 (a) and (b), the remarkable importance of seeding 
density could be seen for a lung tumour primary culture. It was seen 
that in a 24 well dish, 10,000 - 100,000 cells (which would be
expected to produce excessive growth in a short time, for many of 
lung cell lines) did not result in significant cell growth after 7 
days. For the tumour sample shown, 250,000 cells seeded in a single 
well were necessary to significantly encourage cell growth. Using 
with epithelial primary cultures, Middleton [1976, 1977] demonstrated 
that pigmented retina epithelial cells lacking contacts with other 
cells, spread poorly on the substratum, but spreading was promoted 
when the isolated cells formed stable lateral contacts with other 
cells. This may help to explain the poor growth and spreading 
observed here with cells at low density.
It is also clear from work with normal and malignant cell lines that 
a certain cut-off seeding density is present, below which cells will 
refuse to grow, and above which they will grow successfully. This 
may be due to secretion of autocrine growth factors into the culture 
medium [Todaro and De Larco, 1978] which may be diluted to 
ineffective levels if not being produced in high enough levels. A 
further relationship between growth factors and cell density has been 
shown by Centrella [et al., 1987] with respect to the growth
stimulatory effect of Transforming Growth Factor type J3 (TGFJ3) on 
osteoblast cells. In confluent cells, DNA synthesis was progressively 
enhanced by treatment with 0.15 - 15ng/ml TGFB after 23 hours
treatment, whereas in subconfluent cells, 15ng/ml was less than 
maximal, and in sparse cell cultures, this concentration was 
inhibitory. Such a relationship, or similar conflicting 
relationships regarding cell densities, may exist with other growth 
factors present in serum, explaining why the effect of increasing 
cell seeding density does not simply result in a linear response of 
cell proliferation.
Density dependent growth observations have led to the use of feeder
layers of cells to stimulate monolayer primary cultures as well as
growth in agar [Me Manus and Clynes, 1984]. Differences in growth
factor production as well as numbers of growth factor receptors in
cells from different tumour tissue, will obviously mean that cut-off 
densities needed for establishment of a culture will vary with 
individual samples. However, repeated observations of density
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dependence during this work led to the belief that significant growth 
would generally not occur unless very high cell numbers (at least 7.5 
x 104 cells/ 24 well dish) were seeded. Generally it was found that 
mediastynal and bronchoscopy samples were too small to allow 
isolation of sufficient numbers of cells to establish the culture.
This observation led to setting up such samples in smaller dishes as
2opposed to 25cm flasks (30 mm dishes and 24- well cluster dishes), 
however growth was still modest. It is possible that 96 well dishes 
would improve their growth somewhat.
For one third of the samples processed however, there was no 
attachment to the substratum. This may have been due to requirements 
for basement membrane proteins such as fibrin, collagen and laminin 
which mediate the substrate binding and cytoplasmic spreading of
anchorage dependent cells, and have been found to be important in
promoting the attachment, growth and differentiation of diverse cell 
types in vitro [Gummer et al., 1990, Daneker et al. , 1989]. This
has led to commercial formulations of such products (which are very 
expensive). Attachment factors such as laminin have intrinsic 
mitogenic properties and thus also function as growth factors 
[product information on Biomatrix Products, Universal Biologicals 
Ltd., 1988]. Whilst lack of time prevented investigation of these 
points, they have been raised to explain why many of the tumour 
samples may have failed to attach initially - clearly this area needs 
more work when culturing lung tumour tissue. Obviously there is a 
great possibility that in some (if not many) of the samples in
question, the cells were dead (trypan blue exclusion counts would 
not be sufficient to demonstrate this, as cells which had only just 
died would be most likely to have intact membranes still).
In many of the cultures, fibroblast growth was favoured over 
epithelial growth. In one third of cultures, fibroblast growth
occured even though no epithelial cells grew. This may be due to the 
isolation procedures used, or to inadequacy of the culture medium 
which selectively encouraged fibroblast growth. In almost all cases 
when epithelial cell growth did occur, fibroblast cells (even if 
present in very low numbers) eventually overgrew the cultures. It is 
possible that the fibroblasts are being activated or stimulated to 
grow when cultured in vitro with epithelial cells. Shkrapp [1990]
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reported the in vitro growth stimulation of neoplastic lung 
epithelial cells by lung fibroblast-conditioned medium, however it 
may also be possible that they produce an inhibitor for epithelial 
growth. It is also possible that the epithelial cells present 
produce paracrine factors which stimulate the growth of fibroblast 
cell types.
Fibroblasts are relatively easy cells to culture in vitro, as the 
lower plating densities needed have demonstrated (Figure S.ll.c) - 
thus it seems that the nutritional balance of the culture medium 
being used is suitable for these cells, but is lacking where 
epithelial cells are concerned. Investigation into the effect of some 
different basal media on the growth of these two cell types did show 
significant differences in the extent of epithelial cell growth. 
Additionally some differential growth between the two cell types was 
observed. This work was only preliminary but pointed to the need to 
investigate this factor more fully. A combination of Hams F12 and 
MEM (50%) followed then by Hams F12 alone encouraged greater 
epithelial cell growth than fibroblast growth. RPMI-1640 however 
preferentially encouraged fibroblast growth.
In 3.7% of samples significant cell growth did occur, however cell 
growth did not continue long enough for cell lines to be established. 
In some cases again, fibroblast growth overtook that of the 
epithelial culture, however in some cases the culture simply stopped 
proliferating. Cells became darker and more granular and began to 
differentiate. While controversy still exists around the 
relationship between differentiation and proliferation, it has been 
suggested that these are two independent parameters which may have 
unrelated prognostic significance [Dische et al. , 1989].
Nevertheless the inverse association between the two has been often 
observed [Foulds, 1969] (and thus has led to the use of grading 
techniques for determining prognosis [Kemp and Hendrickson, 1982]) - 
cell division usually stops when signs of specialized structures or 
functions become apparent in cells that have been dividing at less 
than the maximum rate [Berril, 1963]. It is not yet fully known what 
makes cells which are growing in culture begin to differentiate. 
Serum has been shown to cause terminal squamous differentiation of 
normal human bronchial epithelial cells, the primary factor involved
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(for normal human bronchial epithelial cells) being reported by Masui 
et al., [1986] to be TGF3. High concentrations of extracellular
calcium and vitamin has also been shown to be important in
induction of differentiation of squamous cells [Lechner et al . , 1983,
1984], so the use of low calcium media is important. Miyashita et 
al. , [1989] have suggested that while an increase in ionized
cytosolic calcium is associated with serum-induced squamous 
differentiation, serum factors in addition to TGFB mediate such 
changes. Thus the importance of the culture medium, including serum 
,is obvious; not only in affecting growth rate but in regulating 
differentiation - it is thought to be the most crucial variable in 
vitro irrespective of the tissue culture system used [Hodges, 1976]. 
Barnes et al., [1980, 1984] postulated that each differentiated cell 
type has its own unique growth factor requirements, and that 
differentiated tumour cells have nutritional requirements similar to 
those of their normal counterparts, and Gazdar and Oie [1986] has 
found the former postulation to be true for the major forms of lung 
cancer. These workers recognize that the growth requirements for 
squamous cell carcinoma are complex and not fully defined, and part 
of the problem lies in a failure to identify all of the complex 
requirements for permitting replication of squamous cells while 
avoiding terminal differentiation.
The extreme importance of serum on primary lung growth was 
demonstrated in this work for a number of tumour samples. Not only 
does the concentration of serum drastically effect cell growth (10% 
serum was needed for substantial growth) but the influence of 
different batches was unquestionably shown. Thus the need for
screening serum batches on a number of primary samples was seen. The
recurrent poor performance of NuFCS was noted in 3 separate samples 
when compared to some FCS batches (Figures 5.13 (a) and (b), 5.13.4), 
but the differing effect of 15FCS compared to 10FFCS is seen in the 
two different samples in Figures 5.13 (a) and 3.13 (b). The
possibility of using an 'indicator' cell line to screen for good and
bad serum batches of relevance was considered, and in screening 5 
lung cell lines over an entire range of serum batches (see section 
4.1), the similar response of Calu 3 (a very slow growing 
adenocarcinoma) to the primary culture tested in Figure 5.13.4 was 
observed. If a significant relationship could be shown to exist, in
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terms of serum preferance for this cell line and a number of primary 
lung sampes, then serum screening with this cell line would help to 
eliminate bad batches for primary culture work. It may also 
highlight batches which would be specifically good for primary 
culture of similar tissues (note that the response of Calu-3 was 
significantly different to the other lung lines - and the batches 
offering better growth differed - thus choice of a 'good' serum batch 
for cell line growth may not be effective for primary culture.
Supplementation of batch 25FCS serum with added growth factors did 
not result in increased growth, however the addition of 
hydrocortisone to 10% serum (Figure 5.14) did result in significant 
stimulation over growth as seen alone. It is therefore clear that 
the relatiohships involved in growth factor stimulation are highly 
complex. Either T.I.E.S are inhibitory in combination or these 
growth factors are competing for binding sites with H. The 
importance of added growth factors was also found by Gazdar and Oie
[1986], who reported that in addition to Insulin, Transferrin and a 
steroid hormone, serum, cholera toxin, low Ca++ and feeder layers 
were required for lung squamous cell culture growth.
Relatively few cell lines have been established from the primary 
carcinomas of many organs, and many of the cell lines which are 
established are from metastases [Leibovitz, 1986], thus it would 
appear that with the present culture conditions only some tissue 
samples are capable of forming cell lines. Additionally the 
heterogeneity of tumours, which has been well established 
[Holozinger et al., 1980] suggests that not all cells in the tumour 
are capable of continually renewing themselves, and it may only be a 
certain subpopulation of cells (the clonogenic cells, which may 
equate with the stem cells i_n vivo) which may be capable of forming a 
cell line. For chemosensitivity testing, establishment of cell lines 
is not important, but obtaining adequate cells for testing is. In 
such work it is imperative that the cell types present in the culture 
can be identified so that chemosensitivity testing of the tumour 
cells only can occur. Immunocytochemistry techniques may be used to 
distinguish different cell types, however distinguishing between 
normal and malignant epithelial cells is more difficult. Cytological 
indications, similar to those used in histological techniques for 
identifying malignant cells, such as increased numbers of nucleoli
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and increased incidence of abnormal mitoses may be used [Gilvarry et 
al. , 1989]. Flow cytometry technology with sorting facilities can
create invaluable opportunities in this area if such is available to 
the investigator for use.
6.34 Success of various processing methods
Culture media enriched with cell clumplets from mechanical 
disaggregation was found to generate the greatest numbers of samples 
with epithelial cell growth. In comparative work where tissue pieces 
were disaggregated by mechanical and enzymatic methods, more 
fibroblast growth was present in the enzymatically treated culture.
This too was noted by Leibovitz [1986] and Dietel et al., [1987].
Blood and lymph cell contamination was thought to be a significant 
problem in many of the cultures, as these cells settled on the 
substratum and prevented cell attachment. Cells which did attach 
appeared granular and did not proliferate, compared to counterpart 
cultures with fewer blood cells present. This may have been due to 
physical factors such as settling, or due to toxins or growth 
inhibitors released by blood and lymphatic cells. Impairment of 
macrophage function can be achieved by addition of tumour conditioned 
medium (CM) [Otu et al., 1977], however there are several reports
that tumours can stimulate macrophages [Meltzer et al., 1977,
Mantovani, 1978]. Cocultivation of tumour cells and macrophages 
therefore, may stimulate the latter cell type [Kaplan and Seljelid,
1977]. Thus the importance of cell separation techniques was 
considered to be extremely important, and significant efforts in this 
area would be worthwhile. The presence of dead and dying cells is 
also inhibitory to viable cell growth, due to the release of 
lysosomal enzymes (this led to the development of detoxification
media for sample transport and growth [Leibovitz, 1975]).
Discontinuous density gradients have been found useful for separation 
of red blood cells, most hemopoietic cells, dead cells and debris 
[Leibovitz 1985], however this area needs further work. Techniques 
for separation of stromal cells would be most welcome. Utilization 
of differential substrate affinities for attachment have been used to 
address this method [Riddle, personal communication; see Steinberg, 
1970].
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6 .35 Fibroblast removal
In comparison of a number of modifications of differential 
trypsinization for removal of Fibroblasts, use of 0.04% EDTA and 
0.01% Trypsin at 2°C for 10 minutes showed most success, however 
this was determined to be of use only when epithelial cells were 
present in tightly growing colonies, and not as single cells or 
disperse colonies invaded by fibroblast growth. Toxicity of 
Geneticin to fibroblast cells was demonstrated in a time dependant, 
dose response manner. It was established that little cell kill 
occurred after a single day's exposure to the drug - at least 2 day 
exposure was recommended. In addition, concentrations greater than 
250pg/ ml did not elicit any further cell kill after 2 or more days 
exposure to Geneticin. The differential toxicity of this agent to a 
number of passage 3 fibroblast cultures was also seen, so this must 
be borne in mind. Generally though, use of 200/jg/ ml Geneticin for 2 
days in a number of mixed primary cultures (subsequent to this work) 
did not result in good success, so the problem remained to a large 
extent. It is thought that prevention of fibroblast growth by cell 
separation techniques during sample preparation, and use of low 
calcium medium would offer a better approach to control of fibroblast 
growth in these cultures.
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7. CONCLUSIONS
For each cell line shown there was a linear relationship between cell 
number and OD for each of the assays. This however should first be 
established for each cell line and for the endpoint to be used, as a 
linear relationship may not be assumed (this was not as clear with 
SCC-9 cells for example as with the other lines shown here).
The AP assay was found to offer the best combination of sensitivity, 
linearity, flexibility, ease of performance, reproducibility and 
precision, of all the assays.
The CVDE assay was easy to perform and combined moderate sensitivity 
with linearity. In some repeat experiments however it was much less 
reproducible than the AP, NR or MTT assays. If results are required 
immediately, then the time lag while plates are being dried after
rinsing is disadvantageous, but if plates are to be stored and read
later, this may be advantageous.
The NR assay was reasonably insensitive to low cell numbers (and was 
less precise (greater variation in replicate wells) than some of the 
other methods) but was more reproducible (as regards inter-assay 
variability) than the other assays and was least prone to variation in 
assay activity when cells in different phases of growth were tested.
While the SRB assay was almost as sensitive as the APNaoH method, it 
involved many more steps, and appeared to be less reproducible and 
precise.
The MTT assay, although simple and quick to perform was technically 
cumbersome because the formazan crystals are prone to easy
disturbance, resulting in lower precision than the other assays. It
was also relatively insensitive. The SDS modification of this assay 
which was particularly easy to perform, and overcame the technical 
difficulty of the MTT assay, was substantially less sensitive than the 
normal method, and thus was found to be of limited value.
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Differences in activity per cell were apparent for each of the assays 
described, when cells are grown under different conditions. It is 
therefore vital to construct standard curves of cell number versus OD 
for these assays under the precise conditions of the experiment, if 
absolute values of cell numbers are required.
In 6-day continuous exposure experiments, the assays described in this 
thesis were found to be equally relevant in assessment of toxicity for 
a range of chemicals with mechanisms of action related to their 
action. They were also found to correlate well with viability 
determined by clonogenicity after 4 or 5 days exposure to Vinblastine 
(at the specific concentrations described). Up to 2 days after drug 
exposure however, none of the miniaturized, colorimetric assays 
described, accurately assessed cell viability but overestimated it as 
did the Trypan Blue exclusion method.
Small variations in cell pretreatment regime and trypsinization 
duration directly before a toxicity experiment did not result in 
substantial differences in the outcome of the toxicity experiment. 
Cell seeding density, drug exposure regime and duration of assay
however, directly affected the subsequently determined IC5 Q>
Cell seeding density, basal medium, serum batch and added growth
factors all have substantial effect on establishment of a primary lung 
tumour culture.
The miniaturized, colorimetric assays described
successfully used as rapid indicators of serum batch
multiple drug resistance and efficacy of new drugs.
The assays described in this work have numerous potential applications 
in environmental toxicity testing, including those shown in this 
thesis.
here were 
activity,
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8.RECOMMENDATIONS
Further work on cell separation, attachment factors, optimization of 
basal medium and supplementation with growth factors is essential 
before the assays described here can be make an successful impact on 
chemosensitivity testing of lung tumour samples.
Problems of fibroblast overgrowth and cell differentiation are 
inhibitory to culture success, and need to be further addressed.
In using cell culture assays for environmental toxicity testing, 
substantial work on sample pretreatment and biotransformation is 
required.
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APPENDICES
APPENDIX A.
Calculations
(a) Sensitivity:
Calculate slope of linear portion of line
Y2 -  Y1 
X2 - XI
39 19.5
70 -  35
19.5
35
0.557
(b) IC50:
IC50 “ 0.7 ng/ml
(c) Toxicity, in Toxic Units (TU's) = 1000 / IC^q = 1,428.6
(d) SUM formula:
d
I n =i fo
V n(fl- I)
Ce) Coefficient of Variation: «* mean/ SEM
APPENDIX B
Molecular structures of compounds used in toxicity studies
HjNCONHOH •  IX
Hydroxyurea 2,4-Dinitrophenol
a
C IN  | |V  J * H,
C l'
.Pi-
|\
NH
a
C ii
2.7SA
Cis-Platium
R * CH3 
Vinblastine
L -Mcthylvalinc L-Mcthylvalinc
S arcos in t  
I
L -  Proline
D -  Volin«
\ I 
L-Threoninci
C = 0
5^,
c h 3
Sarcosint
L -  Prolin«I
D-Valin«
I
L-Thr«oninciC=0 
NH2
CH3
. 2 HOOCICHOHICOOH> I
'coacM,
Actinomycin D Navelbine
APPENDIX C 
Conversion of MTT to MTT formazan:
Tétrazolium salt
/ ~ \
APPENDIX D
Abbreviations
AP
A.T.C.C
B.O.D.
C.M.
C.O.D.
CVar
CVDE
D.C.S. 
D.H.S.
D.M.
DMEM
D.M.S.O.
E.C.
EC50
E.D.T.A.
F.C.S. 
F.D.A.
F.R.A.M.E.
G.A.A.
H.E.T. 
H.T.S.C.A. 
IA
ICc
ID
'50
50 
L. A.
MDR
MEM
MTT
MTT/SDS
N.E.A.A.
NR
NBCS
O.D.
O.E.C.D.
P.B.S.
r.p.m.
S.E.M
Acid Phosphatase
American Type Culture Collection 
Biological Oxygen Demand 
Collection Medium 
Chemical Oxygen Demand 
Coefficient of Variation 
Crystal Violet Dye Elution 
Donor Calf Serum 
Donor Horse Serum 
Dissection Medium 
Duelbeccos modification of MEM 
Dimethyl Sulphoxide 
European Community
Effective Concentration for 50% of population
Ethylene diamino tetra-acetic acid
Foetal Calf Serum
Food and Drugs Administration
Fund for the Replacement of Animals in experimental 
testing
Glacial Acetic Acid 
Hens Egg Test
Human Tumour Stem Cell Assay 
Image Analysis
Inhibitory Concentration to 50% of population
Inhibitory Dose to 50% of population
Local Authority
Multiple Drug Resistance
Minimal Essential Medium
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide
SDS modification of MTT assay 
Nonessential amino acids 
Neutral Red 
New Born Calf Serum 
Optical Density
Organisation for Economic Co-operation and Development 
Phosphate Buffered Saline 
Revolutions per minute 
Standard error of the mean
SDS Sodium Dodecyl Sulfate
SRB Sulforhodamine B
S.T.A. Short Term Assay
TU Toxic Unit
T.V. Trypsin Versene

